#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Heritability of brain activity related to response inhibition: a longitudinal genetic study in adolescent twins
#Text=The ability to inhibit prepotent but context- or goal-inappropriate responses is essential for adaptive self-regulation of behavior.
1-1	0-12	Heritability	_	
1-2	13-15	of	_	
1-3	16-21	brain	_	
1-4	22-30	activity	_	
1-5	31-38	related	_	
1-6	39-41	to	_	
1-7	42-50	response	_	
1-8	51-61	inhibition	_	
1-9	61-62	:	_	
1-10	63-64	a	_	
1-11	65-77	longitudinal	_	
1-12	78-85	genetic	_	
1-13	86-91	study	_	
1-14	92-94	in	_	
1-15	95-105	adolescent	_	
1-16	106-111	twins	_	
1-17	112-115	The	_	
1-18	116-123	ability	_	
1-19	124-126	to	_	
1-20	127-134	inhibit	_	
1-21	135-144	prepotent	_	
1-22	145-148	but	_	
1-23	149-156	context	_	
1-24	156-157	-	_	
1-25	158-160	or	_	
1-26	161-179	goal-inappropriate	_	
1-27	180-189	responses	_	
1-28	190-192	is	_	
1-29	193-202	essential	_	
1-30	203-206	for	_	
1-31	207-215	adaptive	_	
1-32	216-231	self-regulation	_	
1-33	232-234	of	_	
1-34	235-243	behavior	_	
1-35	243-244	.	_	

#Text=Deficits in response inhibition, a key component of impulsivity, have been implicated as a core dysfunction in a range of neuropsychiatric disorders such as ADHD and addictions.
2-1	245-253	Deficits	_	
2-2	254-256	in	_	
2-3	257-265	response	_	
2-4	266-276	inhibition	_	
2-5	276-277	,	_	
2-6	278-279	a	_	
2-7	280-283	key	_	
2-8	284-293	component	_	
2-9	294-296	of	_	
2-10	297-308	impulsivity	_	
2-11	308-309	,	_	
2-12	310-314	have	_	
2-13	315-319	been	_	
2-14	320-330	implicated	_	
2-15	331-333	as	_	
2-16	334-335	a	_	
2-17	336-340	core	_	
2-18	341-352	dysfunction	_	
2-19	353-355	in	_	
2-20	356-357	a	_	
2-21	358-363	range	_	
2-22	364-366	of	_	
2-23	367-383	neuropsychiatric	_	
2-24	384-393	disorders	_	
2-25	394-398	such	_	
2-26	399-401	as	_	
2-27	402-406	ADHD	http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder	
2-28	407-410	and	_	
2-29	411-421	addictions	_	
2-30	421-422	.	_	

#Text=Identification of genetically transmitted variation in the neural underpinnings of response inhibition can help to elucidate etiological pathways to these disorders and establish the links between genes, brain, and behavior.
3-1	423-437	Identification	_	
3-2	438-440	of	_	
3-3	441-452	genetically	_	
3-4	453-464	transmitted	_	
3-5	465-474	variation	_	
3-6	475-477	in	_	
3-7	478-481	the	_	
3-8	482-488	neural	_	
3-9	489-502	underpinnings	_	
3-10	503-505	of	_	
3-11	506-514	response	_	
3-12	515-525	inhibition	_	
3-13	526-529	can	_	
3-14	530-534	help	_	
3-15	535-537	to	_	
3-16	538-547	elucidate	_	
3-17	548-559	etiological	_	
3-18	560-568	pathways	_	
3-19	569-571	to	_	
3-20	572-577	these	_	
3-21	578-587	disorders	_	
3-22	588-591	and	_	
3-23	592-601	establish	_	
3-24	602-605	the	_	
3-25	606-611	links	_	
3-26	612-619	between	_	
3-27	620-625	genes	_	
3-28	625-626	,	_	
3-29	627-632	brain	_	
3-30	632-633	,	_	
3-31	634-637	and	_	
3-32	638-646	behavior	_	
3-33	646-647	.	_	

#Text=However, little is known about genetic influences on the neural mechanisms of response inhibition during adolescence, a developmental period characterized by weak self-regulation of behavior.
4-1	648-655	However	_	
4-2	655-656	,	_	
4-3	657-663	little	_	
4-4	664-666	is	_	
4-5	667-672	known	_	
4-6	673-678	about	_	
4-7	679-686	genetic	_	
4-8	687-697	influences	_	
4-9	698-700	on	_	
4-10	701-704	the	_	
4-11	705-711	neural	_	
4-12	712-722	mechanisms	_	
4-13	723-725	of	_	
4-14	726-734	response	_	
4-15	735-745	inhibition	_	
4-16	746-752	during	_	
4-17	753-764	adolescence	_	
4-18	764-765	,	_	
4-19	766-767	a	_	
4-20	768-781	developmental	_	
4-21	782-788	period	_	
4-22	789-802	characterized	_	
4-23	803-805	by	_	
4-24	806-810	weak	_	
4-25	811-826	self-regulation	_	
4-26	827-829	of	_	
4-27	830-838	behavior	_	
4-28	838-839	.	_	

#Text=Here we investigated heritability of ERPs elicited in a Go/No-Go task in a large sample of adolescent twins assessed longitudinally at ages 12, 14, and 16.
5-1	840-844	Here	_	
5-2	845-847	we	_	
5-3	848-860	investigated	_	
5-4	861-873	heritability	_	
5-5	874-876	of	_	
5-6	877-881	ERPs	_	
5-7	882-890	elicited	_	
5-8	891-893	in	_	
5-9	894-895	a	_	
5-10	896-898	Go	http://maven.renci.org/NeuroBridge/neurobridge#GoNoGoTask[1]	
5-11	898-899	/	http://maven.renci.org/NeuroBridge/neurobridge#GoNoGoTask[1]	
5-12	899-904	No-Go	http://maven.renci.org/NeuroBridge/neurobridge#GoNoGoTask[1]	
5-13	905-909	task	http://maven.renci.org/NeuroBridge/neurobridge#GoNoGoTask[1]	
5-14	910-912	in	_	
5-15	913-914	a	_	
5-16	915-920	large	_	
5-17	921-927	sample	_	
5-18	928-930	of	_	
5-19	931-941	adolescent	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
5-20	942-947	twins	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
5-21	948-956	assessed	_	
5-22	957-971	longitudinally	_	
5-23	972-974	at	_	
5-24	975-979	ages	_	
5-25	980-982	12	_	
5-26	982-983	,	_	
5-27	984-986	14	_	
5-28	986-987	,	_	
5-29	988-991	and	_	
5-30	992-994	16	_	
5-31	994-995	.	_	

#Text=Genetic analyses showed significant heritability of inhibition-related frontal N2 and P3 components at all three ages, with 50 to 60% of inter-individual variability being attributable to genetic factors.
6-1	996-1003	Genetic	_	
6-2	1004-1012	analyses	_	
6-3	1013-1019	showed	_	
6-4	1020-1031	significant	_	
6-5	1032-1044	heritability	_	
6-6	1045-1047	of	_	
6-7	1048-1066	inhibition-related	_	
6-8	1067-1074	frontal	_	
6-9	1075-1077	N2	_	
6-10	1078-1081	and	_	
6-11	1082-1084	P3	_	
6-12	1085-1095	components	_	
6-13	1096-1098	at	_	
6-14	1099-1102	all	_	
6-15	1103-1108	three	_	
6-16	1109-1113	ages	_	
6-17	1113-1114	,	_	
6-18	1115-1119	with	_	
6-19	1120-1122	50	_	
6-20	1123-1125	to	_	
6-21	1126-1129	60%	_	
6-22	1130-1132	of	_	
6-23	1133-1149	inter-individual	_	
6-24	1150-1161	variability	_	
6-25	1162-1167	being	_	
6-26	1168-1180	attributable	_	
6-27	1181-1183	to	_	
6-28	1184-1191	genetic	_	
6-29	1192-1199	factors	_	
6-30	1199-1200	.	_	

#Text=These genetic influences included both common genetic factors active at different ages and novel genetic influences emerging during development.
7-1	1201-1206	These	_	
7-2	1207-1214	genetic	_	
7-3	1215-1225	influences	_	
7-4	1226-1234	included	_	
7-5	1235-1239	both	_	
7-6	1240-1246	common	_	
7-7	1247-1254	genetic	_	
7-8	1255-1262	factors	_	
7-9	1263-1269	active	_	
7-10	1270-1272	at	_	
7-11	1273-1282	different	_	
7-12	1283-1287	ages	_	
7-13	1288-1291	and	_	
7-14	1292-1297	novel	_	
7-15	1298-1305	genetic	_	
7-16	1306-1316	influences	_	
7-17	1317-1325	emerging	_	
7-18	1326-1332	during	_	
7-19	1333-1344	development	_	
7-20	1344-1345	.	_	

#Text=Finally, individual differences in the rate of developmental changes from age 12 to age 16 were significantly influenced by genetic factors.
8-1	1346-1353	Finally	_	
8-2	1353-1354	,	_	
8-3	1355-1365	individual	_	
8-4	1366-1377	differences	_	
8-5	1378-1380	in	_	
8-6	1381-1384	the	_	
8-7	1385-1389	rate	_	
8-8	1390-1392	of	_	
8-9	1393-1406	developmental	_	
8-10	1407-1414	changes	_	
8-11	1415-1419	from	_	
8-12	1420-1423	age	_	
8-13	1424-1426	12	_	
8-14	1427-1429	to	_	
8-15	1430-1433	age	_	
8-16	1434-1436	16	_	
8-17	1437-1441	were	_	
8-18	1442-1455	significantly	_	
8-19	1456-1466	influenced	_	
8-20	1467-1469	by	_	
8-21	1470-1477	genetic	_	
8-22	1478-1485	factors	_	
8-23	1485-1486	.	_	

#Text=In conclusion, the present study provides the first evidence for genetic influences on neural correlates of response inhibition during adolescence and suggests that ERPs elicited in the Go/No-Go task can serve as intermediate neurophysiological phenotypes (endophenotypes) for the study of disinhibition and impulse control disorders.
#Text=1.
9-1	1487-1489	In	_	
9-2	1490-1500	conclusion	_	
9-3	1500-1501	,	_	
9-4	1502-1505	the	_	
9-5	1506-1513	present	_	
9-6	1514-1519	study	_	
9-7	1520-1528	provides	_	
9-8	1529-1532	the	_	
9-9	1533-1538	first	_	
9-10	1539-1547	evidence	_	
9-11	1548-1551	for	_	
9-12	1552-1559	genetic	_	
9-13	1560-1570	influences	_	
9-14	1571-1573	on	_	
9-15	1574-1580	neural	_	
9-16	1581-1591	correlates	_	
9-17	1592-1594	of	_	
9-18	1595-1603	response	_	
9-19	1604-1614	inhibition	_	
9-20	1615-1621	during	_	
9-21	1622-1633	adolescence	_	
9-22	1634-1637	and	_	
9-23	1638-1646	suggests	_	
9-24	1647-1651	that	_	
9-25	1652-1656	ERPs	_	
9-26	1657-1665	elicited	_	
9-27	1666-1668	in	_	
9-28	1669-1672	the	_	
9-29	1673-1675	Go	_	
9-30	1675-1676	/	_	
9-31	1676-1681	No-Go	_	
9-32	1682-1686	task	_	
9-33	1687-1690	can	_	
9-34	1691-1696	serve	_	
9-35	1697-1699	as	_	
9-36	1700-1712	intermediate	_	
9-37	1713-1731	neurophysiological	_	
9-38	1732-1742	phenotypes	_	
9-39	1743-1744	(	_	
9-40	1744-1758	endophenotypes	_	
9-41	1758-1759	)	_	
9-42	1760-1763	for	_	
9-43	1764-1767	the	_	
9-44	1768-1773	study	_	
9-45	1774-1776	of	_	
9-46	1777-1790	disinhibition	_	
9-47	1791-1794	and	_	
9-48	1795-1802	impulse	_	
9-49	1803-1810	control	_	
9-50	1811-1820	disorders	_	
9-51	1820-1821	.	_	
9-52	1822-1823	1	_	
9-53	1823-1824	.	_	

#Text=Introduction
#Text=1.1.
10-1	1825-1837	Introduction	_	
10-2	1838-1841	1.1	_	
10-3	1841-1842	.	_	

#Text=ERP correlates of response inhibition and their functional significance
#Text=Response inhibition (RI), or ability to voluntarily suppress a prepared but context- or goal-inappropriate action plays a critical role in the self-regulation of adaptive goal-directed behavior.
11-1	1843-1846	ERP	_	
11-2	1847-1857	correlates	_	
11-3	1858-1860	of	_	
11-4	1861-1869	response	_	
11-5	1870-1880	inhibition	_	
11-6	1881-1884	and	_	
11-7	1885-1890	their	_	
11-8	1891-1901	functional	_	
11-9	1902-1914	significance	_	
11-10	1915-1923	Response	_	
11-11	1924-1934	inhibition	_	
11-12	1935-1936	(	_	
11-13	1936-1938	RI	_	
11-14	1938-1939	)	_	
11-15	1939-1940	,	_	
11-16	1941-1943	or	_	
11-17	1944-1951	ability	_	
11-18	1952-1954	to	_	
11-19	1955-1966	voluntarily	_	
11-20	1967-1975	suppress	_	
11-21	1976-1977	a	_	
11-22	1978-1986	prepared	_	
11-23	1987-1990	but	_	
11-24	1991-1998	context	_	
11-25	1998-1999	-	_	
11-26	2000-2002	or	_	
11-27	2003-2021	goal-inappropriate	_	
11-28	2022-2028	action	_	
11-29	2029-2034	plays	_	
11-30	2035-2036	a	_	
11-31	2037-2045	critical	_	
11-32	2046-2050	role	_	
11-33	2051-2053	in	_	
11-34	2054-2057	the	_	
11-35	2058-2073	self-regulation	_	
11-36	2074-2076	of	_	
11-37	2077-2085	adaptive	_	
11-38	2086-2099	goal-directed	_	
11-39	2100-2108	behavior	_	
11-40	2108-2109	.	_	

#Text=Response inhibition is considered an essential facet of executive functioning and cognitive control, and weak response inhibition constitutes a key component of impulsivity.
12-1	2110-2118	Response	_	
12-2	2119-2129	inhibition	_	
12-3	2130-2132	is	_	
12-4	2133-2143	considered	_	
12-5	2144-2146	an	_	
12-6	2147-2156	essential	_	
12-7	2157-2162	facet	_	
12-8	2163-2165	of	_	
12-9	2166-2175	executive	_	
12-10	2176-2187	functioning	_	
12-11	2188-2191	and	_	
12-12	2192-2201	cognitive	_	
12-13	2202-2209	control	_	
12-14	2209-2210	,	_	
12-15	2211-2214	and	_	
12-16	2215-2219	weak	_	
12-17	2220-2228	response	_	
12-18	2229-2239	inhibition	_	
12-19	2240-2251	constitutes	_	
12-20	2252-2253	a	_	
12-21	2254-2257	key	_	
12-22	2258-2267	component	_	
12-23	2268-2270	of	_	
12-24	2271-2282	impulsivity	_	
12-25	2282-2283	.	_	

#Text=The neural dynamics underlying response inhibition has been extensively studied using brain event-related potential (ERPs),which represent a direct real-time measure of neuronal activity and permit the discrimination between consecutive stages of cognitive processing that unfold at the time scale of tens to hundreds of milliseconds.
13-1	2284-2287	The	_	
13-2	2288-2294	neural	_	
13-3	2295-2303	dynamics	_	
13-4	2304-2314	underlying	_	
13-5	2315-2323	response	_	
13-6	2324-2334	inhibition	_	
13-7	2335-2338	has	_	
13-8	2339-2343	been	_	
13-9	2344-2355	extensively	_	
13-10	2356-2363	studied	_	
13-11	2364-2369	using	_	
13-12	2370-2375	brain	_	
13-13	2376-2389	event-related	_	
13-14	2390-2399	potential	_	
13-15	2400-2401	(	_	
13-16	2401-2405	ERPs	_	
13-17	2405-2406	)	_	
13-18	2406-2407	,	_	
13-19	2407-2412	which	_	
13-20	2413-2422	represent	_	
13-21	2423-2424	a	_	
13-22	2425-2431	direct	_	
13-23	2432-2441	real-time	_	
13-24	2442-2449	measure	_	
13-25	2450-2452	of	_	
13-26	2453-2461	neuronal	_	
13-27	2462-2470	activity	_	
13-28	2471-2474	and	_	
13-29	2475-2481	permit	_	
13-30	2482-2485	the	_	
13-31	2486-2500	discrimination	_	
13-32	2501-2508	between	_	
13-33	2509-2520	consecutive	_	
13-34	2521-2527	stages	_	
13-35	2528-2530	of	_	
13-36	2531-2540	cognitive	_	
13-37	2541-2551	processing	_	
13-38	2552-2556	that	_	
13-39	2557-2563	unfold	_	
13-40	2564-2566	at	_	
13-41	2567-2570	the	_	
13-42	2571-2575	time	_	
13-43	2576-2581	scale	_	
13-44	2582-2584	of	_	
13-45	2585-2589	tens	_	
13-46	2590-2592	to	_	
13-47	2593-2601	hundreds	_	
13-48	2602-2604	of	_	
13-49	2605-2617	milliseconds	_	
13-50	2617-2618	.	_	

#Text=Most ERP studies of response inhibition employ Go/No-Go tasks in which participants are instructed to respond to Go stimuli and to withhold their responses to No-Go stimuli, as well as stop-signal tasks in which participants have to stop the response triggered by a Go stimulus if a stop stimulus is presented shortly after the Go stimulus.
14-1	2619-2623	Most	_	
14-2	2624-2627	ERP	_	
14-3	2628-2635	studies	_	
14-4	2636-2638	of	_	
14-5	2639-2647	response	_	
14-6	2648-2658	inhibition	_	
14-7	2659-2665	employ	_	
14-8	2666-2668	Go	_	
14-9	2668-2669	/	_	
14-10	2669-2674	No-Go	_	
14-11	2675-2680	tasks	_	
14-12	2681-2683	in	_	
14-13	2684-2689	which	_	
14-14	2690-2702	participants	_	
14-15	2703-2706	are	_	
14-16	2707-2717	instructed	_	
14-17	2718-2720	to	_	
14-18	2721-2728	respond	_	
14-19	2729-2731	to	_	
14-20	2732-2734	Go	_	
14-21	2735-2742	stimuli	_	
14-22	2743-2746	and	_	
14-23	2747-2749	to	_	
14-24	2750-2758	withhold	_	
14-25	2759-2764	their	_	
14-26	2765-2774	responses	_	
14-27	2775-2777	to	_	
14-28	2778-2783	No-Go	_	
14-29	2784-2791	stimuli	_	
14-30	2791-2792	,	_	
14-31	2793-2795	as	_	
14-32	2796-2800	well	_	
14-33	2801-2803	as	_	
14-34	2804-2815	stop-signal	_	
14-35	2816-2821	tasks	_	
14-36	2822-2824	in	_	
14-37	2825-2830	which	_	
14-38	2831-2843	participants	_	
14-39	2844-2848	have	_	
14-40	2849-2851	to	_	
14-41	2852-2856	stop	_	
14-42	2857-2860	the	_	
14-43	2861-2869	response	_	
14-44	2870-2879	triggered	_	
14-45	2880-2882	by	_	
14-46	2883-2884	a	_	
14-47	2885-2887	Go	_	
14-48	2888-2896	stimulus	_	
14-49	2897-2899	if	_	
14-50	2900-2901	a	_	
14-51	2902-2906	stop	_	
14-52	2907-2915	stimulus	_	
14-53	2916-2918	is	_	
14-54	2919-2928	presented	_	
14-55	2929-2936	shortly	_	
14-56	2937-2942	after	_	
14-57	2943-2946	the	_	
14-58	2947-2949	Go	_	
14-59	2950-2958	stimulus	_	
14-60	2958-2959	.	_	

#Text=There are two ERP components that have been consistently associated with response inhibition.
15-1	2960-2965	There	_	
15-2	2966-2969	are	_	
15-3	2970-2973	two	_	
15-4	2974-2977	ERP	_	
15-5	2978-2988	components	_	
15-6	2989-2993	that	_	
15-7	2994-2998	have	_	
15-8	2999-3003	been	_	
15-9	3004-3016	consistently	_	
15-10	3017-3027	associated	_	
15-11	3028-3032	with	_	
15-12	3033-3041	response	_	
15-13	3042-3052	inhibition	_	
15-14	3052-3053	.	_	

#Text=The first is the midline frontal N2 component which is observed at 200–270 ms post-stimulus in successful No-Go trials.
16-1	3054-3057	The	_	
16-2	3058-3063	first	_	
16-3	3064-3066	is	_	
16-4	3067-3070	the	_	
16-5	3071-3078	midline	_	
16-6	3079-3086	frontal	_	
16-7	3087-3089	N2	_	
16-8	3090-3099	component	_	
16-9	3100-3105	which	_	
16-10	3106-3108	is	_	
16-11	3109-3117	observed	_	
16-12	3118-3120	at	_	
16-13	3121-3124	200	_	
16-14	3124-3125	–	_	
16-15	3125-3128	270	_	
16-16	3129-3131	ms	_	
16-17	3132-3145	post-stimulus	_	
16-18	3146-3148	in	_	
16-19	3149-3159	successful	_	
16-20	3160-3165	No-Go	_	
16-21	3166-3172	trials	_	
16-22	3172-3173	.	_	

#Text=The frontal No-Go N2 component, interpreted as a correlate of inhibition in earlier studies, more recently has been viewed as manifestation of a conflict between incompatible response tendencies.
17-1	3174-3177	The	_	
17-2	3178-3185	frontal	_	
17-3	3186-3191	No-Go	_	
17-4	3192-3194	N2	_	
17-5	3195-3204	component	_	
17-6	3204-3205	,	_	
17-7	3206-3217	interpreted	_	
17-8	3218-3220	as	_	
17-9	3221-3222	a	_	
17-10	3223-3232	correlate	_	
17-11	3233-3235	of	_	
17-12	3236-3246	inhibition	_	
17-13	3247-3249	in	_	
17-14	3250-3257	earlier	_	
17-15	3258-3265	studies	_	
17-16	3265-3266	,	_	
17-17	3267-3271	more	_	
17-18	3272-3280	recently	_	
17-19	3281-3284	has	_	
17-20	3285-3289	been	_	
17-21	3290-3296	viewed	_	
17-22	3297-3299	as	_	
17-23	3300-3313	manifestation	_	
17-24	3314-3316	of	_	
17-25	3317-3318	a	_	
17-26	3319-3327	conflict	_	
17-27	3328-3335	between	_	
17-28	3336-3348	incompatible	_	
17-29	3349-3357	response	_	
17-30	3358-3368	tendencies	_	
17-31	3368-3369	.	_	

#Text=The conflict account of N2 suggests that N2 reflects detection of a conflict caused by the competition between the execution and the inhibition of a single response.
18-1	3370-3373	The	_	
18-2	3374-3382	conflict	_	
18-3	3383-3390	account	_	
18-4	3391-3393	of	_	
18-5	3394-3396	N2	_	
18-6	3397-3405	suggests	_	
18-7	3406-3410	that	_	
18-8	3411-3413	N2	_	
18-9	3414-3422	reflects	_	
18-10	3423-3432	detection	_	
18-11	3433-3435	of	_	
18-12	3436-3437	a	_	
18-13	3438-3446	conflict	_	
18-14	3447-3453	caused	_	
18-15	3454-3456	by	_	
18-16	3457-3460	the	_	
18-17	3461-3472	competition	_	
18-18	3473-3480	between	_	
18-19	3481-3484	the	_	
18-20	3485-3494	execution	_	
18-21	3495-3498	and	_	
18-22	3499-3502	the	_	
18-23	3503-3513	inhibition	_	
18-24	3514-3516	of	_	
18-25	3517-3518	a	_	
18-26	3519-3525	single	_	
18-27	3526-3534	response	_	
18-28	3534-3535	.	_	

#Text=The second ERP component associated with successful withholding of a response is the No-Go P3 wave peaking in the time window of 250–500 ms which is substantially enhanced in frontal and central areas on No-Go trial relative to Go trials.
19-1	3536-3539	The	_	
19-2	3540-3546	second	_	
19-3	3547-3550	ERP	_	
19-4	3551-3560	component	_	
19-5	3561-3571	associated	_	
19-6	3572-3576	with	_	
19-7	3577-3587	successful	_	
19-8	3588-3599	withholding	_	
19-9	3600-3602	of	_	
19-10	3603-3604	a	_	
19-11	3605-3613	response	_	
19-12	3614-3616	is	_	
19-13	3617-3620	the	_	
19-14	3621-3626	No-Go	_	
19-15	3627-3629	P3	_	
19-16	3630-3634	wave	_	
19-17	3635-3642	peaking	_	
19-18	3643-3645	in	_	
19-19	3646-3649	the	_	
19-20	3650-3654	time	_	
19-21	3655-3661	window	_	
19-22	3662-3664	of	_	
19-23	3665-3668	250	_	
19-24	3668-3669	–	_	
19-25	3669-3672	500	_	
19-26	3673-3675	ms	_	
19-27	3676-3681	which	_	
19-28	3682-3684	is	_	
19-29	3685-3698	substantially	_	
19-30	3699-3707	enhanced	_	
19-31	3708-3710	in	_	
19-32	3711-3718	frontal	_	
19-33	3719-3722	and	_	
19-34	3723-3730	central	_	
19-35	3731-3736	areas	_	
19-36	3737-3739	on	_	
19-37	3740-3745	No-Go	_	
19-38	3746-3751	trial	_	
19-39	3752-3760	relative	_	
19-40	3761-3763	to	_	
19-41	3764-3766	Go	_	
19-42	3767-3773	trials	_	
19-43	3773-3774	.	_	

#Text=This effect, labeled as “No-Go anteriorization” of P3, has been proposed as a robust topographical marker of the activation of frontal circuitry related to response inhibition.
20-1	3775-3779	This	_	
20-2	3780-3786	effect	_	
20-3	3786-3787	,	_	
20-4	3788-3795	labeled	_	
20-5	3796-3798	as	_	
20-6	3799-3800	“	_	
20-7	3800-3805	No-Go	_	
20-8	3806-3821	anteriorization	_	
20-9	3821-3822	”	_	
20-10	3823-3825	of	_	
20-11	3826-3828	P3	_	
20-12	3828-3829	,	_	
20-13	3830-3833	has	_	
20-14	3834-3838	been	_	
20-15	3839-3847	proposed	_	
20-16	3848-3850	as	_	
20-17	3851-3852	a	_	
20-18	3853-3859	robust	_	
20-19	3860-3873	topographical	_	
20-20	3874-3880	marker	_	
20-21	3881-3883	of	_	
20-22	3884-3887	the	_	
20-23	3888-3898	activation	_	
20-24	3899-3901	of	_	
20-25	3902-3909	frontal	_	
20-26	3910-3919	circuitry	_	
20-27	3920-3927	related	_	
20-28	3928-3930	to	_	
20-29	3931-3939	response	_	
20-30	3940-3950	inhibition	_	
20-31	3950-3951	.	_	

#Text=In contrast to N2, there is stronger evidence linking the No-Go P3 to response inhibition.
21-1	3952-3954	In	_	
21-2	3955-3963	contrast	_	
21-3	3964-3966	to	_	
21-4	3967-3969	N2	_	
21-5	3969-3970	,	_	
21-6	3971-3976	there	_	
21-7	3977-3979	is	_	
21-8	3980-3988	stronger	_	
21-9	3989-3997	evidence	_	
21-10	3998-4005	linking	_	
21-11	4006-4009	the	_	
21-12	4010-4015	No-Go	_	
21-13	4016-4018	P3	_	
21-14	4019-4021	to	_	
21-15	4022-4030	response	_	
21-16	4031-4041	inhibition	_	
21-17	4041-4042	.	_	

#Text=Although studies comparing neural correlates of withholding of overt and covert responses suggested that No-Go P3 is related to both cognitive and motor inhibition, the P3 effect was greatly enhanced when motor inhibition was required.
22-1	4043-4051	Although	_	
22-2	4052-4059	studies	_	
22-3	4060-4069	comparing	_	
22-4	4070-4076	neural	_	
22-5	4077-4087	correlates	_	
22-6	4088-4090	of	_	
22-7	4091-4102	withholding	_	
22-8	4103-4105	of	_	
22-9	4106-4111	overt	_	
22-10	4112-4115	and	_	
22-11	4116-4122	covert	_	
22-12	4123-4132	responses	_	
22-13	4133-4142	suggested	_	
22-14	4143-4147	that	_	
22-15	4148-4153	No-Go	_	
22-16	4154-4156	P3	_	
22-17	4157-4159	is	_	
22-18	4160-4167	related	_	
22-19	4168-4170	to	_	
22-20	4171-4175	both	_	
22-21	4176-4185	cognitive	_	
22-22	4186-4189	and	_	
22-23	4190-4195	motor	_	
22-24	4196-4206	inhibition	_	
22-25	4206-4207	,	_	
22-26	4208-4211	the	_	
22-27	4212-4214	P3	_	
22-28	4215-4221	effect	_	
22-29	4222-4225	was	_	
22-30	4226-4233	greatly	_	
22-31	4234-4242	enhanced	_	
22-32	4243-4247	when	_	
22-33	4248-4253	motor	_	
22-34	4254-4264	inhibition	_	
22-35	4265-4268	was	_	
22-36	4269-4277	required	_	
22-37	4277-4278	.	_	

#Text=Thus, No-Go N2 and P3 represent distinct and temporally dissociable processes related to response inhibition: the N2 is implicated in the detection of conflict between a prepared response and the need to inhibit it, whereas No-Go P3 is seen as a manifestation of motor inhibition.
#Text=1.2.
23-1	4279-4283	Thus	_	
23-2	4283-4284	,	_	
23-3	4285-4290	No-Go	_	
23-4	4291-4293	N2	_	
23-5	4294-4297	and	_	
23-6	4298-4300	P3	_	
23-7	4301-4310	represent	_	
23-8	4311-4319	distinct	_	
23-9	4320-4323	and	_	
23-10	4324-4334	temporally	_	
23-11	4335-4346	dissociable	_	
23-12	4347-4356	processes	_	
23-13	4357-4364	related	_	
23-14	4365-4367	to	_	
23-15	4368-4376	response	_	
23-16	4377-4387	inhibition	_	
23-17	4387-4388	:	_	
23-18	4389-4392	the	_	
23-19	4393-4395	N2	_	
23-20	4396-4398	is	_	
23-21	4399-4409	implicated	_	
23-22	4410-4412	in	_	
23-23	4413-4416	the	_	
23-24	4417-4426	detection	_	
23-25	4427-4429	of	_	
23-26	4430-4438	conflict	_	
23-27	4439-4446	between	_	
23-28	4447-4448	a	_	
23-29	4449-4457	prepared	_	
23-30	4458-4466	response	_	
23-31	4467-4470	and	_	
23-32	4471-4474	the	_	
23-33	4475-4479	need	_	
23-34	4480-4482	to	_	
23-35	4483-4490	inhibit	_	
23-36	4491-4493	it	_	
23-37	4493-4494	,	_	
23-38	4495-4502	whereas	_	
23-39	4503-4508	No-Go	_	
23-40	4509-4511	P3	_	
23-41	4512-4514	is	_	
23-42	4515-4519	seen	_	
23-43	4520-4522	as	_	
23-44	4523-4524	a	_	
23-45	4525-4538	manifestation	_	
23-46	4539-4541	of	_	
23-47	4542-4547	motor	_	
23-48	4548-4558	inhibition	_	
23-49	4558-4559	.	_	
23-50	4560-4563	1.2	_	
23-51	4563-4564	.	_	

#Text=Neuroanatomical substrates of response inhibition: ERP and fMRI studies
#Text=Human lesion studies have shown that the medial prefrontal cortex, including the anterior cingulate and the supplementary motor areas, plays a key role in both response preparation and inhibition.
24-1	4565-4580	Neuroanatomical	_	
24-2	4581-4591	substrates	_	
24-3	4592-4594	of	_	
24-4	4595-4603	response	_	
24-5	4604-4614	inhibition	_	
24-6	4614-4615	:	_	
24-7	4616-4619	ERP	_	
24-8	4620-4623	and	_	
24-9	4624-4628	fMRI	_	
24-10	4629-4636	studies	_	
24-11	4637-4642	Human	_	
24-12	4643-4649	lesion	_	
24-13	4650-4657	studies	_	
24-14	4658-4662	have	_	
24-15	4663-4668	shown	_	
24-16	4669-4673	that	_	
24-17	4674-4677	the	_	
24-18	4678-4684	medial	_	
24-19	4685-4695	prefrontal	_	
24-20	4696-4702	cortex	_	
24-21	4702-4703	,	_	
24-22	4704-4713	including	_	
24-23	4714-4717	the	_	
24-24	4718-4726	anterior	_	
24-25	4727-4736	cingulate	_	
24-26	4737-4740	and	_	
24-27	4741-4744	the	_	
24-28	4745-4758	supplementary	_	
24-29	4759-4764	motor	_	
24-30	4765-4770	areas	_	
24-31	4770-4771	,	_	
24-32	4772-4777	plays	_	
24-33	4778-4779	a	_	
24-34	4780-4783	key	_	
24-35	4784-4788	role	_	
24-36	4789-4791	in	_	
24-37	4792-4796	both	_	
24-38	4797-4805	response	_	
24-39	4806-4817	preparation	_	
24-40	4818-4821	and	_	
24-41	4822-4832	inhibition	_	
24-42	4832-4833	.	_	

#Text=Studies using source localization methods as well as studies combining fMRI and ERP measurement in the same Go/No-Go tasks have consistently associated the No-Go N2 component with the activation of the anterior cingulate cortex (ACC).
25-1	4834-4841	Studies	_	
25-2	4842-4847	using	_	
25-3	4848-4854	source	_	
25-4	4855-4867	localization	_	
25-5	4868-4875	methods	_	
25-6	4876-4878	as	_	
25-7	4879-4883	well	_	
25-8	4884-4886	as	_	
25-9	4887-4894	studies	_	
25-10	4895-4904	combining	_	
25-11	4905-4909	fMRI	_	
25-12	4910-4913	and	_	
25-13	4914-4917	ERP	_	
25-14	4918-4929	measurement	_	
25-15	4930-4932	in	_	
25-16	4933-4936	the	_	
25-17	4937-4941	same	_	
25-18	4942-4944	Go	_	
25-19	4944-4945	/	_	
25-20	4945-4950	No-Go	_	
25-21	4951-4956	tasks	_	
25-22	4957-4961	have	_	
25-23	4962-4974	consistently	_	
25-24	4975-4985	associated	_	
25-25	4986-4989	the	_	
25-26	4990-4995	No-Go	_	
25-27	4996-4998	N2	_	
25-28	4999-5008	component	_	
25-29	5009-5013	with	_	
25-30	5014-5017	the	_	
25-31	5018-5028	activation	_	
25-32	5029-5031	of	_	
25-33	5032-5035	the	_	
25-34	5036-5044	anterior	_	
25-35	5045-5054	cingulate	_	
25-36	5055-5061	cortex	_	
25-37	5062-5063	(	_	
25-38	5063-5066	ACC	_	
25-39	5066-5067	)	_	
25-40	5067-5068	.	_	

#Text=The sources for No-Go P3 were found in the ACC, premotor areas, and the dorsolateral prefrontal cortex.
26-1	5069-5072	The	_	
26-2	5073-5080	sources	_	
26-3	5081-5084	for	_	
26-4	5085-5090	No-Go	_	
26-5	5091-5093	P3	_	
26-6	5094-5098	were	_	
26-7	5099-5104	found	_	
26-8	5105-5107	in	_	
26-9	5108-5111	the	_	
26-10	5112-5115	ACC	_	
26-11	5115-5116	,	_	
26-12	5117-5125	premotor	_	
26-13	5126-5131	areas	_	
26-14	5131-5132	,	_	
26-15	5133-5136	and	_	
26-16	5137-5140	the	_	
26-17	5141-5153	dorsolateral	_	
26-18	5154-5164	prefrontal	_	
26-19	5165-5171	cortex	_	
26-20	5171-5172	.	_	

#Text=More recently, neural substrates of N2 and P3 were further clarified by multimodal imaging studies capitalizing on high temporal resolution of EEG and high spatial resolution of fMRI.
27-1	5173-5177	More	_	
27-2	5178-5186	recently	_	
27-3	5186-5187	,	_	
27-4	5188-5194	neural	_	
27-5	5195-5205	substrates	_	
27-6	5206-5208	of	_	
27-7	5209-5211	N2	_	
27-8	5212-5215	and	_	
27-9	5216-5218	P3	_	
27-10	5219-5223	were	_	
27-11	5224-5231	further	_	
27-12	5232-5241	clarified	_	
27-13	5242-5244	by	_	
27-14	5245-5255	multimodal	_	
27-15	5256-5263	imaging	_	
27-16	5264-5271	studies	_	
27-17	5272-5284	capitalizing	_	
27-18	5285-5287	on	_	
27-19	5288-5292	high	_	
27-20	5293-5301	temporal	_	
27-21	5302-5312	resolution	_	
27-22	5313-5315	of	_	
27-23	5316-5319	EEG	_	
27-24	5320-5323	and	_	
27-25	5324-5328	high	_	
27-26	5329-5336	spatial	_	
27-27	5337-5347	resolution	_	
27-28	5348-5350	of	_	
27-29	5351-5355	fMRI	_	
27-30	5355-5356	.	_	

#Text=A study using separate ERP and fMRI recordings in the same subjects showed strong correlations between No-Go N2 and activation in the caudal part of the ACC and executive control regions in the dorsolateral prefrontal cortex.
28-1	5357-5358	A	_	
28-2	5359-5364	study	_	
28-3	5365-5370	using	_	
28-4	5371-5379	separate	_	
28-5	5380-5383	ERP	_	
28-6	5384-5387	and	_	
28-7	5388-5392	fMRI	_	
28-8	5393-5403	recordings	_	
28-9	5404-5406	in	_	
28-10	5407-5410	the	_	
28-11	5411-5415	same	_	
28-12	5416-5424	subjects	_	
28-13	5425-5431	showed	_	
28-14	5432-5438	strong	_	
28-15	5439-5451	correlations	_	
28-16	5452-5459	between	_	
28-17	5460-5465	No-Go	_	
28-18	5466-5468	N2	_	
28-19	5469-5472	and	_	
28-20	5473-5483	activation	_	
28-21	5484-5486	in	_	
28-22	5487-5490	the	_	
28-23	5491-5497	caudal	_	
28-24	5498-5502	part	_	
28-25	5503-5505	of	_	
28-26	5506-5509	the	_	
28-27	5510-5513	ACC	_	
28-28	5514-5517	and	_	
28-29	5518-5527	executive	_	
28-30	5528-5535	control	_	
28-31	5536-5543	regions	_	
28-32	5544-5546	in	_	
28-33	5547-5550	the	_	
28-34	5551-5563	dorsolateral	_	
28-35	5564-5574	prefrontal	_	
28-36	5575-5581	cortex	_	
28-37	5581-5582	.	_	

#Text=In a study with simultaneous EEG and fMRI recording during a stop-signal task, N2/P3 ERP complex produced by successful response inhibition was associated with activation in a functional network of regions known from previous fMRI studies to be involved in response inhibition, most notably, the anterior midcingulate cortex, pre-supplementary motor area, and the anterior insula.
29-1	5583-5585	In	_	
29-2	5586-5587	a	_	
29-3	5588-5593	study	_	
29-4	5594-5598	with	_	
29-5	5599-5611	simultaneous	_	
29-6	5612-5615	EEG	_	
29-7	5616-5619	and	_	
29-8	5620-5624	fMRI	_	
29-9	5625-5634	recording	_	
29-10	5635-5641	during	_	
29-11	5642-5643	a	_	
29-12	5644-5655	stop-signal	_	
29-13	5656-5660	task	_	
29-14	5660-5661	,	_	
29-15	5662-5664	N2	_	
29-16	5664-5665	/	_	
29-17	5665-5667	P3	_	
29-18	5668-5671	ERP	_	
29-19	5672-5679	complex	_	
29-20	5680-5688	produced	_	
29-21	5689-5691	by	_	
29-22	5692-5702	successful	_	
29-23	5703-5711	response	_	
29-24	5712-5722	inhibition	_	
29-25	5723-5726	was	_	
29-26	5727-5737	associated	_	
29-27	5738-5742	with	_	
29-28	5743-5753	activation	_	
29-29	5754-5756	in	_	
29-30	5757-5758	a	_	
29-31	5759-5769	functional	_	
29-32	5770-5777	network	_	
29-33	5778-5780	of	_	
29-34	5781-5788	regions	_	
29-35	5789-5794	known	_	
29-36	5795-5799	from	_	
29-37	5800-5808	previous	_	
29-38	5809-5813	fMRI	_	
29-39	5814-5821	studies	_	
29-40	5822-5824	to	_	
29-41	5825-5827	be	_	
29-42	5828-5836	involved	_	
29-43	5837-5839	in	_	
29-44	5840-5848	response	_	
29-45	5849-5859	inhibition	_	
29-46	5859-5860	,	_	
29-47	5861-5865	most	_	
29-48	5866-5873	notably	_	
29-49	5873-5874	,	_	
29-50	5875-5878	the	_	
29-51	5879-5887	anterior	_	
29-52	5888-5900	midcingulate	_	
29-53	5901-5907	cortex	_	
29-54	5907-5908	,	_	
29-55	5909-5926	pre-supplementary	_	
29-56	5927-5932	motor	_	
29-57	5933-5937	area	_	
29-58	5937-5938	,	_	
29-59	5939-5942	and	_	
29-60	5943-5946	the	_	
29-61	5947-5955	anterior	_	
29-62	5956-5962	insula	_	
29-63	5962-5963	.	_	

#Text=A subsequent review of source localization and imaging studies provided a more detailed account of separate brain regions implicated in N2 and P3 generation.
30-1	5964-5965	A	_	
30-2	5966-5976	subsequent	_	
30-3	5977-5983	review	_	
30-4	5984-5986	of	_	
30-5	5987-5993	source	_	
30-6	5994-6006	localization	_	
30-7	6007-6010	and	_	
30-8	6011-6018	imaging	_	
30-9	6019-6026	studies	_	
30-10	6027-6035	provided	_	
30-11	6036-6037	a	_	
30-12	6038-6042	more	_	
30-13	6043-6051	detailed	_	
30-14	6052-6059	account	_	
30-15	6060-6062	of	_	
30-16	6063-6071	separate	_	
30-17	6072-6077	brain	_	
30-18	6078-6085	regions	_	
30-19	6086-6096	implicated	_	
30-20	6097-6099	in	_	
30-21	6100-6102	N2	_	
30-22	6103-6106	and	_	
30-23	6107-6109	P3	_	
30-24	6110-6120	generation	_	
30-25	6120-6121	.	_	

#Text=Converging evidence suggests that N2 reflects activity in the medial and lateral prefrontal cortices, with the medial source located in the anterior midcingulate region, in line with ERP source localization studies consistently implicating a generator in the ACC.
31-1	6122-6132	Converging	_	
31-2	6133-6141	evidence	_	
31-3	6142-6150	suggests	_	
31-4	6151-6155	that	_	
31-5	6156-6158	N2	_	
31-6	6159-6167	reflects	_	
31-7	6168-6176	activity	_	
31-8	6177-6179	in	_	
31-9	6180-6183	the	_	
31-10	6184-6190	medial	_	
31-11	6191-6194	and	_	
31-12	6195-6202	lateral	_	
31-13	6203-6213	prefrontal	_	
31-14	6214-6222	cortices	_	
31-15	6222-6223	,	_	
31-16	6224-6228	with	_	
31-17	6229-6232	the	_	
31-18	6233-6239	medial	_	
31-19	6240-6246	source	_	
31-20	6247-6254	located	_	
31-21	6255-6257	in	_	
31-22	6258-6261	the	_	
31-23	6262-6270	anterior	_	
31-24	6271-6283	midcingulate	_	
31-25	6284-6290	region	_	
31-26	6290-6291	,	_	
31-27	6292-6294	in	_	
31-28	6295-6299	line	_	
31-29	6300-6304	with	_	
31-30	6305-6308	ERP	_	
31-31	6309-6315	source	_	
31-32	6316-6328	localization	_	
31-33	6329-6336	studies	_	
31-34	6337-6349	consistently	_	
31-35	6350-6361	implicating	_	
31-36	6362-6363	a	_	
31-37	6364-6373	generator	_	
31-38	6374-6376	in	_	
31-39	6377-6380	the	_	
31-40	6381-6384	ACC	_	
31-41	6384-6385	.	_	

#Text=Furthermore, in another study N2, but not P3, correlated with morphological variation in the anterior cingulate region.
32-1	6386-6397	Furthermore	_	
32-2	6397-6398	,	_	
32-3	6399-6401	in	_	
32-4	6402-6409	another	_	
32-5	6410-6415	study	_	
32-6	6416-6418	N2	_	
32-7	6418-6419	,	_	
32-8	6420-6423	but	_	
32-9	6424-6427	not	_	
32-10	6428-6430	P3	_	
32-11	6430-6431	,	_	
32-12	6432-6442	correlated	_	
32-13	6443-6447	with	_	
32-14	6448-6461	morphological	_	
32-15	6462-6471	variation	_	
32-16	6472-6474	in	_	
32-17	6475-6478	the	_	
32-18	6479-6487	anterior	_	
32-19	6488-6497	cingulate	_	
32-20	6498-6504	region	_	
32-21	6504-6505	.	_	

#Text=Frontocentral P3 showed associations with a broader network of regions including medial frontal and precentral regions, including the pre-SMA, anterior insulae, and temporoparietal regions.
33-1	6506-6519	Frontocentral	_	
33-2	6520-6522	P3	_	
33-3	6523-6529	showed	_	
33-4	6530-6542	associations	_	
33-5	6543-6547	with	_	
33-6	6548-6549	a	_	
33-7	6550-6557	broader	_	
33-8	6558-6565	network	_	
33-9	6566-6568	of	_	
33-10	6569-6576	regions	_	
33-11	6577-6586	including	_	
33-12	6587-6593	medial	_	
33-13	6594-6601	frontal	_	
33-14	6602-6605	and	_	
33-15	6606-6616	precentral	_	
33-16	6617-6624	regions	_	
33-17	6624-6625	,	_	
33-18	6626-6635	including	_	
33-19	6636-6639	the	_	
33-20	6640-6647	pre-SMA	_	
33-21	6647-6648	,	_	
33-22	6649-6657	anterior	_	
33-23	6658-6665	insulae	_	
33-24	6665-6666	,	_	
33-25	6667-6670	and	_	
33-26	6671-6686	temporoparietal	_	
33-27	6687-6694	regions	_	
33-28	6694-6695	.	_	

#Text=Interestingly, both N2 and P3 correlated with activation of the midcingular region, although N2 sources were located more anteriorly than P3 sources.
#Text=1.3.
34-1	6696-6709	Interestingly	_	
34-2	6709-6710	,	_	
34-3	6711-6715	both	_	
34-4	6716-6718	N2	_	
34-5	6719-6722	and	_	
34-6	6723-6725	P3	_	
34-7	6726-6736	correlated	_	
34-8	6737-6741	with	_	
34-9	6742-6752	activation	_	
34-10	6753-6755	of	_	
34-11	6756-6759	the	_	
34-12	6760-6771	midcingular	_	
34-13	6772-6778	region	_	
34-14	6778-6779	,	_	
34-15	6780-6788	although	_	
34-16	6789-6791	N2	_	
34-17	6792-6799	sources	_	
34-18	6800-6804	were	_	
34-19	6805-6812	located	_	
34-20	6813-6817	more	_	
34-21	6818-6828	anteriorly	_	
34-22	6829-6833	than	_	
34-23	6834-6836	P3	_	
34-24	6837-6844	sources	_	
34-25	6844-6845	.	_	
34-26	6846-6849	1.3	_	
34-27	6849-6850	.	_	

#Text=Developmental changes in the neural correlates of response inhibition
#Text=Structural and functional imaging data suggest that brain regions supporting cognitive control, most notably, the anterior cingulate (ACC) and dorsolateral prefrontal cortex (DLPFC), continue to develop during adolescence.
35-1	6851-6864	Developmental	_	
35-2	6865-6872	changes	_	
35-3	6873-6875	in	_	
35-4	6876-6879	the	_	
35-5	6880-6886	neural	_	
35-6	6887-6897	correlates	_	
35-7	6898-6900	of	_	
35-8	6901-6909	response	_	
35-9	6910-6920	inhibition	_	
35-10	6921-6931	Structural	_	
35-11	6932-6935	and	_	
35-12	6936-6946	functional	_	
35-13	6947-6954	imaging	_	
35-14	6955-6959	data	_	
35-15	6960-6967	suggest	_	
35-16	6968-6972	that	_	
35-17	6973-6978	brain	_	
35-18	6979-6986	regions	_	
35-19	6987-6997	supporting	_	
35-20	6998-7007	cognitive	_	
35-21	7008-7015	control	_	
35-22	7015-7016	,	_	
35-23	7017-7021	most	_	
35-24	7022-7029	notably	_	
35-25	7029-7030	,	_	
35-26	7031-7034	the	_	
35-27	7035-7043	anterior	_	
35-28	7044-7053	cingulate	_	
35-29	7054-7055	(	_	
35-30	7055-7058	ACC	_	
35-31	7058-7059	)	_	
35-32	7060-7063	and	_	
35-33	7064-7076	dorsolateral	_	
35-34	7077-7087	prefrontal	_	
35-35	7088-7094	cortex	_	
35-36	7095-7096	(	_	
35-37	7096-7101	DLPFC	_	
35-38	7101-7102	)	_	
35-39	7102-7103	,	_	
35-40	7104-7112	continue	_	
35-41	7113-7115	to	_	
35-42	7116-7123	develop	_	
35-43	7124-7130	during	_	
35-44	7131-7142	adolescence	_	
35-45	7142-7143	.	_	

#Text=Consistent with this evidence, ERP studies of response inhibition indicate substantial differences in inhibition-related brain activity between children and adults.
36-1	7144-7154	Consistent	_	
36-2	7155-7159	with	_	
36-3	7160-7164	this	_	
36-4	7165-7173	evidence	_	
36-5	7173-7174	,	_	
36-6	7175-7178	ERP	_	
36-7	7179-7186	studies	_	
36-8	7187-7189	of	_	
36-9	7190-7198	response	_	
36-10	7199-7209	inhibition	_	
36-11	7210-7218	indicate	_	
36-12	7219-7230	substantial	_	
36-13	7231-7242	differences	_	
36-14	7243-7245	in	_	
36-15	7246-7264	inhibition-related	_	
36-16	7265-7270	brain	_	
36-17	7271-7279	activity	_	
36-18	7280-7287	between	_	
36-19	7288-7296	children	_	
36-20	7297-7300	and	_	
36-21	7301-7307	adults	_	
36-22	7307-7308	.	_	

#Text=A comparison of children at age 9 and young adults with respect to ERPs in a Go/No-Go task found a well-pronounced N2 component that was larger in children compared with adults, however, the No-Go P3 was absent in children.
37-1	7309-7310	A	_	
37-2	7311-7321	comparison	_	
37-3	7322-7324	of	_	
37-4	7325-7333	children	_	
37-5	7334-7336	at	_	
37-6	7337-7340	age	_	
37-7	7341-7342	9	_	
37-8	7343-7346	and	_	
37-9	7347-7352	young	_	
37-10	7353-7359	adults	_	
37-11	7360-7364	with	_	
37-12	7365-7372	respect	_	
37-13	7373-7375	to	_	
37-14	7376-7380	ERPs	_	
37-15	7381-7383	in	_	
37-16	7384-7385	a	_	
37-17	7386-7388	Go	_	
37-18	7388-7389	/	_	
37-19	7389-7394	No-Go	_	
37-20	7395-7399	task	_	
37-21	7400-7405	found	_	
37-22	7406-7407	a	_	
37-23	7408-7423	well-pronounced	_	
37-24	7424-7426	N2	_	
37-25	7427-7436	component	_	
37-26	7437-7441	that	_	
37-27	7442-7445	was	_	
37-28	7446-7452	larger	_	
37-29	7453-7455	in	_	
37-30	7456-7464	children	_	
37-31	7465-7473	compared	_	
37-32	7474-7478	with	_	
37-33	7479-7485	adults	_	
37-34	7485-7486	,	_	
37-35	7487-7494	however	_	
37-36	7494-7495	,	_	
37-37	7496-7499	the	_	
37-38	7500-7505	No-Go	_	
37-39	7506-7508	P3	_	
37-40	7509-7512	was	_	
37-41	7513-7519	absent	_	
37-42	7520-7522	in	_	
37-43	7523-7531	children	_	
37-44	7531-7532	.	_	

#Text=These results were corroborated in a subsequent study with an extended age range, a cross-sectional study comparing children at age 6–7 and 9–10 years and young adults suggested a decrease of N2 amplitude and increase of P3 with age.
38-1	7533-7538	These	_	
38-2	7539-7546	results	_	
38-3	7547-7551	were	_	
38-4	7552-7564	corroborated	_	
38-5	7565-7567	in	_	
38-6	7568-7569	a	_	
38-7	7570-7580	subsequent	_	
38-8	7581-7586	study	_	
38-9	7587-7591	with	_	
38-10	7592-7594	an	_	
38-11	7595-7603	extended	_	
38-12	7604-7607	age	_	
38-13	7608-7613	range	_	
38-14	7613-7614	,	_	
38-15	7615-7616	a	_	
38-16	7617-7632	cross-sectional	_	
38-17	7633-7638	study	_	
38-18	7639-7648	comparing	_	
38-19	7649-7657	children	_	
38-20	7658-7660	at	_	
38-21	7661-7664	age	_	
38-22	7665-7666	6	_	
38-23	7666-7667	–	_	
38-24	7667-7668	7	_	
38-25	7669-7672	and	_	
38-26	7673-7674	9	_	
38-27	7674-7675	–	_	
38-28	7675-7677	10	_	
38-29	7678-7683	years	_	
38-30	7684-7687	and	_	
38-31	7688-7693	young	_	
38-32	7694-7700	adults	_	
38-33	7701-7710	suggested	_	
38-34	7711-7712	a	_	
38-35	7713-7721	decrease	_	
38-36	7722-7724	of	_	
38-37	7725-7727	N2	_	
38-38	7728-7737	amplitude	_	
38-39	7738-7741	and	_	
38-40	7742-7750	increase	_	
38-41	7751-7753	of	_	
38-42	7754-7756	P3	_	
38-43	7757-7761	with	_	
38-44	7762-7765	age	_	
38-45	7765-7766	.	_	

#Text=Convergent results were obtained in another cross-sectional study of children and adults: the N2 component assessed in an auditory Go/No-Go task diminished with age, while No-Go P3 showed a substantial increase.
39-1	7767-7777	Convergent	_	
39-2	7778-7785	results	_	
39-3	7786-7790	were	_	
39-4	7791-7799	obtained	_	
39-5	7800-7802	in	_	
39-6	7803-7810	another	_	
39-7	7811-7826	cross-sectional	_	
39-8	7827-7832	study	_	
39-9	7833-7835	of	_	
39-10	7836-7844	children	_	
39-11	7845-7848	and	_	
39-12	7849-7855	adults	_	
39-13	7855-7856	:	_	
39-14	7857-7860	the	_	
39-15	7861-7863	N2	_	
39-16	7864-7873	component	_	
39-17	7874-7882	assessed	_	
39-18	7883-7885	in	_	
39-19	7886-7888	an	_	
39-20	7889-7897	auditory	_	
39-21	7898-7900	Go	_	
39-22	7900-7901	/	_	
39-23	7901-7906	No-Go	_	
39-24	7907-7911	task	_	
39-25	7912-7922	diminished	_	
39-26	7923-7927	with	_	
39-27	7928-7931	age	_	
39-28	7931-7932	,	_	
39-29	7933-7938	while	_	
39-30	7939-7944	No-Go	_	
39-31	7945-7947	P3	_	
39-32	7948-7954	showed	_	
39-33	7955-7956	a	_	
39-34	7957-7968	substantial	_	
39-35	7969-7977	increase	_	
39-36	7977-7978	.	_	

#Text=From the conflict monitoring perspective, the decrease in N2 amplitude may reflect a decrease in the level of experienced conflict, perhaps due to more efficient processing in the ACC.
40-1	7979-7983	From	_	
40-2	7984-7987	the	_	
40-3	7988-7996	conflict	_	
40-4	7997-8007	monitoring	_	
40-5	8008-8019	perspective	_	
40-6	8019-8020	,	_	
40-7	8021-8024	the	_	
40-8	8025-8033	decrease	_	
40-9	8034-8036	in	_	
40-10	8037-8039	N2	_	
40-11	8040-8049	amplitude	_	
40-12	8050-8053	may	_	
40-13	8054-8061	reflect	_	
40-14	8062-8063	a	_	
40-15	8064-8072	decrease	_	
40-16	8073-8075	in	_	
40-17	8076-8079	the	_	
40-18	8080-8085	level	_	
40-19	8086-8088	of	_	
40-20	8089-8100	experienced	_	
40-21	8101-8109	conflict	_	
40-22	8109-8110	,	_	
40-23	8111-8118	perhaps	_	
40-24	8119-8122	due	_	
40-25	8123-8125	to	_	
40-26	8126-8130	more	_	
40-27	8131-8140	efficient	_	
40-28	8141-8151	processing	_	
40-29	8152-8154	in	_	
40-30	8155-8158	the	_	
40-31	8159-8162	ACC	_	
40-32	8162-8163	.	_	

#Text=It is important to note that the same developmental pattern was observed in studies using visual and auditory stimuli, suggesting that No-Go ERP components and their developmental changes represent general, modality-independent neural processing underlying response inhibition.
41-1	8164-8166	It	_	
41-2	8167-8169	is	_	
41-3	8170-8179	important	_	
41-4	8180-8182	to	_	
41-5	8183-8187	note	_	
41-6	8188-8192	that	_	
41-7	8193-8196	the	_	
41-8	8197-8201	same	_	
41-9	8202-8215	developmental	_	
41-10	8216-8223	pattern	_	
41-11	8224-8227	was	_	
41-12	8228-8236	observed	_	
41-13	8237-8239	in	_	
41-14	8240-8247	studies	_	
41-15	8248-8253	using	_	
41-16	8254-8260	visual	_	
41-17	8261-8264	and	_	
41-18	8265-8273	auditory	_	
41-19	8274-8281	stimuli	_	
41-20	8281-8282	,	_	
41-21	8283-8293	suggesting	_	
41-22	8294-8298	that	_	
41-23	8299-8304	No-Go	_	
41-24	8305-8308	ERP	_	
41-25	8309-8319	components	_	
41-26	8320-8323	and	_	
41-27	8324-8329	their	_	
41-28	8330-8343	developmental	_	
41-29	8344-8351	changes	_	
41-30	8352-8361	represent	_	
41-31	8362-8369	general	_	
41-32	8369-8370	,	_	
41-33	8371-8391	modality-independent	_	
41-34	8392-8398	neural	_	
41-35	8399-8409	processing	_	
41-36	8410-8420	underlying	_	
41-37	8421-8429	response	_	
41-38	8430-8440	inhibition	_	
41-39	8440-8441	.	_	

#Text=However, another study of children of 5–16 years of age reported an increase in both N2 and P3 components with age.
42-1	8442-8449	However	_	
42-2	8449-8450	,	_	
42-3	8451-8458	another	_	
42-4	8459-8464	study	_	
42-5	8465-8467	of	_	
42-6	8468-8476	children	_	
42-7	8477-8479	of	_	
42-8	8480-8481	5	_	
42-9	8481-8482	–	_	
42-10	8482-8484	16	_	
42-11	8485-8490	years	_	
42-12	8491-8493	of	_	
42-13	8494-8497	age	_	
42-14	8498-8506	reported	_	
42-15	8507-8509	an	_	
42-16	8510-8518	increase	_	
42-17	8519-8521	in	_	
42-18	8522-8526	both	_	
42-19	8527-8529	N2	_	
42-20	8530-8533	and	_	
42-21	8534-8536	P3	_	
42-22	8537-8547	components	_	
42-23	8548-8552	with	_	
42-24	8553-8556	age	_	
42-25	8556-8557	.	_	

#Text=This discrepancy may be related to task differences (the latter study involved using negative emotion induction) as well as small sample sizes in these studies.
43-1	8558-8562	This	_	
43-2	8563-8574	discrepancy	_	
43-3	8575-8578	may	_	
43-4	8579-8581	be	_	
43-5	8582-8589	related	_	
43-6	8590-8592	to	_	
43-7	8593-8597	task	_	
43-8	8598-8609	differences	_	
43-9	8610-8611	(	_	
43-10	8611-8614	the	_	
43-11	8615-8621	latter	_	
43-12	8622-8627	study	_	
43-13	8628-8636	involved	_	
43-14	8637-8642	using	_	
43-15	8643-8651	negative	_	
43-16	8652-8659	emotion	_	
43-17	8660-8669	induction	_	
43-18	8669-8670	)	_	
43-19	8671-8673	as	_	
43-20	8674-8678	well	_	
43-21	8679-8681	as	_	
43-22	8682-8687	small	_	
43-23	8688-8694	sample	_	
43-24	8695-8700	sizes	_	
43-25	8701-8703	in	_	
43-26	8704-8709	these	_	
43-27	8710-8717	studies	_	
43-28	8717-8718	.	_	

#Text=Overall, these studies suggest that neurophysiological mechanisms of response inhibition continue to develop during adolescence and even young adulthood, and suggest that No-Go N2 and P3 potentials may have distinct developmental trajectories.
44-1	8719-8726	Overall	_	
44-2	8726-8727	,	_	
44-3	8728-8733	these	_	
44-4	8734-8741	studies	_	
44-5	8742-8749	suggest	_	
44-6	8750-8754	that	_	
44-7	8755-8773	neurophysiological	_	
44-8	8774-8784	mechanisms	_	
44-9	8785-8787	of	_	
44-10	8788-8796	response	_	
44-11	8797-8807	inhibition	_	
44-12	8808-8816	continue	_	
44-13	8817-8819	to	_	
44-14	8820-8827	develop	_	
44-15	8828-8834	during	_	
44-16	8835-8846	adolescence	_	
44-17	8847-8850	and	_	
44-18	8851-8855	even	_	
44-19	8856-8861	young	_	
44-20	8862-8871	adulthood	_	
44-21	8871-8872	,	_	
44-22	8873-8876	and	_	
44-23	8877-8884	suggest	_	
44-24	8885-8889	that	_	
44-25	8890-8895	No-Go	_	
44-26	8896-8898	N2	_	
44-27	8899-8902	and	_	
44-28	8903-8905	P3	_	
44-29	8906-8916	potentials	_	
44-30	8917-8920	may	_	
44-31	8921-8925	have	_	
44-32	8926-8934	distinct	_	
44-33	8935-8948	developmental	_	
44-34	8949-8961	trajectories	_	
44-35	8961-8962	.	_	

#Text=Findings from developmental ERP studies are generally consistent with functional magnetic resonance imaging (fMRI) studies of response inhibition.
45-1	8963-8971	Findings	_	
45-2	8972-8976	from	_	
45-3	8977-8990	developmental	_	
45-4	8991-8994	ERP	_	
45-5	8995-9002	studies	_	
45-6	9003-9006	are	_	
45-7	9007-9016	generally	_	
45-8	9017-9027	consistent	_	
45-9	9028-9032	with	_	
45-10	9033-9043	functional	_	
45-11	9044-9052	magnetic	_	
45-12	9053-9062	resonance	_	
45-13	9063-9070	imaging	_	
45-14	9071-9072	(	_	
45-15	9072-9076	fMRI	_	
45-16	9076-9077	)	_	
45-17	9078-9085	studies	_	
45-18	9086-9088	of	_	
45-19	9089-9097	response	_	
45-20	9098-9108	inhibition	_	
45-21	9108-9109	.	_	

#Text=These studies suggest that functional activation underlying inhibitory control in lateral and medial frontal regions increases with age and provide evidence for increasing inter-regional connectivity within task-relevant fronto-striatal and fronto-parieto-temporal networks.
#Text=1.4.
46-1	9110-9115	These	_	
46-2	9116-9123	studies	_	
46-3	9124-9131	suggest	_	
46-4	9132-9136	that	_	
46-5	9137-9147	functional	_	
46-6	9148-9158	activation	_	
46-7	9159-9169	underlying	_	
46-8	9170-9180	inhibitory	_	
46-9	9181-9188	control	_	
46-10	9189-9191	in	_	
46-11	9192-9199	lateral	_	
46-12	9200-9203	and	_	
46-13	9204-9210	medial	_	
46-14	9211-9218	frontal	_	
46-15	9219-9226	regions	_	
46-16	9227-9236	increases	_	
46-17	9237-9241	with	_	
46-18	9242-9245	age	_	
46-19	9246-9249	and	_	
46-20	9250-9257	provide	_	
46-21	9258-9266	evidence	_	
46-22	9267-9270	for	_	
46-23	9271-9281	increasing	_	
46-24	9282-9296	inter-regional	_	
46-25	9297-9309	connectivity	_	
46-26	9310-9316	within	_	
46-27	9317-9330	task-relevant	_	
46-28	9331-9346	fronto-striatal	_	
46-29	9347-9350	and	_	
46-30	9351-9374	fronto-parieto-temporal	_	
46-31	9375-9383	networks	_	
46-32	9383-9384	.	_	
46-33	9385-9388	1.4	_	
46-34	9388-9389	.	_	

#Text=Neural correlates of response inhibition, Individual differences, and psychopathology
#Text=Deficits in response inhibition in adolescence are associated with increased risk for maladaptive behaviors and psychopathology, most notably, a range of “externalizing” neuropsychiatric disorders characterized by poor inhibitory control and impulsivity, such as ADHD, conduct and antisocial disorders, and substance abuse.
47-1	9390-9396	Neural	_	
47-2	9397-9407	correlates	_	
47-3	9408-9410	of	_	
47-4	9411-9419	response	_	
47-5	9420-9430	inhibition	_	
47-6	9430-9431	,	_	
47-7	9432-9442	Individual	_	
47-8	9443-9454	differences	_	
47-9	9454-9455	,	_	
47-10	9456-9459	and	_	
47-11	9460-9475	psychopathology	_	
47-12	9476-9484	Deficits	_	
47-13	9485-9487	in	_	
47-14	9488-9496	response	_	
47-15	9497-9507	inhibition	_	
47-16	9508-9510	in	_	
47-17	9511-9522	adolescence	_	
47-18	9523-9526	are	_	
47-19	9527-9537	associated	_	
47-20	9538-9542	with	_	
47-21	9543-9552	increased	_	
47-22	9553-9557	risk	_	
47-23	9558-9561	for	_	
47-24	9562-9573	maladaptive	_	
47-25	9574-9583	behaviors	_	
47-26	9584-9587	and	_	
47-27	9588-9603	psychopathology	_	
47-28	9603-9604	,	_	
47-29	9605-9609	most	_	
47-30	9610-9617	notably	_	
47-31	9617-9618	,	_	
47-32	9619-9620	a	_	
47-33	9621-9626	range	_	
47-34	9627-9629	of	_	
47-35	9630-9631	“	_	
47-36	9631-9644	externalizing	_	
47-37	9644-9645	”	_	
47-38	9646-9662	neuropsychiatric	_	
47-39	9663-9672	disorders	_	
47-40	9673-9686	characterized	_	
47-41	9687-9689	by	_	
47-42	9690-9694	poor	_	
47-43	9695-9705	inhibitory	_	
47-44	9706-9713	control	_	
47-45	9714-9717	and	_	
47-46	9718-9729	impulsivity	_	
47-47	9729-9730	,	_	
47-48	9731-9735	such	_	
47-49	9736-9738	as	_	
47-50	9739-9743	ADHD	_	
47-51	9743-9744	,	_	
47-52	9745-9752	conduct	_	
47-53	9753-9756	and	_	
47-54	9757-9767	antisocial	_	
47-55	9768-9777	disorders	_	
47-56	9777-9778	,	_	
47-57	9779-9782	and	_	
47-58	9783-9792	substance	_	
47-59	9793-9798	abuse	_	
47-60	9798-9799	.	_	

#Text=In particular, an influential theory of attention deficit and hyperactivity disorder (ADHD) posits that response inhibition deficit plays a central role in the disorder etiology, whereas deficits in working memory, attention, and emotional regulation can be secondary to inhibition deficit.
48-1	9800-9802	In	_	
48-2	9803-9813	particular	_	
48-3	9813-9814	,	_	
48-4	9815-9817	an	_	
48-5	9818-9829	influential	_	
48-6	9830-9836	theory	_	
48-7	9837-9839	of	_	
48-8	9840-9849	attention	_	
48-9	9850-9857	deficit	_	
48-10	9858-9861	and	_	
48-11	9862-9875	hyperactivity	_	
48-12	9876-9884	disorder	_	
48-13	9885-9886	(	_	
48-14	9886-9890	ADHD	_	
48-15	9890-9891	)	_	
48-16	9892-9898	posits	_	
48-17	9899-9903	that	_	
48-18	9904-9912	response	_	
48-19	9913-9923	inhibition	_	
48-20	9924-9931	deficit	_	
48-21	9932-9937	plays	_	
48-22	9938-9939	a	_	
48-23	9940-9947	central	_	
48-24	9948-9952	role	_	
48-25	9953-9955	in	_	
48-26	9956-9959	the	_	
48-27	9960-9968	disorder	_	
48-28	9969-9977	etiology	_	
48-29	9977-9978	,	_	
48-30	9979-9986	whereas	_	
48-31	9987-9995	deficits	_	
48-32	9996-9998	in	_	
48-33	9999-10006	working	_	
48-34	10007-10013	memory	_	
48-35	10013-10014	,	_	
48-36	10015-10024	attention	_	
48-37	10024-10025	,	_	
48-38	10026-10029	and	_	
48-39	10030-10039	emotional	_	
48-40	10040-10050	regulation	_	
48-41	10051-10054	can	_	
48-42	10055-10057	be	_	
48-43	10058-10067	secondary	_	
48-44	10068-10070	to	_	
48-45	10071-10081	inhibition	_	
48-46	10082-10089	deficit	_	
48-47	10089-10090	.	_	

#Text=Deficits in inhibitory control can be a common factor underlying a constellation of impulsive, disruptive, and reckless behaviors, demonstrated in many epidemiological studies and labeled as behavioral disinhibition, externalizing factor, or psychological dysregulation.
49-1	10091-10099	Deficits	_	
49-2	10100-10102	in	_	
49-3	10103-10113	inhibitory	_	
49-4	10114-10121	control	_	
49-5	10122-10125	can	_	
49-6	10126-10128	be	_	
49-7	10129-10130	a	_	
49-8	10131-10137	common	_	
49-9	10138-10144	factor	_	
49-10	10145-10155	underlying	_	
49-11	10156-10157	a	_	
49-12	10158-10171	constellation	_	
49-13	10172-10174	of	_	
49-14	10175-10184	impulsive	_	
49-15	10184-10185	,	_	
49-16	10186-10196	disruptive	_	
49-17	10196-10197	,	_	
49-18	10198-10201	and	_	
49-19	10202-10210	reckless	_	
49-20	10211-10220	behaviors	_	
49-21	10220-10221	,	_	
49-22	10222-10234	demonstrated	_	
49-23	10235-10237	in	_	
49-24	10238-10242	many	_	
49-25	10243-10258	epidemiological	_	
49-26	10259-10266	studies	_	
49-27	10267-10270	and	_	
49-28	10271-10278	labeled	_	
49-29	10279-10281	as	_	
49-30	10282-10292	behavioral	_	
49-31	10293-10306	disinhibition	_	
49-32	10306-10307	,	_	
49-33	10308-10321	externalizing	_	
49-34	10322-10328	factor	_	
49-35	10328-10329	,	_	
49-36	10330-10332	or	_	
49-37	10333-10346	psychological	_	
49-38	10347-10360	dysregulation	_	
49-39	10360-10361	.	_	

#Text=It is reasonable to expect that this spectrum of disinhibited behaviors is mediated by abnormalities in the neural mechanisms of RI, and increased prevalence of these behaviors during adolescence may be related to immaturity of the neurophysiological substrates of response inhibition due to their late development.
50-1	10362-10364	It	_	
50-2	10365-10367	is	_	
50-3	10368-10378	reasonable	_	
50-4	10379-10381	to	_	
50-5	10382-10388	expect	_	
50-6	10389-10393	that	_	
50-7	10394-10398	this	_	
50-8	10399-10407	spectrum	_	
50-9	10408-10410	of	_	
50-10	10411-10423	disinhibited	_	
50-11	10424-10433	behaviors	_	
50-12	10434-10436	is	_	
50-13	10437-10445	mediated	_	
50-14	10446-10448	by	_	
50-15	10449-10462	abnormalities	_	
50-16	10463-10465	in	_	
50-17	10466-10469	the	_	
50-18	10470-10476	neural	_	
50-19	10477-10487	mechanisms	_	
50-20	10488-10490	of	_	
50-21	10491-10493	RI	_	
50-22	10493-10494	,	_	
50-23	10495-10498	and	_	
50-24	10499-10508	increased	_	
50-25	10509-10519	prevalence	_	
50-26	10520-10522	of	_	
50-27	10523-10528	these	_	
50-28	10529-10538	behaviors	_	
50-29	10539-10545	during	_	
50-30	10546-10557	adolescence	_	
50-31	10558-10561	may	_	
50-32	10562-10564	be	_	
50-33	10565-10572	related	_	
50-34	10573-10575	to	_	
50-35	10576-10586	immaturity	_	
50-36	10587-10589	of	_	
50-37	10590-10593	the	_	
50-38	10594-10612	neurophysiological	_	
50-39	10613-10623	substrates	_	
50-40	10624-10626	of	_	
50-41	10627-10635	response	_	
50-42	10636-10646	inhibition	_	
50-43	10647-10650	due	_	
50-44	10651-10653	to	_	
50-45	10654-10659	their	_	
50-46	10660-10664	late	_	
50-47	10665-10676	development	_	
50-48	10676-10677	.	_	

#Text=This perspective on adolescent disinhibitory psychopathology is supported by evidence for abnormal No-Go N2 and P3 components in externalizing spectrum disorders.
51-1	10678-10682	This	_	
51-2	10683-10694	perspective	_	
51-3	10695-10697	on	_	
51-4	10698-10708	adolescent	_	
51-5	10709-10722	disinhibitory	_	
51-6	10723-10738	psychopathology	_	
51-7	10739-10741	is	_	
51-8	10742-10751	supported	_	
51-9	10752-10754	by	_	
51-10	10755-10763	evidence	_	
51-11	10764-10767	for	_	
51-12	10768-10776	abnormal	_	
51-13	10777-10782	No-Go	_	
51-14	10783-10785	N2	_	
51-15	10786-10789	and	_	
51-16	10790-10792	P3	_	
51-17	10793-10803	components	_	
51-18	10804-10806	in	_	
51-19	10807-10820	externalizing	_	
51-20	10821-10829	spectrum	_	
51-21	10830-10839	disorders	_	
51-22	10839-10840	.	_	

#Text=Reduced No-Go P3 has been reported in both children and adult individuals with ADHD.
52-1	10841-10848	Reduced	_	
52-2	10849-10854	No-Go	_	
52-3	10855-10857	P3	_	
52-4	10858-10861	has	_	
52-5	10862-10866	been	_	
52-6	10867-10875	reported	_	
52-7	10876-10878	in	_	
52-8	10879-10883	both	_	
52-9	10884-10892	children	_	
52-10	10893-10896	and	_	
52-11	10897-10902	adult	_	
52-12	10903-10914	individuals	_	
52-13	10915-10919	with	_	
52-14	10920-10924	ADHD	_	
52-15	10924-10925	.	_	

#Text=Abnormal No-Go ERP components have been found in children with externalizing disorders: the clinical sample had larger N2 magnitudes and smaller frontal P3 magnitudes compared with controls.
53-1	10926-10934	Abnormal	_	
53-2	10935-10940	No-Go	_	
53-3	10941-10944	ERP	_	
53-4	10945-10955	components	_	
53-5	10956-10960	have	_	
53-6	10961-10965	been	_	
53-7	10966-10971	found	_	
53-8	10972-10974	in	_	
53-9	10975-10983	children	_	
53-10	10984-10988	with	_	
53-11	10989-11002	externalizing	_	
53-12	11003-11012	disorders	_	
53-13	11012-11013	:	_	
53-14	11014-11017	the	_	
53-15	11018-11026	clinical	_	
53-16	11027-11033	sample	_	
53-17	11034-11037	had	_	
53-18	11038-11044	larger	_	
53-19	11045-11047	N2	_	
53-20	11048-11058	magnitudes	_	
53-21	11059-11062	and	_	
53-22	11063-11070	smaller	_	
53-23	11071-11078	frontal	_	
53-24	11079-11081	P3	_	
53-25	11082-11092	magnitudes	_	
53-26	11093-11101	compared	_	
53-27	11102-11106	with	_	
53-28	11107-11115	controls	_	
53-29	11115-11116	.	_	

#Text=A study of juvenile delinquents with antisocial personality characteristics reported amplitude reduction of both N2 and P3 No-Go components.
54-1	11117-11118	A	_	
54-2	11119-11124	study	_	
54-3	11125-11127	of	_	
54-4	11128-11136	juvenile	_	
54-5	11137-11148	delinquents	_	
54-6	11149-11153	with	_	
54-7	11154-11164	antisocial	_	
54-8	11165-11176	personality	_	
54-9	11177-11192	characteristics	_	
54-10	11193-11201	reported	_	
54-11	11202-11211	amplitude	_	
54-12	11212-11221	reduction	_	
54-13	11222-11224	of	_	
54-14	11225-11229	both	_	
54-15	11230-11232	N2	_	
54-16	11233-11236	and	_	
54-17	11237-11239	P3	_	
54-18	11240-11245	No-Go	_	
54-19	11246-11256	components	_	
54-20	11256-11257	.	_	

#Text=A study of adult psychopaths showed a marked reduction of the N2 component and a lack of No-Go P3 effect, with psychopaths showing the opposite direction of the Go versus No-Go difference compared to controls.
55-1	11258-11259	A	_	
55-2	11260-11265	study	_	
55-3	11266-11268	of	_	
55-4	11269-11274	adult	_	
55-5	11275-11286	psychopaths	_	
55-6	11287-11293	showed	_	
55-7	11294-11295	a	_	
55-8	11296-11302	marked	_	
55-9	11303-11312	reduction	_	
55-10	11313-11315	of	_	
55-11	11316-11319	the	_	
55-12	11320-11322	N2	_	
55-13	11323-11332	component	_	
55-14	11333-11336	and	_	
55-15	11337-11338	a	_	
55-16	11339-11343	lack	_	
55-17	11344-11346	of	_	
55-18	11347-11352	No-Go	_	
55-19	11353-11355	P3	_	
55-20	11356-11362	effect	_	
55-21	11362-11363	,	_	
55-22	11364-11368	with	_	
55-23	11369-11380	psychopaths	_	
55-24	11381-11388	showing	_	
55-25	11389-11392	the	_	
55-26	11393-11401	opposite	_	
55-27	11402-11411	direction	_	
55-28	11412-11414	of	_	
55-29	11415-11418	the	_	
55-30	11419-11421	Go	_	
55-31	11422-11428	versus	_	
55-32	11429-11434	No-Go	_	
55-33	11435-11445	difference	_	
55-34	11446-11454	compared	_	
55-35	11455-11457	to	_	
55-36	11458-11466	controls	_	
55-37	11466-11467	.	_	

#Text=These results of ERP studies converge with findings from fMRI studies of response inhibition showing reduced activation of inhibition-related network in adolescent substance users.
56-1	11468-11473	These	_	
56-2	11474-11481	results	_	
56-3	11482-11484	of	_	
56-4	11485-11488	ERP	_	
56-5	11489-11496	studies	_	
56-6	11497-11505	converge	_	
56-7	11506-11510	with	_	
56-8	11511-11519	findings	_	
56-9	11520-11524	from	_	
56-10	11525-11529	fMRI	_	
56-11	11530-11537	studies	_	
56-12	11538-11540	of	_	
56-13	11541-11549	response	_	
56-14	11550-11560	inhibition	_	
56-15	11561-11568	showing	_	
56-16	11569-11576	reduced	_	
56-17	11577-11587	activation	_	
56-18	11588-11590	of	_	
56-19	11591-11609	inhibition-related	_	
56-20	11610-11617	network	_	
56-21	11618-11620	in	_	
56-22	11621-11631	adolescent	_	
56-23	11632-11641	substance	_	
56-24	11642-11647	users	_	
56-25	11647-11648	.	_	

#Text=Furthermore, behavioral correlates of altered neural mechanisms of response inhibition as indicated by No-Go ERPs are not limited to externalizing-spectrum behaviors: inhibitory deficits may be associated with a broader range of behaviors characterized by poor self-control such as overeating, as evidenced by the finding of reduced No-Go P3 component and its diminished anteriorization in obese children, which was paralleled by poorer inhibitory performance.
57-1	11649-11660	Furthermore	_	
57-2	11660-11661	,	_	
57-3	11662-11672	behavioral	_	
57-4	11673-11683	correlates	_	
57-5	11684-11686	of	_	
57-6	11687-11694	altered	_	
57-7	11695-11701	neural	_	
57-8	11702-11712	mechanisms	_	
57-9	11713-11715	of	_	
57-10	11716-11724	response	_	
57-11	11725-11735	inhibition	_	
57-12	11736-11738	as	_	
57-13	11739-11748	indicated	_	
57-14	11749-11751	by	_	
57-15	11752-11757	No-Go	_	
57-16	11758-11762	ERPs	_	
57-17	11763-11766	are	_	
57-18	11767-11770	not	_	
57-19	11771-11778	limited	_	
57-20	11779-11781	to	_	
57-21	11782-11804	externalizing-spectrum	_	
57-22	11805-11814	behaviors	_	
57-23	11814-11815	:	_	
57-24	11816-11826	inhibitory	_	
57-25	11827-11835	deficits	_	
57-26	11836-11839	may	_	
57-27	11840-11842	be	_	
57-28	11843-11853	associated	_	
57-29	11854-11858	with	_	
57-30	11859-11860	a	_	
57-31	11861-11868	broader	_	
57-32	11869-11874	range	_	
57-33	11875-11877	of	_	
57-34	11878-11887	behaviors	_	
57-35	11888-11901	characterized	_	
57-36	11902-11904	by	_	
57-37	11905-11909	poor	_	
57-38	11910-11922	self-control	_	
57-39	11923-11927	such	_	
57-40	11928-11930	as	_	
57-41	11931-11941	overeating	_	
57-42	11941-11942	,	_	
57-43	11943-11945	as	_	
57-44	11946-11955	evidenced	_	
57-45	11956-11958	by	_	
57-46	11959-11962	the	_	
57-47	11963-11970	finding	_	
57-48	11971-11973	of	_	
57-49	11974-11981	reduced	_	
57-50	11982-11987	No-Go	_	
57-51	11988-11990	P3	_	
57-52	11991-12000	component	_	
57-53	12001-12004	and	_	
57-54	12005-12008	its	_	
57-55	12009-12019	diminished	_	
57-56	12020-12035	anteriorization	_	
57-57	12036-12038	in	_	
57-58	12039-12044	obese	_	
57-59	12045-12053	children	_	
57-60	12053-12054	,	_	
57-61	12055-12060	which	_	
57-62	12061-12064	was	_	
57-63	12065-12075	paralleled	_	
57-64	12076-12078	by	_	
57-65	12079-12085	poorer	_	
57-66	12086-12096	inhibitory	_	
57-67	12097-12108	performance	_	
57-68	12108-12109	.	_	

#Text=However, the opposite extreme, i.e. overactive response inhibition-related neural activation is not necessarily beneficial: an ERP study in children suggested that increased N2 (linked to the anterior cingulate cortical activity in that study) might be a biomarker inhibited social behavior and increased risk for later anxiety problems.
58-1	12110-12117	However	_	
58-2	12117-12118	,	_	
58-3	12119-12122	the	_	
58-4	12123-12131	opposite	_	
58-5	12132-12139	extreme	_	
58-6	12139-12140	,	_	
58-7	12141-12144	i.e	_	
58-8	12144-12145	.	_	
58-9	12146-12156	overactive	_	
58-10	12157-12165	response	_	
58-11	12166-12184	inhibition-related	_	
58-12	12185-12191	neural	_	
58-13	12192-12202	activation	_	
58-14	12203-12205	is	_	
58-15	12206-12209	not	_	
58-16	12210-12221	necessarily	_	
58-17	12222-12232	beneficial	_	
58-18	12232-12233	:	_	
58-19	12234-12236	an	_	
58-20	12237-12240	ERP	_	
58-21	12241-12246	study	_	
58-22	12247-12249	in	_	
58-23	12250-12258	children	_	
58-24	12259-12268	suggested	_	
58-25	12269-12273	that	_	
58-26	12274-12283	increased	_	
58-27	12284-12286	N2	_	
58-28	12287-12288	(	_	
58-29	12288-12294	linked	_	
58-30	12295-12297	to	_	
58-31	12298-12301	the	_	
58-32	12302-12310	anterior	_	
58-33	12311-12320	cingulate	_	
58-34	12321-12329	cortical	_	
58-35	12330-12338	activity	_	
58-36	12339-12341	in	_	
58-37	12342-12346	that	_	
58-38	12347-12352	study	_	
58-39	12352-12353	)	_	
58-40	12354-12359	might	_	
58-41	12360-12362	be	_	
58-42	12363-12364	a	_	
58-43	12365-12374	biomarker	_	
58-44	12375-12384	inhibited	_	
58-45	12385-12391	social	_	
58-46	12392-12400	behavior	_	
58-47	12401-12404	and	_	
58-48	12405-12414	increased	_	
58-49	12415-12419	risk	_	
58-50	12420-12423	for	_	
58-51	12424-12429	later	_	
58-52	12430-12437	anxiety	_	
58-53	12438-12446	problems	_	
58-54	12446-12447	.	_	

#Text=Taken together, these data suggest a possibility that an intermediate level of inhibition-related activity may be most beneficial for adaptive behavior because it provides an optimal combination of control and flexibility of response production and suppression.
59-1	12448-12453	Taken	_	
59-2	12454-12462	together	_	
59-3	12462-12463	,	_	
59-4	12464-12469	these	_	
59-5	12470-12474	data	_	
59-6	12475-12482	suggest	_	
59-7	12483-12484	a	_	
59-8	12485-12496	possibility	_	
59-9	12497-12501	that	_	
59-10	12502-12504	an	_	
59-11	12505-12517	intermediate	_	
59-12	12518-12523	level	_	
59-13	12524-12526	of	_	
59-14	12527-12545	inhibition-related	_	
59-15	12546-12554	activity	_	
59-16	12555-12558	may	_	
59-17	12559-12561	be	_	
59-18	12562-12566	most	_	
59-19	12567-12577	beneficial	_	
59-20	12578-12581	for	_	
59-21	12582-12590	adaptive	_	
59-22	12591-12599	behavior	_	
59-23	12600-12607	because	_	
59-24	12608-12610	it	_	
59-25	12611-12619	provides	_	
59-26	12620-12622	an	_	
59-27	12623-12630	optimal	_	
59-28	12631-12642	combination	_	
59-29	12643-12645	of	_	
59-30	12646-12653	control	_	
59-31	12654-12657	and	_	
59-32	12658-12669	flexibility	_	
59-33	12670-12672	of	_	
59-34	12673-12681	response	_	
59-35	12682-12692	production	_	
59-36	12693-12696	and	_	
59-37	12697-12708	suppression	_	
59-38	12708-12709	.	_	

#Text=The relationships between neural mechanisms of response inhibition and individual differences in normal-range behavior remains unclear due to the scarcity of studies, especially those using developmental designs.
60-1	12710-12713	The	_	
60-2	12714-12727	relationships	_	
60-3	12728-12735	between	_	
60-4	12736-12742	neural	_	
60-5	12743-12753	mechanisms	_	
60-6	12754-12756	of	_	
60-7	12757-12765	response	_	
60-8	12766-12776	inhibition	_	
60-9	12777-12780	and	_	
60-10	12781-12791	individual	_	
60-11	12792-12803	differences	_	
60-12	12804-12806	in	_	
60-13	12807-12819	normal-range	_	
60-14	12820-12828	behavior	_	
60-15	12829-12836	remains	_	
60-16	12837-12844	unclear	_	
60-17	12845-12848	due	_	
60-18	12849-12851	to	_	
60-19	12852-12855	the	_	
60-20	12856-12864	scarcity	_	
60-21	12865-12867	of	_	
60-22	12868-12875	studies	_	
60-23	12875-12876	,	_	
60-24	12877-12887	especially	_	
60-25	12888-12893	those	_	
60-26	12894-12899	using	_	
60-27	12900-12913	developmental	_	
60-28	12914-12921	designs	_	
60-29	12921-12922	.	_	

#Text=Finally, emerging evidence suggests that abnormalities in ERP correlates of response inhibition may be associated with familial and, presumably, genetic risk for addictive disorders. reported significantly reduced No-Go P3 along with the relatively less anteriorized topography in alcoholics.
61-1	12923-12930	Finally	_	
61-2	12930-12931	,	_	
61-3	12932-12940	emerging	_	
61-4	12941-12949	evidence	_	
61-5	12950-12958	suggests	_	
61-6	12959-12963	that	_	
61-7	12964-12977	abnormalities	_	
61-8	12978-12980	in	_	
61-9	12981-12984	ERP	_	
61-10	12985-12995	correlates	_	
61-11	12996-12998	of	_	
61-12	12999-13007	response	_	
61-13	13008-13018	inhibition	_	
61-14	13019-13022	may	_	
61-15	13023-13025	be	_	
61-16	13026-13036	associated	_	
61-17	13037-13041	with	_	
61-18	13042-13050	familial	_	
61-19	13051-13054	and	_	
61-20	13054-13055	,	_	
61-21	13056-13066	presumably	_	
61-22	13066-13067	,	_	
61-23	13068-13075	genetic	_	
61-24	13076-13080	risk	_	
61-25	13081-13084	for	_	
61-26	13085-13094	addictive	_	
61-27	13095-13104	disorders	_	
61-28	13104-13105	.	_	
61-29	13106-13114	reported	_	
61-30	13115-13128	significantly	_	
61-31	13129-13136	reduced	_	
61-32	13137-13142	No-Go	_	
61-33	13143-13145	P3	_	
61-34	13146-13151	along	_	
61-35	13152-13156	with	_	
61-36	13157-13160	the	_	
61-37	13161-13171	relatively	_	
61-38	13172-13176	less	_	
61-39	13177-13189	anteriorized	_	
61-40	13190-13200	topography	_	
61-41	13201-13203	in	_	
61-42	13204-13214	alcoholics	_	
61-43	13214-13215	.	_	

#Text=Further analysis of ERPs in family members of alcoholic probands revealed a similar deficit in offspring of alcoholics, suggesting that reduced No-Go P3 can be an endophenotypic marker of risk for the development of alcoholism and related disorders.
62-1	13216-13223	Further	_	
62-2	13224-13232	analysis	_	
62-3	13233-13235	of	_	
62-4	13236-13240	ERPs	_	
62-5	13241-13243	in	_	
62-6	13244-13250	family	_	
62-7	13251-13258	members	_	
62-8	13259-13261	of	_	
62-9	13262-13271	alcoholic	_	
62-10	13272-13280	probands	_	
62-11	13281-13289	revealed	_	
62-12	13290-13291	a	_	
62-13	13292-13299	similar	_	
62-14	13300-13307	deficit	_	
62-15	13308-13310	in	_	
62-16	13311-13320	offspring	_	
62-17	13321-13323	of	_	
62-18	13324-13334	alcoholics	_	
62-19	13334-13335	,	_	
62-20	13336-13346	suggesting	_	
62-21	13347-13351	that	_	
62-22	13352-13359	reduced	_	
62-23	13360-13365	No-Go	_	
62-24	13366-13368	P3	_	
62-25	13369-13372	can	_	
62-26	13373-13375	be	_	
62-27	13376-13378	an	_	
62-28	13379-13393	endophenotypic	_	
62-29	13394-13400	marker	_	
62-30	13401-13403	of	_	
62-31	13404-13408	risk	_	
62-32	13409-13412	for	_	
62-33	13413-13416	the	_	
62-34	13417-13428	development	_	
62-35	13429-13431	of	_	
62-36	13432-13442	alcoholism	_	
62-37	13443-13446	and	_	
62-38	13447-13454	related	_	
62-39	13455-13464	disorders	_	
62-40	13464-13465	.	_	

#Text=In summary, No-Go P3 showed more consistent impairments in clinical and at-risk populations, whereas findings for N2 have been more variable.
#Text=1.5.
63-1	13466-13468	In	_	
63-2	13469-13476	summary	_	
63-3	13476-13477	,	_	
63-4	13478-13483	No-Go	_	
63-5	13484-13486	P3	_	
63-6	13487-13493	showed	_	
63-7	13494-13498	more	_	
63-8	13499-13509	consistent	_	
63-9	13510-13521	impairments	_	
63-10	13522-13524	in	_	
63-11	13525-13533	clinical	_	
63-12	13534-13537	and	_	
63-13	13538-13545	at-risk	_	
63-14	13546-13557	populations	_	
63-15	13557-13558	,	_	
63-16	13559-13566	whereas	_	
63-17	13567-13575	findings	_	
63-18	13576-13579	for	_	
63-19	13580-13582	N2	_	
63-20	13583-13587	have	_	
63-21	13588-13592	been	_	
63-22	13593-13597	more	_	
63-23	13598-13606	variable	_	
63-24	13606-13607	.	_	
63-25	13608-13611	1.5	_	
63-26	13611-13612	.	_	

#Text=Response inhibition-related ERPs as intermediate phenotypes linking genes and behavior
#Text=Numerous twin, family, and adoption studies demonstrated that individual differences in personality, behavior, and psychopathology are strongly influenced by genetic factors.
64-1	13613-13621	Response	_	
64-2	13622-13640	inhibition-related	_	
64-3	13641-13645	ERPs	_	
64-4	13646-13648	as	_	
64-5	13649-13661	intermediate	_	
64-6	13662-13672	phenotypes	_	
64-7	13673-13680	linking	_	
64-8	13681-13686	genes	_	
64-9	13687-13690	and	_	
64-10	13691-13699	behavior	_	
64-11	13700-13708	Numerous	_	
64-12	13709-13713	twin	_	
64-13	13713-13714	,	_	
64-14	13715-13721	family	_	
64-15	13721-13722	,	_	
64-16	13723-13726	and	_	
64-17	13727-13735	adoption	_	
64-18	13736-13743	studies	_	
64-19	13744-13756	demonstrated	_	
64-20	13757-13761	that	_	
64-21	13762-13772	individual	_	
64-22	13773-13784	differences	_	
64-23	13785-13787	in	_	
64-24	13788-13799	personality	_	
64-25	13799-13800	,	_	
64-26	13801-13809	behavior	_	
64-27	13809-13810	,	_	
64-28	13811-13814	and	_	
64-29	13815-13830	psychopathology	_	
64-30	13831-13834	are	_	
64-31	13835-13843	strongly	_	
64-32	13844-13854	influenced	_	
64-33	13855-13857	by	_	
64-34	13858-13865	genetic	_	
64-35	13866-13873	factors	_	
64-36	13873-13874	.	_	

#Text=However, efforts to identify specific genes so far yielded modest results; furthermore, when such genes are identified, the mechanisms by which they influence behavioral phenotypes remain largely unknown.
65-1	13875-13882	However	_	
65-2	13882-13883	,	_	
65-3	13884-13891	efforts	_	
65-4	13892-13894	to	_	
65-5	13895-13903	identify	_	
65-6	13904-13912	specific	_	
65-7	13913-13918	genes	_	
65-8	13919-13921	so	_	
65-9	13922-13925	far	_	
65-10	13926-13933	yielded	_	
65-11	13934-13940	modest	_	
65-12	13941-13948	results	_	
65-13	13948-13949	;	_	
65-14	13950-13961	furthermore	_	
65-15	13961-13962	,	_	
65-16	13963-13967	when	_	
65-17	13968-13972	such	_	
65-18	13973-13978	genes	_	
65-19	13979-13982	are	_	
65-20	13983-13993	identified	_	
65-21	13993-13994	,	_	
65-22	13995-13998	the	_	
65-23	13999-14009	mechanisms	_	
65-24	14010-14012	by	_	
65-25	14013-14018	which	_	
65-26	14019-14023	they	_	
65-27	14024-14033	influence	_	
65-28	14034-14044	behavioral	_	
65-29	14045-14055	phenotypes	_	
65-30	14056-14062	remain	_	
65-31	14063-14070	largely	_	
65-32	14071-14078	unknown	_	
65-33	14078-14079	.	_	

#Text=It has been suggested that these issues can be addressed by shifting the focus of genetic studies from complex (and likely heterogeneous) behavioral phenotypes to brain-based intermediate phenotypes, sometimes referred to as “endophenotypes”.
66-1	14080-14082	It	_	
66-2	14083-14086	has	_	
66-3	14087-14091	been	_	
66-4	14092-14101	suggested	_	
66-5	14102-14106	that	_	
66-6	14107-14112	these	_	
66-7	14113-14119	issues	_	
66-8	14120-14123	can	_	
66-9	14124-14126	be	_	
66-10	14127-14136	addressed	_	
66-11	14137-14139	by	_	
66-12	14140-14148	shifting	_	
66-13	14149-14152	the	_	
66-14	14153-14158	focus	_	
66-15	14159-14161	of	_	
66-16	14162-14169	genetic	_	
66-17	14170-14177	studies	_	
66-18	14178-14182	from	_	
66-19	14183-14190	complex	_	
66-20	14191-14192	(	_	
66-21	14192-14195	and	_	
66-22	14196-14202	likely	_	
66-23	14203-14216	heterogeneous	_	
66-24	14216-14217	)	_	
66-25	14218-14228	behavioral	_	
66-26	14229-14239	phenotypes	_	
66-27	14240-14242	to	_	
66-28	14243-14254	brain-based	_	
66-29	14255-14267	intermediate	_	
66-30	14268-14278	phenotypes	_	
66-31	14278-14279	,	_	
66-32	14280-14289	sometimes	_	
66-33	14290-14298	referred	_	
66-34	14299-14301	to	_	
66-35	14302-14304	as	_	
66-36	14305-14306	“	_	
66-37	14306-14320	endophenotypes	_	
66-38	14320-14321	”	_	
66-39	14321-14322	.	_	

#Text=By focusing on neurobiological processes that are more proximal to immediate effects of genes than complex behavioral phenotypes, this approach may both facilitate the identification of relevant genes and, most importantly, clarify the mechanisms and pathways mediating the effects of these genes on behavior.
67-1	14323-14325	By	_	
67-2	14326-14334	focusing	_	
67-3	14335-14337	on	_	
67-4	14338-14353	neurobiological	_	
67-5	14354-14363	processes	_	
67-6	14364-14368	that	_	
67-7	14369-14372	are	_	
67-8	14373-14377	more	_	
67-9	14378-14386	proximal	_	
67-10	14387-14389	to	_	
67-11	14390-14399	immediate	_	
67-12	14400-14407	effects	_	
67-13	14408-14410	of	_	
67-14	14411-14416	genes	_	
67-15	14417-14421	than	_	
67-16	14422-14429	complex	_	
67-17	14430-14440	behavioral	_	
67-18	14441-14451	phenotypes	_	
67-19	14451-14452	,	_	
67-20	14453-14457	this	_	
67-21	14458-14466	approach	_	
67-22	14467-14470	may	_	
67-23	14471-14475	both	_	
67-24	14476-14486	facilitate	_	
67-25	14487-14490	the	_	
67-26	14491-14505	identification	_	
67-27	14506-14508	of	_	
67-28	14509-14517	relevant	_	
67-29	14518-14523	genes	_	
67-30	14524-14527	and	_	
67-31	14527-14528	,	_	
67-32	14529-14533	most	_	
67-33	14534-14545	importantly	_	
67-34	14545-14546	,	_	
67-35	14547-14554	clarify	_	
67-36	14555-14558	the	_	
67-37	14559-14569	mechanisms	_	
67-38	14570-14573	and	_	
67-39	14574-14582	pathways	_	
67-40	14583-14592	mediating	_	
67-41	14593-14596	the	_	
67-42	14597-14604	effects	_	
67-43	14605-14607	of	_	
67-44	14608-14613	these	_	
67-45	14614-14619	genes	_	
67-46	14620-14622	on	_	
67-47	14623-14631	behavior	_	
67-48	14631-14632	.	_	

#Text=One important attribute of such an intermediate phenotype is heritability.
68-1	14633-14636	One	_	
68-2	14637-14646	important	_	
68-3	14647-14656	attribute	_	
68-4	14657-14659	of	_	
68-5	14660-14664	such	_	
68-6	14665-14667	an	_	
68-7	14668-14680	intermediate	_	
68-8	14681-14690	phenotype	_	
68-9	14691-14693	is	_	
68-10	14694-14706	heritability	_	
68-11	14706-14707	.	_	

#Text=We have previously demonstrated significant heritability of No-Go N2 and P3 components in adults and proposed that these neural markers of response inhibition can serve as endophenotypes for genetic studies of disorders characterized by neurobehavioral disinhibition.
69-1	14708-14710	We	_	
69-2	14711-14715	have	_	
69-3	14716-14726	previously	_	
69-4	14727-14739	demonstrated	_	
69-5	14740-14751	significant	_	
69-6	14752-14764	heritability	_	
69-7	14765-14767	of	_	
69-8	14768-14773	No-Go	_	
69-9	14774-14776	N2	_	
69-10	14777-14780	and	_	
69-11	14781-14783	P3	_	
69-12	14784-14794	components	_	
69-13	14795-14797	in	_	
69-14	14798-14804	adults	_	
69-15	14805-14808	and	_	
69-16	14809-14817	proposed	_	
69-17	14818-14822	that	_	
69-18	14823-14828	these	_	
69-19	14829-14835	neural	_	
69-20	14836-14843	markers	_	
69-21	14844-14846	of	_	
69-22	14847-14855	response	_	
69-23	14856-14866	inhibition	_	
69-24	14867-14870	can	_	
69-25	14871-14876	serve	_	
69-26	14877-14879	as	_	
69-27	14880-14894	endophenotypes	_	
69-28	14895-14898	for	_	
69-29	14899-14906	genetic	_	
69-30	14907-14914	studies	_	
69-31	14915-14917	of	_	
69-32	14918-14927	disorders	_	
69-33	14928-14941	characterized	_	
69-34	14942-14944	by	_	
69-35	14945-14960	neurobehavioral	_	
69-36	14961-14974	disinhibition	_	
69-37	14974-14975	.	_	

#Text=However, little is known about heritability of the neural correlates of response inhibition during adolescence.
70-1	14976-14983	However	_	
70-2	14983-14984	,	_	
70-3	14985-14991	little	_	
70-4	14992-14994	is	_	
70-5	14995-15000	known	_	
70-6	15001-15006	about	_	
70-7	15007-15019	heritability	_	
70-8	15020-15022	of	_	
70-9	15023-15026	the	_	
70-10	15027-15033	neural	_	
70-11	15034-15044	correlates	_	
70-12	15045-15047	of	_	
70-13	15048-15056	response	_	
70-14	15057-15067	inhibition	_	
70-15	15068-15074	during	_	
70-16	15075-15086	adolescence	_	
70-17	15086-15087	.	_	

#Text=This is a significant gap in knowledge because this developmental period is characterized by relative immaturity of the prefrontal cortex and increased risk for impulse control disorders.
71-1	15088-15092	This	_	
71-2	15093-15095	is	_	
71-3	15096-15097	a	_	
71-4	15098-15109	significant	_	
71-5	15110-15113	gap	_	
71-6	15114-15116	in	_	
71-7	15117-15126	knowledge	_	
71-8	15127-15134	because	_	
71-9	15135-15139	this	_	
71-10	15140-15153	developmental	_	
71-11	15154-15160	period	_	
71-12	15161-15163	is	_	
71-13	15164-15177	characterized	_	
71-14	15178-15180	by	_	
71-15	15181-15189	relative	_	
71-16	15190-15200	immaturity	_	
71-17	15201-15203	of	_	
71-18	15204-15207	the	_	
71-19	15208-15218	prefrontal	_	
71-20	15219-15225	cortex	_	
71-21	15226-15229	and	_	
71-22	15230-15239	increased	_	
71-23	15240-15244	risk	_	
71-24	15245-15248	for	_	
71-25	15249-15256	impulse	_	
71-26	15257-15264	control	_	
71-27	15265-15274	disorders	_	
71-28	15274-15275	.	_	

#Text=Therefore, understanding the developmental course of the neural mechanisms of response inhibition and their genetic end environmental determinants can provide important knowledge about the etiological mechanisms of these disorders.
#Text=1.6.
72-1	15276-15285	Therefore	_	
72-2	15285-15286	,	_	
72-3	15287-15300	understanding	_	
72-4	15301-15304	the	_	
72-5	15305-15318	developmental	_	
72-6	15319-15325	course	_	
72-7	15326-15328	of	_	
72-8	15329-15332	the	_	
72-9	15333-15339	neural	_	
72-10	15340-15350	mechanisms	_	
72-11	15351-15353	of	_	
72-12	15354-15362	response	_	
72-13	15363-15373	inhibition	_	
72-14	15374-15377	and	_	
72-15	15378-15383	their	_	
72-16	15384-15391	genetic	_	
72-17	15392-15395	end	_	
72-18	15396-15409	environmental	_	
72-19	15410-15422	determinants	_	
72-20	15423-15426	can	_	
72-21	15427-15434	provide	_	
72-22	15435-15444	important	_	
72-23	15445-15454	knowledge	_	
72-24	15455-15460	about	_	
72-25	15461-15464	the	_	
72-26	15465-15476	etiological	_	
72-27	15477-15487	mechanisms	_	
72-28	15488-15490	of	_	
72-29	15491-15496	these	_	
72-30	15497-15506	disorders	_	
72-31	15506-15507	.	_	
72-32	15508-15511	1.6	_	
72-33	15511-15512	.	_	

#Text=Integration of genetic and developmental approaches and aims of the present study
#Text=Investigation of genetic influences during a period of active development presents a number of challenges due to complex interplay between developmental and genetic factors.
73-1	15513-15524	Integration	_	
73-2	15525-15527	of	_	
73-3	15528-15535	genetic	_	
73-4	15536-15539	and	_	
73-5	15540-15553	developmental	_	
73-6	15554-15564	approaches	_	
73-7	15565-15568	and	_	
73-8	15569-15573	aims	_	
73-9	15574-15576	of	_	
73-10	15577-15580	the	_	
73-11	15581-15588	present	_	
73-12	15589-15594	study	_	
73-13	15595-15608	Investigation	_	
73-14	15609-15611	of	_	
73-15	15612-15619	genetic	_	
73-16	15620-15630	influences	_	
73-17	15631-15637	during	_	
73-18	15638-15639	a	_	
73-19	15640-15646	period	_	
73-20	15647-15649	of	_	
73-21	15650-15656	active	_	
73-22	15657-15668	development	_	
73-23	15669-15677	presents	_	
73-24	15678-15679	a	_	
73-25	15680-15686	number	_	
73-26	15687-15689	of	_	
73-27	15690-15700	challenges	_	
73-28	15701-15704	due	_	
73-29	15705-15707	to	_	
73-30	15708-15715	complex	_	
73-31	15716-15725	interplay	_	
73-32	15726-15733	between	_	
73-33	15734-15747	developmental	_	
73-34	15748-15751	and	_	
73-35	15752-15759	genetic	_	
73-36	15760-15767	factors	_	
73-37	15767-15768	.	_	

#Text=First, the role of genetic factors may change with development (change of heritability).
74-1	15769-15774	First	_	
74-2	15774-15775	,	_	
74-3	15776-15779	the	_	
74-4	15780-15784	role	_	
74-5	15785-15787	of	_	
74-6	15788-15795	genetic	_	
74-7	15796-15803	factors	_	
74-8	15804-15807	may	_	
74-9	15808-15814	change	_	
74-10	15815-15819	with	_	
74-11	15820-15831	development	_	
74-12	15832-15833	(	_	
74-13	15833-15839	change	_	
74-14	15840-15842	of	_	
74-15	15843-15855	heritability	_	
74-16	15855-15856	)	_	
74-17	15856-15857	.	_	

#Text=Furthermore, the structure of genetic influences may also change with development: some genes influencing inhibition may be expressed at one but not another developmental stage (change in genetic architecture).
75-1	15858-15869	Furthermore	_	
75-2	15869-15870	,	_	
75-3	15871-15874	the	_	
75-4	15875-15884	structure	_	
75-5	15885-15887	of	_	
75-6	15888-15895	genetic	_	
75-7	15896-15906	influences	_	
75-8	15907-15910	may	_	
75-9	15911-15915	also	_	
75-10	15916-15922	change	_	
75-11	15923-15927	with	_	
75-12	15928-15939	development	_	
75-13	15939-15940	:	_	
75-14	15941-15945	some	_	
75-15	15946-15951	genes	_	
75-16	15952-15963	influencing	_	
75-17	15964-15974	inhibition	_	
75-18	15975-15978	may	_	
75-19	15979-15981	be	_	
75-20	15982-15991	expressed	_	
75-21	15992-15994	at	_	
75-22	15995-15998	one	_	
75-23	15999-16002	but	_	
75-24	16003-16006	not	_	
75-25	16007-16014	another	_	
75-26	16015-16028	developmental	_	
75-27	16029-16034	stage	_	
75-28	16035-16036	(	_	
75-29	16036-16042	change	_	
75-30	16043-16045	in	_	
75-31	16046-16053	genetic	_	
75-32	16054-16066	architecture	_	
75-33	16066-16067	)	_	
75-34	16067-16068	.	_	

#Text=Consequently, even when genetic influences are of the same magnitude at different ages, the nature of these genetic influences (i.e. the set of genes influencing the phenotype) may be different: some genes may be active only at earlier stages of development and then “turned off”, while others may become active at later developmental stages.
76-1	16069-16081	Consequently	_	
76-2	16081-16082	,	_	
76-3	16083-16087	even	_	
76-4	16088-16092	when	_	
76-5	16093-16100	genetic	_	
76-6	16101-16111	influences	_	
76-7	16112-16115	are	_	
76-8	16116-16118	of	_	
76-9	16119-16122	the	_	
76-10	16123-16127	same	_	
76-11	16128-16137	magnitude	_	
76-12	16138-16140	at	_	
76-13	16141-16150	different	_	
76-14	16151-16155	ages	_	
76-15	16155-16156	,	_	
76-16	16157-16160	the	_	
76-17	16161-16167	nature	_	
76-18	16168-16170	of	_	
76-19	16171-16176	these	_	
76-20	16177-16184	genetic	_	
76-21	16185-16195	influences	_	
76-22	16196-16197	(	_	
76-23	16197-16200	i.e	_	
76-24	16200-16201	.	_	
76-25	16202-16205	the	_	
76-26	16206-16209	set	_	
76-27	16210-16212	of	_	
76-28	16213-16218	genes	_	
76-29	16219-16230	influencing	_	
76-30	16231-16234	the	_	
76-31	16235-16244	phenotype	_	
76-32	16244-16245	)	_	
76-33	16246-16249	may	_	
76-34	16250-16252	be	_	
76-35	16253-16262	different	_	
76-36	16262-16263	:	_	
76-37	16264-16268	some	_	
76-38	16269-16274	genes	_	
76-39	16275-16278	may	_	
76-40	16279-16281	be	_	
76-41	16282-16288	active	_	
76-42	16289-16293	only	_	
76-43	16294-16296	at	_	
76-44	16297-16304	earlier	_	
76-45	16305-16311	stages	_	
76-46	16312-16314	of	_	
76-47	16315-16326	development	_	
76-48	16327-16330	and	_	
76-49	16331-16335	then	_	
76-50	16336-16337	“	_	
76-51	16337-16343	turned	_	
76-52	16344-16347	off	_	
76-53	16347-16348	”	_	
76-54	16348-16349	,	_	
76-55	16350-16355	while	_	
76-56	16356-16362	others	_	
76-57	16363-16366	may	_	
76-58	16367-16373	become	_	
76-59	16374-16380	active	_	
76-60	16381-16383	at	_	
76-61	16384-16389	later	_	
76-62	16390-16403	developmental	_	
76-63	16404-16410	stages	_	
76-64	16410-16411	.	_	

#Text=Finally, genetic factors can affect not only the overall expression of a phenotype at different points in development, but also the developmental process itself, resulting in genetically determined individual differences in developmental trajectories (heritability of change).
77-1	16412-16419	Finally	_	
77-2	16419-16420	,	_	
77-3	16421-16428	genetic	_	
77-4	16429-16436	factors	_	
77-5	16437-16440	can	_	
77-6	16441-16447	affect	_	
77-7	16448-16451	not	_	
77-8	16452-16456	only	_	
77-9	16457-16460	the	_	
77-10	16461-16468	overall	_	
77-11	16469-16479	expression	_	
77-12	16480-16482	of	_	
77-13	16483-16484	a	_	
77-14	16485-16494	phenotype	_	
77-15	16495-16497	at	_	
77-16	16498-16507	different	_	
77-17	16508-16514	points	_	
77-18	16515-16517	in	_	
77-19	16518-16529	development	_	
77-20	16529-16530	,	_	
77-21	16531-16534	but	_	
77-22	16535-16539	also	_	
77-23	16540-16543	the	_	
77-24	16544-16557	developmental	_	
77-25	16558-16565	process	_	
77-26	16566-16572	itself	_	
77-27	16572-16573	,	_	
77-28	16574-16583	resulting	_	
77-29	16584-16586	in	_	
77-30	16587-16598	genetically	_	
77-31	16599-16609	determined	_	
77-32	16610-16620	individual	_	
77-33	16621-16632	differences	_	
77-34	16633-16635	in	_	
77-35	16636-16649	developmental	_	
77-36	16650-16662	trajectories	_	
77-37	16663-16664	(	_	
77-38	16664-16676	heritability	_	
77-39	16677-16679	of	_	
77-40	16680-16686	change	_	
77-41	16686-16687	)	_	
77-42	16687-16688	.	_	

#Text=This complex set of interrelated problems can be approached only by the integration of genetic and developmental approaches within a longitudinal twin design, which is both developmentally and genetically informative.
78-1	16689-16693	This	_	
78-2	16694-16701	complex	_	
78-3	16702-16705	set	_	
78-4	16706-16708	of	_	
78-5	16709-16721	interrelated	_	
78-6	16722-16730	problems	_	
78-7	16731-16734	can	_	
78-8	16735-16737	be	_	
78-9	16738-16748	approached	_	
78-10	16749-16753	only	_	
78-11	16754-16756	by	_	
78-12	16757-16760	the	_	
78-13	16761-16772	integration	_	
78-14	16773-16775	of	_	
78-15	16776-16783	genetic	_	
78-16	16784-16787	and	_	
78-17	16788-16801	developmental	_	
78-18	16802-16812	approaches	_	
78-19	16813-16819	within	_	
78-20	16820-16821	a	_	
78-21	16822-16834	longitudinal	_	
78-22	16835-16839	twin	_	
78-23	16840-16846	design	_	
78-24	16846-16847	,	_	
78-25	16848-16853	which	_	
78-26	16854-16856	is	_	
78-27	16857-16861	both	_	
78-28	16862-16877	developmentally	_	
78-29	16878-16881	and	_	
78-30	16882-16893	genetically	_	
78-31	16894-16905	informative	_	
78-32	16905-16906	.	_	

#Text=Here we use data from an ongoing population-based longitudinal study of adolescent twins to address a number of fundamental questions: Do neural correlates of response inhibition show developmental changes during adolescence?
79-1	16907-16911	Here	_	
79-2	16912-16914	we	_	
79-3	16915-16918	use	_	
79-4	16919-16923	data	_	
79-5	16924-16928	from	_	
79-6	16929-16931	an	_	
79-7	16932-16939	ongoing	_	
79-8	16940-16956	population-based	_	
79-9	16957-16969	longitudinal	_	
79-10	16970-16975	study	_	
79-11	16976-16978	of	_	
79-12	16979-16989	adolescent	_	
79-13	16990-16995	twins	_	
79-14	16996-16998	to	_	
79-15	16999-17006	address	_	
79-16	17007-17008	a	_	
79-17	17009-17015	number	_	
79-18	17016-17018	of	_	
79-19	17019-17030	fundamental	_	
79-20	17031-17040	questions	_	
79-21	17040-17041	:	_	
79-22	17042-17044	Do	_	
79-23	17045-17051	neural	_	
79-24	17052-17062	correlates	_	
79-25	17063-17065	of	_	
79-26	17066-17074	response	_	
79-27	17075-17085	inhibition	_	
79-28	17086-17090	show	_	
79-29	17091-17104	developmental	_	
79-30	17105-17112	changes	_	
79-31	17113-17119	during	_	
79-32	17120-17131	adolescence	_	
79-33	17131-17132	?	_	

#Text=Do individual differences in these neural phenotypes show developmental stability despite population-level changes in mean values?
80-1	17133-17135	Do	_	
80-2	17136-17146	individual	_	
80-3	17147-17158	differences	_	
80-4	17159-17161	in	_	
80-5	17162-17167	these	_	
80-6	17168-17174	neural	_	
80-7	17175-17185	phenotypes	_	
80-8	17186-17190	show	_	
80-9	17191-17204	developmental	_	
80-10	17205-17214	stability	_	
80-11	17215-17222	despite	_	
80-12	17223-17239	population-level	_	
80-13	17240-17247	changes	_	
80-14	17248-17250	in	_	
80-15	17251-17255	mean	_	
80-16	17256-17262	values	_	
80-17	17262-17263	?	_	

#Text=Are these individual differences heritable?
81-1	17264-17267	Are	_	
81-2	17268-17273	these	_	
81-3	17274-17284	individual	_	
81-4	17285-17296	differences	_	
81-5	17297-17306	heritable	_	
81-6	17306-17307	?	_	

#Text=Do same or different genetic factors influence ERP traits at different ages?
82-1	17308-17310	Do	_	
82-2	17311-17315	same	_	
82-3	17316-17318	or	_	
82-4	17319-17328	different	_	
82-5	17329-17336	genetic	_	
82-6	17337-17344	factors	_	
82-7	17345-17354	influence	_	
82-8	17355-17358	ERP	_	
82-9	17359-17365	traits	_	
82-10	17366-17368	at	_	
82-11	17369-17378	different	_	
82-12	17379-17383	ages	_	
82-13	17383-17384	?	_	

#Text=Does heritability vary significantly as a function of age (change of heritability)?
83-1	17385-17389	Does	_	
83-2	17390-17402	heritability	_	
83-3	17403-17407	vary	_	
83-4	17408-17421	significantly	_	
83-5	17422-17424	as	_	
83-6	17425-17426	a	_	
83-7	17427-17435	function	_	
83-8	17436-17438	of	_	
83-9	17439-17442	age	_	
83-10	17443-17444	(	_	
83-11	17444-17450	change	_	
83-12	17451-17453	of	_	
83-13	17454-17466	heritability	_	
83-14	17466-17467	)	_	
83-15	17467-17468	?	_	

#Text=Are individual differences in the rate of development influenced by genes (heritability of change)?
84-1	17469-17472	Are	_	
84-2	17473-17483	individual	_	
84-3	17484-17495	differences	_	
84-4	17496-17498	in	_	
84-5	17499-17502	the	_	
84-6	17503-17507	rate	_	
84-7	17508-17510	of	_	
84-8	17511-17522	development	_	
84-9	17523-17533	influenced	_	
84-10	17534-17536	by	_	
84-11	17537-17542	genes	_	
84-12	17543-17544	(	_	
84-13	17544-17556	heritability	_	
84-14	17557-17559	of	_	
84-15	17560-17566	change	_	
84-16	17566-17567	)	_	
84-17	17567-17568	?	_	

#Text=2.
85-1	17569-17570	2	_	
85-2	17570-17571	.	_	

#Text=Method
#Text=2.1.
86-1	17572-17578	Method	http://www.case.edu/ProvCaRe/provcare#StudyMethod[3]	
86-2	17579-17582	2.1	http://www.case.edu/ProvCaRe/provcare#StudyMethod[3]	
86-3	17582-17583	.	http://www.case.edu/ProvCaRe/provcare#StudyMethod[3]	

#Text=Participants
#Text=Subjects were adolescent twins participating in a longitudinal study of Genetics, Neurocognition, and Adolescent Substance Abuse (GNASA).
87-1	17584-17596	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-2	17597-17605	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-3	17606-17610	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-4	17611-17621	adolescent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-5	17622-17627	twins	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-6	17628-17641	participating	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-7	17642-17644	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-8	17645-17646	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-9	17647-17659	longitudinal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-10	17660-17665	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-11	17666-17668	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-12	17669-17677	Genetics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-13	17677-17678	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-14	17679-17693	Neurocognition	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-15	17693-17694	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-16	17695-17698	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-17	17699-17709	Adolescent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-18	17710-17719	Substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-19	17720-17725	Abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-20	17726-17727	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-21	17727-17732	GNASA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-22	17732-17733	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
87-23	17733-17734	.	_	

#Text=All participants were recruited from the local population using a state birth records database, therefore, the sample is largely representative of the general population.
88-1	17735-17738	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-2	17739-17751	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-3	17752-17756	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-4	17757-17766	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-5	17767-17771	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-6	17772-17775	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-7	17776-17781	local	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-8	17782-17792	population	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-9	17793-17798	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-10	17799-17800	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-11	17801-17806	state	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-12	17807-17812	birth	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-13	17813-17820	records	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-14	17821-17829	database	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-15	17829-17830	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-16	17831-17840	therefore	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-17	17840-17841	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-18	17842-17845	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-19	17846-17852	sample	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-20	17853-17855	is	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-21	17856-17863	largely	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-22	17864-17878	representative	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-23	17879-17881	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-24	17882-17885	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-25	17886-17893	general	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-26	17894-17904	population	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
88-27	17904-17905	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	

#Text=Exclusion criteria were minimal and included a history of serious head trauma and health conditions precluding a laboratory visit or the ability to perform the experimental tasks (e.g. severe visual impairment or mental retardation).
89-1	17906-17915	Exclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-2	17916-17924	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-3	17925-17929	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-4	17930-17937	minimal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-5	17938-17941	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-6	17942-17950	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-7	17951-17952	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-8	17953-17960	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-9	17961-17963	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-10	17964-17971	serious	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-11	17972-17976	head	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-12	17977-17983	trauma	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-13	17984-17987	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-14	17988-17994	health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-15	17995-18005	conditions	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-16	18006-18016	precluding	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-17	18017-18018	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-18	18019-18029	laboratory	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-19	18030-18035	visit	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-20	18036-18038	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-21	18039-18042	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-22	18043-18050	ability	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-23	18051-18053	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-24	18054-18061	perform	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-25	18062-18065	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-26	18066-18078	experimental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-27	18079-18084	tasks	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-28	18085-18086	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-29	18086-18089	e.g	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-30	18089-18090	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-31	18091-18097	severe	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-32	18098-18104	visual	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-33	18105-18115	impairment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-34	18116-18118	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-35	18119-18125	mental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-36	18126-18137	retardation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-37	18137-18138	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
89-38	18138-18139	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=The first assessment (baseline) was conducted at age 12, and follow up assessments were conducted at ages 14 and 16.
90-1	18140-18143	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-2	18144-18149	first	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-3	18150-18160	assessment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-4	18161-18162	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-5	18162-18170	baseline	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-6	18170-18171	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-7	18172-18175	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-8	18176-18185	conducted	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-9	18186-18188	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-10	18189-18192	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-11	18193-18195	12	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-12	18195-18196	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-13	18197-18200	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-14	18201-18207	follow	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-15	18208-18210	up	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-16	18211-18222	assessments	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-17	18223-18227	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-18	18228-18237	conducted	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-19	18238-18240	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-20	18241-18245	ages	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-21	18246-18248	14	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-22	18249-18252	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-23	18253-18255	16	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
90-24	18255-18256	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	

#Text=The Continuous Performance Task (CPT) described below was administered to a total of 743 subjects at age 12, 614 subjects at age 14, and 404 subjects at age 16 (for a more detailed description of the sample, see Table 1).
91-1	18257-18260	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-2	18261-18271	Continuous	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-3	18272-18283	Performance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-4	18284-18288	Task	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-5	18289-18290	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-6	18290-18293	CPT	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-7	18293-18294	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-8	18295-18304	described	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-9	18305-18310	below	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-10	18311-18314	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-11	18315-18327	administered	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-12	18328-18330	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-13	18331-18332	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-14	18333-18338	total	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-15	18339-18341	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-16	18342-18345	743	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-17	18346-18354	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-18	18355-18357	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-19	18358-18361	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-20	18362-18364	12	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-21	18364-18365	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-22	18366-18369	614	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-23	18370-18378	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-24	18379-18381	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-25	18382-18385	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-26	18386-18388	14	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-27	18388-18389	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-28	18390-18393	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-29	18394-18397	404	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-30	18398-18406	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-31	18407-18409	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-32	18410-18413	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-33	18414-18416	16	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-34	18417-18418	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-35	18418-18421	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-36	18422-18423	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-37	18424-18428	more	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-38	18429-18437	detailed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-39	18438-18449	description	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-40	18450-18452	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-41	18453-18456	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-42	18457-18463	sample	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-43	18463-18464	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-44	18465-18468	see	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-45	18469-18474	Table	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-46	18475-18476	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-47	18476-18477	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
91-48	18477-18478	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	

#Text=Zygosity was determined using a set of 160 DNA markers, an interview administered to the twins’ parents, and research assistants’ ratings of twins’ physical similarity.
92-1	18479-18487	Zygosity	_	
92-2	18488-18491	was	_	
92-3	18492-18502	determined	_	
92-4	18503-18508	using	_	
92-5	18509-18510	a	_	
92-6	18511-18514	set	_	
92-7	18515-18517	of	_	
92-8	18518-18521	160	_	
92-9	18522-18525	DNA	_	
92-10	18526-18533	markers	_	
92-11	18533-18534	,	_	
92-12	18535-18537	an	_	
92-13	18538-18547	interview	_	
92-14	18548-18560	administered	_	
92-15	18561-18563	to	_	
92-16	18564-18567	the	_	
92-17	18568-18573	twins	_	
92-18	18573-18574	’	_	
92-19	18575-18582	parents	_	
92-20	18582-18583	,	_	
92-21	18584-18587	and	_	
92-22	18588-18596	research	_	
92-23	18597-18607	assistants	_	
92-24	18607-18608	’	_	
92-25	18609-18616	ratings	_	
92-26	18617-18619	of	_	
92-27	18620-18625	twins	_	
92-28	18625-18626	’	_	
92-29	18627-18635	physical	_	
92-30	18636-18646	similarity	_	
92-31	18646-18647	.	_	

#Text=The study was approved by Washington University Institutional Review Board, and written informed assent and consent were obtained from adolescent participants and their parents, respectively, after complete description of the study to the subjects and their parents.
#Text=2.2.
93-1	18648-18651	The	_	
93-2	18652-18657	study	_	
93-3	18658-18661	was	_	
93-4	18662-18670	approved	_	
93-5	18671-18673	by	_	
93-6	18674-18684	Washington	_	
93-7	18685-18695	University	_	
93-8	18696-18709	Institutional	_	
93-9	18710-18716	Review	_	
93-10	18717-18722	Board	_	
93-11	18722-18723	,	_	
93-12	18724-18727	and	_	
93-13	18728-18735	written	_	
93-14	18736-18744	informed	_	
93-15	18745-18751	assent	_	
93-16	18752-18755	and	_	
93-17	18756-18763	consent	_	
93-18	18764-18768	were	_	
93-19	18769-18777	obtained	_	
93-20	18778-18782	from	_	
93-21	18783-18793	adolescent	_	
93-22	18794-18806	participants	_	
93-23	18807-18810	and	_	
93-24	18811-18816	their	_	
93-25	18817-18824	parents	_	
93-26	18824-18825	,	_	
93-27	18826-18838	respectively	_	
93-28	18838-18839	,	_	
93-29	18840-18845	after	_	
93-30	18846-18854	complete	_	
93-31	18855-18866	description	_	
93-32	18867-18869	of	_	
93-33	18870-18873	the	_	
93-34	18874-18879	study	_	
93-35	18880-18882	to	_	
93-36	18883-18886	the	_	
93-37	18887-18895	subjects	_	
93-38	18896-18899	and	_	
93-39	18900-18905	their	_	
93-40	18906-18913	parents	_	
93-41	18913-18914	.	_	
93-42	18915-18918	2.2	_	
93-43	18918-18919	.	_	

#Text=Materials and procedure
#Text=Participants were administered a slightly modified Go/No-Go version of the Continuous Performance Test (CPT) that has been shown to be a reliable measure of response inhibition.
94-1	18920-18929	Materials	_	
94-2	18930-18933	and	_	
94-3	18934-18943	procedure	_	
94-4	18944-18956	Participants	_	
94-5	18957-18961	were	_	
94-6	18962-18974	administered	_	
94-7	18975-18976	a	_	
94-8	18977-18985	slightly	_	
94-9	18986-18994	modified	_	
94-10	18995-18997	Go	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[9]	
94-11	18997-18998	/	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[9]	
94-12	18998-19003	No-Go	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[9]	
94-13	19004-19011	version	_	
94-14	19012-19014	of	_	
94-15	19015-19018	the	_	
94-16	19019-19029	Continuous	_	
94-17	19030-19041	Performance	_	
94-18	19042-19046	Test	_	
94-19	19047-19048	(	_	
94-20	19048-19051	CPT	_	
94-21	19051-19052	)	_	
94-22	19053-19057	that	_	
94-23	19058-19061	has	_	
94-24	19062-19066	been	_	
94-25	19067-19072	shown	_	
94-26	19073-19075	to	_	
94-27	19076-19078	be	_	
94-28	19079-19080	a	_	
94-29	19081-19089	reliable	_	
94-30	19090-19097	measure	_	
94-31	19098-19100	of	_	
94-32	19101-19109	response	_	
94-33	19110-19120	inhibition	_	
94-34	19120-19121	.	_	

#Text=A series of letters was presented sequentially, one at a time, for 0.2 s with inter-stimulus interval of 2 s (Fig. 1).
95-1	19122-19123	A	_	
95-2	19124-19130	series	_	
95-3	19131-19133	of	_	
95-4	19134-19141	letters	_	
95-5	19142-19145	was	_	
95-6	19146-19155	presented	_	
95-7	19156-19168	sequentially	_	
95-8	19168-19169	,	_	
95-9	19170-19173	one	_	
95-10	19174-19176	at	_	
95-11	19177-19178	a	_	
95-12	19179-19183	time	_	
95-13	19183-19184	,	_	
95-14	19185-19188	for	_	
95-15	19189-19192	0.2	_	
95-16	19193-19194	s	_	
95-17	19195-19199	with	_	
95-18	19200-19214	inter-stimulus	_	
95-19	19215-19223	interval	_	
95-20	19224-19226	of	_	
95-21	19227-19228	2	_	
95-22	19229-19230	s	_	
95-23	19231-19232	(	_	
95-24	19232-19235	Fig	_	
95-25	19235-19236	.	_	
95-26	19237-19238	1	_	
95-27	19238-19239	)	_	
95-28	19239-19240	.	_	

#Text=The subjects were instructed to respond as quickly as possible to a letter X preceded by a letter O (O-X combination) by pressing a button on a response pad with the right index finger, but to withhold their response when the letter O was followed by any other letter than X (O-non-X combination).
96-1	19241-19244	The	_	
96-2	19245-19253	subjects	_	
96-3	19254-19258	were	_	
96-4	19259-19269	instructed	_	
96-5	19270-19272	to	_	
96-6	19273-19280	respond	_	
96-7	19281-19283	as	_	
96-8	19284-19291	quickly	_	
96-9	19292-19294	as	_	
96-10	19295-19303	possible	_	
96-11	19304-19306	to	_	
96-12	19307-19308	a	_	
96-13	19309-19315	letter	_	
96-14	19316-19317	X	_	
96-15	19318-19326	preceded	_	
96-16	19327-19329	by	_	
96-17	19330-19331	a	_	
96-18	19332-19338	letter	_	
96-19	19339-19340	O	_	
96-20	19341-19342	(	_	
96-21	19342-19345	O-X	_	
96-22	19346-19357	combination	_	
96-23	19357-19358	)	_	
96-24	19359-19361	by	_	
96-25	19362-19370	pressing	_	
96-26	19371-19372	a	_	
96-27	19373-19379	button	_	
96-28	19380-19382	on	_	
96-29	19383-19384	a	_	
96-30	19385-19393	response	_	
96-31	19394-19397	pad	_	
96-32	19398-19402	with	_	
96-33	19403-19406	the	_	
96-34	19407-19412	right	_	
96-35	19413-19418	index	_	
96-36	19419-19425	finger	_	
96-37	19425-19426	,	_	
96-38	19427-19430	but	_	
96-39	19431-19433	to	_	
96-40	19434-19442	withhold	_	
96-41	19443-19448	their	_	
96-42	19449-19457	response	_	
96-43	19458-19462	when	_	
96-44	19463-19466	the	_	
96-45	19467-19473	letter	_	
96-46	19474-19475	O	_	
96-47	19476-19479	was	_	
96-48	19480-19488	followed	_	
96-49	19489-19491	by	_	
96-50	19492-19495	any	_	
96-51	19496-19501	other	_	
96-52	19502-19508	letter	_	
96-53	19509-19513	than	_	
96-54	19514-19515	X	_	
96-55	19516-19517	(	_	
96-56	19517-19524	O-non-X	_	
96-57	19525-19536	combination	_	
96-58	19536-19537	)	_	
96-59	19537-19538	.	_	

#Text=Response speed and accuracy were equally emphasized.
97-1	19539-19547	Response	_	
97-2	19548-19553	speed	_	
97-3	19554-19557	and	_	
97-4	19558-19566	accuracy	_	
97-5	19567-19571	were	_	
97-6	19572-19579	equally	_	
97-7	19580-19590	emphasized	_	
97-8	19590-19591	.	_	

#Text=A total of 400 letters were presented, of which 80 (20%) were cue stimuli (the letter “O”), 40 (10%) were Go stimuli (X following O), 40 (10%) were No-Go stimuli (any letter other than X following O), and the remaining 240 stimuli were distracters (12 letters not including O or X).
98-1	19592-19593	A	_	
98-2	19594-19599	total	_	
98-3	19600-19602	of	_	
98-4	19603-19606	400	_	
98-5	19607-19614	letters	_	
98-6	19615-19619	were	_	
98-7	19620-19629	presented	_	
98-8	19629-19630	,	_	
98-9	19631-19633	of	_	
98-10	19634-19639	which	_	
98-11	19640-19642	80	_	
98-12	19643-19644	(	_	
98-13	19644-19647	20%	_	
98-14	19647-19648	)	_	
98-15	19649-19653	were	_	
98-16	19654-19657	cue	_	
98-17	19658-19665	stimuli	_	
98-18	19666-19667	(	_	
98-19	19667-19670	the	_	
98-20	19671-19677	letter	_	
98-21	19678-19679	“	_	
98-22	19679-19680	O	_	
98-23	19680-19681	”	_	
98-24	19681-19682	)	_	
98-25	19682-19683	,	_	
98-26	19684-19686	40	_	
98-27	19687-19688	(	_	
98-28	19688-19691	10%	_	
98-29	19691-19692	)	_	
98-30	19693-19697	were	_	
98-31	19698-19700	Go	_	
98-32	19701-19708	stimuli	_	
98-33	19709-19710	(	_	
98-34	19710-19711	X	_	
98-35	19712-19721	following	_	
98-36	19722-19723	O	_	
98-37	19723-19724	)	_	
98-38	19724-19725	,	_	
98-39	19726-19728	40	_	
98-40	19729-19730	(	_	
98-41	19730-19733	10%	_	
98-42	19733-19734	)	_	
98-43	19735-19739	were	_	
98-44	19740-19745	No-Go	_	
98-45	19746-19753	stimuli	_	
98-46	19754-19755	(	_	
98-47	19755-19758	any	_	
98-48	19759-19765	letter	_	
98-49	19766-19771	other	_	
98-50	19772-19776	than	_	
98-51	19777-19778	X	_	
98-52	19779-19788	following	_	
98-53	19789-19790	O	_	
98-54	19790-19791	)	_	
98-55	19791-19792	,	_	
98-56	19793-19796	and	_	
98-57	19797-19800	the	_	
98-58	19801-19810	remaining	_	
98-59	19811-19814	240	_	
98-60	19815-19822	stimuli	_	
98-61	19823-19827	were	_	
98-62	19828-19839	distracters	_	
98-63	19840-19841	(	_	
98-64	19841-19843	12	_	
98-65	19844-19851	letters	_	
98-66	19852-19855	not	_	
98-67	19856-19865	including	_	
98-68	19866-19867	O	_	
98-69	19868-19870	or	_	
98-70	19871-19872	X	_	
98-71	19872-19873	)	_	
98-72	19873-19874	.	_	

#Text=Thus, the O-X combination represented a Go trial, whereas any O-not-X combination such as O-Z, O-K, etc. represented a No-Go trial, and there were a total of 40 O-X (Go) and 40 O-non-X (No-Go) trials in the task presented in a pseudo-random order.
99-1	19875-19879	Thus	_	
99-2	19879-19880	,	_	
99-3	19881-19884	the	_	
99-4	19885-19888	O-X	_	
99-5	19889-19900	combination	_	
99-6	19901-19912	represented	_	
99-7	19913-19914	a	_	
99-8	19915-19917	Go	_	
99-9	19918-19923	trial	_	
99-10	19923-19924	,	_	
99-11	19925-19932	whereas	_	
99-12	19933-19936	any	_	
99-13	19937-19944	O-not-X	_	
99-14	19945-19956	combination	_	
99-15	19957-19961	such	_	
99-16	19962-19964	as	_	
99-17	19965-19968	O-Z	_	
99-18	19968-19969	,	_	
99-19	19970-19973	O-K	_	
99-20	19973-19974	,	_	
99-21	19975-19978	etc	_	
99-22	19978-19979	.	_	
99-23	19980-19991	represented	_	
99-24	19992-19993	a	_	
99-25	19994-19999	No-Go	_	
99-26	20000-20005	trial	_	
99-27	20005-20006	,	_	
99-28	20007-20010	and	_	
99-29	20011-20016	there	_	
99-30	20017-20021	were	_	
99-31	20022-20023	a	_	
99-32	20024-20029	total	_	
99-33	20030-20032	of	_	
99-34	20033-20035	40	_	
99-35	20036-20039	O-X	_	
99-36	20040-20041	(	_	
99-37	20041-20043	Go	_	
99-38	20043-20044	)	_	
99-39	20045-20048	and	_	
99-40	20049-20051	40	_	
99-41	20052-20059	O-non-X	_	
99-42	20060-20061	(	_	
99-43	20061-20066	No-Go	_	
99-44	20066-20067	)	_	
99-45	20068-20074	trials	_	
99-46	20075-20077	in	_	
99-47	20078-20081	the	_	
99-48	20082-20086	task	_	
99-49	20087-20096	presented	_	
99-50	20097-20099	in	_	
99-51	20100-20101	a	_	
99-52	20102-20115	pseudo-random	_	
99-53	20116-20121	order	_	
99-54	20121-20122	.	_	

#Text=The letter O served as a warning cue informing the subject that the next stimulus is likely to be a Go signal and thus triggered a motor preparation and response prepotency.
100-1	20123-20126	The	_	
100-2	20127-20133	letter	_	
100-3	20134-20135	O	_	
100-4	20136-20142	served	_	
100-5	20143-20145	as	_	
100-6	20146-20147	a	_	
100-7	20148-20155	warning	_	
100-8	20156-20159	cue	_	
100-9	20160-20169	informing	_	
100-10	20170-20173	the	_	
100-11	20174-20181	subject	_	
100-12	20182-20186	that	_	
100-13	20187-20190	the	_	
100-14	20191-20195	next	_	
100-15	20196-20204	stimulus	_	
100-16	20205-20207	is	_	
100-17	20208-20214	likely	_	
100-18	20215-20217	to	_	
100-19	20218-20220	be	_	
100-20	20221-20222	a	_	
100-21	20223-20225	Go	_	
100-22	20226-20232	signal	_	
100-23	20233-20236	and	_	
100-24	20237-20241	thus	_	
100-25	20242-20251	triggered	_	
100-26	20252-20253	a	_	
100-27	20254-20259	motor	_	
100-28	20260-20271	preparation	_	
100-29	20272-20275	and	_	
100-30	20276-20284	response	_	
100-31	20285-20295	prepotency	_	
100-32	20295-20296	.	_	

#Text=A No-Go stimulus (any letter other than X) presented after O required withholding of the pre-activated response.
101-1	20297-20298	A	_	
101-2	20299-20304	No-Go	_	
101-3	20305-20313	stimulus	_	
101-4	20314-20315	(	_	
101-5	20315-20318	any	_	
101-6	20319-20325	letter	_	
101-7	20326-20331	other	_	
101-8	20332-20336	than	_	
101-9	20337-20338	X	_	
101-10	20338-20339	)	_	
101-11	20340-20349	presented	_	
101-12	20350-20355	after	_	
101-13	20356-20357	O	_	
101-14	20358-20366	required	_	
101-15	20367-20378	withholding	_	
101-16	20379-20381	of	_	
101-17	20382-20385	the	_	
101-18	20386-20399	pre-activated	_	
101-19	20400-20408	response	_	
101-20	20408-20409	.	_	

#Text=It is important to note that equal probability of Go and No-Go stimuli ensured that Go versus No-Go differences are not confounded with oddball effects that are typically observed when stimuli differ in their frequency.
#Text=2.3.
102-1	20410-20412	It	_	
102-2	20413-20415	is	_	
102-3	20416-20425	important	_	
102-4	20426-20428	to	_	
102-5	20429-20433	note	_	
102-6	20434-20438	that	_	
102-7	20439-20444	equal	_	
102-8	20445-20456	probability	_	
102-9	20457-20459	of	_	
102-10	20460-20462	Go	_	
102-11	20463-20466	and	_	
102-12	20467-20472	No-Go	_	
102-13	20473-20480	stimuli	_	
102-14	20481-20488	ensured	_	
102-15	20489-20493	that	_	
102-16	20494-20496	Go	_	
102-17	20497-20503	versus	_	
102-18	20504-20509	No-Go	_	
102-19	20510-20521	differences	_	
102-20	20522-20525	are	_	
102-21	20526-20529	not	_	
102-22	20530-20540	confounded	_	
102-23	20541-20545	with	_	
102-24	20546-20553	oddball	_	
102-25	20554-20561	effects	_	
102-26	20562-20566	that	_	
102-27	20567-20570	are	_	
102-28	20571-20580	typically	_	
102-29	20581-20589	observed	_	
102-30	20590-20594	when	_	
102-31	20595-20602	stimuli	_	
102-32	20603-20609	differ	_	
102-33	20610-20612	in	_	
102-34	20613-20618	their	_	
102-35	20619-20628	frequency	_	
102-36	20628-20629	.	_	
102-37	20630-20633	2.3	_	
102-38	20633-20634	.	_	

#Text=EEG recording and ERP analysis
#Text=The EEG was recorded from 30 scalp locations according to the extended 10–20 system using an elastic cap with Ag/AgCl electrodes and a ground electrode on the forehead, with high- and low-pass filters set at 0.05 and 100 Hz, respectively.
103-1	20635-20638	EEG	_	
103-2	20639-20648	recording	_	
103-3	20649-20652	and	_	
103-4	20653-20656	ERP	_	
103-5	20657-20665	analysis	_	
103-6	20666-20669	The	_	
103-7	20670-20673	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
103-8	20674-20677	was	_	
103-9	20678-20686	recorded	_	
103-10	20687-20691	from	_	
103-11	20692-20694	30	_	
103-12	20695-20700	scalp	_	
103-13	20701-20710	locations	_	
103-14	20711-20720	according	_	
103-15	20721-20723	to	_	
103-16	20724-20727	the	_	
103-17	20728-20736	extended	_	
103-18	20737-20739	10	_	
103-19	20739-20740	–	_	
103-20	20740-20742	20	_	
103-21	20743-20749	system	_	
103-22	20750-20755	using	_	
103-23	20756-20758	an	_	
103-24	20759-20766	elastic	_	
103-25	20767-20770	cap	_	
103-26	20771-20775	with	_	
103-27	20776-20778	Ag	_	
103-28	20778-20779	/	_	
103-29	20779-20783	AgCl	_	
103-30	20784-20794	electrodes	_	
103-31	20795-20798	and	_	
103-32	20799-20800	a	_	
103-33	20801-20807	ground	_	
103-34	20808-20817	electrode	_	
103-35	20818-20820	on	_	
103-36	20821-20824	the	_	
103-37	20825-20833	forehead	_	
103-38	20833-20834	,	_	
103-39	20835-20839	with	_	
103-40	20840-20844	high	_	
103-41	20844-20845	-	_	
103-42	20846-20849	and	_	
103-43	20850-20858	low-pass	_	
103-44	20859-20866	filters	_	
103-45	20867-20870	set	_	
103-46	20871-20873	at	_	
103-47	20874-20878	0.05	_	
103-48	20879-20882	and	_	
103-49	20883-20886	100	_	
103-50	20887-20889	Hz	_	
103-51	20889-20890	,	_	
103-52	20891-20903	respectively	_	
103-53	20903-20904	.	_	

#Text=The left mastoid served as reference, and an averaged mastoid reference was digitally computed off-line using the right mastoid recording as a separate channel.
104-1	20905-20908	The	_	
104-2	20909-20913	left	_	
104-3	20914-20921	mastoid	_	
104-4	20922-20928	served	_	
104-5	20929-20931	as	_	
104-6	20932-20941	reference	_	
104-7	20941-20942	,	_	
104-8	20943-20946	and	_	
104-9	20947-20949	an	_	
104-10	20950-20958	averaged	_	
104-11	20959-20966	mastoid	_	
104-12	20967-20976	reference	_	
104-13	20977-20980	was	_	
104-14	20981-20990	digitally	_	
104-15	20991-20999	computed	_	
104-16	21000-21008	off-line	_	
104-17	21009-21014	using	_	
104-18	21015-21018	the	_	
104-19	21019-21024	right	_	
104-20	21025-21032	mastoid	_	
104-21	21033-21042	recording	_	
104-22	21043-21045	as	_	
104-23	21046-21047	a	_	
104-24	21048-21056	separate	_	
104-25	21057-21064	channel	_	
104-26	21064-21065	.	_	

#Text=Vertical electro-oculogram recording was used for eyeblink artifact correction using a regression-based procedure.
105-1	21066-21074	Vertical	_	
105-2	21075-21092	electro-oculogram	_	
105-3	21093-21102	recording	_	
105-4	21103-21106	was	_	
105-5	21107-21111	used	_	
105-6	21112-21115	for	_	
105-7	21116-21124	eyeblink	_	
105-8	21125-21133	artifact	_	
105-9	21134-21144	correction	_	
105-10	21145-21150	using	_	
105-11	21151-21152	a	_	
105-12	21153-21169	regression-based	_	
105-13	21170-21179	procedure	_	
105-14	21179-21180	.	_	

#Text=After screening for artifacts, EEG signals were subjected to 30 Hz low-pass filtering, and 1000 ms epochs time-locked to the response were extracted (from -200 to 900 ms relative to the stimulus onset), baseline-corrected using a 200 ms baseline, and averaged separately for correct Go and No-Go trials, i.e. correct button presses and withholding of the response, respectively (trials with missed responses to Go stimuli and false alarm responses to No-Go stimuli were excluded).
106-1	21181-21186	After	_	
106-2	21187-21196	screening	_	
106-3	21197-21200	for	_	
106-4	21201-21210	artifacts	_	
106-5	21210-21211	,	_	
106-6	21212-21215	EEG	_	
106-7	21216-21223	signals	_	
106-8	21224-21228	were	_	
106-9	21229-21238	subjected	_	
106-10	21239-21241	to	_	
106-11	21242-21244	30	_	
106-12	21245-21247	Hz	_	
106-13	21248-21256	low-pass	_	
106-14	21257-21266	filtering	_	
106-15	21266-21267	,	_	
106-16	21268-21271	and	_	
106-17	21272-21276	1000	_	
106-18	21277-21279	ms	_	
106-19	21280-21286	epochs	_	
106-20	21287-21298	time-locked	_	
106-21	21299-21301	to	_	
106-22	21302-21305	the	_	
106-23	21306-21314	response	_	
106-24	21315-21319	were	_	
106-25	21320-21329	extracted	_	
106-26	21330-21331	(	_	
106-27	21331-21335	from	_	
106-28	21336-21337	-	_	
106-29	21337-21340	200	_	
106-30	21341-21343	to	_	
106-31	21344-21347	900	_	
106-32	21348-21350	ms	_	
106-33	21351-21359	relative	_	
106-34	21360-21362	to	_	
106-35	21363-21366	the	_	
106-36	21367-21375	stimulus	_	
106-37	21376-21381	onset	_	
106-38	21381-21382	)	_	
106-39	21382-21383	,	_	
106-40	21384-21402	baseline-corrected	_	
106-41	21403-21408	using	_	
106-42	21409-21410	a	_	
106-43	21411-21414	200	_	
106-44	21415-21417	ms	_	
106-45	21418-21426	baseline	_	
106-46	21426-21427	,	_	
106-47	21428-21431	and	_	
106-48	21432-21440	averaged	_	
106-49	21441-21451	separately	_	
106-50	21452-21455	for	_	
106-51	21456-21463	correct	_	
106-52	21464-21466	Go	_	
106-53	21467-21470	and	_	
106-54	21471-21476	No-Go	_	
106-55	21477-21483	trials	_	
106-56	21483-21484	,	_	
106-57	21485-21488	i.e	_	
106-58	21488-21489	.	_	
106-59	21490-21497	correct	_	
106-60	21498-21504	button	_	
106-61	21505-21512	presses	_	
106-62	21513-21516	and	_	
106-63	21517-21528	withholding	_	
106-64	21529-21531	of	_	
106-65	21532-21535	the	_	
106-66	21536-21544	response	_	
106-67	21544-21545	,	_	
106-68	21546-21558	respectively	_	
106-69	21559-21560	(	_	
106-70	21560-21566	trials	_	
106-71	21567-21571	with	_	
106-72	21572-21578	missed	_	
106-73	21579-21588	responses	_	
106-74	21589-21591	to	_	
106-75	21592-21594	Go	_	
106-76	21595-21602	stimuli	_	
106-77	21603-21606	and	_	
106-78	21607-21612	false	_	
106-79	21613-21618	alarm	_	
106-80	21619-21628	responses	_	
106-81	21629-21631	to	_	
106-82	21632-21637	No-Go	_	
106-83	21638-21645	stimuli	_	
106-84	21646-21650	were	_	
106-85	21651-21659	excluded	_	
106-86	21659-21660	)	_	
106-87	21660-21661	.	_	

#Text=The P3 peak was detected as the most positive voltage value within 300–500 ms window, and scored as absolute amplitude relative to baseline.
107-1	21662-21665	The	_	
107-2	21666-21668	P3	_	
107-3	21669-21673	peak	_	
107-4	21674-21677	was	_	
107-5	21678-21686	detected	_	
107-6	21687-21689	as	_	
107-7	21690-21693	the	_	
107-8	21694-21698	most	_	
107-9	21699-21707	positive	_	
107-10	21708-21715	voltage	_	
107-11	21716-21721	value	_	
107-12	21722-21728	within	_	
107-13	21729-21732	300	_	
107-14	21732-21733	–	_	
107-15	21733-21736	500	_	
107-16	21737-21739	ms	_	
107-17	21740-21746	window	_	
107-18	21746-21747	,	_	
107-19	21748-21751	and	_	
107-20	21752-21758	scored	_	
107-21	21759-21761	as	_	
107-22	21762-21770	absolute	_	
107-23	21771-21780	amplitude	_	
107-24	21781-21789	relative	_	
107-25	21790-21792	to	_	
107-26	21793-21801	baseline	_	
107-27	21801-21802	.	_	

#Text=The NoGo N2 peak was detected as the most negative voltage value within 190–360 ms window following the stimulus.
108-1	21803-21806	The	_	
108-2	21807-21811	NoGo	_	
108-3	21812-21814	N2	_	
108-4	21815-21819	peak	_	
108-5	21820-21823	was	_	
108-6	21824-21832	detected	_	
108-7	21833-21835	as	_	
108-8	21836-21839	the	_	
108-9	21840-21844	most	_	
108-10	21845-21853	negative	_	
108-11	21854-21861	voltage	_	
108-12	21862-21867	value	_	
108-13	21868-21874	within	_	
108-14	21875-21878	190	_	
108-15	21878-21879	–	_	
108-16	21879-21882	360	_	
108-17	21883-21885	ms	_	
108-18	21886-21892	window	_	
108-19	21893-21902	following	_	
108-20	21903-21906	the	_	
108-21	21907-21915	stimulus	_	
108-22	21915-21916	.	_	

#Text=N2 amplitude was scored as peak-to-peak difference between N2 and the amplitude of the immediately preceding positive trough as in previous studies.
109-1	21917-21919	N2	_	
109-2	21920-21929	amplitude	_	
109-3	21930-21933	was	_	
109-4	21934-21940	scored	_	
109-5	21941-21943	as	_	
109-6	21944-21956	peak-to-peak	_	
109-7	21957-21967	difference	_	
109-8	21968-21975	between	_	
109-9	21976-21978	N2	_	
109-10	21979-21982	and	_	
109-11	21983-21986	the	_	
109-12	21987-21996	amplitude	_	
109-13	21997-21999	of	_	
109-14	22000-22003	the	_	
109-15	22004-22015	immediately	_	
109-16	22016-22025	preceding	_	
109-17	22026-22034	positive	_	
109-18	22035-22041	trough	_	
109-19	22042-22044	as	_	
109-20	22045-22047	in	_	
109-21	22048-22056	previous	_	
109-22	22057-22064	studies	_	
109-23	22064-22065	.	_	

#Text=The use of different scoring methods for P3 and N2 was driven by the following considerations: P3 in the present task is a high-amplitude late component that can be reliably evaluated relative to the pre-stimulus baseline.
110-1	22066-22069	The	_	
110-2	22070-22073	use	_	
110-3	22074-22076	of	_	
110-4	22077-22086	different	_	
110-5	22087-22094	scoring	_	
110-6	22095-22102	methods	_	
110-7	22103-22106	for	_	
110-8	22107-22109	P3	_	
110-9	22110-22113	and	_	
110-10	22114-22116	N2	_	
110-11	22117-22120	was	_	
110-12	22121-22127	driven	_	
110-13	22128-22130	by	_	
110-14	22131-22134	the	_	
110-15	22135-22144	following	_	
110-16	22145-22159	considerations	_	
110-17	22159-22160	:	_	
110-18	22161-22163	P3	_	
110-19	22164-22166	in	_	
110-20	22167-22170	the	_	
110-21	22171-22178	present	_	
110-22	22179-22183	task	_	
110-23	22184-22186	is	_	
110-24	22187-22188	a	_	
110-25	22189-22203	high-amplitude	_	
110-26	22204-22208	late	_	
110-27	22209-22218	component	_	
110-28	22219-22223	that	_	
110-29	22224-22227	can	_	
110-30	22228-22230	be	_	
110-31	22231-22239	reliably	_	
110-32	22240-22249	evaluated	_	
110-33	22250-22258	relative	_	
110-34	22259-22261	to	_	
110-35	22262-22265	the	_	
110-36	22266-22278	pre-stimulus	_	
110-37	22279-22287	baseline	_	
110-38	22287-22288	.	_	

#Text=In contrast, N2 is a smaller component overlapping with the ascending limb of the larger P3 component.
111-1	22289-22291	In	_	
111-2	22292-22300	contrast	_	
111-3	22300-22301	,	_	
111-4	22302-22304	N2	_	
111-5	22305-22307	is	_	
111-6	22308-22309	a	_	
111-7	22310-22317	smaller	_	
111-8	22318-22327	component	_	
111-9	22328-22339	overlapping	_	
111-10	22340-22344	with	_	
111-11	22345-22348	the	_	
111-12	22349-22358	ascending	_	
111-13	22359-22363	limb	_	
111-14	22364-22366	of	_	
111-15	22367-22370	the	_	
111-16	22371-22377	larger	_	
111-17	22378-22380	P3	_	
111-18	22381-22390	component	_	
111-19	22390-22391	.	_	

#Text=Therefore, absolute N2 amplitude is strongly influenced by the rate of increase in P3 positivity, such that earlier onset and/or steeper increase in P3 lead to greater reduction of absolute N2 amplitude.
112-1	22392-22401	Therefore	_	
112-2	22401-22402	,	_	
112-3	22403-22411	absolute	_	
112-4	22412-22414	N2	_	
112-5	22415-22424	amplitude	_	
112-6	22425-22427	is	_	
112-7	22428-22436	strongly	_	
112-8	22437-22447	influenced	_	
112-9	22448-22450	by	_	
112-10	22451-22454	the	_	
112-11	22455-22459	rate	_	
112-12	22460-22462	of	_	
112-13	22463-22471	increase	_	
112-14	22472-22474	in	_	
112-15	22475-22477	P3	_	
112-16	22478-22488	positivity	_	
112-17	22488-22489	,	_	
112-18	22490-22494	such	_	
112-19	22495-22499	that	_	
112-20	22500-22507	earlier	_	
112-21	22508-22513	onset	_	
112-22	22514-22517	and	_	
112-23	22517-22518	/	_	
112-24	22518-22520	or	_	
112-25	22521-22528	steeper	_	
112-26	22529-22537	increase	_	
112-27	22538-22540	in	_	
112-28	22541-22543	P3	_	
112-29	22544-22548	lead	_	
112-30	22549-22551	to	_	
112-31	22552-22559	greater	_	
112-32	22560-22569	reduction	_	
112-33	22570-22572	of	_	
112-34	22573-22581	absolute	_	
112-35	22582-22584	N2	_	
112-36	22585-22594	amplitude	_	
112-37	22594-22595	.	_	

#Text=Measuring N2 relative to the preceding positive trough mitigates this confounding as indicated by lower correlation between peak-to-peak N2 and No-Go P3 amplitudes (r= 0.11) relative to the correlation between absolute N2 amplitude and No-Go P3 amplitude (r= 0.43), i.e. a reduction from 18% to 1% of shared variance.
#Text=2.4.
113-1	22596-22605	Measuring	_	
113-2	22606-22608	N2	_	
113-3	22609-22617	relative	_	
113-4	22618-22620	to	_	
113-5	22621-22624	the	_	
113-6	22625-22634	preceding	_	
113-7	22635-22643	positive	_	
113-8	22644-22650	trough	_	
113-9	22651-22660	mitigates	_	
113-10	22661-22665	this	_	
113-11	22666-22677	confounding	_	
113-12	22678-22680	as	_	
113-13	22681-22690	indicated	_	
113-14	22691-22693	by	_	
113-15	22694-22699	lower	_	
113-16	22700-22711	correlation	_	
113-17	22712-22719	between	_	
113-18	22720-22732	peak-to-peak	_	
113-19	22733-22735	N2	_	
113-20	22736-22739	and	_	
113-21	22740-22745	No-Go	_	
113-22	22746-22748	P3	_	
113-23	22749-22759	amplitudes	_	
113-24	22760-22761	(	_	
113-25	22761-22762	r	_	
113-26	22762-22763	=	_	
113-27	22764-22768	0.11	_	
113-28	22768-22769	)	_	
113-29	22770-22778	relative	_	
113-30	22779-22781	to	_	
113-31	22782-22785	the	_	
113-32	22786-22797	correlation	_	
113-33	22798-22805	between	_	
113-34	22806-22814	absolute	_	
113-35	22815-22817	N2	_	
113-36	22818-22827	amplitude	_	
113-37	22828-22831	and	_	
113-38	22832-22837	No-Go	_	
113-39	22838-22840	P3	_	
113-40	22841-22850	amplitude	_	
113-41	22851-22852	(	_	
113-42	22852-22853	r	_	
113-43	22853-22854	=	_	
113-44	22855-22859	0.43	_	
113-45	22859-22860	)	_	
113-46	22860-22861	,	_	
113-47	22862-22865	i.e	_	
113-48	22865-22866	.	_	
113-49	22867-22868	a	_	
113-50	22869-22878	reduction	_	
113-51	22879-22883	from	_	
113-52	22884-22887	18%	_	
113-53	22888-22890	to	_	
113-54	22891-22893	1%	_	
113-55	22894-22896	of	_	
113-56	22897-22903	shared	_	
113-57	22904-22912	variance	_	
113-58	22912-22913	.	_	
113-59	22914-22917	2.4	_	
113-60	22917-22918	.	_	

#Text=Genetic analysis and assessment of heritability
#Text=Genetic analyses of twin data were conducted by fitting linear structural equation models (SEM) using the Mx package, which is a standard approach in twin genetic research.
114-1	22919-22926	Genetic	_	
114-2	22927-22935	analysis	_	
114-3	22936-22939	and	_	
114-4	22940-22950	assessment	_	
114-5	22951-22953	of	_	
114-6	22954-22966	heritability	_	
114-7	22967-22974	Genetic	_	
114-8	22975-22983	analyses	_	
114-9	22984-22986	of	_	
114-10	22987-22991	twin	_	
114-11	22992-22996	data	_	
114-12	22997-23001	were	_	
114-13	23002-23011	conducted	_	
114-14	23012-23014	by	_	
114-15	23015-23022	fitting	_	
114-16	23023-23029	linear	_	
114-17	23030-23040	structural	_	
114-18	23041-23049	equation	_	
114-19	23050-23056	models	_	
114-20	23057-23058	(	_	
114-21	23058-23061	SEM	_	
114-22	23061-23062	)	_	
114-23	23063-23068	using	_	
114-24	23069-23072	the	_	
114-25	23073-23075	Mx	_	
114-26	23076-23083	package	_	
114-27	23083-23084	,	_	
114-28	23085-23090	which	_	
114-29	23091-23093	is	_	
114-30	23094-23095	a	_	
114-31	23096-23104	standard	_	
114-32	23105-23113	approach	_	
114-33	23114-23116	in	_	
114-34	23117-23121	twin	_	
114-35	23122-23129	genetic	_	
114-36	23130-23138	research	_	
114-37	23138-23139	.	_	

#Text=Since our data included longitudinal observations, we fit a trivariate Cholesky model (see) with measurements taken at ages 12, 14, and 16 entered as separate variables (Fig. 5A).
115-1	23140-23145	Since	_	
115-2	23146-23149	our	_	
115-3	23150-23154	data	_	
115-4	23155-23163	included	_	
115-5	23164-23176	longitudinal	_	
115-6	23177-23189	observations	_	
115-7	23189-23190	,	_	
115-8	23191-23193	we	_	
115-9	23194-23197	fit	_	
115-10	23198-23199	a	_	
115-11	23200-23210	trivariate	_	
115-12	23211-23219	Cholesky	_	
115-13	23220-23225	model	_	
115-14	23226-23227	(	_	
115-15	23227-23230	see	_	
115-16	23230-23231	)	_	
115-17	23232-23236	with	_	
115-18	23237-23249	measurements	_	
115-19	23250-23255	taken	_	
115-20	23256-23258	at	_	
115-21	23259-23263	ages	_	
115-22	23264-23266	12	_	
115-23	23266-23267	,	_	
115-24	23268-23270	14	_	
115-25	23270-23271	,	_	
115-26	23272-23275	and	_	
115-27	23276-23278	16	_	
115-28	23279-23286	entered	_	
115-29	23287-23289	as	_	
115-30	23290-23298	separate	_	
115-31	23299-23308	variables	_	
115-32	23309-23310	(	_	
115-33	23310-23313	Fig	_	
115-34	23313-23314	.	_	
115-35	23315-23317	5A	_	
115-36	23317-23318	)	_	
115-37	23318-23319	.	_	

#Text=This multivariate approach allows one to estimate heritability of ERP phenotypes at each age, to estimate the extent of genetic overlap across ages (i.e. to what extent the same genetic factors influence these phenotypes at different ages) and whether there are novel genetic influences at later ages, and to test for age differences in heritability.
116-1	23320-23324	This	_	
116-2	23325-23337	multivariate	_	
116-3	23338-23346	approach	_	
116-4	23347-23353	allows	_	
116-5	23354-23357	one	_	
116-6	23358-23360	to	_	
116-7	23361-23369	estimate	_	
116-8	23370-23382	heritability	_	
116-9	23383-23385	of	_	
116-10	23386-23389	ERP	_	
116-11	23390-23400	phenotypes	_	
116-12	23401-23403	at	_	
116-13	23404-23408	each	_	
116-14	23409-23412	age	_	
116-15	23412-23413	,	_	
116-16	23414-23416	to	_	
116-17	23417-23425	estimate	_	
116-18	23426-23429	the	_	
116-19	23430-23436	extent	_	
116-20	23437-23439	of	_	
116-21	23440-23447	genetic	_	
116-22	23448-23455	overlap	_	
116-23	23456-23462	across	_	
116-24	23463-23467	ages	_	
116-25	23468-23469	(	_	
116-26	23469-23472	i.e	_	
116-27	23472-23473	.	_	
116-28	23474-23476	to	_	
116-29	23477-23481	what	_	
116-30	23482-23488	extent	_	
116-31	23489-23492	the	_	
116-32	23493-23497	same	_	
116-33	23498-23505	genetic	_	
116-34	23506-23513	factors	_	
116-35	23514-23523	influence	_	
116-36	23524-23529	these	_	
116-37	23530-23540	phenotypes	_	
116-38	23541-23543	at	_	
116-39	23544-23553	different	_	
116-40	23554-23558	ages	_	
116-41	23558-23559	)	_	
116-42	23560-23563	and	_	
116-43	23564-23571	whether	_	
116-44	23572-23577	there	_	
116-45	23578-23581	are	_	
116-46	23582-23587	novel	_	
116-47	23588-23595	genetic	_	
116-48	23596-23606	influences	_	
116-49	23607-23609	at	_	
116-50	23610-23615	later	_	
116-51	23616-23620	ages	_	
116-52	23620-23621	,	_	
116-53	23622-23625	and	_	
116-54	23626-23628	to	_	
116-55	23629-23633	test	_	
116-56	23634-23637	for	_	
116-57	23638-23641	age	_	
116-58	23642-23653	differences	_	
116-59	23654-23656	in	_	
116-60	23657-23669	heritability	_	
116-61	23669-23670	.	_	

#Text=Structural equation models of twin data assume that phenotypic variance arises from the following factors: additive genetic influences (A), non-additive genetic influences (D) including within-locus allelic interaction (dominance) and between-locus interaction (epistasis), environmental influences shared by family members (C), and individually unique (unshared) environmental influences (E).
117-1	23671-23681	Structural	_	
117-2	23682-23690	equation	_	
117-3	23691-23697	models	_	
117-4	23698-23700	of	_	
117-5	23701-23705	twin	_	
117-6	23706-23710	data	_	
117-7	23711-23717	assume	_	
117-8	23718-23722	that	_	
117-9	23723-23733	phenotypic	_	
117-10	23734-23742	variance	_	
117-11	23743-23749	arises	_	
117-12	23750-23754	from	_	
117-13	23755-23758	the	_	
117-14	23759-23768	following	_	
117-15	23769-23776	factors	_	
117-16	23776-23777	:	_	
117-17	23778-23786	additive	_	
117-18	23787-23794	genetic	_	
117-19	23795-23805	influences	_	
117-20	23806-23807	(	_	
117-21	23807-23808	A	_	
117-22	23808-23809	)	_	
117-23	23809-23810	,	_	
117-24	23811-23823	non-additive	_	
117-25	23824-23831	genetic	_	
117-26	23832-23842	influences	_	
117-27	23843-23844	(	_	
117-28	23844-23845	D	_	
117-29	23845-23846	)	_	
117-30	23847-23856	including	_	
117-31	23857-23869	within-locus	_	
117-32	23870-23877	allelic	_	
117-33	23878-23889	interaction	_	
117-34	23890-23891	(	_	
117-35	23891-23900	dominance	_	
117-36	23900-23901	)	_	
117-37	23902-23905	and	_	
117-38	23906-23919	between-locus	_	
117-39	23920-23931	interaction	_	
117-40	23932-23933	(	_	
117-41	23933-23942	epistasis	_	
117-42	23942-23943	)	_	
117-43	23943-23944	,	_	
117-44	23945-23958	environmental	_	
117-45	23959-23969	influences	_	
117-46	23970-23976	shared	_	
117-47	23977-23979	by	_	
117-48	23980-23986	family	_	
117-49	23987-23994	members	_	
117-50	23995-23996	(	_	
117-51	23996-23997	C	_	
117-52	23997-23998	)	_	
117-53	23998-23999	,	_	
117-54	24000-24003	and	_	
117-55	24004-24016	individually	_	
117-56	24017-24023	unique	_	
117-57	24024-24025	(	_	
117-58	24025-24033	unshared	_	
117-59	24033-24034	)	_	
117-60	24035-24048	environmental	_	
117-61	24049-24059	influences	_	
117-62	24060-24061	(	_	
117-63	24061-24062	E	_	
117-64	24062-24063	)	_	
117-65	24063-24064	.	_	

#Text=It is important to note that A, D, and C increase similarity within twin pairs, whereas E decreases it.
118-1	24065-24067	It	_	
118-2	24068-24070	is	_	
118-3	24071-24080	important	_	
118-4	24081-24083	to	_	
118-5	24084-24088	note	_	
118-6	24089-24093	that	_	
118-7	24094-24095	A	_	
118-8	24095-24096	,	_	
118-9	24097-24098	D	_	
118-10	24098-24099	,	_	
118-11	24100-24103	and	_	
118-12	24104-24105	C	_	
118-13	24106-24114	increase	_	
118-14	24115-24125	similarity	_	
118-15	24126-24132	within	_	
118-16	24133-24137	twin	_	
118-17	24138-24143	pairs	_	
118-18	24143-24144	,	_	
118-19	24145-24152	whereas	_	
118-20	24153-24154	E	_	
118-21	24155-24164	decreases	_	
118-22	24165-24167	it	_	
118-23	24167-24168	.	_	

#Text=When using only data from twin pairs reared together, it is only possible to test three of these four components simultaneously, and a decision regarding whether to test an ADE or an ACE model is made based upon the observed twin correlations (see).
119-1	24169-24173	When	_	
119-2	24174-24179	using	_	
119-3	24180-24184	only	_	
119-4	24185-24189	data	_	
119-5	24190-24194	from	_	
119-6	24195-24199	twin	_	
119-7	24200-24205	pairs	_	
119-8	24206-24212	reared	_	
119-9	24213-24221	together	_	
119-10	24221-24222	,	_	
119-11	24223-24225	it	_	
119-12	24226-24228	is	_	
119-13	24229-24233	only	_	
119-14	24234-24242	possible	_	
119-15	24243-24245	to	_	
119-16	24246-24250	test	_	
119-17	24251-24256	three	_	
119-18	24257-24259	of	_	
119-19	24260-24265	these	_	
119-20	24266-24270	four	_	
119-21	24271-24281	components	_	
119-22	24282-24296	simultaneously	_	
119-23	24296-24297	,	_	
119-24	24298-24301	and	_	
119-25	24302-24303	a	_	
119-26	24304-24312	decision	_	
119-27	24313-24322	regarding	_	
119-28	24323-24330	whether	_	
119-29	24331-24333	to	_	
119-30	24334-24338	test	_	
119-31	24339-24341	an	_	
119-32	24342-24345	ADE	_	
119-33	24346-24348	or	_	
119-34	24349-24351	an	_	
119-35	24352-24355	ACE	_	
119-36	24356-24361	model	_	
119-37	24362-24364	is	_	
119-38	24365-24369	made	_	
119-39	24370-24375	based	_	
119-40	24376-24380	upon	_	
119-41	24381-24384	the	_	
119-42	24385-24393	observed	_	
119-43	24394-24398	twin	_	
119-44	24399-24411	correlations	_	
119-45	24412-24413	(	_	
119-46	24413-24416	see	_	
119-47	24416-24417	)	_	
119-48	24417-24418	.	_	

#Text=Heritability, which can be estimated using these models, is the percentage of the total variance of the trait attributable to genetic factors.
120-1	24419-24431	Heritability	_	
120-2	24431-24432	,	_	
120-3	24433-24438	which	_	
120-4	24439-24442	can	_	
120-5	24443-24445	be	_	
120-6	24446-24455	estimated	_	
120-7	24456-24461	using	_	
120-8	24462-24467	these	_	
120-9	24468-24474	models	_	
120-10	24474-24475	,	_	
120-11	24476-24478	is	_	
120-12	24479-24482	the	_	
120-13	24483-24493	percentage	_	
120-14	24494-24496	of	_	
120-15	24497-24500	the	_	
120-16	24501-24506	total	_	
120-17	24507-24515	variance	_	
120-18	24516-24518	of	_	
120-19	24519-24522	the	_	
120-20	24523-24528	trait	_	
120-21	24529-24541	attributable	_	
120-22	24542-24544	to	_	
120-23	24545-24552	genetic	_	
120-24	24553-24560	factors	_	
120-25	24560-24561	.	_	

#Text=For a more detailed introduction into the genetic methods that can be applied to psychophysiological traits, we refer the reader to methodological and review papers.
121-1	24562-24565	For	_	
121-2	24566-24567	a	_	
121-3	24568-24572	more	_	
121-4	24573-24581	detailed	_	
121-5	24582-24594	introduction	_	
121-6	24595-24599	into	_	
121-7	24600-24603	the	_	
121-8	24604-24611	genetic	_	
121-9	24612-24619	methods	_	
121-10	24620-24624	that	_	
121-11	24625-24628	can	_	
121-12	24629-24631	be	_	
121-13	24632-24639	applied	_	
121-14	24640-24642	to	_	
121-15	24643-24662	psychophysiological	_	
121-16	24663-24669	traits	_	
121-17	24669-24670	,	_	
121-18	24671-24673	we	_	
121-19	24674-24679	refer	_	
121-20	24680-24683	the	_	
121-21	24684-24690	reader	_	
121-22	24691-24693	to	_	
121-23	24694-24708	methodological	_	
121-24	24709-24712	and	_	
121-25	24713-24719	review	_	
121-26	24720-24726	papers	_	
121-27	24726-24727	.	_	

#Text=Path coefficients were estimated using the method of maximum likelihood, and the goodness of model fit was indicated by −2 times the log likelihood (−2LL).
122-1	24728-24732	Path	_	
122-2	24733-24745	coefficients	_	
122-3	24746-24750	were	_	
122-4	24751-24760	estimated	_	
122-5	24761-24766	using	_	
122-6	24767-24770	the	_	
122-7	24771-24777	method	_	
122-8	24778-24780	of	_	
122-9	24781-24788	maximum	_	
122-10	24789-24799	likelihood	_	
122-11	24799-24800	,	_	
122-12	24801-24804	and	_	
122-13	24805-24808	the	_	
122-14	24809-24817	goodness	_	
122-15	24818-24820	of	_	
122-16	24821-24826	model	_	
122-17	24827-24830	fit	_	
122-18	24831-24834	was	_	
122-19	24835-24844	indicated	_	
122-20	24845-24847	by	_	
122-21	24848-24849	−	_	
122-22	24849-24850	2	_	
122-23	24851-24856	times	_	
122-24	24857-24860	the	_	
122-25	24861-24864	log	_	
122-26	24865-24875	likelihood	_	
122-27	24876-24877	(	_	
122-28	24877-24878	−	_	
122-29	24878-24881	2LL	_	
122-30	24881-24882	)	_	
122-31	24882-24883	.	_	

#Text=As described elsewhere, the fit of nested submodels was tested by dropping individual paths from the full model (e.g., genetic overlap across assessments, or novel genetic influences at later ages), with the significance of individual paths tested by comparing the fit of the restricted submodel with the fit of the more general model using a χ2 test with degrees of freedom corresponding to the difference in the degrees of freedom between two models (e.g., df=1 if only one parameter is dropped in the restricted model).
123-1	24884-24886	As	_	
123-2	24887-24896	described	_	
123-3	24897-24906	elsewhere	_	
123-4	24906-24907	,	_	
123-5	24908-24911	the	_	
123-6	24912-24915	fit	_	
123-7	24916-24918	of	_	
123-8	24919-24925	nested	_	
123-9	24926-24935	submodels	_	
123-10	24936-24939	was	_	
123-11	24940-24946	tested	_	
123-12	24947-24949	by	_	
123-13	24950-24958	dropping	_	
123-14	24959-24969	individual	_	
123-15	24970-24975	paths	_	
123-16	24976-24980	from	_	
123-17	24981-24984	the	_	
123-18	24985-24989	full	_	
123-19	24990-24995	model	_	
123-20	24996-24997	(	_	
123-21	24997-25000	e.g	_	
123-22	25000-25001	.	_	
123-23	25001-25002	,	_	
123-24	25003-25010	genetic	_	
123-25	25011-25018	overlap	_	
123-26	25019-25025	across	_	
123-27	25026-25037	assessments	_	
123-28	25037-25038	,	_	
123-29	25039-25041	or	_	
123-30	25042-25047	novel	_	
123-31	25048-25055	genetic	_	
123-32	25056-25066	influences	_	
123-33	25067-25069	at	_	
123-34	25070-25075	later	_	
123-35	25076-25080	ages	_	
123-36	25080-25081	)	_	
123-37	25081-25082	,	_	
123-38	25083-25087	with	_	
123-39	25088-25091	the	_	
123-40	25092-25104	significance	_	
123-41	25105-25107	of	_	
123-42	25108-25118	individual	_	
123-43	25119-25124	paths	_	
123-44	25125-25131	tested	_	
123-45	25132-25134	by	_	
123-46	25135-25144	comparing	_	
123-47	25145-25148	the	_	
123-48	25149-25152	fit	_	
123-49	25153-25155	of	_	
123-50	25156-25159	the	_	
123-51	25160-25170	restricted	_	
123-52	25171-25179	submodel	_	
123-53	25180-25184	with	_	
123-54	25185-25188	the	_	
123-55	25189-25192	fit	_	
123-56	25193-25195	of	_	
123-57	25196-25199	the	_	
123-58	25200-25204	more	_	
123-59	25205-25212	general	_	
123-60	25213-25218	model	_	
123-61	25219-25224	using	_	
123-62	25225-25226	a	_	
123-63	25227-25229	χ2	_	
123-64	25230-25234	test	_	
123-65	25235-25239	with	_	
123-66	25240-25247	degrees	_	
123-67	25248-25250	of	_	
123-68	25251-25258	freedom	_	
123-69	25259-25272	corresponding	_	
123-70	25273-25275	to	_	
123-71	25276-25279	the	_	
123-72	25280-25290	difference	_	
123-73	25291-25293	in	_	
123-74	25294-25297	the	_	
123-75	25298-25305	degrees	_	
123-76	25306-25308	of	_	
123-77	25309-25316	freedom	_	
123-78	25317-25324	between	_	
123-79	25325-25328	two	_	
123-80	25329-25335	models	_	
123-81	25336-25337	(	_	
123-82	25337-25340	e.g	_	
123-83	25340-25341	.	_	
123-84	25341-25342	,	_	
123-85	25343-25345	df	_	
123-86	25345-25346	=	_	
123-87	25346-25347	1	_	
123-88	25348-25350	if	_	
123-89	25351-25355	only	_	
123-90	25356-25359	one	_	
123-91	25360-25369	parameter	_	
123-92	25370-25372	is	_	
123-93	25373-25380	dropped	_	
123-94	25381-25383	in	_	
123-95	25384-25387	the	_	
123-96	25388-25398	restricted	_	
123-97	25399-25404	model	_	
123-98	25404-25405	)	_	
123-99	25405-25406	.	_	

#Text=If dropping a path significantly reduced the goodness of fit (the change in χ2 was significant), the path was retained in the model, otherwise the more parsimonious model was chosen (i.e. the one that accounted for the variance equally well, but with a fewer number of parameters).
124-1	25407-25409	If	_	
124-2	25410-25418	dropping	_	
124-3	25419-25420	a	_	
124-4	25421-25425	path	_	
124-5	25426-25439	significantly	_	
124-6	25440-25447	reduced	_	
124-7	25448-25451	the	_	
124-8	25452-25460	goodness	_	
124-9	25461-25463	of	_	
124-10	25464-25467	fit	_	
124-11	25468-25469	(	_	
124-12	25469-25472	the	_	
124-13	25473-25479	change	_	
124-14	25480-25482	in	_	
124-15	25483-25485	χ2	_	
124-16	25486-25489	was	_	
124-17	25490-25501	significant	_	
124-18	25501-25502	)	_	
124-19	25502-25503	,	_	
124-20	25504-25507	the	_	
124-21	25508-25512	path	_	
124-22	25513-25516	was	_	
124-23	25517-25525	retained	_	
124-24	25526-25528	in	_	
124-25	25529-25532	the	_	
124-26	25533-25538	model	_	
124-27	25538-25539	,	_	
124-28	25540-25549	otherwise	_	
124-29	25550-25553	the	_	
124-30	25554-25558	more	_	
124-31	25559-25571	parsimonious	_	
124-32	25572-25577	model	_	
124-33	25578-25581	was	_	
124-34	25582-25588	chosen	_	
124-35	25589-25590	(	_	
124-36	25590-25593	i.e	_	
124-37	25593-25594	.	_	
124-38	25595-25598	the	_	
124-39	25599-25602	one	_	
124-40	25603-25607	that	_	
124-41	25608-25617	accounted	_	
124-42	25618-25621	for	_	
124-43	25622-25625	the	_	
124-44	25626-25634	variance	_	
124-45	25635-25642	equally	_	
124-46	25643-25647	well	_	
124-47	25647-25648	,	_	
124-48	25649-25652	but	_	
124-49	25653-25657	with	_	
124-50	25658-25659	a	_	
124-51	25660-25665	fewer	_	
124-52	25666-25672	number	_	
124-53	25673-25675	of	_	
124-54	25676-25686	parameters	_	
124-55	25686-25687	)	_	
124-56	25687-25688	.	_	

#Text=The fit of the nested submodels was also assessed through Akaike’s Information Criterion (AIC), where AIC= χ2 − 2df (see).
125-1	25689-25692	The	_	
125-2	25693-25696	fit	_	
125-3	25697-25699	of	_	
125-4	25700-25703	the	_	
125-5	25704-25710	nested	_	
125-6	25711-25720	submodels	_	
125-7	25721-25724	was	_	
125-8	25725-25729	also	_	
125-9	25730-25738	assessed	_	
125-10	25739-25746	through	_	
125-11	25747-25753	Akaike	_	
125-12	25753-25754	’	_	
125-13	25754-25755	s	_	
125-14	25756-25767	Information	_	
125-15	25768-25777	Criterion	_	
125-16	25778-25779	(	_	
125-17	25779-25782	AIC	_	
125-18	25782-25783	)	_	
125-19	25783-25784	,	_	
125-20	25785-25790	where	_	
125-21	25791-25794	AIC	_	
125-22	25794-25795	=	_	
125-23	25796-25798	χ2	_	
125-24	25799-25800	−	_	
125-25	25801-25804	2df	_	
125-26	25805-25806	(	_	
125-27	25806-25809	see	_	
125-28	25809-25810	)	_	
125-29	25810-25811	.	_	

#Text=Lower AIC values indicate better fit.
126-1	25812-25817	Lower	_	
126-2	25818-25821	AIC	_	
126-3	25822-25828	values	_	
126-4	25829-25837	indicate	_	
126-5	25838-25844	better	_	
126-6	25845-25848	fit	_	
126-7	25848-25849	.	_	

#Text=In the case of longitudinal data, structural equation modeling permits not only the assessment of heritability at each age, but also the estimation of the extent of the overlap between genetic factors influencing the trait at different ages.
127-1	25850-25852	In	_	
127-2	25853-25856	the	_	
127-3	25857-25861	case	_	
127-4	25862-25864	of	_	
127-5	25865-25877	longitudinal	_	
127-6	25878-25882	data	_	
127-7	25882-25883	,	_	
127-8	25884-25894	structural	_	
127-9	25895-25903	equation	_	
127-10	25904-25912	modeling	_	
127-11	25913-25920	permits	_	
127-12	25921-25924	not	_	
127-13	25925-25929	only	_	
127-14	25930-25933	the	_	
127-15	25934-25944	assessment	_	
127-16	25945-25947	of	_	
127-17	25948-25960	heritability	_	
127-18	25961-25963	at	_	
127-19	25964-25968	each	_	
127-20	25969-25972	age	_	
127-21	25972-25973	,	_	
127-22	25974-25977	but	_	
127-23	25978-25982	also	_	
127-24	25983-25986	the	_	
127-25	25987-25997	estimation	_	
127-26	25998-26000	of	_	
127-27	26001-26004	the	_	
127-28	26005-26011	extent	_	
127-29	26012-26014	of	_	
127-30	26015-26018	the	_	
127-31	26019-26026	overlap	_	
127-32	26027-26034	between	_	
127-33	26035-26042	genetic	_	
127-34	26043-26050	factors	_	
127-35	26051-26062	influencing	_	
127-36	26063-26066	the	_	
127-37	26067-26072	trait	_	
127-38	26073-26075	at	_	
127-39	26076-26085	different	_	
127-40	26086-26090	ages	_	
127-41	26090-26091	.	_	

#Text=For example, genetic factors influencing an ERP variable at age 12 may also influence it at ages 14 and 16, which results in a significant genetic correlation across ages.
128-1	26092-26095	For	_	
128-2	26096-26103	example	_	
128-3	26103-26104	,	_	
128-4	26105-26112	genetic	_	
128-5	26113-26120	factors	_	
128-6	26121-26132	influencing	_	
128-7	26133-26135	an	_	
128-8	26136-26139	ERP	_	
128-9	26140-26148	variable	_	
128-10	26149-26151	at	_	
128-11	26152-26155	age	_	
128-12	26156-26158	12	_	
128-13	26159-26162	may	_	
128-14	26163-26167	also	_	
128-15	26168-26177	influence	_	
128-16	26178-26180	it	_	
128-17	26181-26183	at	_	
128-18	26184-26188	ages	_	
128-19	26189-26191	14	_	
128-20	26192-26195	and	_	
128-21	26196-26198	16	_	
128-22	26198-26199	,	_	
128-23	26200-26205	which	_	
128-24	26206-26213	results	_	
128-25	26214-26216	in	_	
128-26	26217-26218	a	_	
128-27	26219-26230	significant	_	
128-28	26231-26238	genetic	_	
128-29	26239-26250	correlation	_	
128-30	26251-26257	across	_	
128-31	26258-26262	ages	_	
128-32	26262-26263	.	_	

#Text=Such genetic correlations, along with environmental correlations, give rise to cross-age phenotypic correlations, i.e. longitudinal stability.
129-1	26264-26268	Such	_	
129-2	26269-26276	genetic	_	
129-3	26277-26289	correlations	_	
129-4	26289-26290	,	_	
129-5	26291-26296	along	_	
129-6	26297-26301	with	_	
129-7	26302-26315	environmental	_	
129-8	26316-26328	correlations	_	
129-9	26328-26329	,	_	
129-10	26330-26334	give	_	
129-11	26335-26339	rise	_	
129-12	26340-26342	to	_	
129-13	26343-26352	cross-age	_	
129-14	26353-26363	phenotypic	_	
129-15	26364-26376	correlations	_	
129-16	26376-26377	,	_	
129-17	26378-26381	i.e	_	
129-18	26381-26382	.	_	
129-19	26383-26395	longitudinal	_	
129-20	26396-26405	stability	_	
129-21	26405-26406	.	_	

#Text=However, in addition to these age-invariant influences, there may be novel genetic influences emerging at later ages due to e.g. developmental changes in gene expression.
130-1	26407-26414	However	_	
130-2	26414-26415	,	_	
130-3	26416-26418	in	_	
130-4	26419-26427	addition	_	
130-5	26428-26430	to	_	
130-6	26431-26436	these	_	
130-7	26437-26450	age-invariant	_	
130-8	26451-26461	influences	_	
130-9	26461-26462	,	_	
130-10	26463-26468	there	_	
130-11	26469-26472	may	_	
130-12	26473-26475	be	_	
130-13	26476-26481	novel	_	
130-14	26482-26489	genetic	_	
130-15	26490-26500	influences	_	
130-16	26501-26509	emerging	_	
130-17	26510-26512	at	_	
130-18	26513-26518	later	_	
130-19	26519-26523	ages	_	
130-20	26524-26527	due	_	
130-21	26528-26530	to	_	
130-22	26531-26534	e.g	_	
130-23	26534-26535	.	_	
130-24	26536-26549	developmental	_	
130-25	26550-26557	changes	_	
130-26	26558-26560	in	_	
130-27	26561-26565	gene	_	
130-28	26566-26576	expression	_	
130-29	26576-26577	.	_	

#Text=These genetic factors contribute to the overall heritability of a trait but not to genetic correlation across ages.
131-1	26578-26583	These	_	
131-2	26584-26591	genetic	_	
131-3	26592-26599	factors	_	
131-4	26600-26610	contribute	_	
131-5	26611-26613	to	_	
131-6	26614-26617	the	_	
131-7	26618-26625	overall	_	
131-8	26626-26638	heritability	_	
131-9	26639-26641	of	_	
131-10	26642-26643	a	_	
131-11	26644-26649	trait	_	
131-12	26650-26653	but	_	
131-13	26654-26657	not	_	
131-14	26658-26660	to	_	
131-15	26661-26668	genetic	_	
131-16	26669-26680	correlation	_	
131-17	26681-26687	across	_	
131-18	26688-26692	ages	_	
131-19	26692-26693	.	_	

#Text=Such novel genetic (and environmental) influences may explain the fact that cross-age phenotypic correlation is far from perfect.
132-1	26694-26698	Such	_	
132-2	26699-26704	novel	_	
132-3	26705-26712	genetic	_	
132-4	26713-26714	(	_	
132-5	26714-26717	and	_	
132-6	26718-26731	environmental	_	
132-7	26731-26732	)	_	
132-8	26733-26743	influences	_	
132-9	26744-26747	may	_	
132-10	26748-26755	explain	_	
132-11	26756-26759	the	_	
132-12	26760-26764	fact	_	
132-13	26765-26769	that	_	
132-14	26770-26779	cross-age	_	
132-15	26780-26790	phenotypic	_	
132-16	26791-26802	correlation	_	
132-17	26803-26805	is	_	
132-18	26806-26809	far	_	
132-19	26810-26814	from	_	
132-20	26815-26822	perfect	_	
132-21	26822-26823	.	_	

#Text=The Cholesky models utilized in the present analyses assessed the significance of both genetic continuity and novel genetic influence across adolescence.
133-1	26824-26827	The	_	
133-2	26828-26836	Cholesky	_	
133-3	26837-26843	models	_	
133-4	26844-26852	utilized	_	
133-5	26853-26855	in	_	
133-6	26856-26859	the	_	
133-7	26860-26867	present	_	
133-8	26868-26876	analyses	_	
133-9	26877-26885	assessed	_	
133-10	26886-26889	the	_	
133-11	26890-26902	significance	_	
133-12	26903-26905	of	_	
133-13	26906-26910	both	_	
133-14	26911-26918	genetic	_	
133-15	26919-26929	continuity	_	
133-16	26930-26933	and	_	
133-17	26934-26939	novel	_	
133-18	26940-26947	genetic	_	
133-19	26948-26957	influence	_	
133-20	26958-26964	across	_	
133-21	26965-26976	adolescence	_	
133-22	26976-26977	.	_	

#Text=To test for significant differences in heritability across age, we compared the goodness of fit of alternative Cholesky models in which heritability was constrained to be equal or allowed to vary across ages.
134-1	26978-26980	To	_	
134-2	26981-26985	test	_	
134-3	26986-26989	for	_	
134-4	26990-27001	significant	_	
134-5	27002-27013	differences	_	
134-6	27014-27016	in	_	
134-7	27017-27029	heritability	_	
134-8	27030-27036	across	_	
134-9	27037-27040	age	_	
134-10	27040-27041	,	_	
134-11	27042-27044	we	_	
134-12	27045-27053	compared	_	
134-13	27054-27057	the	_	
134-14	27058-27066	goodness	_	
134-15	27067-27069	of	_	
134-16	27070-27073	fit	_	
134-17	27074-27076	of	_	
134-18	27077-27088	alternative	_	
134-19	27089-27097	Cholesky	_	
134-20	27098-27104	models	_	
134-21	27105-27107	in	_	
134-22	27108-27113	which	_	
134-23	27114-27126	heritability	_	
134-24	27127-27130	was	_	
134-25	27131-27142	constrained	_	
134-26	27143-27145	to	_	
134-27	27146-27148	be	_	
134-28	27149-27154	equal	_	
134-29	27155-27157	or	_	
134-30	27158-27165	allowed	_	
134-31	27166-27168	to	_	
134-32	27169-27173	vary	_	
134-33	27174-27180	across	_	
134-34	27181-27185	ages	_	
134-35	27185-27186	.	_	

#Text=To examine genetic and environmental influences on the extent of developmental changes, we computed individual age difference scores for ERP variables by subtracting values at age 12 from the corresponding values at age 16 and used them as new phenotypes in genetic analysis.
135-1	27187-27189	To	_	
135-2	27190-27197	examine	_	
135-3	27198-27205	genetic	_	
135-4	27206-27209	and	_	
135-5	27210-27223	environmental	_	
135-6	27224-27234	influences	_	
135-7	27235-27237	on	_	
135-8	27238-27241	the	_	
135-9	27242-27248	extent	_	
135-10	27249-27251	of	_	
135-11	27252-27265	developmental	_	
135-12	27266-27273	changes	_	
135-13	27273-27274	,	_	
135-14	27275-27277	we	_	
135-15	27278-27286	computed	_	
135-16	27287-27297	individual	_	
135-17	27298-27301	age	_	
135-18	27302-27312	difference	_	
135-19	27313-27319	scores	_	
135-20	27320-27323	for	_	
135-21	27324-27327	ERP	_	
135-22	27328-27337	variables	_	
135-23	27338-27340	by	_	
135-24	27341-27352	subtracting	_	
135-25	27353-27359	values	_	
135-26	27360-27362	at	_	
135-27	27363-27366	age	_	
135-28	27367-27369	12	_	
135-29	27370-27374	from	_	
135-30	27375-27378	the	_	
135-31	27379-27392	corresponding	_	
135-32	27393-27399	values	_	
135-33	27400-27402	at	_	
135-34	27403-27406	age	_	
135-35	27407-27409	16	_	
135-36	27410-27413	and	_	
135-37	27414-27418	used	_	
135-38	27419-27423	them	_	
135-39	27424-27426	as	_	
135-40	27427-27430	new	_	
135-41	27431-27441	phenotypes	_	
135-42	27442-27444	in	_	
135-43	27445-27452	genetic	_	
135-44	27453-27461	analysis	_	
135-45	27461-27462	.	_	

#Text=The main advantage of this approach is that it does not make any assumptions about the shape of the developmental trajectory (an alternative approach would be using a biometric growth modeling, however, with only three time points modeling the developmental trajectory could be inaccurate).
136-1	27463-27466	The	_	
136-2	27467-27471	main	_	
136-3	27472-27481	advantage	_	
136-4	27482-27484	of	_	
136-5	27485-27489	this	_	
136-6	27490-27498	approach	_	
136-7	27499-27501	is	_	
136-8	27502-27506	that	_	
136-9	27507-27509	it	_	
136-10	27510-27514	does	_	
136-11	27515-27518	not	_	
136-12	27519-27523	make	_	
136-13	27524-27527	any	_	
136-14	27528-27539	assumptions	_	
136-15	27540-27545	about	_	
136-16	27546-27549	the	_	
136-17	27550-27555	shape	_	
136-18	27556-27558	of	_	
136-19	27559-27562	the	_	
136-20	27563-27576	developmental	_	
136-21	27577-27587	trajectory	_	
136-22	27588-27589	(	_	
136-23	27589-27591	an	_	
136-24	27592-27603	alternative	_	
136-25	27604-27612	approach	_	
136-26	27613-27618	would	_	
136-27	27619-27621	be	_	
136-28	27622-27627	using	_	
136-29	27628-27629	a	_	
136-30	27630-27639	biometric	_	
136-31	27640-27646	growth	_	
136-32	27647-27655	modeling	_	
136-33	27655-27656	,	_	
136-34	27657-27664	however	_	
136-35	27664-27665	,	_	
136-36	27666-27670	with	_	
136-37	27671-27675	only	_	
136-38	27676-27681	three	_	
136-39	27682-27686	time	_	
136-40	27687-27693	points	_	
136-41	27694-27702	modeling	_	
136-42	27703-27706	the	_	
136-43	27707-27720	developmental	_	
136-44	27721-27731	trajectory	_	
136-45	27732-27737	could	_	
136-46	27738-27740	be	_	
136-47	27741-27751	inaccurate	_	
136-48	27751-27752	)	_	
136-49	27752-27753	.	_	

#Text=A detailed description of genetic model fitting and comparison of alternative models is presented in the Supplementary Material.
#Text=3.
137-1	27754-27755	A	_	
137-2	27756-27764	detailed	_	
137-3	27765-27776	description	_	
137-4	27777-27779	of	_	
137-5	27780-27787	genetic	_	
137-6	27788-27793	model	_	
137-7	27794-27801	fitting	_	
137-8	27802-27805	and	_	
137-9	27806-27816	comparison	_	
137-10	27817-27819	of	_	
137-11	27820-27831	alternative	_	
137-12	27832-27838	models	_	
137-13	27839-27841	is	_	
137-14	27842-27851	presented	_	
137-15	27852-27854	in	_	
137-16	27855-27858	the	_	
137-17	27859-27872	Supplementary	_	
137-18	27873-27881	Material	_	
137-19	27881-27882	.	_	
137-20	27883-27884	3	_	
137-21	27884-27885	.	_	

#Text=Results
#Text=3.1.
138-1	27886-27893	Results	_	
138-2	27894-27897	3.1	_	
138-3	27897-27898	.	_	

#Text=Go versus No-Go differences
#Text=Averaged ERP waveforms elicited in Go and No-Go trials are shown in Fig. 2 for selected midline electrodes and in Supplementary Fig. 1 for all 30 scalp locations.
139-1	27899-27901	Go	_	
139-2	27902-27908	versus	_	
139-3	27909-27914	No-Go	_	
139-4	27915-27926	differences	_	
139-5	27927-27935	Averaged	_	
139-6	27936-27939	ERP	_	
139-7	27940-27949	waveforms	_	
139-8	27950-27958	elicited	_	
139-9	27959-27961	in	_	
139-10	27962-27964	Go	_	
139-11	27965-27968	and	_	
139-12	27969-27974	No-Go	_	
139-13	27975-27981	trials	_	
139-14	27982-27985	are	_	
139-15	27986-27991	shown	_	
139-16	27992-27994	in	_	
139-17	27995-27998	Fig	_	
139-18	27998-27999	.	_	
139-19	28000-28001	2	_	
139-20	28002-28005	for	_	
139-21	28006-28014	selected	_	
139-22	28015-28022	midline	_	
139-23	28023-28033	electrodes	_	
139-24	28034-28037	and	_	
139-25	28038-28040	in	_	
139-26	28041-28054	Supplementary	_	
139-27	28055-28058	Fig	_	
139-28	28058-28059	.	_	
139-29	28060-28061	1	_	
139-30	28062-28065	for	_	
139-31	28066-28069	all	_	
139-32	28070-28072	30	_	
139-33	28073-28078	scalp	_	
139-34	28079-28088	locations	_	
139-35	28088-28089	.	_	

#Text=Consistent with previous studies, we observed a striking difference between ERP responses to Go and No-Go stimuli.
140-1	28090-28100	Consistent	_	
140-2	28101-28105	with	_	
140-3	28106-28114	previous	_	
140-4	28115-28122	studies	_	
140-5	28122-28123	,	_	
140-6	28124-28126	we	_	
140-7	28127-28135	observed	_	
140-8	28136-28137	a	_	
140-9	28138-28146	striking	_	
140-10	28147-28157	difference	_	
140-11	28158-28165	between	_	
140-12	28166-28169	ERP	_	
140-13	28170-28179	responses	_	
140-14	28180-28182	to	_	
140-15	28183-28185	Go	_	
140-16	28186-28189	and	_	
140-17	28190-28195	No-Go	_	
140-18	28196-28203	stimuli	_	
140-19	28203-28204	.	_	

#Text=It is important to note that because Go and No-Go stimuli were equiprobable, the No-Go versus Go ERP differences in the present study are not confounded with the frequency (oddball) effect, as may be the case in Go/No-Go tasks using frequent Go and infrequent No-Go stimuli.
141-1	28205-28207	It	_	
141-2	28208-28210	is	_	
141-3	28211-28220	important	_	
141-4	28221-28223	to	_	
141-5	28224-28228	note	_	
141-6	28229-28233	that	_	
141-7	28234-28241	because	_	
141-8	28242-28244	Go	_	
141-9	28245-28248	and	_	
141-10	28249-28254	No-Go	_	
141-11	28255-28262	stimuli	_	
141-12	28263-28267	were	_	
141-13	28268-28280	equiprobable	_	
141-14	28280-28281	,	_	
141-15	28282-28285	the	_	
141-16	28286-28291	No-Go	_	
141-17	28292-28298	versus	_	
141-18	28299-28301	Go	_	
141-19	28302-28305	ERP	_	
141-20	28306-28317	differences	_	
141-21	28318-28320	in	_	
141-22	28321-28324	the	_	
141-23	28325-28332	present	_	
141-24	28333-28338	study	_	
141-25	28339-28342	are	_	
141-26	28343-28346	not	_	
141-27	28347-28357	confounded	_	
141-28	28358-28362	with	_	
141-29	28363-28366	the	_	
141-30	28367-28376	frequency	_	
141-31	28377-28378	(	_	
141-32	28378-28385	oddball	_	
141-33	28385-28386	)	_	
141-34	28387-28393	effect	_	
141-35	28393-28394	,	_	
141-36	28395-28397	as	_	
141-37	28398-28401	may	_	
141-38	28402-28404	be	_	
141-39	28405-28408	the	_	
141-40	28409-28413	case	_	
141-41	28414-28416	in	_	
141-42	28417-28419	Go	_	
141-43	28419-28420	/	_	
141-44	28420-28425	No-Go	_	
141-45	28426-28431	tasks	_	
141-46	28432-28437	using	_	
141-47	28438-28446	frequent	_	
141-48	28447-28449	Go	_	
141-49	28450-28453	and	_	
141-50	28454-28464	infrequent	_	
141-51	28465-28470	No-Go	_	
141-52	28471-28478	stimuli	_	
141-53	28478-28479	.	_	

#Text=No-Go trials produced a prominent frontal N2 and P3 components that were virtually absent in Go trials.
142-1	28480-28485	No-Go	_	
142-2	28486-28492	trials	_	
142-3	28493-28501	produced	_	
142-4	28502-28503	a	_	
142-5	28504-28513	prominent	_	
142-6	28514-28521	frontal	_	
142-7	28522-28524	N2	_	
142-8	28525-28528	and	_	
142-9	28529-28531	P3	_	
142-10	28532-28542	components	_	
142-11	28543-28547	that	_	
142-12	28548-28552	were	_	
142-13	28553-28562	virtually	_	
142-14	28563-28569	absent	_	
142-15	28570-28572	in	_	
142-16	28573-28575	Go	_	
142-17	28576-28582	trials	_	
142-18	28582-28583	.	_	

#Text=The scalp distribution of ERP components (Fig. 2, 3, Supplementary Fig. 1) shows a distinctive “anteriorization” of the P3 component in the No-Go condition, consistent with previous studies.
143-1	28584-28587	The	_	
143-2	28588-28593	scalp	_	
143-3	28594-28606	distribution	_	
143-4	28607-28609	of	_	
143-5	28610-28613	ERP	_	
143-6	28614-28624	components	_	
143-7	28625-28626	(	_	
143-8	28626-28629	Fig	_	
143-9	28629-28630	.	_	
143-10	28631-28632	2	_	
143-11	28632-28633	,	_	
143-12	28634-28635	3	_	
143-13	28635-28636	,	_	
143-14	28637-28650	Supplementary	_	
143-15	28651-28654	Fig	_	
143-16	28654-28655	.	_	
143-17	28656-28657	1	_	
143-18	28657-28658	)	_	
143-19	28659-28664	shows	_	
143-20	28665-28666	a	_	
143-21	28667-28678	distinctive	_	
143-22	28679-28680	“	_	
143-23	28680-28695	anteriorization	_	
143-24	28695-28696	”	_	
143-25	28697-28699	of	_	
143-26	28700-28703	the	_	
143-27	28704-28706	P3	_	
143-28	28707-28716	component	_	
143-29	28717-28719	in	_	
143-30	28720-28723	the	_	
143-31	28724-28729	No-Go	_	
143-32	28730-28739	condition	_	
143-33	28739-28740	,	_	
143-34	28741-28751	consistent	_	
143-35	28752-28756	with	_	
143-36	28757-28765	previous	_	
143-37	28766-28773	studies	_	
143-38	28773-28774	.	_	

#Text=In contrast, Go stimuli elicited a P3 component peaking at the mid-parietal (Pz) location, with its morphology and scalp topography being very similar to a classical oddball P3.
#Text=3.2.
144-1	28775-28777	In	_	
144-2	28778-28786	contrast	_	
144-3	28786-28787	,	_	
144-4	28788-28790	Go	_	
144-5	28791-28798	stimuli	_	
144-6	28799-28807	elicited	_	
144-7	28808-28809	a	_	
144-8	28810-28812	P3	_	
144-9	28813-28822	component	_	
144-10	28823-28830	peaking	_	
144-11	28831-28833	at	_	
144-12	28834-28837	the	_	
144-13	28838-28850	mid-parietal	_	
144-14	28851-28852	(	_	
144-15	28852-28854	Pz	_	
144-16	28854-28855	)	_	
144-17	28856-28864	location	_	
144-18	28864-28865	,	_	
144-19	28866-28870	with	_	
144-20	28871-28874	its	_	
144-21	28875-28885	morphology	_	
144-22	28886-28889	and	_	
144-23	28890-28895	scalp	_	
144-24	28896-28906	topography	_	
144-25	28907-28912	being	_	
144-26	28913-28917	very	_	
144-27	28918-28925	similar	_	
144-28	28926-28928	to	_	
144-29	28929-28930	a	_	
144-30	28931-28940	classical	_	
144-31	28941-28948	oddball	_	
144-32	28949-28951	P3	_	
144-33	28951-28952	.	_	
144-34	28953-28956	3.2	_	
144-35	28956-28957	.	_	

#Text=Developmental changes
#Text=Different ERP components showed distinct and highly significant patterns of age-related changes (Fig 4).
145-1	28958-28971	Developmental	_	
145-2	28972-28979	changes	_	
145-3	28980-28989	Different	_	
145-4	28990-28993	ERP	_	
145-5	28994-29004	components	_	
145-6	29005-29011	showed	_	
145-7	29012-29020	distinct	_	
145-8	29021-29024	and	_	
145-9	29025-29031	highly	_	
145-10	29032-29043	significant	_	
145-11	29044-29052	patterns	_	
145-12	29053-29055	of	_	
145-13	29056-29067	age-related	_	
145-14	29068-29075	changes	_	
145-15	29076-29077	(	_	
145-16	29077-29080	Fig	_	
145-17	29081-29082	4	_	
145-18	29082-29083	)	_	
145-19	29083-29084	.	_	

#Text=The frontal No-Go N2 component decreased with age (F[1,363]=507.2, p<.001), whereas No-Go P3 increased with age (F[1,363]=31.1, p<.001).
146-1	29085-29088	The	_	
146-2	29089-29096	frontal	_	
146-3	29097-29102	No-Go	_	
146-4	29103-29105	N2	_	
146-5	29106-29115	component	_	
146-6	29116-29125	decreased	_	
146-7	29126-29130	with	_	
146-8	29131-29134	age	_	
146-9	29135-29136	(	_	
146-10	29136-29137	F	_	
146-11	29137-29138	[	_	
146-12	29138-29143	1,363	_	
146-13	29143-29144	]	_	
146-14	29144-29145	=	_	
146-15	29145-29150	507.2	_	
146-16	29150-29151	,	_	
146-17	29152-29153	p	_	
146-18	29153-29154	<	_	
146-19	29154-29158	.001	_	
146-20	29158-29159	)	_	
146-21	29159-29160	,	_	
146-22	29161-29168	whereas	_	
146-23	29169-29174	No-Go	_	
146-24	29175-29177	P3	_	
146-25	29178-29187	increased	_	
146-26	29188-29192	with	_	
146-27	29193-29196	age	_	
146-28	29197-29198	(	_	
146-29	29198-29199	F	_	
146-30	29199-29200	[	_	
146-31	29200-29205	1,363	_	
146-32	29205-29206	]	_	
146-33	29206-29207	=	_	
146-34	29207-29211	31.1	_	
146-35	29211-29212	,	_	
146-36	29213-29214	p	_	
146-37	29214-29215	<	_	
146-38	29215-29219	.001	_	
146-39	29219-29220	)	_	
146-40	29220-29221	.	_	

#Text=The parietal Go-P3 decreased with age (F[1,363]=115.3, p<.001).
147-1	29222-29225	The	_	
147-2	29226-29234	parietal	_	
147-3	29235-29240	Go-P3	_	
147-4	29241-29250	decreased	_	
147-5	29251-29255	with	_	
147-6	29256-29259	age	_	
147-7	29260-29261	(	_	
147-8	29261-29262	F	_	
147-9	29262-29263	[	_	
147-10	29263-29268	1,363	_	
147-11	29268-29269	]	_	
147-12	29269-29270	=	_	
147-13	29270-29275	115.3	_	
147-14	29275-29276	,	_	
147-15	29277-29278	p	_	
147-16	29278-29279	<	_	
147-17	29279-29283	.001	_	
147-18	29283-29284	)	_	
147-19	29284-29285	.	_	

#Text=As expected, task performance (accuracy and speed, Mean±SD) showed substantial improvement with age: the rate of missed responses decreased from 12.1±13.9 to 2.5±4.9%, the rate of false alarms (responses in No-Go trials) dropped from 9.1±10.4 to 5.3±6.0%, and the mean reaction time in Go trials decreased from 362±78 to 324±54 ms (all effects of age were highly significant, p<.001).
#Text=3.3.
148-1	29286-29288	As	_	
148-2	29289-29297	expected	_	
148-3	29297-29298	,	_	
148-4	29299-29303	task	_	
148-5	29304-29315	performance	_	
148-6	29316-29317	(	_	
148-7	29317-29325	accuracy	_	
148-8	29326-29329	and	_	
148-9	29330-29335	speed	_	
148-10	29335-29336	,	_	
148-11	29337-29341	Mean	_	
148-12	29341-29342	±	_	
148-13	29342-29344	SD	_	
148-14	29344-29345	)	_	
148-15	29346-29352	showed	_	
148-16	29353-29364	substantial	_	
148-17	29365-29376	improvement	_	
148-18	29377-29381	with	_	
148-19	29382-29385	age	_	
148-20	29385-29386	:	_	
148-21	29387-29390	the	_	
148-22	29391-29395	rate	_	
148-23	29396-29398	of	_	
148-24	29399-29405	missed	_	
148-25	29406-29415	responses	_	
148-26	29416-29425	decreased	_	
148-27	29426-29430	from	_	
148-28	29431-29435	12.1	_	
148-29	29435-29436	±	_	
148-30	29436-29440	13.9	_	
148-31	29441-29443	to	_	
148-32	29444-29447	2.5	_	
148-33	29447-29448	±	_	
148-34	29448-29452	4.9%	_	
148-35	29452-29453	,	_	
148-36	29454-29457	the	_	
148-37	29458-29462	rate	_	
148-38	29463-29465	of	_	
148-39	29466-29471	false	_	
148-40	29472-29478	alarms	_	
148-41	29479-29480	(	_	
148-42	29480-29489	responses	_	
148-43	29490-29492	in	_	
148-44	29493-29498	No-Go	_	
148-45	29499-29505	trials	_	
148-46	29505-29506	)	_	
148-47	29507-29514	dropped	_	
148-48	29515-29519	from	_	
148-49	29520-29523	9.1	_	
148-50	29523-29524	±	_	
148-51	29524-29528	10.4	_	
148-52	29529-29531	to	_	
148-53	29532-29535	5.3	_	
148-54	29535-29536	±	_	
148-55	29536-29540	6.0%	_	
148-56	29540-29541	,	_	
148-57	29542-29545	and	_	
148-58	29546-29549	the	_	
148-59	29550-29554	mean	_	
148-60	29555-29563	reaction	_	
148-61	29564-29568	time	_	
148-62	29569-29571	in	_	
148-63	29572-29574	Go	_	
148-64	29575-29581	trials	_	
148-65	29582-29591	decreased	_	
148-66	29592-29596	from	_	
148-67	29597-29600	362	_	
148-68	29600-29601	±	_	
148-69	29601-29603	78	_	
148-70	29604-29606	to	_	
148-71	29607-29610	324	_	
148-72	29610-29611	±	_	
148-73	29611-29613	54	_	
148-74	29614-29616	ms	_	
148-75	29617-29618	(	_	
148-76	29618-29621	all	_	
148-77	29622-29629	effects	_	
148-78	29630-29632	of	_	
148-79	29633-29636	age	_	
148-80	29637-29641	were	_	
148-81	29642-29648	highly	_	
148-82	29649-29660	significant	_	
148-83	29660-29661	,	_	
148-84	29662-29663	p	_	
148-85	29663-29664	<	_	
148-86	29664-29668	.001	_	
148-87	29668-29669	)	_	
148-88	29669-29670	.	_	
148-89	29671-29674	3.3	_	
148-90	29674-29675	.	_	

#Text=Gender differences
#Text=Analysis of gender differences showed that girls had slightly larger N2 components (F[1,362]=4.39, p=.04.
149-1	29676-29682	Gender	_	
149-2	29683-29694	differences	_	
149-3	29695-29703	Analysis	_	
149-4	29704-29706	of	_	
149-5	29707-29713	gender	_	
149-6	29714-29725	differences	_	
149-7	29726-29732	showed	_	
149-8	29733-29737	that	_	
149-9	29738-29743	girls	_	
149-10	29744-29747	had	_	
149-11	29748-29756	slightly	_	
149-12	29757-29763	larger	_	
149-13	29764-29766	N2	_	
149-14	29767-29777	components	_	
149-15	29778-29779	(	_	
149-16	29779-29780	F	_	
149-17	29780-29781	[	_	
149-18	29781-29786	1,362	_	
149-19	29786-29787	]	_	
149-20	29787-29788	=	_	
149-21	29788-29792	4.39	_	
149-22	29792-29793	,	_	
149-23	29794-29795	p	_	
149-24	29795-29796	=	_	
149-25	29796-29799	.04	_	
149-26	29799-29800	.	_	

#Text=Follow-up analyses by age showed that gender differences were non-significant at age 12 but reached significance at ages 14 and 16 (p<.05), however, the effect size was small (Cohen’s d=.21 and .25, respectively).
150-1	29801-29810	Follow-up	_	
150-2	29811-29819	analyses	_	
150-3	29820-29822	by	_	
150-4	29823-29826	age	_	
150-5	29827-29833	showed	_	
150-6	29834-29838	that	_	
150-7	29839-29845	gender	_	
150-8	29846-29857	differences	_	
150-9	29858-29862	were	_	
150-10	29863-29878	non-significant	_	
150-11	29879-29881	at	_	
150-12	29882-29885	age	_	
150-13	29886-29888	12	_	
150-14	29889-29892	but	_	
150-15	29893-29900	reached	_	
150-16	29901-29913	significance	_	
150-17	29914-29916	at	_	
150-18	29917-29921	ages	_	
150-19	29922-29924	14	_	
150-20	29925-29928	and	_	
150-21	29929-29931	16	_	
150-22	29932-29933	(	_	
150-23	29933-29934	p	_	
150-24	29934-29935	<	_	
150-25	29935-29938	.05	_	
150-26	29938-29939	)	_	
150-27	29939-29940	,	_	
150-28	29941-29948	however	_	
150-29	29948-29949	,	_	
150-30	29950-29953	the	_	
150-31	29954-29960	effect	_	
150-32	29961-29965	size	_	
150-33	29966-29969	was	_	
150-34	29970-29975	small	_	
150-35	29976-29977	(	_	
150-36	29977-29982	Cohen	_	
150-37	29982-29983	’	_	
150-38	29983-29984	s	_	
150-39	29985-29986	d	_	
150-40	29986-29987	=	_	
150-41	29987-29990	.21	_	
150-42	29991-29994	and	_	
150-43	29995-29998	.25	_	
150-44	29998-29999	,	_	
150-45	30000-30012	respectively	_	
150-46	30012-30013	)	_	
150-47	30013-30014	.	_	

#Text=There was no significant main effect of gender on No-Go or Go P3.
#Text=3.4.
151-1	30015-30020	There	_	
151-2	30021-30024	was	_	
151-3	30025-30027	no	_	
151-4	30028-30039	significant	_	
151-5	30040-30044	main	_	
151-6	30045-30051	effect	_	
151-7	30052-30054	of	_	
151-8	30055-30061	gender	_	
151-9	30062-30064	on	_	
151-10	30065-30070	No-Go	_	
151-11	30071-30073	or	_	
151-12	30074-30076	Go	_	
151-13	30077-30079	P3	_	
151-14	30079-30080	.	_	
151-15	30081-30084	3.4	_	
151-16	30084-30085	.	_	

#Text=Longitudinal stability of individual differences
#Text=All ERP components showed highly significant correlations between the same measures at different ages ranging from .53 to .71, indicating temporal stability of individual differences (Table 2).
152-1	30086-30098	Longitudinal	_	
152-2	30099-30108	stability	_	
152-3	30109-30111	of	_	
152-4	30112-30122	individual	_	
152-5	30123-30134	differences	_	
152-6	30135-30138	All	_	
152-7	30139-30142	ERP	_	
152-8	30143-30153	components	_	
152-9	30154-30160	showed	_	
152-10	30161-30167	highly	_	
152-11	30168-30179	significant	_	
152-12	30180-30192	correlations	_	
152-13	30193-30200	between	_	
152-14	30201-30204	the	_	
152-15	30205-30209	same	_	
152-16	30210-30218	measures	_	
152-17	30219-30221	at	_	
152-18	30222-30231	different	_	
152-19	30232-30236	ages	_	
152-20	30237-30244	ranging	_	
152-21	30245-30249	from	_	
152-22	30250-30253	.53	_	
152-23	30254-30256	to	_	
152-24	30257-30260	.71	_	
152-25	30260-30261	,	_	
152-26	30262-30272	indicating	_	
152-27	30273-30281	temporal	_	
152-28	30282-30291	stability	_	
152-29	30292-30294	of	_	
152-30	30295-30305	individual	_	
152-31	30306-30317	differences	_	
152-32	30318-30319	(	_	
152-33	30319-30324	Table	_	
152-34	30325-30326	2	_	
152-35	30326-30327	)	_	
152-36	30327-30328	.	_	

#Text=In other words, rank ordering of individuals remained relatively stable despite the systematic age-related trends in absolute values described above.
#Text=3.5.
153-1	30329-30331	In	_	
153-2	30332-30337	other	_	
153-3	30338-30343	words	_	
153-4	30343-30344	,	_	
153-5	30345-30349	rank	_	
153-6	30350-30358	ordering	_	
153-7	30359-30361	of	_	
153-8	30362-30373	individuals	_	
153-9	30374-30382	remained	_	
153-10	30383-30393	relatively	_	
153-11	30394-30400	stable	_	
153-12	30401-30408	despite	_	
153-13	30409-30412	the	_	
153-14	30413-30423	systematic	_	
153-15	30424-30435	age-related	_	
153-16	30436-30442	trends	_	
153-17	30443-30445	in	_	
153-18	30446-30454	absolute	_	
153-19	30455-30461	values	_	
153-20	30462-30471	described	_	
153-21	30472-30477	above	_	
153-22	30477-30478	.	_	
153-23	30479-30482	3.5	_	
153-24	30482-30483	.	_	

#Text=Twin correlations and heritability
#Text=Twin-pair correlations for frontal No-Go N2 and P3 and parietal Go P3 amplitudes are shown in Table 3.
154-1	30484-30488	Twin	_	
154-2	30489-30501	correlations	_	
154-3	30502-30505	and	_	
154-4	30506-30518	heritability	_	
154-5	30519-30528	Twin-pair	_	
154-6	30529-30541	correlations	_	
154-7	30542-30545	for	_	
154-8	30546-30553	frontal	_	
154-9	30554-30559	No-Go	_	
154-10	30560-30562	N2	_	
154-11	30563-30566	and	_	
154-12	30567-30569	P3	_	
154-13	30570-30573	and	_	
154-14	30574-30582	parietal	_	
154-15	30583-30585	Go	_	
154-16	30586-30588	P3	_	
154-17	30589-30599	amplitudes	_	
154-18	30600-30603	are	_	
154-19	30604-30609	shown	_	
154-20	30610-30612	in	_	
154-21	30613-30618	Table	_	
154-22	30619-30620	3	_	
154-23	30620-30621	.	_	

#Text=The pattern of MZ and DZ correlations suggests 1) significant familiality for all ERP measures (rMZ was statistically significant in all cases), 2) significant genetic influences for all measures at all ages (rMZ>rDZ), and 3) the possibility of non-additive genetic influences, particularly at age 16 (rMZ>2 rDZ).
155-1	30622-30625	The	_	
155-2	30626-30633	pattern	_	
155-3	30634-30636	of	_	
155-4	30637-30639	MZ	_	
155-5	30640-30643	and	_	
155-6	30644-30646	DZ	_	
155-7	30647-30659	correlations	_	
155-8	30660-30668	suggests	_	
155-9	30669-30670	1	_	
155-10	30670-30671	)	_	
155-11	30672-30683	significant	_	
155-12	30684-30695	familiality	_	
155-13	30696-30699	for	_	
155-14	30700-30703	all	_	
155-15	30704-30707	ERP	_	
155-16	30708-30716	measures	_	
155-17	30717-30718	(	_	
155-18	30718-30721	rMZ	_	
155-19	30722-30725	was	_	
155-20	30726-30739	statistically	_	
155-21	30740-30751	significant	_	
155-22	30752-30754	in	_	
155-23	30755-30758	all	_	
155-24	30759-30764	cases	_	
155-25	30764-30765	)	_	
155-26	30765-30766	,	_	
155-27	30767-30768	2	_	
155-28	30768-30769	)	_	
155-29	30770-30781	significant	_	
155-30	30782-30789	genetic	_	
155-31	30790-30800	influences	_	
155-32	30801-30804	for	_	
155-33	30805-30808	all	_	
155-34	30809-30817	measures	_	
155-35	30818-30820	at	_	
155-36	30821-30824	all	_	
155-37	30825-30829	ages	_	
155-38	30830-30831	(	_	
155-39	30831-30834	rMZ	_	
155-40	30834-30835	>	_	
155-41	30835-30838	rDZ	_	
155-42	30838-30839	)	_	
155-43	30839-30840	,	_	
155-44	30841-30844	and	_	
155-45	30845-30846	3	_	
155-46	30846-30847	)	_	
155-47	30848-30851	the	_	
155-48	30852-30863	possibility	_	
155-49	30864-30866	of	_	
155-50	30867-30879	non-additive	_	
155-51	30880-30887	genetic	_	
155-52	30888-30898	influences	_	
155-53	30898-30899	,	_	
155-54	30900-30912	particularly	_	
155-55	30913-30915	at	_	
155-56	30916-30919	age	_	
155-57	30920-30922	16	_	
155-58	30923-30924	(	_	
155-59	30924-30927	rMZ	_	
155-60	30927-30928	>	_	
155-61	30928-30929	2	_	
155-62	30930-30933	rDZ	_	
155-63	30933-30934	)	_	
155-64	30934-30935	.	_	

#Text=Below we describe the results of fitting and comparing different models for each of the ERP variables.
156-1	30936-30941	Below	_	
156-2	30942-30944	we	_	
156-3	30945-30953	describe	_	
156-4	30954-30957	the	_	
156-5	30958-30965	results	_	
156-6	30966-30968	of	_	
156-7	30969-30976	fitting	_	
156-8	30977-30980	and	_	
156-9	30981-30990	comparing	_	
156-10	30991-31000	different	_	
156-11	31001-31007	models	_	
156-12	31008-31011	for	_	
156-13	31012-31016	each	_	
156-14	31017-31019	of	_	
156-15	31020-31023	the	_	
156-16	31024-31027	ERP	_	
156-17	31028-31037	variables	_	
156-18	31037-31038	.	_	

#Text=Path diagrams for different types of models are illustrated in Fig. 5 using No-Go P3 as an example (a full set of models and the corresponding estimated path coefficients is presented in Supplementary Fig. 2).
157-1	31039-31043	Path	_	
157-2	31044-31052	diagrams	_	
157-3	31053-31056	for	_	
157-4	31057-31066	different	_	
157-5	31067-31072	types	_	
157-6	31073-31075	of	_	
157-7	31076-31082	models	_	
157-8	31083-31086	are	_	
157-9	31087-31098	illustrated	_	
157-10	31099-31101	in	_	
157-11	31102-31105	Fig	_	
157-12	31105-31106	.	_	
157-13	31107-31108	5	_	
157-14	31109-31114	using	_	
157-15	31115-31120	No-Go	_	
157-16	31121-31123	P3	_	
157-17	31124-31126	as	_	
157-18	31127-31129	an	_	
157-19	31130-31137	example	_	
157-20	31138-31139	(	_	
157-21	31139-31140	a	_	
157-22	31141-31145	full	_	
157-23	31146-31149	set	_	
157-24	31150-31152	of	_	
157-25	31153-31159	models	_	
157-26	31160-31163	and	_	
157-27	31164-31167	the	_	
157-28	31168-31181	corresponding	_	
157-29	31182-31191	estimated	_	
157-30	31192-31196	path	_	
157-31	31197-31209	coefficients	_	
157-32	31210-31212	is	_	
157-33	31213-31222	presented	_	
157-34	31223-31225	in	_	
157-35	31226-31239	Supplementary	_	
157-36	31240-31243	Fig	_	
157-37	31243-31244	.	_	
157-38	31245-31246	2	_	
157-39	31246-31247	)	_	
157-40	31247-31248	.	_	

#Text=A detailed description of genetic model fitting and comparison of alternative models is presented in the Supplementary Material, including longitudinal Cholesky models (Supplementary Table 1) and analysis of changes from age 12 to age 16 (Supplementary Table 2).
158-1	31249-31250	A	_	
158-2	31251-31259	detailed	_	
158-3	31260-31271	description	_	
158-4	31272-31274	of	_	
158-5	31275-31282	genetic	_	
158-6	31283-31288	model	_	
158-7	31289-31296	fitting	_	
158-8	31297-31300	and	_	
158-9	31301-31311	comparison	_	
158-10	31312-31314	of	_	
158-11	31315-31326	alternative	_	
158-12	31327-31333	models	_	
158-13	31334-31336	is	_	
158-14	31337-31346	presented	_	
158-15	31347-31349	in	_	
158-16	31350-31353	the	_	
158-17	31354-31367	Supplementary	_	
158-18	31368-31376	Material	_	
158-19	31376-31377	,	_	
158-20	31378-31387	including	_	
158-21	31388-31400	longitudinal	_	
158-22	31401-31409	Cholesky	_	
158-23	31410-31416	models	_	
158-24	31417-31418	(	_	
158-25	31418-31431	Supplementary	_	
158-26	31432-31437	Table	_	
158-27	31438-31439	1	_	
158-28	31439-31440	)	_	
158-29	31441-31444	and	_	
158-30	31445-31453	analysis	_	
158-31	31454-31456	of	_	
158-32	31457-31464	changes	_	
158-33	31465-31469	from	_	
158-34	31470-31473	age	_	
158-35	31474-31476	12	_	
158-36	31477-31479	to	_	
158-37	31480-31483	age	_	
158-38	31484-31486	16	_	
158-39	31487-31488	(	_	
158-40	31488-31501	Supplementary	_	
158-41	31502-31507	Table	_	
158-42	31508-31509	2	_	
158-43	31509-31510	)	_	
158-44	31510-31511	.	_	

#Text=In summary, for each of the three variables non-additive genetic influences were non-significant, and AE model including additive genetic and non-shared environmental factors was the best fitting one.
159-1	31512-31514	In	_	
159-2	31515-31522	summary	_	
159-3	31522-31523	,	_	
159-4	31524-31527	for	_	
159-5	31528-31532	each	_	
159-6	31533-31535	of	_	
159-7	31536-31539	the	_	
159-8	31540-31545	three	_	
159-9	31546-31555	variables	_	
159-10	31556-31568	non-additive	_	
159-11	31569-31576	genetic	_	
159-12	31577-31587	influences	_	
159-13	31588-31592	were	_	
159-14	31593-31608	non-significant	_	
159-15	31608-31609	,	_	
159-16	31610-31613	and	_	
159-17	31614-31616	AE	_	
159-18	31617-31622	model	_	
159-19	31623-31632	including	_	
159-20	31633-31641	additive	_	
159-21	31642-31649	genetic	_	
159-22	31650-31653	and	_	
159-23	31654-31664	non-shared	_	
159-24	31665-31678	environmental	_	
159-25	31679-31686	factors	_	
159-26	31687-31690	was	_	
159-27	31691-31694	the	_	
159-28	31695-31699	best	_	
159-29	31700-31707	fitting	_	
159-30	31708-31711	one	_	
159-31	31711-31712	.	_	

#Text=Maximum-likelihood estimation of model parameters showed that all three ERP components indicated significant heritability at each assessment, indicating that 50–60% of inter-individual variability can be attributed to genetic factors (Table 3 and Fig. 6).
#Text=3.6.
160-1	31713-31731	Maximum-likelihood	_	
160-2	31732-31742	estimation	_	
160-3	31743-31745	of	_	
160-4	31746-31751	model	_	
160-5	31752-31762	parameters	_	
160-6	31763-31769	showed	_	
160-7	31770-31774	that	_	
160-8	31775-31778	all	_	
160-9	31779-31784	three	_	
160-10	31785-31788	ERP	_	
160-11	31789-31799	components	_	
160-12	31800-31809	indicated	_	
160-13	31810-31821	significant	_	
160-14	31822-31834	heritability	_	
160-15	31835-31837	at	_	
160-16	31838-31842	each	_	
160-17	31843-31853	assessment	_	
160-18	31853-31854	,	_	
160-19	31855-31865	indicating	_	
160-20	31866-31870	that	_	
160-21	31871-31873	50	_	
160-22	31873-31874	–	_	
160-23	31874-31877	60%	_	
160-24	31878-31880	of	_	
160-25	31881-31897	inter-individual	_	
160-26	31898-31909	variability	_	
160-27	31910-31913	can	_	
160-28	31914-31916	be	_	
160-29	31917-31927	attributed	_	
160-30	31928-31930	to	_	
160-31	31931-31938	genetic	_	
160-32	31939-31946	factors	_	
160-33	31947-31948	(	_	
160-34	31948-31953	Table	_	
160-35	31954-31955	3	_	
160-36	31956-31959	and	_	
160-37	31960-31963	Fig	_	
160-38	31963-31964	.	_	
160-39	31965-31966	6	_	
160-40	31966-31967	)	_	
160-41	31967-31968	.	_	
160-42	31969-31972	3.6	_	
160-43	31972-31973	.	_	

#Text=Testing for age-related changes in heritability and genetic architecture
#Text=To test for significance of the relatively minor differences in heritability estimates across age, we compared the goodness of fit of alternative models in which heritability was constrained to be equal or allowed to vary across age.
161-1	31974-31981	Testing	_	
161-2	31982-31985	for	_	
161-3	31986-31997	age-related	_	
161-4	31998-32005	changes	_	
161-5	32006-32008	in	_	
161-6	32009-32021	heritability	_	
161-7	32022-32025	and	_	
161-8	32026-32033	genetic	_	
161-9	32034-32046	architecture	_	
161-10	32047-32049	To	_	
161-11	32050-32054	test	_	
161-12	32055-32058	for	_	
161-13	32059-32071	significance	_	
161-14	32072-32074	of	_	
161-15	32075-32078	the	_	
161-16	32079-32089	relatively	_	
161-17	32090-32095	minor	_	
161-18	32096-32107	differences	_	
161-19	32108-32110	in	_	
161-20	32111-32123	heritability	_	
161-21	32124-32133	estimates	_	
161-22	32134-32140	across	_	
161-23	32141-32144	age	_	
161-24	32144-32145	,	_	
161-25	32146-32148	we	_	
161-26	32149-32157	compared	_	
161-27	32158-32161	the	_	
161-28	32162-32170	goodness	_	
161-29	32171-32173	of	_	
161-30	32174-32177	fit	_	
161-31	32178-32180	of	_	
161-32	32181-32192	alternative	_	
161-33	32193-32199	models	_	
161-34	32200-32202	in	_	
161-35	32203-32208	which	_	
161-36	32209-32221	heritability	_	
161-37	32222-32225	was	_	
161-38	32226-32237	constrained	_	
161-39	32238-32240	to	_	
161-40	32241-32243	be	_	
161-41	32244-32249	equal	_	
161-42	32250-32252	or	_	
161-43	32253-32260	allowed	_	
161-44	32261-32263	to	_	
161-45	32264-32268	vary	_	
161-46	32269-32275	across	_	
161-47	32276-32279	age	_	
161-48	32279-32280	.	_	

#Text=These analyses showed that heritability can be equated across age without a significant decrement of model fit, indicating the lack of significant changes in the magnitude of heritability with age for any of the ERP components (Supplementary Table 1).
162-1	32281-32286	These	_	
162-2	32287-32295	analyses	_	
162-3	32296-32302	showed	_	
162-4	32303-32307	that	_	
162-5	32308-32320	heritability	_	
162-6	32321-32324	can	_	
162-7	32325-32327	be	_	
162-8	32328-32335	equated	_	
162-9	32336-32342	across	_	
162-10	32343-32346	age	_	
162-11	32347-32354	without	_	
162-12	32355-32356	a	_	
162-13	32357-32368	significant	_	
162-14	32369-32378	decrement	_	
162-15	32379-32381	of	_	
162-16	32382-32387	model	_	
162-17	32388-32391	fit	_	
162-18	32391-32392	,	_	
162-19	32393-32403	indicating	_	
162-20	32404-32407	the	_	
162-21	32408-32412	lack	_	
162-22	32413-32415	of	_	
162-23	32416-32427	significant	_	
162-24	32428-32435	changes	_	
162-25	32436-32438	in	_	
162-26	32439-32442	the	_	
162-27	32443-32452	magnitude	_	
162-28	32453-32455	of	_	
162-29	32456-32468	heritability	_	
162-30	32469-32473	with	_	
162-31	32474-32477	age	_	
162-32	32478-32481	for	_	
162-33	32482-32485	any	_	
162-34	32486-32488	of	_	
162-35	32489-32492	the	_	
162-36	32493-32496	ERP	_	
162-37	32497-32507	components	_	
162-38	32508-32509	(	_	
162-39	32509-32522	Supplementary	_	
162-40	32523-32528	Table	_	
162-41	32529-32530	1	_	
162-42	32530-32531	)	_	
162-43	32531-32532	.	_	

#Text=Analysis of genetic covariance showed a substantial overlap among genetic influences at different ages (Table 4).
163-1	32533-32541	Analysis	_	
163-2	32542-32544	of	_	
163-3	32545-32552	genetic	_	
163-4	32553-32563	covariance	_	
163-5	32564-32570	showed	_	
163-6	32571-32572	a	_	
163-7	32573-32584	substantial	_	
163-8	32585-32592	overlap	_	
163-9	32593-32598	among	_	
163-10	32599-32606	genetic	_	
163-11	32607-32617	influences	_	
163-12	32618-32620	at	_	
163-13	32621-32630	different	_	
163-14	32631-32635	ages	_	
163-15	32636-32637	(	_	
163-16	32637-32642	Table	_	
163-17	32643-32644	4	_	
163-18	32644-32645	)	_	
163-19	32645-32646	.	_	

#Text=Cross-age genetic correlations ranged from .79 to .99, indicating a 63 to 98% overlap among genetic factors influencing ERP amplitudes at different ages (i.e. the largely same set of genes influences the ERP parameters at ages 12, 14, and 16).
164-1	32647-32656	Cross-age	_	
164-2	32657-32664	genetic	_	
164-3	32665-32677	correlations	_	
164-4	32678-32684	ranged	_	
164-5	32685-32689	from	_	
164-6	32690-32693	.79	_	
164-7	32694-32696	to	_	
164-8	32697-32700	.99	_	
164-9	32700-32701	,	_	
164-10	32702-32712	indicating	_	
164-11	32713-32714	a	_	
164-12	32715-32717	63	_	
164-13	32718-32720	to	_	
164-14	32721-32724	98%	_	
164-15	32725-32732	overlap	_	
164-16	32733-32738	among	_	
164-17	32739-32746	genetic	_	
164-18	32747-32754	factors	_	
164-19	32755-32766	influencing	_	
164-20	32767-32770	ERP	_	
164-21	32771-32781	amplitudes	_	
164-22	32782-32784	at	_	
164-23	32785-32794	different	_	
164-24	32795-32799	ages	_	
164-25	32800-32801	(	_	
164-26	32801-32804	i.e	_	
164-27	32804-32805	.	_	
164-28	32806-32809	the	_	
164-29	32810-32817	largely	_	
164-30	32818-32822	same	_	
164-31	32823-32826	set	_	
164-32	32827-32829	of	_	
164-33	32830-32835	genes	_	
164-34	32836-32846	influences	_	
164-35	32847-32850	the	_	
164-36	32851-32854	ERP	_	
164-37	32855-32865	parameters	_	
164-38	32866-32868	at	_	
164-39	32869-32873	ages	_	
164-40	32874-32876	12	_	
164-41	32876-32877	,	_	
164-42	32878-32880	14	_	
164-43	32880-32881	,	_	
164-44	32882-32885	and	_	
164-45	32886-32888	16	_	
164-46	32888-32889	)	_	
164-47	32889-32890	.	_	

#Text=However, this overlap was not complete, and significant age-specific genetic influences were also detected for No-Go N2 and P3.
165-1	32891-32898	However	_	
165-2	32898-32899	,	_	
165-3	32900-32904	this	_	
165-4	32905-32912	overlap	_	
165-5	32913-32916	was	_	
165-6	32917-32920	not	_	
165-7	32921-32929	complete	_	
165-8	32929-32930	,	_	
165-9	32931-32934	and	_	
165-10	32935-32946	significant	_	
165-11	32947-32959	age-specific	_	
165-12	32960-32967	genetic	_	
165-13	32968-32978	influences	_	
165-14	32979-32983	were	_	
165-15	32984-32988	also	_	
165-16	32989-32997	detected	_	
165-17	32998-33001	for	_	
165-18	33002-33007	No-Go	_	
165-19	33008-33010	N2	_	
165-20	33011-33014	and	_	
165-21	33015-33017	P3	_	
165-22	33017-33018	.	_	

#Text=For N2, novel (i.e. not shared with age 12) genetic influences emerged at age 14 and were transmitted to age 16 (the genetic path from age 14 to 16 could not be dropped without a significant decrement in model fit) but no new genetic influences were detected at age 16.
166-1	33019-33022	For	_	
166-2	33023-33025	N2	_	
166-3	33025-33026	,	_	
166-4	33027-33032	novel	_	
166-5	33033-33034	(	_	
166-6	33034-33037	i.e	_	
166-7	33037-33038	.	_	
166-8	33039-33042	not	_	
166-9	33043-33049	shared	_	
166-10	33050-33054	with	_	
166-11	33055-33058	age	_	
166-12	33059-33061	12	_	
166-13	33061-33062	)	_	
166-14	33063-33070	genetic	_	
166-15	33071-33081	influences	_	
166-16	33082-33089	emerged	_	
166-17	33090-33092	at	_	
166-18	33093-33096	age	_	
166-19	33097-33099	14	_	
166-20	33100-33103	and	_	
166-21	33104-33108	were	_	
166-22	33109-33120	transmitted	_	
166-23	33121-33123	to	_	
166-24	33124-33127	age	_	
166-25	33128-33130	16	_	
166-26	33131-33132	(	_	
166-27	33132-33135	the	_	
166-28	33136-33143	genetic	_	
166-29	33144-33148	path	_	
166-30	33149-33153	from	_	
166-31	33154-33157	age	_	
166-32	33158-33160	14	_	
166-33	33161-33163	to	_	
166-34	33164-33166	16	_	
166-35	33167-33172	could	_	
166-36	33173-33176	not	_	
166-37	33177-33179	be	_	
166-38	33180-33187	dropped	_	
166-39	33188-33195	without	_	
166-40	33196-33197	a	_	
166-41	33198-33209	significant	_	
166-42	33210-33219	decrement	_	
166-43	33220-33222	in	_	
166-44	33223-33228	model	_	
166-45	33229-33232	fit	_	
166-46	33232-33233	)	_	
166-47	33234-33237	but	_	
166-48	33238-33240	no	_	
166-49	33241-33244	new	_	
166-50	33245-33252	genetic	_	
166-51	33253-33263	influences	_	
166-52	33264-33268	were	_	
166-53	33269-33277	detected	_	
166-54	33278-33280	at	_	
166-55	33281-33284	age	_	
166-56	33285-33287	16	_	
166-57	33287-33288	.	_	

#Text=For No-Go P3, novel genetic influences also emerged at age 14 but were not transmitted to age 16, and there were no new genetic influences at age 16.
167-1	33289-33292	For	_	
167-2	33293-33298	No-Go	_	
167-3	33299-33301	P3	_	
167-4	33301-33302	,	_	
167-5	33303-33308	novel	_	
167-6	33309-33316	genetic	_	
167-7	33317-33327	influences	_	
167-8	33328-33332	also	_	
167-9	33333-33340	emerged	_	
167-10	33341-33343	at	_	
167-11	33344-33347	age	_	
167-12	33348-33350	14	_	
167-13	33351-33354	but	_	
167-14	33355-33359	were	_	
167-15	33360-33363	not	_	
167-16	33364-33375	transmitted	_	
167-17	33376-33378	to	_	
167-18	33379-33382	age	_	
167-19	33383-33385	16	_	
167-20	33385-33386	,	_	
167-21	33387-33390	and	_	
167-22	33391-33396	there	_	
167-23	33397-33401	were	_	
167-24	33402-33404	no	_	
167-25	33405-33408	new	_	
167-26	33409-33416	genetic	_	
167-27	33417-33427	influences	_	
167-28	33428-33430	at	_	
167-29	33431-33434	age	_	
167-30	33435-33437	16	_	
167-31	33437-33438	.	_	

#Text=This pattern of results suggests age-limited genetic factors that operated at age 14 but not 12 or 16.
168-1	33439-33443	This	_	
168-2	33444-33451	pattern	_	
168-3	33452-33454	of	_	
168-4	33455-33462	results	_	
168-5	33463-33471	suggests	_	
168-6	33472-33483	age-limited	_	
168-7	33484-33491	genetic	_	
168-8	33492-33499	factors	_	
168-9	33500-33504	that	_	
168-10	33505-33513	operated	_	
168-11	33514-33516	at	_	
168-12	33517-33520	age	_	
168-13	33521-33523	14	_	
168-14	33524-33527	but	_	
168-15	33528-33531	not	_	
168-16	33532-33534	12	_	
168-17	33535-33537	or	_	
168-18	33538-33540	16	_	
168-19	33540-33541	.	_	

#Text=In contrast to No-Go N2 and P3, the parietal Go P3 amplitude did not show evidence for age-specific genetic effects: a model with one common genetic factor for all three assessments fit the data well, whereas one with independent genetic factors for each occasion did not.
169-1	33542-33544	In	_	
169-2	33545-33553	contrast	_	
169-3	33554-33556	to	_	
169-4	33557-33562	No-Go	_	
169-5	33563-33565	N2	_	
169-6	33566-33569	and	_	
169-7	33570-33572	P3	_	
169-8	33572-33573	,	_	
169-9	33574-33577	the	_	
169-10	33578-33586	parietal	_	
169-11	33587-33589	Go	_	
169-12	33590-33592	P3	_	
169-13	33593-33602	amplitude	_	
169-14	33603-33606	did	_	
169-15	33607-33610	not	_	
169-16	33611-33615	show	_	
169-17	33616-33624	evidence	_	
169-18	33625-33628	for	_	
169-19	33629-33641	age-specific	_	
169-20	33642-33649	genetic	_	
169-21	33650-33657	effects	_	
169-22	33657-33658	:	_	
169-23	33659-33660	a	_	
169-24	33661-33666	model	_	
169-25	33667-33671	with	_	
169-26	33672-33675	one	_	
169-27	33676-33682	common	_	
169-28	33683-33690	genetic	_	
169-29	33691-33697	factor	_	
169-30	33698-33701	for	_	
169-31	33702-33705	all	_	
169-32	33706-33711	three	_	
169-33	33712-33723	assessments	_	
169-34	33724-33727	fit	_	
169-35	33728-33731	the	_	
169-36	33732-33736	data	_	
169-37	33737-33741	well	_	
169-38	33741-33742	,	_	
169-39	33743-33750	whereas	_	
169-40	33751-33754	one	_	
169-41	33755-33759	with	_	
169-42	33760-33771	independent	_	
169-43	33772-33779	genetic	_	
169-44	33780-33787	factors	_	
169-45	33788-33791	for	_	
169-46	33792-33796	each	_	
169-47	33797-33805	occasion	_	
169-48	33806-33809	did	_	
169-49	33810-33813	not	_	
169-50	33813-33814	.	_	

#Text=Thus, a model with significant heritability but no new genetic influences was the most parsimonious one for Go P3 amplitude (see Supplementary Table 1).
170-1	33815-33819	Thus	_	
170-2	33819-33820	,	_	
170-3	33821-33822	a	_	
170-4	33823-33828	model	_	
170-5	33829-33833	with	_	
170-6	33834-33845	significant	_	
170-7	33846-33858	heritability	_	
170-8	33859-33862	but	_	
170-9	33863-33865	no	_	
170-10	33866-33869	new	_	
170-11	33870-33877	genetic	_	
170-12	33878-33888	influences	_	
170-13	33889-33892	was	_	
170-14	33893-33896	the	_	
170-15	33897-33901	most	_	
170-16	33902-33914	parsimonious	_	
170-17	33915-33918	one	_	
170-18	33919-33922	for	_	
170-19	33923-33925	Go	_	
170-20	33926-33928	P3	_	
170-21	33929-33938	amplitude	_	
170-22	33939-33940	(	_	
170-23	33940-33943	see	_	
170-24	33944-33957	Supplementary	_	
170-25	33958-33963	Table	_	
170-26	33964-33965	1	_	
170-27	33965-33966	)	_	
170-28	33966-33967	.	_	

#Text=Correspondingly, genetic correlations among assessments were >.90 (Table 4).
#Text=3.7.
171-1	33968-33983	Correspondingly	_	
171-2	33983-33984	,	_	
171-3	33985-33992	genetic	_	
171-4	33993-34005	correlations	_	
171-5	34006-34011	among	_	
171-6	34012-34023	assessments	_	
171-7	34024-34028	were	_	
171-8	34029-34030	>	_	
171-9	34030-34033	.90	_	
171-10	34034-34035	(	_	
171-11	34035-34040	Table	_	
171-12	34041-34042	4	_	
171-13	34042-34043	)	_	
171-14	34043-34044	.	_	
171-15	34045-34048	3.7	_	
171-16	34048-34049	.	_	

#Text=Genetic influences on the rate of development (heritability of change)
#Text=The univariate genetic analysis of age difference scores indicating the amount of age-related change (Table 5) showed modest but significant heritability of all three ERP phenotypes, suggesting that individual differences in the rate of age-related changes of No-Go ERP components (Fig. 4) are influenced by genetic factors.
#Text=4.
172-1	34050-34057	Genetic	_	
172-2	34058-34068	influences	_	
172-3	34069-34071	on	_	
172-4	34072-34075	the	_	
172-5	34076-34080	rate	_	
172-6	34081-34083	of	_	
172-7	34084-34095	development	_	
172-8	34096-34097	(	_	
172-9	34097-34109	heritability	_	
172-10	34110-34112	of	_	
172-11	34113-34119	change	_	
172-12	34119-34120	)	_	
172-13	34121-34124	The	_	
172-14	34125-34135	univariate	_	
172-15	34136-34143	genetic	_	
172-16	34144-34152	analysis	_	
172-17	34153-34155	of	_	
172-18	34156-34159	age	_	
172-19	34160-34170	difference	_	
172-20	34171-34177	scores	_	
172-21	34178-34188	indicating	_	
172-22	34189-34192	the	_	
172-23	34193-34199	amount	_	
172-24	34200-34202	of	_	
172-25	34203-34214	age-related	_	
172-26	34215-34221	change	_	
172-27	34222-34223	(	_	
172-28	34223-34228	Table	_	
172-29	34229-34230	5	_	
172-30	34230-34231	)	_	
172-31	34232-34238	showed	_	
172-32	34239-34245	modest	_	
172-33	34246-34249	but	_	
172-34	34250-34261	significant	_	
172-35	34262-34274	heritability	_	
172-36	34275-34277	of	_	
172-37	34278-34281	all	_	
172-38	34282-34287	three	_	
172-39	34288-34291	ERP	_	
172-40	34292-34302	phenotypes	_	
172-41	34302-34303	,	_	
172-42	34304-34314	suggesting	_	
172-43	34315-34319	that	_	
172-44	34320-34330	individual	_	
172-45	34331-34342	differences	_	
172-46	34343-34345	in	_	
172-47	34346-34349	the	_	
172-48	34350-34354	rate	_	
172-49	34355-34357	of	_	
172-50	34358-34369	age-related	_	
172-51	34370-34377	changes	_	
172-52	34378-34380	of	_	
172-53	34381-34386	No-Go	_	
172-54	34387-34390	ERP	_	
172-55	34391-34401	components	_	
172-56	34402-34403	(	_	
172-57	34403-34406	Fig	_	
172-58	34406-34407	.	_	
172-59	34408-34409	4	_	
172-60	34409-34410	)	_	
172-61	34411-34414	are	_	
172-62	34415-34425	influenced	_	
172-63	34426-34428	by	_	
172-64	34429-34436	genetic	_	
172-65	34437-34444	factors	_	
172-66	34444-34445	.	_	
172-67	34446-34447	4	_	
172-68	34447-34448	.	_	

#Text=Discussion
#Text=The present study provides the first evidence for heritability of brain activity related to response inhibition in adolescence.
173-1	34449-34459	Discussion	_	
173-2	34460-34463	The	_	
173-3	34464-34471	present	_	
173-4	34472-34477	study	_	
173-5	34478-34486	provides	_	
173-6	34487-34490	the	_	
173-7	34491-34496	first	_	
173-8	34497-34505	evidence	_	
173-9	34506-34509	for	_	
173-10	34510-34522	heritability	_	
173-11	34523-34525	of	_	
173-12	34526-34531	brain	_	
173-13	34532-34540	activity	_	
173-14	34541-34548	related	_	
173-15	34549-34551	to	_	
173-16	34552-34560	response	_	
173-17	34561-34571	inhibition	_	
173-18	34572-34574	in	_	
173-19	34575-34586	adolescence	_	
173-20	34586-34587	.	_	

#Text=To our knowledge, it is also the first longitudinal study of developmental changes in inhibition-related ERPs during adolescence.
174-1	34588-34590	To	_	
174-2	34591-34594	our	_	
174-3	34595-34604	knowledge	_	
174-4	34604-34605	,	_	
174-5	34606-34608	it	_	
174-6	34609-34611	is	_	
174-7	34612-34616	also	_	
174-8	34617-34620	the	_	
174-9	34621-34626	first	_	
174-10	34627-34639	longitudinal	_	
174-11	34640-34645	study	_	
174-12	34646-34648	of	_	
174-13	34649-34662	developmental	_	
174-14	34663-34670	changes	_	
174-15	34671-34673	in	_	
174-16	34674-34692	inhibition-related	_	
174-17	34693-34697	ERPs	_	
174-18	34698-34704	during	_	
174-19	34705-34716	adolescence	_	
174-20	34716-34717	.	_	

#Text=In summary, the present analyses lead to the following conclusions: 1) neural correlates of response inhibition undergo significant developmental changes during adolescence, with distinct subprocesses indicated by N2 and P3 (conflict processing and motor inhibition) showing different developmental trajectories; 2) despite these changes, individual differences remain relatively stable over age; 3) neural correlates of response inhibition are strongly influenced by genetic factors throughout adolescence, with little change in heritability over age; 4) these genetic influences include both common genetic factors active at different ages and novel genetic influences emerging during development, and 5) individual differences in developmental trajectory (the rate of change) in inhibition-related brain activity are significantly influenced by genetic factors.
175-1	34718-34720	In	_	
175-2	34721-34728	summary	_	
175-3	34728-34729	,	_	
175-4	34730-34733	the	_	
175-5	34734-34741	present	_	
175-6	34742-34750	analyses	_	
175-7	34751-34755	lead	_	
175-8	34756-34758	to	_	
175-9	34759-34762	the	_	
175-10	34763-34772	following	_	
175-11	34773-34784	conclusions	_	
175-12	34784-34785	:	_	
175-13	34786-34787	1	_	
175-14	34787-34788	)	_	
175-15	34789-34795	neural	_	
175-16	34796-34806	correlates	_	
175-17	34807-34809	of	_	
175-18	34810-34818	response	_	
175-19	34819-34829	inhibition	_	
175-20	34830-34837	undergo	_	
175-21	34838-34849	significant	_	
175-22	34850-34863	developmental	_	
175-23	34864-34871	changes	_	
175-24	34872-34878	during	_	
175-25	34879-34890	adolescence	_	
175-26	34890-34891	,	_	
175-27	34892-34896	with	_	
175-28	34897-34905	distinct	_	
175-29	34906-34918	subprocesses	_	
175-30	34919-34928	indicated	_	
175-31	34929-34931	by	_	
175-32	34932-34934	N2	_	
175-33	34935-34938	and	_	
175-34	34939-34941	P3	_	
175-35	34942-34943	(	_	
175-36	34943-34951	conflict	_	
175-37	34952-34962	processing	_	
175-38	34963-34966	and	_	
175-39	34967-34972	motor	_	
175-40	34973-34983	inhibition	_	
175-41	34983-34984	)	_	
175-42	34985-34992	showing	_	
175-43	34993-35002	different	_	
175-44	35003-35016	developmental	_	
175-45	35017-35029	trajectories	_	
175-46	35029-35030	;	_	
175-47	35031-35032	2	_	
175-48	35032-35033	)	_	
175-49	35034-35041	despite	_	
175-50	35042-35047	these	_	
175-51	35048-35055	changes	_	
175-52	35055-35056	,	_	
175-53	35057-35067	individual	_	
175-54	35068-35079	differences	_	
175-55	35080-35086	remain	_	
175-56	35087-35097	relatively	_	
175-57	35098-35104	stable	_	
175-58	35105-35109	over	_	
175-59	35110-35113	age	_	
175-60	35113-35114	;	_	
175-61	35115-35116	3	_	
175-62	35116-35117	)	_	
175-63	35118-35124	neural	_	
175-64	35125-35135	correlates	_	
175-65	35136-35138	of	_	
175-66	35139-35147	response	_	
175-67	35148-35158	inhibition	_	
175-68	35159-35162	are	_	
175-69	35163-35171	strongly	_	
175-70	35172-35182	influenced	_	
175-71	35183-35185	by	_	
175-72	35186-35193	genetic	_	
175-73	35194-35201	factors	_	
175-74	35202-35212	throughout	_	
175-75	35213-35224	adolescence	_	
175-76	35224-35225	,	_	
175-77	35226-35230	with	_	
175-78	35231-35237	little	_	
175-79	35238-35244	change	_	
175-80	35245-35247	in	_	
175-81	35248-35260	heritability	_	
175-82	35261-35265	over	_	
175-83	35266-35269	age	_	
175-84	35269-35270	;	_	
175-85	35271-35272	4	_	
175-86	35272-35273	)	_	
175-87	35274-35279	these	_	
175-88	35280-35287	genetic	_	
175-89	35288-35298	influences	_	
175-90	35299-35306	include	_	
175-91	35307-35311	both	_	
175-92	35312-35318	common	_	
175-93	35319-35326	genetic	_	
175-94	35327-35334	factors	_	
175-95	35335-35341	active	_	
175-96	35342-35344	at	_	
175-97	35345-35354	different	_	
175-98	35355-35359	ages	_	
175-99	35360-35363	and	_	
175-100	35364-35369	novel	_	
175-101	35370-35377	genetic	_	
175-102	35378-35388	influences	_	
175-103	35389-35397	emerging	_	
175-104	35398-35404	during	_	
175-105	35405-35416	development	_	
175-106	35416-35417	,	_	
175-107	35418-35421	and	_	
175-108	35422-35423	5	_	
175-109	35423-35424	)	_	
175-110	35425-35435	individual	_	
175-111	35436-35447	differences	_	
175-112	35448-35450	in	_	
175-113	35451-35464	developmental	_	
175-114	35465-35475	trajectory	_	
175-115	35476-35477	(	_	
175-116	35477-35480	the	_	
175-117	35481-35485	rate	_	
175-118	35486-35488	of	_	
175-119	35489-35495	change	_	
175-120	35495-35496	)	_	
175-121	35497-35499	in	_	
175-122	35500-35518	inhibition-related	_	
175-123	35519-35524	brain	_	
175-124	35525-35533	activity	_	
175-125	35534-35537	are	_	
175-126	35538-35551	significantly	_	
175-127	35552-35562	influenced	_	
175-128	35563-35565	by	_	
175-129	35566-35573	genetic	_	
175-130	35574-35581	factors	_	
175-131	35581-35582	.	_	

#Text=Taken together, these results significantly extend our previous finding of heritability of response-inhibition-related ERPs and provide novel insights into the interplay of genetic and developmental influences on the neural underpinnings of inhibitory control during a sensitive developmental period when deficits in inhibitory control may increase the risk for a range of maladaptive behaviors and psychopathology.
176-1	35583-35588	Taken	_	
176-2	35589-35597	together	_	
176-3	35597-35598	,	_	
176-4	35599-35604	these	_	
176-5	35605-35612	results	_	
176-6	35613-35626	significantly	_	
176-7	35627-35633	extend	_	
176-8	35634-35637	our	_	
176-9	35638-35646	previous	_	
176-10	35647-35654	finding	_	
176-11	35655-35657	of	_	
176-12	35658-35670	heritability	_	
176-13	35671-35673	of	_	
176-14	35674-35701	response-inhibition-related	_	
176-15	35702-35706	ERPs	_	
176-16	35707-35710	and	_	
176-17	35711-35718	provide	_	
176-18	35719-35724	novel	_	
176-19	35725-35733	insights	_	
176-20	35734-35738	into	_	
176-21	35739-35742	the	_	
176-22	35743-35752	interplay	_	
176-23	35753-35755	of	_	
176-24	35756-35763	genetic	_	
176-25	35764-35767	and	_	
176-26	35768-35781	developmental	_	
176-27	35782-35792	influences	_	
176-28	35793-35795	on	_	
176-29	35796-35799	the	_	
176-30	35800-35806	neural	_	
176-31	35807-35820	underpinnings	_	
176-32	35821-35823	of	_	
176-33	35824-35834	inhibitory	_	
176-34	35835-35842	control	_	
176-35	35843-35849	during	_	
176-36	35850-35851	a	_	
176-37	35852-35861	sensitive	_	
176-38	35862-35875	developmental	_	
176-39	35876-35882	period	_	
176-40	35883-35887	when	_	
176-41	35888-35896	deficits	_	
176-42	35897-35899	in	_	
176-43	35900-35910	inhibitory	_	
176-44	35911-35918	control	_	
176-45	35919-35922	may	_	
176-46	35923-35931	increase	_	
176-47	35932-35935	the	_	
176-48	35936-35940	risk	_	
176-49	35941-35944	for	_	
176-50	35945-35946	a	_	
176-51	35947-35952	range	_	
176-52	35953-35955	of	_	
176-53	35956-35967	maladaptive	_	
176-54	35968-35977	behaviors	_	
176-55	35978-35981	and	_	
176-56	35982-35997	psychopathology	_	
176-57	35997-35998	.	_	

#Text=Thus, response inhibition-related ERPs represent developmentally stable and highly heritable traits that can potentially serve as intermediate neurobiological phenotypes for genetic studies of developmental neuropsychiatric disorders.
#Text=4.2.
177-1	35999-36003	Thus	_	
177-2	36003-36004	,	_	
177-3	36005-36013	response	_	
177-4	36014-36032	inhibition-related	_	
177-5	36033-36037	ERPs	_	
177-6	36038-36047	represent	_	
177-7	36048-36063	developmentally	_	
177-8	36064-36070	stable	_	
177-9	36071-36074	and	_	
177-10	36075-36081	highly	_	
177-11	36082-36091	heritable	_	
177-12	36092-36098	traits	_	
177-13	36099-36103	that	_	
177-14	36104-36107	can	_	
177-15	36108-36119	potentially	_	
177-16	36120-36125	serve	_	
177-17	36126-36128	as	_	
177-18	36129-36141	intermediate	_	
177-19	36142-36157	neurobiological	_	
177-20	36158-36168	phenotypes	_	
177-21	36169-36172	for	_	
177-22	36173-36180	genetic	_	
177-23	36181-36188	studies	_	
177-24	36189-36191	of	_	
177-25	36192-36205	developmental	_	
177-26	36206-36222	neuropsychiatric	_	
177-27	36223-36232	disorders	_	
177-28	36232-36233	.	_	
177-29	36234-36237	4.2	_	
177-30	36237-36238	.	_	

#Text=Neural correlates of response inhibition undergo significant developmental changes over adolescence
#Text=Reduction in N2 and increase in P3 with age is consistent with a previous cross-sectional study.
178-1	36239-36245	Neural	_	
178-2	36246-36256	correlates	_	
178-3	36257-36259	of	_	
178-4	36260-36268	response	_	
178-5	36269-36279	inhibition	_	
178-6	36280-36287	undergo	_	
178-7	36288-36299	significant	_	
178-8	36300-36313	developmental	_	
178-9	36314-36321	changes	_	
178-10	36322-36326	over	_	
178-11	36327-36338	adolescence	_	
178-12	36339-36348	Reduction	_	
178-13	36349-36351	in	_	
178-14	36352-36354	N2	_	
178-15	36355-36358	and	_	
178-16	36359-36367	increase	_	
178-17	36368-36370	in	_	
178-18	36371-36373	P3	_	
178-19	36374-36378	with	_	
178-20	36379-36382	age	_	
178-21	36383-36385	is	_	
178-22	36386-36396	consistent	_	
178-23	36397-36401	with	_	
178-24	36402-36403	a	_	
178-25	36404-36412	previous	_	
178-26	36413-36428	cross-sectional	_	
178-27	36429-36434	study	_	
178-28	36434-36435	.	_	

#Text=The divergence of developmental trajectories of No-Go N2 and P3 is consistent with the notion that these components reflect distinct cognitive processes.
179-1	36436-36439	The	_	
179-2	36440-36450	divergence	_	
179-3	36451-36453	of	_	
179-4	36454-36467	developmental	_	
179-5	36468-36480	trajectories	_	
179-6	36481-36483	of	_	
179-7	36484-36489	No-Go	_	
179-8	36490-36492	N2	_	
179-9	36493-36496	and	_	
179-10	36497-36499	P3	_	
179-11	36500-36502	is	_	
179-12	36503-36513	consistent	_	
179-13	36514-36518	with	_	
179-14	36519-36522	the	_	
179-15	36523-36529	notion	_	
179-16	36530-36534	that	_	
179-17	36535-36540	these	_	
179-18	36541-36551	components	_	
179-19	36552-36559	reflect	_	
179-20	36560-36568	distinct	_	
179-21	36569-36578	cognitive	_	
179-22	36579-36588	processes	_	
179-23	36588-36589	.	_	

#Text=Accumulating evidence suggests that N2 reflects the detection of conflict associated with the need to suppress a pre-activated response by the anterior cingulate, whereas No-Go P3 reflects inhibition-related activity in a broader network of regions involving the ACC, supplementary motor area, dorsolateral prefrontal cortex, and the fronto-parietal network.
180-1	36590-36602	Accumulating	_	
180-2	36603-36611	evidence	_	
180-3	36612-36620	suggests	_	
180-4	36621-36625	that	_	
180-5	36626-36628	N2	_	
180-6	36629-36637	reflects	_	
180-7	36638-36641	the	_	
180-8	36642-36651	detection	_	
180-9	36652-36654	of	_	
180-10	36655-36663	conflict	_	
180-11	36664-36674	associated	_	
180-12	36675-36679	with	_	
180-13	36680-36683	the	_	
180-14	36684-36688	need	_	
180-15	36689-36691	to	_	
180-16	36692-36700	suppress	_	
180-17	36701-36702	a	_	
180-18	36703-36716	pre-activated	_	
180-19	36717-36725	response	_	
180-20	36726-36728	by	_	
180-21	36729-36732	the	_	
180-22	36733-36741	anterior	_	
180-23	36742-36751	cingulate	_	
180-24	36751-36752	,	_	
180-25	36753-36760	whereas	_	
180-26	36761-36766	No-Go	_	
180-27	36767-36769	P3	_	
180-28	36770-36778	reflects	_	
180-29	36779-36797	inhibition-related	_	
180-30	36798-36806	activity	_	
180-31	36807-36809	in	_	
180-32	36810-36811	a	_	
180-33	36812-36819	broader	_	
180-34	36820-36827	network	_	
180-35	36828-36830	of	_	
180-36	36831-36838	regions	_	
180-37	36839-36848	involving	_	
180-38	36849-36852	the	_	
180-39	36853-36856	ACC	_	
180-40	36856-36857	,	_	
180-41	36858-36871	supplementary	_	
180-42	36872-36877	motor	_	
180-43	36878-36882	area	_	
180-44	36882-36883	,	_	
180-45	36884-36896	dorsolateral	_	
180-46	36897-36907	prefrontal	_	
180-47	36908-36914	cortex	_	
180-48	36914-36915	,	_	
180-49	36916-36919	and	_	
180-50	36920-36923	the	_	
180-51	36924-36939	fronto-parietal	_	
180-52	36940-36947	network	_	
180-53	36947-36948	.	_	

#Text=A study using EEG and fMRI revealed 2 systems related to RI: the ACC and a network including right prefrontal and parietal areas.
181-1	36949-36950	A	_	
181-2	36951-36956	study	_	
181-3	36957-36962	using	_	
181-4	36963-36966	EEG	_	
181-5	36967-36970	and	_	
181-6	36971-36975	fMRI	_	
181-7	36976-36984	revealed	_	
181-8	36985-36986	2	_	
181-9	36987-36994	systems	_	
181-10	36995-37002	related	_	
181-11	37003-37005	to	_	
181-12	37006-37008	RI	_	
181-13	37008-37009	:	_	
181-14	37010-37013	the	_	
181-15	37014-37017	ACC	_	
181-16	37018-37021	and	_	
181-17	37022-37023	a	_	
181-18	37024-37031	network	_	
181-19	37032-37041	including	_	
181-20	37042-37047	right	_	
181-21	37048-37058	prefrontal	_	
181-22	37059-37062	and	_	
181-23	37063-37071	parietal	_	
181-24	37072-37077	areas	_	
181-25	37077-37078	.	_	

#Text=Furthermore, it was shown that absent-minded subjects tended to rely more on the ACC system, whereas subjects low on the absentmindedness score showed a stronger and more selective use of the frontoparietal system.
182-1	37079-37090	Furthermore	_	
182-2	37090-37091	,	_	
182-3	37092-37094	it	_	
182-4	37095-37098	was	_	
182-5	37099-37104	shown	_	
182-6	37105-37109	that	_	
182-7	37110-37123	absent-minded	_	
182-8	37124-37132	subjects	_	
182-9	37133-37139	tended	_	
182-10	37140-37142	to	_	
182-11	37143-37147	rely	_	
182-12	37148-37152	more	_	
182-13	37153-37155	on	_	
182-14	37156-37159	the	_	
182-15	37160-37163	ACC	_	
182-16	37164-37170	system	_	
182-17	37170-37171	,	_	
182-18	37172-37179	whereas	_	
182-19	37180-37188	subjects	_	
182-20	37189-37192	low	_	
182-21	37193-37195	on	_	
182-22	37196-37199	the	_	
182-23	37200-37216	absentmindedness	_	
182-24	37217-37222	score	_	
182-25	37223-37229	showed	_	
182-26	37230-37231	a	_	
182-27	37232-37240	stronger	_	
182-28	37241-37244	and	_	
182-29	37245-37249	more	_	
182-30	37250-37259	selective	_	
182-31	37260-37263	use	_	
182-32	37264-37266	of	_	
182-33	37267-37270	the	_	
182-34	37271-37285	frontoparietal	_	
182-35	37286-37292	system	_	
182-36	37292-37293	.	_	

#Text=In light of these findings, it is reasonable to suggest that opposite developmental changes of N2 and P3 reflect a changing balance in the relative role of ACC and more extended inhibition network in the processing of No-Go stimuli, such that decreasing activation of the ACC is paralleled by increasing engagement of the dorsolateral prefrontal areas and the frontoparietal network.
183-1	37294-37296	In	_	
183-2	37297-37302	light	_	
183-3	37303-37305	of	_	
183-4	37306-37311	these	_	
183-5	37312-37320	findings	_	
183-6	37320-37321	,	_	
183-7	37322-37324	it	_	
183-8	37325-37327	is	_	
183-9	37328-37338	reasonable	_	
183-10	37339-37341	to	_	
183-11	37342-37349	suggest	_	
183-12	37350-37354	that	_	
183-13	37355-37363	opposite	_	
183-14	37364-37377	developmental	_	
183-15	37378-37385	changes	_	
183-16	37386-37388	of	_	
183-17	37389-37391	N2	_	
183-18	37392-37395	and	_	
183-19	37396-37398	P3	_	
183-20	37399-37406	reflect	_	
183-21	37407-37408	a	_	
183-22	37409-37417	changing	_	
183-23	37418-37425	balance	_	
183-24	37426-37428	in	_	
183-25	37429-37432	the	_	
183-26	37433-37441	relative	_	
183-27	37442-37446	role	_	
183-28	37447-37449	of	_	
183-29	37450-37453	ACC	_	
183-30	37454-37457	and	_	
183-31	37458-37462	more	_	
183-32	37463-37471	extended	_	
183-33	37472-37482	inhibition	_	
183-34	37483-37490	network	_	
183-35	37491-37493	in	_	
183-36	37494-37497	the	_	
183-37	37498-37508	processing	_	
183-38	37509-37511	of	_	
183-39	37512-37517	No-Go	_	
183-40	37518-37525	stimuli	_	
183-41	37525-37526	,	_	
183-42	37527-37531	such	_	
183-43	37532-37536	that	_	
183-44	37537-37547	decreasing	_	
183-45	37548-37558	activation	_	
183-46	37559-37561	of	_	
183-47	37562-37565	the	_	
183-48	37566-37569	ACC	_	
183-49	37570-37572	is	_	
183-50	37573-37583	paralleled	_	
183-51	37584-37586	by	_	
183-52	37587-37597	increasing	_	
183-53	37598-37608	engagement	_	
183-54	37609-37611	of	_	
183-55	37612-37615	the	_	
183-56	37616-37628	dorsolateral	_	
183-57	37629-37639	prefrontal	_	
183-58	37640-37645	areas	_	
183-59	37646-37649	and	_	
183-60	37650-37653	the	_	
183-61	37654-37668	frontoparietal	_	
183-62	37669-37676	network	_	
183-63	37676-37677	.	_	

#Text=From the conflict monitoring perspective, the decrease in N2 amplitude may reflect a decrease in the level of experienced conflict, perhaps due to more efficient processing in the ACC.
184-1	37678-37682	From	_	
184-2	37683-37686	the	_	
184-3	37687-37695	conflict	_	
184-4	37696-37706	monitoring	_	
184-5	37707-37718	perspective	_	
184-6	37718-37719	,	_	
184-7	37720-37723	the	_	
184-8	37724-37732	decrease	_	
184-9	37733-37735	in	_	
184-10	37736-37738	N2	_	
184-11	37739-37748	amplitude	_	
184-12	37749-37752	may	_	
184-13	37753-37760	reflect	_	
184-14	37761-37762	a	_	
184-15	37763-37771	decrease	_	
184-16	37772-37774	in	_	
184-17	37775-37778	the	_	
184-18	37779-37784	level	_	
184-19	37785-37787	of	_	
184-20	37788-37799	experienced	_	
184-21	37800-37808	conflict	_	
184-22	37808-37809	,	_	
184-23	37810-37817	perhaps	_	
184-24	37818-37821	due	_	
184-25	37822-37824	to	_	
184-26	37825-37829	more	_	
184-27	37830-37839	efficient	_	
184-28	37840-37850	processing	_	
184-29	37851-37853	in	_	
184-30	37854-37857	the	_	
184-31	37858-37861	ACC	_	
184-32	37861-37862	.	_	

#Text=Given the broader scalp distribution of No-Go P3 compared with N2, it is reasonable to suggest that this component reflects the activation of a network of regions involved in response inhibition with a “hub” in the ACC.
185-1	37863-37868	Given	_	
185-2	37869-37872	the	_	
185-3	37873-37880	broader	_	
185-4	37881-37886	scalp	_	
185-5	37887-37899	distribution	_	
185-6	37900-37902	of	_	
185-7	37903-37908	No-Go	_	
185-8	37909-37911	P3	_	
185-9	37912-37920	compared	_	
185-10	37921-37925	with	_	
185-11	37926-37928	N2	_	
185-12	37928-37929	,	_	
185-13	37930-37932	it	_	
185-14	37933-37935	is	_	
185-15	37936-37946	reasonable	_	
185-16	37947-37949	to	_	
185-17	37950-37957	suggest	_	
185-18	37958-37962	that	_	
185-19	37963-37967	this	_	
185-20	37968-37977	component	_	
185-21	37978-37986	reflects	_	
185-22	37987-37990	the	_	
185-23	37991-38001	activation	_	
185-24	38002-38004	of	_	
185-25	38005-38006	a	_	
185-26	38007-38014	network	_	
185-27	38015-38017	of	_	
185-28	38018-38025	regions	_	
185-29	38026-38034	involved	_	
185-30	38035-38037	in	_	
185-31	38038-38046	response	_	
185-32	38047-38057	inhibition	_	
185-33	38058-38062	with	_	
185-34	38063-38064	a	_	
185-35	38065-38066	“	_	
185-36	38066-38069	hub	_	
185-37	38069-38070	”	_	
185-38	38071-38073	in	_	
185-39	38074-38077	the	_	
185-40	38078-38081	ACC	_	
185-41	38081-38082	.	_	

#Text=A rapid integration of multiple distributed brain regions into a unified functional network would require mature long-range structural connectivity.
186-1	38083-38084	A	_	
186-2	38085-38090	rapid	_	
186-3	38091-38102	integration	_	
186-4	38103-38105	of	_	
186-5	38106-38114	multiple	_	
186-6	38115-38126	distributed	_	
186-7	38127-38132	brain	_	
186-8	38133-38140	regions	_	
186-9	38141-38145	into	_	
186-10	38146-38147	a	_	
186-11	38148-38155	unified	_	
186-12	38156-38166	functional	_	
186-13	38167-38174	network	_	
186-14	38175-38180	would	_	
186-15	38181-38188	require	_	
186-16	38189-38195	mature	_	
186-17	38196-38206	long-range	_	
186-18	38207-38217	structural	_	
186-19	38218-38230	connectivity	_	
186-20	38230-38231	.	_	

#Text=However, developmental studies indicate a prolonged myelination of human association cortices, particularly the frontal cortex.
#Text=4.3.
187-1	38232-38239	However	_	
187-2	38239-38240	,	_	
187-3	38241-38254	developmental	_	
187-4	38255-38262	studies	_	
187-5	38263-38271	indicate	_	
187-6	38272-38273	a	_	
187-7	38274-38283	prolonged	_	
187-8	38284-38295	myelination	_	
187-9	38296-38298	of	_	
187-10	38299-38304	human	_	
187-11	38305-38316	association	_	
187-12	38317-38325	cortices	_	
187-13	38325-38326	,	_	
187-14	38327-38339	particularly	_	
187-15	38340-38343	the	_	
187-16	38344-38351	frontal	_	
187-17	38352-38358	cortex	_	
187-18	38358-38359	.	_	
187-19	38360-38363	4.3	_	
187-20	38363-38364	.	_	

#Text=Individual differences show significant developmental stability
#Text=Despite the developmental changes described above, individual differences in ERPs remain relatively stable across ages, indicating that No-Go N2 and P3 are reliable indicators of neural processes related to response inhibition in adolescence.
188-1	38365-38375	Individual	_	
188-2	38376-38387	differences	_	
188-3	38388-38392	show	_	
188-4	38393-38404	significant	_	
188-5	38405-38418	developmental	_	
188-6	38419-38428	stability	_	
188-7	38429-38436	Despite	_	
188-8	38437-38440	the	_	
188-9	38441-38454	developmental	_	
188-10	38455-38462	changes	_	
188-11	38463-38472	described	_	
188-12	38473-38478	above	_	
188-13	38478-38479	,	_	
188-14	38480-38490	individual	_	
188-15	38491-38502	differences	_	
188-16	38503-38505	in	_	
188-17	38506-38510	ERPs	_	
188-18	38511-38517	remain	_	
188-19	38518-38528	relatively	_	
188-20	38529-38535	stable	_	
188-21	38536-38542	across	_	
188-22	38543-38547	ages	_	
188-23	38547-38548	,	_	
188-24	38549-38559	indicating	_	
188-25	38560-38564	that	_	
188-26	38565-38570	No-Go	_	
188-27	38571-38573	N2	_	
188-28	38574-38577	and	_	
188-29	38578-38580	P3	_	
188-30	38581-38584	are	_	
188-31	38585-38593	reliable	_	
188-32	38594-38604	indicators	_	
188-33	38605-38607	of	_	
188-34	38608-38614	neural	_	
188-35	38615-38624	processes	_	
188-36	38625-38632	related	_	
188-37	38633-38635	to	_	
188-38	38636-38644	response	_	
188-39	38645-38655	inhibition	_	
188-40	38656-38658	in	_	
188-41	38659-38670	adolescence	_	
188-42	38670-38671	.	_	

#Text=It is important to note that there is no contradiction between developmental changes and developmental stability of individual differences because the latter refers to the preservation of relative rank-ordering of individuals over age despite age-related changes in absolute values.
189-1	38672-38674	It	_	
189-2	38675-38677	is	_	
189-3	38678-38687	important	_	
189-4	38688-38690	to	_	
189-5	38691-38695	note	_	
189-6	38696-38700	that	_	
189-7	38701-38706	there	_	
189-8	38707-38709	is	_	
189-9	38710-38712	no	_	
189-10	38713-38726	contradiction	_	
189-11	38727-38734	between	_	
189-12	38735-38748	developmental	_	
189-13	38749-38756	changes	_	
189-14	38757-38760	and	_	
189-15	38761-38774	developmental	_	
189-16	38775-38784	stability	_	
189-17	38785-38787	of	_	
189-18	38788-38798	individual	_	
189-19	38799-38810	differences	_	
189-20	38811-38818	because	_	
189-21	38819-38822	the	_	
189-22	38823-38829	latter	_	
189-23	38830-38836	refers	_	
189-24	38837-38839	to	_	
189-25	38840-38843	the	_	
189-26	38844-38856	preservation	_	
189-27	38857-38859	of	_	
189-28	38860-38868	relative	_	
189-29	38869-38882	rank-ordering	_	
189-30	38883-38885	of	_	
189-31	38886-38897	individuals	_	
189-32	38898-38902	over	_	
189-33	38903-38906	age	_	
189-34	38907-38914	despite	_	
189-35	38915-38926	age-related	_	
189-36	38927-38934	changes	_	
189-37	38935-38937	in	_	
189-38	38938-38946	absolute	_	
189-39	38947-38953	values	_	
189-40	38953-38954	.	_	

#Text=However, this stability is not perfect and test-retest coefficients are lower than those obtained in adults using a 30-min retest.
190-1	38955-38962	However	_	
190-2	38962-38963	,	_	
190-3	38964-38968	this	_	
190-4	38969-38978	stability	_	
190-5	38979-38981	is	_	
190-6	38982-38985	not	_	
190-7	38986-38993	perfect	_	
190-8	38994-38997	and	_	
190-9	38998-39009	test-retest	_	
190-10	39010-39022	coefficients	_	
190-11	39023-39026	are	_	
190-12	39027-39032	lower	_	
190-13	39033-39037	than	_	
190-14	39038-39043	those	_	
190-15	39044-39052	obtained	_	
190-16	39053-39055	in	_	
190-17	39056-39062	adults	_	
190-18	39063-39068	using	_	
190-19	39069-39070	a	_	
190-20	39071-39073	30	_	
190-21	39073-39074	-	_	
190-22	39074-39077	min	_	
190-23	39078-39084	retest	_	
190-24	39084-39085	.	_	

#Text=Although this difference can be partially attributed to the difference in retest interval, there is another potential source of variability, namely, individual differences in the rate of developmental changes (see 4.6 below).
#Text=4.4.
191-1	39086-39094	Although	_	
191-2	39095-39099	this	_	
191-3	39100-39110	difference	_	
191-4	39111-39114	can	_	
191-5	39115-39117	be	_	
191-6	39118-39127	partially	_	
191-7	39128-39138	attributed	_	
191-8	39139-39141	to	_	
191-9	39142-39145	the	_	
191-10	39146-39156	difference	_	
191-11	39157-39159	in	_	
191-12	39160-39166	retest	_	
191-13	39167-39175	interval	_	
191-14	39175-39176	,	_	
191-15	39177-39182	there	_	
191-16	39183-39185	is	_	
191-17	39186-39193	another	_	
191-18	39194-39203	potential	_	
191-19	39204-39210	source	_	
191-20	39211-39213	of	_	
191-21	39214-39225	variability	_	
191-22	39225-39226	,	_	
191-23	39227-39233	namely	_	
191-24	39233-39234	,	_	
191-25	39235-39245	individual	_	
191-26	39246-39257	differences	_	
191-27	39258-39260	in	_	
191-28	39261-39264	the	_	
191-29	39265-39269	rate	_	
191-30	39270-39272	of	_	
191-31	39273-39286	developmental	_	
191-32	39287-39294	changes	_	
191-33	39295-39296	(	_	
191-34	39296-39299	see	_	
191-35	39300-39303	4.6	_	
191-36	39304-39309	below	_	
191-37	39309-39310	)	_	
191-38	39310-39311	.	_	
191-39	39312-39315	4.4	_	
191-40	39315-39316	.	_	

#Text=Neural correlates of response inhibition are heritable
#Text=Analysis of heritability yielded two major findings.
192-1	39317-39323	Neural	_	
192-2	39324-39334	correlates	_	
192-3	39335-39337	of	_	
192-4	39338-39346	response	_	
192-5	39347-39357	inhibition	_	
192-6	39358-39361	are	_	
192-7	39362-39371	heritable	_	
192-8	39372-39380	Analysis	_	
192-9	39381-39383	of	_	
192-10	39384-39396	heritability	_	
192-11	39397-39404	yielded	_	
192-12	39405-39408	two	_	
192-13	39409-39414	major	_	
192-14	39415-39423	findings	_	
192-15	39423-39424	.	_	

#Text=First, both Go and No-Go ERP components showed significant heritability at all three ages, indicating that 49 to 63% of observed inter-individual variation can be attributed to genetic differences among individuals (Table 3).
193-1	39425-39430	First	_	
193-2	39430-39431	,	_	
193-3	39432-39436	both	_	
193-4	39437-39439	Go	_	
193-5	39440-39443	and	_	
193-6	39444-39449	No-Go	_	
193-7	39450-39453	ERP	_	
193-8	39454-39464	components	_	
193-9	39465-39471	showed	_	
193-10	39472-39483	significant	_	
193-11	39484-39496	heritability	_	
193-12	39497-39499	at	_	
193-13	39500-39503	all	_	
193-14	39504-39509	three	_	
193-15	39510-39514	ages	_	
193-16	39514-39515	,	_	
193-17	39516-39526	indicating	_	
193-18	39527-39531	that	_	
193-19	39532-39534	49	_	
193-20	39535-39537	to	_	
193-21	39538-39541	63%	_	
193-22	39542-39544	of	_	
193-23	39545-39553	observed	_	
193-24	39554-39570	inter-individual	_	
193-25	39571-39580	variation	_	
193-26	39581-39584	can	_	
193-27	39585-39587	be	_	
193-28	39588-39598	attributed	_	
193-29	39599-39601	to	_	
193-30	39602-39609	genetic	_	
193-31	39610-39621	differences	_	
193-32	39622-39627	among	_	
193-33	39628-39639	individuals	_	
193-34	39640-39641	(	_	
193-35	39641-39646	Table	_	
193-36	39647-39648	3	_	
193-37	39648-39649	)	_	
193-38	39649-39650	.	_	

#Text=Second, there was no significant change in the magnitude of heritability over the ages studied.
194-1	39651-39657	Second	_	
194-2	39657-39658	,	_	
194-3	39659-39664	there	_	
194-4	39665-39668	was	_	
194-5	39669-39671	no	_	
194-6	39672-39683	significant	_	
194-7	39684-39690	change	_	
194-8	39691-39693	in	_	
194-9	39694-39697	the	_	
194-10	39698-39707	magnitude	_	
194-11	39708-39710	of	_	
194-12	39711-39723	heritability	_	
194-13	39724-39728	over	_	
194-14	39729-39732	the	_	
194-15	39733-39737	ages	_	
194-16	39738-39745	studied	_	
194-17	39745-39746	.	_	

#Text=Interestingly, these heritability estimates are in the same range as those obtained in our previous study of young adult twins (age: 18–28, heritability estimates: 41 to 60%).
195-1	39747-39760	Interestingly	_	
195-2	39760-39761	,	_	
195-3	39762-39767	these	_	
195-4	39768-39780	heritability	_	
195-5	39781-39790	estimates	_	
195-6	39791-39794	are	_	
195-7	39795-39797	in	_	
195-8	39798-39801	the	_	
195-9	39802-39806	same	_	
195-10	39807-39812	range	_	
195-11	39813-39815	as	_	
195-12	39816-39821	those	_	
195-13	39822-39830	obtained	_	
195-14	39831-39833	in	_	
195-15	39834-39837	our	_	
195-16	39838-39846	previous	_	
195-17	39847-39852	study	_	
195-18	39853-39855	of	_	
195-19	39856-39861	young	_	
195-20	39862-39867	adult	_	
195-21	39868-39873	twins	_	
195-22	39874-39875	(	_	
195-23	39875-39878	age	_	
195-24	39878-39879	:	_	
195-25	39880-39882	18	_	
195-26	39882-39883	–	_	
195-27	39883-39885	28	_	
195-28	39885-39886	,	_	
195-29	39887-39899	heritability	_	
195-30	39900-39909	estimates	_	
195-31	39909-39910	:	_	
195-32	39911-39913	41	_	
195-33	39914-39916	to	_	
195-34	39917-39920	60%	_	
195-35	39920-39921	)	_	
195-36	39921-39922	.	_	

#Text=Taken together, these studies suggest that neuroelectric indicators of response inhibition are strongly influenced by genetic factors in both adolescents and adults, and the overall strength of genetic influences does not change with age.
196-1	39923-39928	Taken	_	
196-2	39929-39937	together	_	
196-3	39937-39938	,	_	
196-4	39939-39944	these	_	
196-5	39945-39952	studies	_	
196-6	39953-39960	suggest	_	
196-7	39961-39965	that	_	
196-8	39966-39979	neuroelectric	_	
196-9	39980-39990	indicators	_	
196-10	39991-39993	of	_	
196-11	39994-40002	response	_	
196-12	40003-40013	inhibition	_	
196-13	40014-40017	are	_	
196-14	40018-40026	strongly	_	
196-15	40027-40037	influenced	_	
196-16	40038-40040	by	_	
196-17	40041-40048	genetic	_	
196-18	40049-40056	factors	_	
196-19	40057-40059	in	_	
196-20	40060-40064	both	_	
196-21	40065-40076	adolescents	_	
196-22	40077-40080	and	_	
196-23	40081-40087	adults	_	
196-24	40087-40088	,	_	
196-25	40089-40092	and	_	
196-26	40093-40096	the	_	
196-27	40097-40104	overall	_	
196-28	40105-40113	strength	_	
196-29	40114-40116	of	_	
196-30	40117-40124	genetic	_	
196-31	40125-40135	influences	_	
196-32	40136-40140	does	_	
196-33	40141-40144	not	_	
196-34	40145-40151	change	_	
196-35	40152-40156	with	_	
196-36	40157-40160	age	_	
196-37	40160-40161	.	_	

#Text=These results, as any finding of strong heritability, raise the issue of pre-determination versus changeability of a trait.
197-1	40162-40167	These	_	
197-2	40168-40175	results	_	
197-3	40175-40176	,	_	
197-4	40177-40179	as	_	
197-5	40180-40183	any	_	
197-6	40184-40191	finding	_	
197-7	40192-40194	of	_	
197-8	40195-40201	strong	_	
197-9	40202-40214	heritability	_	
197-10	40214-40215	,	_	
197-11	40216-40221	raise	_	
197-12	40222-40225	the	_	
197-13	40226-40231	issue	_	
197-14	40232-40234	of	_	
197-15	40235-40252	pre-determination	_	
197-16	40253-40259	versus	_	
197-17	40260-40273	changeability	_	
197-18	40274-40276	of	_	
197-19	40277-40278	a	_	
197-20	40279-40284	trait	_	
197-21	40284-40285	.	_	

#Text=It is important to underscore that high heritability does not necessarily imply that inhibitory control capacity is genetically pre-determined for each particular individual.
198-1	40286-40288	It	_	
198-2	40289-40291	is	_	
198-3	40292-40301	important	_	
198-4	40302-40304	to	_	
198-5	40305-40315	underscore	_	
198-6	40316-40320	that	_	
198-7	40321-40325	high	_	
198-8	40326-40338	heritability	_	
198-9	40339-40343	does	_	
198-10	40344-40347	not	_	
198-11	40348-40359	necessarily	_	
198-12	40360-40365	imply	_	
198-13	40366-40370	that	_	
198-14	40371-40381	inhibitory	_	
198-15	40382-40389	control	_	
198-16	40390-40398	capacity	_	
198-17	40399-40401	is	_	
198-18	40402-40413	genetically	_	
198-19	40414-40428	pre-determined	_	
198-20	40429-40432	for	_	
198-21	40433-40437	each	_	
198-22	40438-40448	particular	_	
198-23	40449-40459	individual	_	
198-24	40459-40460	.	_	

#Text=First, the notion of heritability pertains to the population, not a single individual, and refers to genetic determination of inter-individual variance but not individual value of a trait.
199-1	40461-40466	First	_	
199-2	40466-40467	,	_	
199-3	40468-40471	the	_	
199-4	40472-40478	notion	_	
199-5	40479-40481	of	_	
199-6	40482-40494	heritability	_	
199-7	40495-40503	pertains	_	
199-8	40504-40506	to	_	
199-9	40507-40510	the	_	
199-10	40511-40521	population	_	
199-11	40521-40522	,	_	
199-12	40523-40526	not	_	
199-13	40527-40528	a	_	
199-14	40529-40535	single	_	
199-15	40536-40546	individual	_	
199-16	40546-40547	,	_	
199-17	40548-40551	and	_	
199-18	40552-40558	refers	_	
199-19	40559-40561	to	_	
199-20	40562-40569	genetic	_	
199-21	40570-40583	determination	_	
199-22	40584-40586	of	_	
199-23	40587-40603	inter-individual	_	
199-24	40604-40612	variance	_	
199-25	40613-40616	but	_	
199-26	40617-40620	not	_	
199-27	40621-40631	individual	_	
199-28	40632-40637	value	_	
199-29	40638-40640	of	_	
199-30	40641-40642	a	_	
199-31	40643-40648	trait	_	
199-32	40648-40649	.	_	

#Text=Second, heritability does not imply that individual values of the trait and the population mean value are unchangeable.
200-1	40650-40656	Second	_	
200-2	40656-40657	,	_	
200-3	40658-40670	heritability	_	
200-4	40671-40675	does	_	
200-5	40676-40679	not	_	
200-6	40680-40685	imply	_	
200-7	40686-40690	that	_	
200-8	40691-40701	individual	_	
200-9	40702-40708	values	_	
200-10	40709-40711	of	_	
200-11	40712-40715	the	_	
200-12	40716-40721	trait	_	
200-13	40722-40725	and	_	
200-14	40726-40729	the	_	
200-15	40730-40740	population	_	
200-16	40741-40745	mean	_	
200-17	40746-40751	value	_	
200-18	40752-40755	are	_	
200-19	40756-40768	unchangeable	_	
200-20	40768-40769	.	_	

#Text=In particular, individual values and, accordingly, the population mean value of a certain trait can be elevated in a given population due to e.g. enriched environment or training, but individual differences may still be highly heritable.
201-1	40770-40772	In	_	
201-2	40773-40783	particular	_	
201-3	40783-40784	,	_	
201-4	40785-40795	individual	_	
201-5	40796-40802	values	_	
201-6	40803-40806	and	_	
201-7	40806-40807	,	_	
201-8	40808-40819	accordingly	_	
201-9	40819-40820	,	_	
201-10	40821-40824	the	_	
201-11	40825-40835	population	_	
201-12	40836-40840	mean	_	
201-13	40841-40846	value	_	
201-14	40847-40849	of	_	
201-15	40850-40851	a	_	
201-16	40852-40859	certain	_	
201-17	40860-40865	trait	_	
201-18	40866-40869	can	_	
201-19	40870-40872	be	_	
201-20	40873-40881	elevated	_	
201-21	40882-40884	in	_	
201-22	40885-40886	a	_	
201-23	40887-40892	given	_	
201-24	40893-40903	population	_	
201-25	40904-40907	due	_	
201-26	40908-40910	to	_	
201-27	40911-40914	e.g	_	
201-28	40914-40915	.	_	
201-29	40916-40924	enriched	_	
201-30	40925-40936	environment	_	
201-31	40937-40939	or	_	
201-32	40940-40948	training	_	
201-33	40948-40949	,	_	
201-34	40950-40953	but	_	
201-35	40954-40964	individual	_	
201-36	40965-40976	differences	_	
201-37	40977-40980	may	_	
201-38	40981-40986	still	_	
201-39	40987-40989	be	_	
201-40	40990-40996	highly	_	
201-41	40997-41006	heritable	_	
201-42	41006-41007	.	_	

#Text=In fact, there is evidence that response inhibition-related ERP can be modified by directed training.
202-1	41008-41010	In	_	
202-2	41011-41015	fact	_	
202-3	41015-41016	,	_	
202-4	41017-41022	there	_	
202-5	41023-41025	is	_	
202-6	41026-41034	evidence	_	
202-7	41035-41039	that	_	
202-8	41040-41048	response	_	
202-9	41049-41067	inhibition-related	_	
202-10	41068-41071	ERP	_	
202-11	41072-41075	can	_	
202-12	41076-41078	be	_	
202-13	41079-41087	modified	_	
202-14	41088-41090	by	_	
202-15	41091-41099	directed	_	
202-16	41100-41108	training	_	
202-17	41108-41109	.	_	

#Text=Children aged 8–12 with externalizing problems showed larger N2 and smaller P3 amplitudes relative to controls, but a 3-month cognitive behavioral therapy program resulted in modification of these ERP responses, moreover, greater clinical improvement after treatment was associated with a decrease of N2 amplitude.
203-1	41110-41118	Children	_	
203-2	41119-41123	aged	_	
203-3	41124-41125	8	_	
203-4	41125-41126	–	_	
203-5	41126-41128	12	_	
203-6	41129-41133	with	_	
203-7	41134-41147	externalizing	_	
203-8	41148-41156	problems	_	
203-9	41157-41163	showed	_	
203-10	41164-41170	larger	_	
203-11	41171-41173	N2	_	
203-12	41174-41177	and	_	
203-13	41178-41185	smaller	_	
203-14	41186-41188	P3	_	
203-15	41189-41199	amplitudes	_	
203-16	41200-41208	relative	_	
203-17	41209-41211	to	_	
203-18	41212-41220	controls	_	
203-19	41220-41221	,	_	
203-20	41222-41225	but	_	
203-21	41226-41227	a	_	
203-22	41228-41229	3	_	
203-23	41229-41230	-	_	
203-24	41230-41235	month	_	
203-25	41236-41245	cognitive	_	
203-26	41246-41256	behavioral	_	
203-27	41257-41264	therapy	_	
203-28	41265-41272	program	_	
203-29	41273-41281	resulted	_	
203-30	41282-41284	in	_	
203-31	41285-41297	modification	_	
203-32	41298-41300	of	_	
203-33	41301-41306	these	_	
203-34	41307-41310	ERP	_	
203-35	41311-41320	responses	_	
203-36	41320-41321	,	_	
203-37	41322-41330	moreover	_	
203-38	41330-41331	,	_	
203-39	41332-41339	greater	_	
203-40	41340-41348	clinical	_	
203-41	41349-41360	improvement	_	
203-42	41361-41366	after	_	
203-43	41367-41376	treatment	_	
203-44	41377-41380	was	_	
203-45	41381-41391	associated	_	
203-46	41392-41396	with	_	
203-47	41397-41398	a	_	
203-48	41399-41407	decrease	_	
203-49	41408-41410	of	_	
203-50	41411-41413	N2	_	
203-51	41414-41423	amplitude	_	
203-52	41423-41424	.	_	

#Text=Given the normative developmental decrease in N2 and increase in P3 amplitude, these results suggest a possibility of a developmental lag in the neural correlates of RI, which can be corrected by a therapy program but only in treatment-responsive individuals.
204-1	41425-41430	Given	_	
204-2	41431-41434	the	_	
204-3	41435-41444	normative	_	
204-4	41445-41458	developmental	_	
204-5	41459-41467	decrease	_	
204-6	41468-41470	in	_	
204-7	41471-41473	N2	_	
204-8	41474-41477	and	_	
204-9	41478-41486	increase	_	
204-10	41487-41489	in	_	
204-11	41490-41492	P3	_	
204-12	41493-41502	amplitude	_	
204-13	41502-41503	,	_	
204-14	41504-41509	these	_	
204-15	41510-41517	results	_	
204-16	41518-41525	suggest	_	
204-17	41526-41527	a	_	
204-18	41528-41539	possibility	_	
204-19	41540-41542	of	_	
204-20	41543-41544	a	_	
204-21	41545-41558	developmental	_	
204-22	41559-41562	lag	_	
204-23	41563-41565	in	_	
204-24	41566-41569	the	_	
204-25	41570-41576	neural	_	
204-26	41577-41587	correlates	_	
204-27	41588-41590	of	_	
204-28	41591-41593	RI	_	
204-29	41593-41594	,	_	
204-30	41595-41600	which	_	
204-31	41601-41604	can	_	
204-32	41605-41607	be	_	
204-33	41608-41617	corrected	_	
204-34	41618-41620	by	_	
204-35	41621-41622	a	_	
204-36	41623-41630	therapy	_	
204-37	41631-41638	program	_	
204-38	41639-41642	but	_	
204-39	41643-41647	only	_	
204-40	41648-41650	in	_	
204-41	41651-41671	treatment-responsive	_	
204-42	41672-41683	individuals	_	
204-43	41683-41684	.	_	

#Text=In an fMRI study, neural activity related to response inhibition changes as a function of repeated task practice.
205-1	41685-41687	In	_	
205-2	41688-41690	an	_	
205-3	41691-41695	fMRI	_	
205-4	41696-41701	study	_	
205-5	41701-41702	,	_	
205-6	41703-41709	neural	_	
205-7	41710-41718	activity	_	
205-8	41719-41726	related	_	
205-9	41727-41729	to	_	
205-10	41730-41738	response	_	
205-11	41739-41749	inhibition	_	
205-12	41750-41757	changes	_	
205-13	41758-41760	as	_	
205-14	41761-41762	a	_	
205-15	41763-41771	function	_	
205-16	41772-41774	of	_	
205-17	41775-41783	repeated	_	
205-18	41784-41788	task	_	
205-19	41789-41797	practice	_	
205-20	41797-41798	.	_	

#Text=Taken together, these ERP and fMRI studies suggest that the neural circuitry subserving inhibitory control is amenable to training, despite high heritability at the population level.
#Text=4.5.
206-1	41799-41804	Taken	_	
206-2	41805-41813	together	_	
206-3	41813-41814	,	_	
206-4	41815-41820	these	_	
206-5	41821-41824	ERP	_	
206-6	41825-41828	and	_	
206-7	41829-41833	fMRI	_	
206-8	41834-41841	studies	_	
206-9	41842-41849	suggest	_	
206-10	41850-41854	that	_	
206-11	41855-41858	the	_	
206-12	41859-41865	neural	_	
206-13	41866-41875	circuitry	_	
206-14	41876-41886	subserving	_	
206-15	41887-41897	inhibitory	_	
206-16	41898-41905	control	_	
206-17	41906-41908	is	_	
206-18	41909-41917	amenable	_	
206-19	41918-41920	to	_	
206-20	41921-41929	training	_	
206-21	41929-41930	,	_	
206-22	41931-41938	despite	_	
206-23	41939-41943	high	_	
206-24	41944-41956	heritability	_	
206-25	41957-41959	at	_	
206-26	41960-41963	the	_	
206-27	41964-41974	population	_	
206-28	41975-41980	level	_	
206-29	41980-41981	.	_	
206-30	41982-41985	4.5	_	
206-31	41985-41986	.	_	

#Text=Continuity and change in genetic influences
#Text=Multivariate genetic analyses showed a substantial overlap among genetic factors operating at different ages (Table 4), indicating that 63 to 98% of genetic influences on ERP amplitudes are common across age, i.e. the largely same set of genes influences the ERP parameters at ages 12, 14, and 16.
207-1	41987-41997	Continuity	_	
207-2	41998-42001	and	_	
207-3	42002-42008	change	_	
207-4	42009-42011	in	_	
207-5	42012-42019	genetic	_	
207-6	42020-42030	influences	_	
207-7	42031-42043	Multivariate	_	
207-8	42044-42051	genetic	_	
207-9	42052-42060	analyses	_	
207-10	42061-42067	showed	_	
207-11	42068-42069	a	_	
207-12	42070-42081	substantial	_	
207-13	42082-42089	overlap	_	
207-14	42090-42095	among	_	
207-15	42096-42103	genetic	_	
207-16	42104-42111	factors	_	
207-17	42112-42121	operating	_	
207-18	42122-42124	at	_	
207-19	42125-42134	different	_	
207-20	42135-42139	ages	_	
207-21	42140-42141	(	_	
207-22	42141-42146	Table	_	
207-23	42147-42148	4	_	
207-24	42148-42149	)	_	
207-25	42149-42150	,	_	
207-26	42151-42161	indicating	_	
207-27	42162-42166	that	_	
207-28	42167-42169	63	_	
207-29	42170-42172	to	_	
207-30	42173-42176	98%	_	
207-31	42177-42179	of	_	
207-32	42180-42187	genetic	_	
207-33	42188-42198	influences	_	
207-34	42199-42201	on	_	
207-35	42202-42205	ERP	_	
207-36	42206-42216	amplitudes	_	
207-37	42217-42220	are	_	
207-38	42221-42227	common	_	
207-39	42228-42234	across	_	
207-40	42235-42238	age	_	
207-41	42238-42239	,	_	
207-42	42240-42243	i.e	_	
207-43	42243-42244	.	_	
207-44	42245-42248	the	_	
207-45	42249-42256	largely	_	
207-46	42257-42261	same	_	
207-47	42262-42265	set	_	
207-48	42266-42268	of	_	
207-49	42269-42274	genes	_	
207-50	42275-42285	influences	_	
207-51	42286-42289	the	_	
207-52	42290-42293	ERP	_	
207-53	42294-42304	parameters	_	
207-54	42305-42307	at	_	
207-55	42308-42312	ages	_	
207-56	42313-42315	12	_	
207-57	42315-42316	,	_	
207-58	42317-42319	14	_	
207-59	42319-42320	,	_	
207-60	42321-42324	and	_	
207-61	42325-42327	16	_	
207-62	42327-42328	.	_	

#Text=Although no significant age-related differences in overall heritability were observed, multivariate genetic analyses revealed significant changes in genetic architecture, and these changes differed among ERP variables.
208-1	42329-42337	Although	_	
208-2	42338-42340	no	_	
208-3	42341-42352	significant	_	
208-4	42353-42364	age-related	_	
208-5	42365-42376	differences	_	
208-6	42377-42379	in	_	
208-7	42380-42387	overall	_	
208-8	42388-42400	heritability	_	
208-9	42401-42405	were	_	
208-10	42406-42414	observed	_	
208-11	42414-42415	,	_	
208-12	42416-42428	multivariate	_	
208-13	42429-42436	genetic	_	
208-14	42437-42445	analyses	_	
208-15	42446-42454	revealed	_	
208-16	42455-42466	significant	_	
208-17	42467-42474	changes	_	
208-18	42475-42477	in	_	
208-19	42478-42485	genetic	_	
208-20	42486-42498	architecture	_	
208-21	42498-42499	,	_	
208-22	42500-42503	and	_	
208-23	42504-42509	these	_	
208-24	42510-42517	changes	_	
208-25	42518-42526	differed	_	
208-26	42527-42532	among	_	
208-27	42533-42536	ERP	_	
208-28	42537-42546	variables	_	
208-29	42546-42547	.	_	

#Text=Despite a strong overlap of genetic influences on ERP components at different ages, significant age-specific genetic influences were identified for No-Go ERP components.
209-1	42548-42555	Despite	_	
209-2	42556-42557	a	_	
209-3	42558-42564	strong	_	
209-4	42565-42572	overlap	_	
209-5	42573-42575	of	_	
209-6	42576-42583	genetic	_	
209-7	42584-42594	influences	_	
209-8	42595-42597	on	_	
209-9	42598-42601	ERP	_	
209-10	42602-42612	components	_	
209-11	42613-42615	at	_	
209-12	42616-42625	different	_	
209-13	42626-42630	ages	_	
209-14	42630-42631	,	_	
209-15	42632-42643	significant	_	
209-16	42644-42656	age-specific	_	
209-17	42657-42664	genetic	_	
209-18	42665-42675	influences	_	
209-19	42676-42680	were	_	
209-20	42681-42691	identified	_	
209-21	42692-42695	for	_	
209-22	42696-42701	No-Go	_	
209-23	42702-42705	ERP	_	
209-24	42706-42716	components	_	
209-25	42716-42717	.	_	

#Text=For both N2 and P3, novel genetic influences emerged at age 14 and, in the case of N2, these new genetic factors remained active at age 16, whereas for No-Go P3 they were restricted to age 14 only.
210-1	42718-42721	For	_	
210-2	42722-42726	both	_	
210-3	42727-42729	N2	_	
210-4	42730-42733	and	_	
210-5	42734-42736	P3	_	
210-6	42736-42737	,	_	
210-7	42738-42743	novel	_	
210-8	42744-42751	genetic	_	
210-9	42752-42762	influences	_	
210-10	42763-42770	emerged	_	
210-11	42771-42773	at	_	
210-12	42774-42777	age	_	
210-13	42778-42780	14	_	
210-14	42781-42784	and	_	
210-15	42784-42785	,	_	
210-16	42786-42788	in	_	
210-17	42789-42792	the	_	
210-18	42793-42797	case	_	
210-19	42798-42800	of	_	
210-20	42801-42803	N2	_	
210-21	42803-42804	,	_	
210-22	42805-42810	these	_	
210-23	42811-42814	new	_	
210-24	42815-42822	genetic	_	
210-25	42823-42830	factors	_	
210-26	42831-42839	remained	_	
210-27	42840-42846	active	_	
210-28	42847-42849	at	_	
210-29	42850-42853	age	_	
210-30	42854-42856	16	_	
210-31	42856-42857	,	_	
210-32	42858-42865	whereas	_	
210-33	42866-42869	for	_	
210-34	42870-42875	No-Go	_	
210-35	42876-42878	P3	_	
210-36	42879-42883	they	_	
210-37	42884-42888	were	_	
210-38	42889-42899	restricted	_	
210-39	42900-42902	to	_	
210-40	42903-42906	age	_	
210-41	42907-42909	14	_	
210-42	42910-42914	only	_	
210-43	42914-42915	.	_	

#Text=This pattern of results suggests the possibility of age-limited genetic influences, such that new genes become active between age 12 and 14 and are inactivated between 14 and 16.
211-1	42916-42920	This	_	
211-2	42921-42928	pattern	_	
211-3	42929-42931	of	_	
211-4	42932-42939	results	_	
211-5	42940-42948	suggests	_	
211-6	42949-42952	the	_	
211-7	42953-42964	possibility	_	
211-8	42965-42967	of	_	
211-9	42968-42979	age-limited	_	
211-10	42980-42987	genetic	_	
211-11	42988-42998	influences	_	
211-12	42998-42999	,	_	
211-13	43000-43004	such	_	
211-14	43005-43009	that	_	
211-15	43010-43013	new	_	
211-16	43014-43019	genes	_	
211-17	43020-43026	become	_	
211-18	43027-43033	active	_	
211-19	43034-43041	between	_	
211-20	43042-43045	age	_	
211-21	43046-43048	12	_	
211-22	43049-43052	and	_	
211-23	43053-43055	14	_	
211-24	43056-43059	and	_	
211-25	43060-43063	are	_	
211-26	43064-43075	inactivated	_	
211-27	43076-43083	between	_	
211-28	43084-43086	14	_	
211-29	43087-43090	and	_	
211-30	43091-43093	16	_	
211-31	43093-43094	.	_	

#Text=However, it cannot be ruled out that the overlap between novel genetic influences emerging at age 14 and genetic influences at age 16 were not detected due to smaller number of pairs at age 16 and thus lower statistical power.
212-1	43095-43102	However	_	
212-2	43102-43103	,	_	
212-3	43104-43106	it	_	
212-4	43107-43113	cannot	_	
212-5	43114-43116	be	_	
212-6	43117-43122	ruled	_	
212-7	43123-43126	out	_	
212-8	43127-43131	that	_	
212-9	43132-43135	the	_	
212-10	43136-43143	overlap	_	
212-11	43144-43151	between	_	
212-12	43152-43157	novel	_	
212-13	43158-43165	genetic	_	
212-14	43166-43176	influences	_	
212-15	43177-43185	emerging	_	
212-16	43186-43188	at	_	
212-17	43189-43192	age	_	
212-18	43193-43195	14	_	
212-19	43196-43199	and	_	
212-20	43200-43207	genetic	_	
212-21	43208-43218	influences	_	
212-22	43219-43221	at	_	
212-23	43222-43225	age	_	
212-24	43226-43228	16	_	
212-25	43229-43233	were	_	
212-26	43234-43237	not	_	
212-27	43238-43246	detected	_	
212-28	43247-43250	due	_	
212-29	43251-43253	to	_	
212-30	43254-43261	smaller	_	
212-31	43262-43268	number	_	
212-32	43269-43271	of	_	
212-33	43272-43277	pairs	_	
212-34	43278-43280	at	_	
212-35	43281-43284	age	_	
212-36	43285-43287	16	_	
212-37	43288-43291	and	_	
212-38	43292-43296	thus	_	
212-39	43297-43302	lower	_	
212-40	43303-43314	statistical	_	
212-41	43315-43320	power	_	
212-42	43320-43321	.	_	

#Text=It is important to note that novel genetic influences were detected for responses to No-Go but not Go stimuli, suggesting that the set of genes influencing the mechanisms of response inhibition changes in the course of prefrontal development, probably due to changes in gene expression.
213-1	43322-43324	It	_	
213-2	43325-43327	is	_	
213-3	43328-43337	important	_	
213-4	43338-43340	to	_	
213-5	43341-43345	note	_	
213-6	43346-43350	that	_	
213-7	43351-43356	novel	_	
213-8	43357-43364	genetic	_	
213-9	43365-43375	influences	_	
213-10	43376-43380	were	_	
213-11	43381-43389	detected	_	
213-12	43390-43393	for	_	
213-13	43394-43403	responses	_	
213-14	43404-43406	to	_	
213-15	43407-43412	No-Go	_	
213-16	43413-43416	but	_	
213-17	43417-43420	not	_	
213-18	43421-43423	Go	_	
213-19	43424-43431	stimuli	_	
213-20	43431-43432	,	_	
213-21	43433-43443	suggesting	_	
213-22	43444-43448	that	_	
213-23	43449-43452	the	_	
213-24	43453-43456	set	_	
213-25	43457-43459	of	_	
213-26	43460-43465	genes	_	
213-27	43466-43477	influencing	_	
213-28	43478-43481	the	_	
213-29	43482-43492	mechanisms	_	
213-30	43493-43495	of	_	
213-31	43496-43504	response	_	
213-32	43505-43515	inhibition	_	
213-33	43516-43523	changes	_	
213-34	43524-43526	in	_	
213-35	43527-43530	the	_	
213-36	43531-43537	course	_	
213-37	43538-43540	of	_	
213-38	43541-43551	prefrontal	_	
213-39	43552-43563	development	_	
213-40	43563-43564	,	_	
213-41	43565-43573	probably	_	
213-42	43574-43577	due	_	
213-43	43578-43580	to	_	
213-44	43581-43588	changes	_	
213-45	43589-43591	in	_	
213-46	43592-43596	gene	_	
213-47	43597-43607	expression	_	
213-48	43607-43608	.	_	

#Text=One can speculate that increasing environmental demands during a sensitive developmental period trigger the expression of new genes affecting prefrontally-mediated cognitive control functions.
214-1	43609-43612	One	_	
214-2	43613-43616	can	_	
214-3	43617-43626	speculate	_	
214-4	43627-43631	that	_	
214-5	43632-43642	increasing	_	
214-6	43643-43656	environmental	_	
214-7	43657-43664	demands	_	
214-8	43665-43671	during	_	
214-9	43672-43673	a	_	
214-10	43674-43683	sensitive	_	
214-11	43684-43697	developmental	_	
214-12	43698-43704	period	_	
214-13	43705-43712	trigger	_	
214-14	43713-43716	the	_	
214-15	43717-43727	expression	_	
214-16	43728-43730	of	_	
214-17	43731-43734	new	_	
214-18	43735-43740	genes	_	
214-19	43741-43750	affecting	_	
214-20	43751-43772	prefrontally-mediated	_	
214-21	43773-43782	cognitive	_	
214-22	43783-43790	control	_	
214-23	43791-43800	functions	_	
214-24	43800-43801	.	_	

#Text=In contrast, genetic influences on the mostly parietal cortical activity related to the processing of Go stimuli (resembling classical oddball stimuli) may already be stabilized by age 12 and undergo little change during adolescent development.
#Text=4.6.
215-1	43802-43804	In	_	
215-2	43805-43813	contrast	_	
215-3	43813-43814	,	_	
215-4	43815-43822	genetic	_	
215-5	43823-43833	influences	_	
215-6	43834-43836	on	_	
215-7	43837-43840	the	_	
215-8	43841-43847	mostly	_	
215-9	43848-43856	parietal	_	
215-10	43857-43865	cortical	_	
215-11	43866-43874	activity	_	
215-12	43875-43882	related	_	
215-13	43883-43885	to	_	
215-14	43886-43889	the	_	
215-15	43890-43900	processing	_	
215-16	43901-43903	of	_	
215-17	43904-43906	Go	_	
215-18	43907-43914	stimuli	_	
215-19	43915-43916	(	_	
215-20	43916-43926	resembling	_	
215-21	43927-43936	classical	_	
215-22	43937-43944	oddball	_	
215-23	43945-43952	stimuli	_	
215-24	43952-43953	)	_	
215-25	43954-43957	may	_	
215-26	43958-43965	already	_	
215-27	43966-43968	be	_	
215-28	43969-43979	stabilized	_	
215-29	43980-43982	by	_	
215-30	43983-43986	age	_	
215-31	43987-43989	12	_	
215-32	43990-43993	and	_	
215-33	43994-44001	undergo	_	
215-34	44002-44008	little	_	
215-35	44009-44015	change	_	
215-36	44016-44022	during	_	
215-37	44023-44033	adolescent	_	
215-38	44034-44045	development	_	
215-39	44045-44046	.	_	
215-40	44047-44050	4.6	_	
215-41	44050-44051	.	_	

#Text=Genetic influences on developmental changes in response inhibition
#Text=As described above, there are highly significant developmental changes in the neural markers of response inhibition at the group (population) level.
216-1	44052-44059	Genetic	_	
216-2	44060-44070	influences	_	
216-3	44071-44073	on	_	
216-4	44074-44087	developmental	_	
216-5	44088-44095	changes	_	
216-6	44096-44098	in	_	
216-7	44099-44107	response	_	
216-8	44108-44118	inhibition	_	
216-9	44119-44121	As	_	
216-10	44122-44131	described	_	
216-11	44132-44137	above	_	
216-12	44137-44138	,	_	
216-13	44139-44144	there	_	
216-14	44145-44148	are	_	
216-15	44149-44155	highly	_	
216-16	44156-44167	significant	_	
216-17	44168-44181	developmental	_	
216-18	44182-44189	changes	_	
216-19	44190-44192	in	_	
216-20	44193-44196	the	_	
216-21	44197-44203	neural	_	
216-22	44204-44211	markers	_	
216-23	44212-44214	of	_	
216-24	44215-44223	response	_	
216-25	44224-44234	inhibition	_	
216-26	44235-44237	at	_	
216-27	44238-44241	the	_	
216-28	44242-44247	group	_	
216-29	44248-44249	(	_	
216-30	44249-44259	population	_	
216-31	44259-44260	)	_	
216-32	44261-44266	level	_	
216-33	44266-44267	.	_	

#Text=However, the extent of these changes varies across individuals, suggesting individual differences in the rate of brain maturation.
217-1	44268-44275	However	_	
217-2	44275-44276	,	_	
217-3	44277-44280	the	_	
217-4	44281-44287	extent	_	
217-5	44288-44290	of	_	
217-6	44291-44296	these	_	
217-7	44297-44304	changes	_	
217-8	44305-44311	varies	_	
217-9	44312-44318	across	_	
217-10	44319-44330	individuals	_	
217-11	44330-44331	,	_	
217-12	44332-44342	suggesting	_	
217-13	44343-44353	individual	_	
217-14	44354-44365	differences	_	
217-15	44366-44368	in	_	
217-16	44369-44372	the	_	
217-17	44373-44377	rate	_	
217-18	44378-44380	of	_	
217-19	44381-44386	brain	_	
217-20	44387-44397	maturation	_	
217-21	44397-44398	.	_	

#Text=A genetic analysis of longitudinal difference scores indicated that the rate of developmental changes in the neural processes underlying response inhibition is significantly influenced by genetic factors, although the amount of this influence is modest relative to non-shared environmental influences (Table 5).
218-1	44399-44400	A	_	
218-2	44401-44408	genetic	_	
218-3	44409-44417	analysis	_	
218-4	44418-44420	of	_	
218-5	44421-44433	longitudinal	_	
218-6	44434-44444	difference	_	
218-7	44445-44451	scores	_	
218-8	44452-44461	indicated	_	
218-9	44462-44466	that	_	
218-10	44467-44470	the	_	
218-11	44471-44475	rate	_	
218-12	44476-44478	of	_	
218-13	44479-44492	developmental	_	
218-14	44493-44500	changes	_	
218-15	44501-44503	in	_	
218-16	44504-44507	the	_	
218-17	44508-44514	neural	_	
218-18	44515-44524	processes	_	
218-19	44525-44535	underlying	_	
218-20	44536-44544	response	_	
218-21	44545-44555	inhibition	_	
218-22	44556-44558	is	_	
218-23	44559-44572	significantly	_	
218-24	44573-44583	influenced	_	
218-25	44584-44586	by	_	
218-26	44587-44594	genetic	_	
218-27	44595-44602	factors	_	
218-28	44602-44603	,	_	
218-29	44604-44612	although	_	
218-30	44613-44616	the	_	
218-31	44617-44623	amount	_	
218-32	44624-44626	of	_	
218-33	44627-44631	this	_	
218-34	44632-44641	influence	_	
218-35	44642-44644	is	_	
218-36	44645-44651	modest	_	
218-37	44652-44660	relative	_	
218-38	44661-44663	to	_	
218-39	44664-44674	non-shared	_	
218-40	44675-44688	environmental	_	
218-41	44689-44699	influences	_	
218-42	44700-44701	(	_	
218-43	44701-44706	Table	_	
218-44	44707-44708	5	_	
218-45	44708-44709	)	_	
218-46	44709-44710	.	_	

#Text=This finding has important implications for the understanding of developmental psychopathology and substance abuse.
219-1	44711-44715	This	_	
219-2	44716-44723	finding	_	
219-3	44724-44727	has	_	
219-4	44728-44737	important	_	
219-5	44738-44750	implications	_	
219-6	44751-44754	for	_	
219-7	44755-44758	the	_	
219-8	44759-44772	understanding	_	
219-9	44773-44775	of	_	
219-10	44776-44789	developmental	_	
219-11	44790-44805	psychopathology	_	
219-12	44806-44809	and	_	
219-13	44810-44819	substance	_	
219-14	44820-44825	abuse	_	
219-15	44825-44826	.	_	

#Text=In particular, a delayed maturation of the functional neural system subserving response inhibition may result in a mismatch between individual’s self-control capacity and challenges presented by changing social environment and roles such as increased stress and peer pressure, leading to elevated risk for maladaptive behaviors and psychopathology.
220-1	44827-44829	In	_	
220-2	44830-44840	particular	_	
220-3	44840-44841	,	_	
220-4	44842-44843	a	_	
220-5	44844-44851	delayed	_	
220-6	44852-44862	maturation	_	
220-7	44863-44865	of	_	
220-8	44866-44869	the	_	
220-9	44870-44880	functional	_	
220-10	44881-44887	neural	_	
220-11	44888-44894	system	_	
220-12	44895-44905	subserving	_	
220-13	44906-44914	response	_	
220-14	44915-44925	inhibition	_	
220-15	44926-44929	may	_	
220-16	44930-44936	result	_	
220-17	44937-44939	in	_	
220-18	44940-44941	a	_	
220-19	44942-44950	mismatch	_	
220-20	44951-44958	between	_	
220-21	44959-44969	individual	_	
220-22	44969-44970	’	_	
220-23	44970-44971	s	_	
220-24	44972-44984	self-control	_	
220-25	44985-44993	capacity	_	
220-26	44994-44997	and	_	
220-27	44998-45008	challenges	_	
220-28	45009-45018	presented	_	
220-29	45019-45021	by	_	
220-30	45022-45030	changing	_	
220-31	45031-45037	social	_	
220-32	45038-45049	environment	_	
220-33	45050-45053	and	_	
220-34	45054-45059	roles	_	
220-35	45060-45064	such	_	
220-36	45065-45067	as	_	
220-37	45068-45077	increased	_	
220-38	45078-45084	stress	_	
220-39	45085-45088	and	_	
220-40	45089-45093	peer	_	
220-41	45094-45102	pressure	_	
220-42	45102-45103	,	_	
220-43	45104-45111	leading	_	
220-44	45112-45114	to	_	
220-45	45115-45123	elevated	_	
220-46	45124-45128	risk	_	
220-47	45129-45132	for	_	
220-48	45133-45144	maladaptive	_	
220-49	45145-45154	behaviors	_	
220-50	45155-45158	and	_	
220-51	45159-45174	psychopathology	_	
220-52	45174-45175	.	_	

#Text=Another mismatch may occur between the underdeveloped inhibitory control system and already developed reward/motivation system, leading to impulsive reward seeking such as increased risk-taking and delay discounting behaviors.
221-1	45176-45183	Another	_	
221-2	45184-45192	mismatch	_	
221-3	45193-45196	may	_	
221-4	45197-45202	occur	_	
221-5	45203-45210	between	_	
221-6	45211-45214	the	_	
221-7	45215-45229	underdeveloped	_	
221-8	45230-45240	inhibitory	_	
221-9	45241-45248	control	_	
221-10	45249-45255	system	_	
221-11	45256-45259	and	_	
221-12	45260-45267	already	_	
221-13	45268-45277	developed	_	
221-14	45278-45284	reward	_	
221-15	45284-45285	/	_	
221-16	45285-45295	motivation	_	
221-17	45296-45302	system	_	
221-18	45302-45303	,	_	
221-19	45304-45311	leading	_	
221-20	45312-45314	to	_	
221-21	45315-45324	impulsive	_	
221-22	45325-45331	reward	_	
221-23	45332-45339	seeking	_	
221-24	45340-45344	such	_	
221-25	45345-45347	as	_	
221-26	45348-45357	increased	_	
221-27	45358-45369	risk-taking	_	
221-28	45370-45373	and	_	
221-29	45374-45379	delay	_	
221-30	45380-45391	discounting	_	
221-31	45392-45401	behaviors	_	
221-32	45401-45402	.	_	

#Text=It is reasonable to suggest that this behavioral pattern characteristic of adolescence is at least partially mediated by heritable differences in the rate of brain maturation, particularly prefrontal brain regions that are critical for inhibitory self-regulation of behavior.
#Text=4.8.
222-1	45403-45405	It	_	
222-2	45406-45408	is	_	
222-3	45409-45419	reasonable	_	
222-4	45420-45422	to	_	
222-5	45423-45430	suggest	_	
222-6	45431-45435	that	_	
222-7	45436-45440	this	_	
222-8	45441-45451	behavioral	_	
222-9	45452-45459	pattern	_	
222-10	45460-45474	characteristic	_	
222-11	45475-45477	of	_	
222-12	45478-45489	adolescence	_	
222-13	45490-45492	is	_	
222-14	45493-45495	at	_	
222-15	45496-45501	least	_	
222-16	45502-45511	partially	_	
222-17	45512-45520	mediated	_	
222-18	45521-45523	by	_	
222-19	45524-45533	heritable	_	
222-20	45534-45545	differences	_	
222-21	45546-45548	in	_	
222-22	45549-45552	the	_	
222-23	45553-45557	rate	_	
222-24	45558-45560	of	_	
222-25	45561-45566	brain	_	
222-26	45567-45577	maturation	_	
222-27	45577-45578	,	_	
222-28	45579-45591	particularly	_	
222-29	45592-45602	prefrontal	_	
222-30	45603-45608	brain	_	
222-31	45609-45616	regions	_	
222-32	45617-45621	that	_	
222-33	45622-45625	are	_	
222-34	45626-45634	critical	_	
222-35	45635-45638	for	_	
222-36	45639-45649	inhibitory	_	
222-37	45650-45665	self-regulation	_	
222-38	45666-45668	of	_	
222-39	45669-45677	behavior	_	
222-40	45677-45678	.	_	
222-41	45679-45682	4.8	_	
222-42	45682-45683	.	_	

#Text=Limitations and future directions
#Text=Although the present study provided important novel information about the development and genetics of brain activity related to response inhibition in adolescents, a number of important questions still remain unanswered, warranting future studies.
223-1	45684-45695	Limitations	_	
223-2	45696-45699	and	_	
223-3	45700-45706	future	_	
223-4	45707-45717	directions	_	
223-5	45718-45726	Although	_	
223-6	45727-45730	the	_	
223-7	45731-45738	present	_	
223-8	45739-45744	study	_	
223-9	45745-45753	provided	_	
223-10	45754-45763	important	_	
223-11	45764-45769	novel	_	
223-12	45770-45781	information	_	
223-13	45782-45787	about	_	
223-14	45788-45791	the	_	
223-15	45792-45803	development	_	
223-16	45804-45807	and	_	
223-17	45808-45816	genetics	_	
223-18	45817-45819	of	_	
223-19	45820-45825	brain	_	
223-20	45826-45834	activity	_	
223-21	45835-45842	related	_	
223-22	45843-45845	to	_	
223-23	45846-45854	response	_	
223-24	45855-45865	inhibition	_	
223-25	45866-45868	in	_	
223-26	45869-45880	adolescents	_	
223-27	45880-45881	,	_	
223-28	45882-45883	a	_	
223-29	45884-45890	number	_	
223-30	45891-45893	of	_	
223-31	45894-45903	important	_	
223-32	45904-45913	questions	_	
223-33	45914-45919	still	_	
223-34	45920-45926	remain	_	
223-35	45927-45937	unanswered	_	
223-36	45937-45938	,	_	
223-37	45939-45949	warranting	_	
223-38	45950-45956	future	_	
223-39	45957-45964	studies	_	
223-40	45964-45965	.	_	

#Text=First, estimates of heritability, while important, provide little information about specific genes involved.
224-1	45966-45971	First	_	
224-2	45971-45972	,	_	
224-3	45973-45982	estimates	_	
224-4	45983-45985	of	_	
224-5	45986-45998	heritability	_	
224-6	45998-45999	,	_	
224-7	46000-46005	while	_	
224-8	46006-46015	important	_	
224-9	46015-46016	,	_	
224-10	46017-46024	provide	_	
224-11	46025-46031	little	_	
224-12	46032-46043	information	_	
224-13	46044-46049	about	_	
224-14	46050-46058	specific	_	
224-15	46059-46064	genes	_	
224-16	46065-46073	involved	_	
224-17	46073-46074	.	_	

#Text=The present analysis suggests that there may be at least two distinct sets of genes: the first set may affect the overall level of inhibitory capacity, while the second set may influence developmental changes during mid-adolescence.
225-1	46075-46078	The	_	
225-2	46079-46086	present	_	
225-3	46087-46095	analysis	_	
225-4	46096-46104	suggests	_	
225-5	46105-46109	that	_	
225-6	46110-46115	there	_	
225-7	46116-46119	may	_	
225-8	46120-46122	be	_	
225-9	46123-46125	at	_	
225-10	46126-46131	least	_	
225-11	46132-46135	two	_	
225-12	46136-46144	distinct	_	
225-13	46145-46149	sets	_	
225-14	46150-46152	of	_	
225-15	46153-46158	genes	_	
225-16	46158-46159	:	_	
225-17	46160-46163	the	_	
225-18	46164-46169	first	_	
225-19	46170-46173	set	_	
225-20	46174-46177	may	_	
225-21	46178-46184	affect	_	
225-22	46185-46188	the	_	
225-23	46189-46196	overall	_	
225-24	46197-46202	level	_	
225-25	46203-46205	of	_	
225-26	46206-46216	inhibitory	_	
225-27	46217-46225	capacity	_	
225-28	46225-46226	,	_	
225-29	46227-46232	while	_	
225-30	46233-46236	the	_	
225-31	46237-46243	second	_	
225-32	46244-46247	set	_	
225-33	46248-46251	may	_	
225-34	46252-46261	influence	_	
225-35	46262-46275	developmental	_	
225-36	46276-46283	changes	_	
225-37	46284-46290	during	_	
225-38	46291-46306	mid-adolescence	_	
225-39	46306-46307	.	_	

#Text=An important aim for future genetic investigation of the ERP markers of response inhibition will be identification of genes influencing overall inhibitory control capacity and its developmental changes.
226-1	46308-46310	An	_	
226-2	46311-46320	important	_	
226-3	46321-46324	aim	_	
226-4	46325-46328	for	_	
226-5	46329-46335	future	_	
226-6	46336-46343	genetic	_	
226-7	46344-46357	investigation	_	
226-8	46358-46360	of	_	
226-9	46361-46364	the	_	
226-10	46365-46368	ERP	_	
226-11	46369-46376	markers	_	
226-12	46377-46379	of	_	
226-13	46380-46388	response	_	
226-14	46389-46399	inhibition	_	
226-15	46400-46404	will	_	
226-16	46405-46407	be	_	
226-17	46408-46422	identification	_	
226-18	46423-46425	of	_	
226-19	46426-46431	genes	_	
226-20	46432-46443	influencing	_	
226-21	46444-46451	overall	_	
226-22	46452-46462	inhibitory	_	
226-23	46463-46470	control	_	
226-24	46471-46479	capacity	_	
226-25	46480-46483	and	_	
226-26	46484-46487	its	_	
226-27	46488-46501	developmental	_	
226-28	46502-46509	changes	_	
226-29	46509-46510	.	_	

#Text=Next, the present analysis was limited to an age range of 12 to 16 only.
227-1	46511-46515	Next	_	
227-2	46515-46516	,	_	
227-3	46517-46520	the	_	
227-4	46521-46528	present	_	
227-5	46529-46537	analysis	_	
227-6	46538-46541	was	_	
227-7	46542-46549	limited	_	
227-8	46550-46552	to	_	
227-9	46553-46555	an	_	
227-10	46556-46559	age	_	
227-11	46560-46565	range	_	
227-12	46566-46568	of	_	
227-13	46569-46571	12	_	
227-14	46572-46574	to	_	
227-15	46575-46577	16	_	
227-16	46578-46582	only	_	
227-17	46582-46583	.	_	

#Text=It is important to determine whether developmental changes continue past the age of 16, and whether No-Go ERPs in young adults are influenced by the same genetic factors as in adolescents.
228-1	46584-46586	It	_	
228-2	46587-46589	is	_	
228-3	46590-46599	important	_	
228-4	46600-46602	to	_	
228-5	46603-46612	determine	_	
228-6	46613-46620	whether	_	
228-7	46621-46634	developmental	_	
228-8	46635-46642	changes	_	
228-9	46643-46651	continue	_	
228-10	46652-46656	past	_	
228-11	46657-46660	the	_	
228-12	46661-46664	age	_	
228-13	46665-46667	of	_	
228-14	46668-46670	16	_	
228-15	46670-46671	,	_	
228-16	46672-46675	and	_	
228-17	46676-46683	whether	_	
228-18	46684-46689	No-Go	_	
228-19	46690-46694	ERPs	_	
228-20	46695-46697	in	_	
228-21	46698-46703	young	_	
228-22	46704-46710	adults	_	
228-23	46711-46714	are	_	
228-24	46715-46725	influenced	_	
228-25	46726-46728	by	_	
228-26	46729-46732	the	_	
228-27	46733-46737	same	_	
228-28	46738-46745	genetic	_	
228-29	46746-46753	factors	_	
228-30	46754-46756	as	_	
228-31	46757-46759	in	_	
228-32	46760-46771	adolescents	_	
228-33	46771-46772	.	_	

#Text=The ongoing work in our laboratory will extend the present analyses to older ages including the important period of transition from adolescence to adulthood.
229-1	46773-46776	The	_	
229-2	46777-46784	ongoing	_	
229-3	46785-46789	work	_	
229-4	46790-46792	in	_	
229-5	46793-46796	our	_	
229-6	46797-46807	laboratory	_	
229-7	46808-46812	will	_	
229-8	46813-46819	extend	_	
229-9	46820-46823	the	_	
229-10	46824-46831	present	_	
229-11	46832-46840	analyses	_	
229-12	46841-46843	to	_	
229-13	46844-46849	older	_	
229-14	46850-46854	ages	_	
229-15	46855-46864	including	_	
229-16	46865-46868	the	_	
229-17	46869-46878	important	_	
229-18	46879-46885	period	_	
229-19	46886-46888	of	_	
229-20	46889-46899	transition	_	
229-21	46900-46904	from	_	
229-22	46905-46916	adolescence	_	
229-23	46917-46919	to	_	
229-24	46920-46929	adulthood	_	
229-25	46929-46930	.	_	

#Text=Furthermore, our longitudinal analysis included three time points only, which limited our ability to evaluate the shape of developmental trajectories and fit advanced developmental models such as the growth curves model.
230-1	46931-46942	Furthermore	_	
230-2	46942-46943	,	_	
230-3	46944-46947	our	_	
230-4	46948-46960	longitudinal	_	
230-5	46961-46969	analysis	_	
230-6	46970-46978	included	_	
230-7	46979-46984	three	_	
230-8	46985-46989	time	_	
230-9	46990-46996	points	_	
230-10	46997-47001	only	_	
230-11	47001-47002	,	_	
230-12	47003-47008	which	_	
230-13	47009-47016	limited	_	
230-14	47017-47020	our	_	
230-15	47021-47028	ability	_	
230-16	47029-47031	to	_	
230-17	47032-47040	evaluate	_	
230-18	47041-47044	the	_	
230-19	47045-47050	shape	_	
230-20	47051-47053	of	_	
230-21	47054-47067	developmental	_	
230-22	47068-47080	trajectories	_	
230-23	47081-47084	and	_	
230-24	47085-47088	fit	_	
230-25	47089-47097	advanced	_	
230-26	47098-47111	developmental	_	
230-27	47112-47118	models	_	
230-28	47119-47123	such	_	
230-29	47124-47126	as	_	
230-30	47127-47130	the	_	
230-31	47131-47137	growth	_	
230-32	47138-47144	curves	_	
230-33	47145-47150	model	_	
230-34	47150-47151	.	_	

#Text=The present analyses focused on traditional peak amplitude measures of major ERP components that have been used in the majority of previous studies using Go/No-Go paradigms.
231-1	47152-47155	The	_	
231-2	47156-47163	present	_	
231-3	47164-47172	analyses	_	
231-4	47173-47180	focused	_	
231-5	47181-47183	on	_	
231-6	47184-47195	traditional	_	
231-7	47196-47200	peak	_	
231-8	47201-47210	amplitude	_	
231-9	47211-47219	measures	_	
231-10	47220-47222	of	_	
231-11	47223-47228	major	_	
231-12	47229-47232	ERP	_	
231-13	47233-47243	components	_	
231-14	47244-47248	that	_	
231-15	47249-47253	have	_	
231-16	47254-47258	been	_	
231-17	47259-47263	used	_	
231-18	47264-47266	in	_	
231-19	47267-47270	the	_	
231-20	47271-47279	majority	_	
231-21	47280-47282	of	_	
231-22	47283-47291	previous	_	
231-23	47292-47299	studies	_	
231-24	47300-47305	using	_	
231-25	47306-47308	Go	_	
231-26	47308-47309	/	_	
231-27	47309-47314	No-Go	_	
231-28	47315-47324	paradigms	_	
231-29	47324-47325	.	_	

#Text=However, these ERP components may represent relatively distinct temporally and spatially overlapping processes, and quantification of ERP components can be further improved by the application of methods permitting the isolation of these constituent processes such as the principal component analysis (PCA) and the independent component analysis (ICA).
232-1	47326-47333	However	_	
232-2	47333-47334	,	_	
232-3	47335-47340	these	_	
232-4	47341-47344	ERP	_	
232-5	47345-47355	components	_	
232-6	47356-47359	may	_	
232-7	47360-47369	represent	_	
232-8	47370-47380	relatively	_	
232-9	47381-47389	distinct	_	
232-10	47390-47400	temporally	_	
232-11	47401-47404	and	_	
232-12	47405-47414	spatially	_	
232-13	47415-47426	overlapping	_	
232-14	47427-47436	processes	_	
232-15	47436-47437	,	_	
232-16	47438-47441	and	_	
232-17	47442-47456	quantification	_	
232-18	47457-47459	of	_	
232-19	47460-47463	ERP	_	
232-20	47464-47474	components	_	
232-21	47475-47478	can	_	
232-22	47479-47481	be	_	
232-23	47482-47489	further	_	
232-24	47490-47498	improved	_	
232-25	47499-47501	by	_	
232-26	47502-47505	the	_	
232-27	47506-47517	application	_	
232-28	47518-47520	of	_	
232-29	47521-47528	methods	_	
232-30	47529-47539	permitting	_	
232-31	47540-47543	the	_	
232-32	47544-47553	isolation	_	
232-33	47554-47556	of	_	
232-34	47557-47562	these	_	
232-35	47563-47574	constituent	_	
232-36	47575-47584	processes	_	
232-37	47585-47589	such	_	
232-38	47590-47592	as	_	
232-39	47593-47596	the	_	
232-40	47597-47606	principal	_	
232-41	47607-47616	component	_	
232-42	47617-47625	analysis	_	
232-43	47626-47627	(	_	
232-44	47627-47630	PCA	_	
232-45	47630-47631	)	_	
232-46	47632-47635	and	_	
232-47	47636-47639	the	_	
232-48	47640-47651	independent	_	
232-49	47652-47661	component	_	
232-50	47662-47670	analysis	_	
232-51	47671-47672	(	_	
232-52	47672-47675	ICA	_	
232-53	47675-47676	)	_	
232-54	47676-47677	.	_	

#Text=In particular, recent studies have demonstrated that PCA provides a more fine-grained characterization of separable neural processes involved in response inhibition compared to traditional peak measures, however, little is known about common and specific genetic influences on these characteristics.
233-1	47678-47680	In	_	
233-2	47681-47691	particular	_	
233-3	47691-47692	,	_	
233-4	47693-47699	recent	_	
233-5	47700-47707	studies	_	
233-6	47708-47712	have	_	
233-7	47713-47725	demonstrated	_	
233-8	47726-47730	that	_	
233-9	47731-47734	PCA	_	
233-10	47735-47743	provides	_	
233-11	47744-47745	a	_	
233-12	47746-47750	more	_	
233-13	47751-47763	fine-grained	_	
233-14	47764-47780	characterization	_	
233-15	47781-47783	of	_	
233-16	47784-47793	separable	_	
233-17	47794-47800	neural	_	
233-18	47801-47810	processes	_	
233-19	47811-47819	involved	_	
233-20	47820-47822	in	_	
233-21	47823-47831	response	_	
233-22	47832-47842	inhibition	_	
233-23	47843-47851	compared	_	
233-24	47852-47854	to	_	
233-25	47855-47866	traditional	_	
233-26	47867-47871	peak	_	
233-27	47872-47880	measures	_	
233-28	47880-47881	,	_	
233-29	47882-47889	however	_	
233-30	47889-47890	,	_	
233-31	47891-47897	little	_	
233-32	47898-47900	is	_	
233-33	47901-47906	known	_	
233-34	47907-47912	about	_	
233-35	47913-47919	common	_	
233-36	47920-47923	and	_	
233-37	47924-47932	specific	_	
233-38	47933-47940	genetic	_	
233-39	47941-47951	influences	_	
233-40	47952-47954	on	_	
233-41	47955-47960	these	_	
233-42	47961-47976	characteristics	_	
233-43	47976-47977	.	_	

#Text=Furthermore, averaged ERPs used in the present study provide a relatively limited insight into event-related neuronal dynamics.
234-1	47978-47989	Furthermore	_	
234-2	47989-47990	,	_	
234-3	47991-47999	averaged	_	
234-4	48000-48004	ERPs	_	
234-5	48005-48009	used	_	
234-6	48010-48012	in	_	
234-7	48013-48016	the	_	
234-8	48017-48024	present	_	
234-9	48025-48030	study	_	
234-10	48031-48038	provide	_	
234-11	48039-48040	a	_	
234-12	48041-48051	relatively	_	
234-13	48052-48059	limited	_	
234-14	48060-48067	insight	_	
234-15	48068-48072	into	_	
234-16	48073-48086	event-related	_	
234-17	48087-48095	neuronal	_	
234-18	48096-48104	dynamics	_	
234-19	48104-48105	.	_	

#Text=Analysis of brain oscillations suggests that ERPs related to response inhibition emerge largely due to phase-locking of neuronal oscillations in delta and theta frequency bands.
235-1	48106-48114	Analysis	_	
235-2	48115-48117	of	_	
235-3	48118-48123	brain	_	
235-4	48124-48136	oscillations	_	
235-5	48137-48145	suggests	_	
235-6	48146-48150	that	_	
235-7	48151-48155	ERPs	_	
235-8	48156-48163	related	_	
235-9	48164-48166	to	_	
235-10	48167-48175	response	_	
235-11	48176-48186	inhibition	_	
235-12	48187-48193	emerge	_	
235-13	48194-48201	largely	_	
235-14	48202-48205	due	_	
235-15	48206-48208	to	_	
235-16	48209-48222	phase-locking	_	
235-17	48223-48225	of	_	
235-18	48226-48234	neuronal	_	
235-19	48235-48247	oscillations	_	
235-20	48248-48250	in	_	
235-21	48251-48256	delta	_	
235-22	48257-48260	and	_	
235-23	48261-48266	theta	_	
235-24	48267-48276	frequency	_	
235-25	48277-48282	bands	_	
235-26	48282-48283	.	_	

#Text=It is reasonable to suggest that distinct developmental trajectories of N2 and P3 components described above can potentially be explained by differences in the underlying oscillatory processes, including their frequency, topographical distribution, and time course.
236-1	48284-48286	It	_	
236-2	48287-48289	is	_	
236-3	48290-48300	reasonable	_	
236-4	48301-48303	to	_	
236-5	48304-48311	suggest	_	
236-6	48312-48316	that	_	
236-7	48317-48325	distinct	_	
236-8	48326-48339	developmental	_	
236-9	48340-48352	trajectories	_	
236-10	48353-48355	of	_	
236-11	48356-48358	N2	_	
236-12	48359-48362	and	_	
236-13	48363-48365	P3	_	
236-14	48366-48376	components	_	
236-15	48377-48386	described	_	
236-16	48387-48392	above	_	
236-17	48393-48396	can	_	
236-18	48397-48408	potentially	_	
236-19	48409-48411	be	_	
236-20	48412-48421	explained	_	
236-21	48422-48424	by	_	
236-22	48425-48436	differences	_	
236-23	48437-48439	in	_	
236-24	48440-48443	the	_	
236-25	48444-48454	underlying	_	
236-26	48455-48466	oscillatory	_	
236-27	48467-48476	processes	_	
236-28	48476-48477	,	_	
236-29	48478-48487	including	_	
236-30	48488-48493	their	_	
236-31	48494-48503	frequency	_	
236-32	48503-48504	,	_	
236-33	48505-48518	topographical	_	
236-34	48519-48531	distribution	_	
236-35	48531-48532	,	_	
236-36	48533-48536	and	_	
236-37	48537-48541	time	_	
236-38	48542-48548	course	_	
236-39	48548-48549	.	_	

#Text=Thus, the present analyses should be expanded by focusing on event-related brain oscillations and connectivity in order to better characterize the underlying neural dynamics and to refine phenotypes for genetic association studies.
237-1	48550-48554	Thus	_	
237-2	48554-48555	,	_	
237-3	48556-48559	the	_	
237-4	48560-48567	present	_	
237-5	48568-48576	analyses	_	
237-6	48577-48583	should	_	
237-7	48584-48586	be	_	
237-8	48587-48595	expanded	_	
237-9	48596-48598	by	_	
237-10	48599-48607	focusing	_	
237-11	48608-48610	on	_	
237-12	48611-48624	event-related	_	
237-13	48625-48630	brain	_	
237-14	48631-48643	oscillations	_	
237-15	48644-48647	and	_	
237-16	48648-48660	connectivity	_	
237-17	48661-48663	in	_	
237-18	48664-48669	order	_	
237-19	48670-48672	to	_	
237-20	48673-48679	better	_	
237-21	48680-48692	characterize	_	
237-22	48693-48696	the	_	
237-23	48697-48707	underlying	_	
237-24	48708-48714	neural	_	
237-25	48715-48723	dynamics	_	
237-26	48724-48727	and	_	
237-27	48728-48730	to	_	
237-28	48731-48737	refine	_	
237-29	48738-48748	phenotypes	_	
237-30	48749-48752	for	_	
237-31	48753-48760	genetic	_	
237-32	48761-48772	association	_	
237-33	48773-48780	studies	_	
237-34	48780-48781	.	_	

#Text=Another important issue is further neuroanatomical validation of No-Go ERP and oscillatory EEG measures, which can provide cost-effective neural markers of response inhibition that can be used in large-scale genetic studies of psychopathology where fMRI assessments may be cost-prohibitive.
238-1	48782-48789	Another	_	
238-2	48790-48799	important	_	
238-3	48800-48805	issue	_	
238-4	48806-48808	is	_	
238-5	48809-48816	further	_	
238-6	48817-48832	neuroanatomical	_	
238-7	48833-48843	validation	_	
238-8	48844-48846	of	_	
238-9	48847-48852	No-Go	_	
238-10	48853-48856	ERP	_	
238-11	48857-48860	and	_	
238-12	48861-48872	oscillatory	_	
238-13	48873-48876	EEG	_	
238-14	48877-48885	measures	_	
238-15	48885-48886	,	_	
238-16	48887-48892	which	_	
238-17	48893-48896	can	_	
238-18	48897-48904	provide	_	
238-19	48905-48919	cost-effective	_	
238-20	48920-48926	neural	_	
238-21	48927-48934	markers	_	
238-22	48935-48937	of	_	
238-23	48938-48946	response	_	
238-24	48947-48957	inhibition	_	
238-25	48958-48962	that	_	
238-26	48963-48966	can	_	
238-27	48967-48969	be	_	
238-28	48970-48974	used	_	
238-29	48975-48977	in	_	
238-30	48978-48989	large-scale	_	
238-31	48990-48997	genetic	_	
238-32	48998-49005	studies	_	
238-33	49006-49008	of	_	
238-34	49009-49024	psychopathology	_	
238-35	49025-49030	where	_	
238-36	49031-49035	fMRI	_	
238-37	49036-49047	assessments	_	
238-38	49048-49051	may	_	
238-39	49052-49054	be	_	
238-40	49055-49071	cost-prohibitive	_	
238-41	49071-49072	.	_	

#Text=Finally, another interesting direction for future studies is the examination of relationships between brain correlates of response inhibition and behavior.
239-1	49073-49080	Finally	_	
239-2	49080-49081	,	_	
239-3	49082-49089	another	_	
239-4	49090-49101	interesting	_	
239-5	49102-49111	direction	_	
239-6	49112-49115	for	_	
239-7	49116-49122	future	_	
239-8	49123-49130	studies	_	
239-9	49131-49133	is	_	
239-10	49134-49137	the	_	
239-11	49138-49149	examination	_	
239-12	49150-49152	of	_	
239-13	49153-49166	relationships	_	
239-14	49167-49174	between	_	
239-15	49175-49180	brain	_	
239-16	49181-49191	correlates	_	
239-17	49192-49194	of	_	
239-18	49195-49203	response	_	
239-19	49204-49214	inhibition	_	
239-20	49215-49218	and	_	
239-21	49219-49227	behavior	_	
239-22	49227-49228	.	_	

#Text=It is important to establish whether genetically transmitted differences in the neural mechanisms of response inhibition predict individual differences in behavior using both cross-sectional and prospective analyses.
#Text=4.9.
240-1	49229-49231	It	_	
240-2	49232-49234	is	_	
240-3	49235-49244	important	_	
240-4	49245-49247	to	_	
240-5	49248-49257	establish	_	
240-6	49258-49265	whether	_	
240-7	49266-49277	genetically	_	
240-8	49278-49289	transmitted	_	
240-9	49290-49301	differences	_	
240-10	49302-49304	in	_	
240-11	49305-49308	the	_	
240-12	49309-49315	neural	_	
240-13	49316-49326	mechanisms	_	
240-14	49327-49329	of	_	
240-15	49330-49338	response	_	
240-16	49339-49349	inhibition	_	
240-17	49350-49357	predict	_	
240-18	49358-49368	individual	_	
240-19	49369-49380	differences	_	
240-20	49381-49383	in	_	
240-21	49384-49392	behavior	_	
240-22	49393-49398	using	_	
240-23	49399-49403	both	_	
240-24	49404-49419	cross-sectional	_	
240-25	49420-49423	and	_	
240-26	49424-49435	prospective	_	
240-27	49436-49444	analyses	_	
240-28	49444-49445	.	_	
240-29	49446-49449	4.9	_	
240-30	49449-49450	.	_	

#Text=Conclusions
#Text=The present study provides the first evidence for genetic influences on neural correlates of response inhibition during adolescence and suggests that ERPs elicited in the Go/No-Go task can serve as intermediate neurophysiological phenotypes (endophenotypes) for the study of disinhibition and impulse control disorders.
241-1	49451-49462	Conclusions	_	
241-2	49463-49466	The	_	
241-3	49467-49474	present	_	
241-4	49475-49480	study	_	
241-5	49481-49489	provides	_	
241-6	49490-49493	the	_	
241-7	49494-49499	first	_	
241-8	49500-49508	evidence	_	
241-9	49509-49512	for	_	
241-10	49513-49520	genetic	_	
241-11	49521-49531	influences	_	
241-12	49532-49534	on	_	
241-13	49535-49541	neural	_	
241-14	49542-49552	correlates	_	
241-15	49553-49555	of	_	
241-16	49556-49564	response	_	
241-17	49565-49575	inhibition	_	
241-18	49576-49582	during	_	
241-19	49583-49594	adolescence	_	
241-20	49595-49598	and	_	
241-21	49599-49607	suggests	_	
241-22	49608-49612	that	_	
241-23	49613-49617	ERPs	_	
241-24	49618-49626	elicited	_	
241-25	49627-49629	in	_	
241-26	49630-49633	the	_	
241-27	49634-49636	Go	_	
241-28	49636-49637	/	_	
241-29	49637-49642	No-Go	_	
241-30	49643-49647	task	_	
241-31	49648-49651	can	_	
241-32	49652-49657	serve	_	
241-33	49658-49660	as	_	
241-34	49661-49673	intermediate	_	
241-35	49674-49692	neurophysiological	_	
241-36	49693-49703	phenotypes	_	
241-37	49704-49705	(	_	
241-38	49705-49719	endophenotypes	_	
241-39	49719-49720	)	_	
241-40	49721-49724	for	_	
241-41	49725-49728	the	_	
241-42	49729-49734	study	_	
241-43	49735-49737	of	_	
241-44	49738-49751	disinhibition	_	
241-45	49752-49755	and	_	
241-46	49756-49763	impulse	_	
241-47	49764-49771	control	_	
241-48	49772-49781	disorders	_	
241-49	49781-49782	.	_	

#Text=Analysis of a unique longitudinal twin dataset led us to the following specific conclusions: 1) neural correlates of response inhibition show significant developmental changes from age 12 to age 16 that are paralleled by significant improvement of performance; 2) despite systematic group-level changes, individual differences show relative developmental stability; 3) neural correlates of response inhibition are highly heritable, with 50 to 60% of inter-individual variability being attributable to genetic factors; 4) the contribution of shared environmental factors is non-significant; 5) overall heritability remains relatively stable with age; 6) genetic influences included both common genetic factors shared across ages as well as novel genetic influences emerging during development (at age 14 and age 16); 7) the rate of developmental changes in the neural correlates of response inhibition is significantly influenced by genetic factors, although heritability is modest.
242-1	49783-49791	Analysis	_	
242-2	49792-49794	of	_	
242-3	49795-49796	a	_	
242-4	49797-49803	unique	_	
242-5	49804-49816	longitudinal	_	
242-6	49817-49821	twin	_	
242-7	49822-49829	dataset	_	
242-8	49830-49833	led	_	
242-9	49834-49836	us	_	
242-10	49837-49839	to	_	
242-11	49840-49843	the	_	
242-12	49844-49853	following	_	
242-13	49854-49862	specific	_	
242-14	49863-49874	conclusions	_	
242-15	49874-49875	:	_	
242-16	49876-49877	1	_	
242-17	49877-49878	)	_	
242-18	49879-49885	neural	_	
242-19	49886-49896	correlates	_	
242-20	49897-49899	of	_	
242-21	49900-49908	response	_	
242-22	49909-49919	inhibition	_	
242-23	49920-49924	show	_	
242-24	49925-49936	significant	_	
242-25	49937-49950	developmental	_	
242-26	49951-49958	changes	_	
242-27	49959-49963	from	_	
242-28	49964-49967	age	_	
242-29	49968-49970	12	_	
242-30	49971-49973	to	_	
242-31	49974-49977	age	_	
242-32	49978-49980	16	_	
242-33	49981-49985	that	_	
242-34	49986-49989	are	_	
242-35	49990-50000	paralleled	_	
242-36	50001-50003	by	_	
242-37	50004-50015	significant	_	
242-38	50016-50027	improvement	_	
242-39	50028-50030	of	_	
242-40	50031-50042	performance	_	
242-41	50042-50043	;	_	
242-42	50044-50045	2	_	
242-43	50045-50046	)	_	
242-44	50047-50054	despite	_	
242-45	50055-50065	systematic	_	
242-46	50066-50077	group-level	_	
242-47	50078-50085	changes	_	
242-48	50085-50086	,	_	
242-49	50087-50097	individual	_	
242-50	50098-50109	differences	_	
242-51	50110-50114	show	_	
242-52	50115-50123	relative	_	
242-53	50124-50137	developmental	_	
242-54	50138-50147	stability	_	
242-55	50147-50148	;	_	
242-56	50149-50150	3	_	
242-57	50150-50151	)	_	
242-58	50152-50158	neural	_	
242-59	50159-50169	correlates	_	
242-60	50170-50172	of	_	
242-61	50173-50181	response	_	
242-62	50182-50192	inhibition	_	
242-63	50193-50196	are	_	
242-64	50197-50203	highly	_	
242-65	50204-50213	heritable	_	
242-66	50213-50214	,	_	
242-67	50215-50219	with	_	
242-68	50220-50222	50	_	
242-69	50223-50225	to	_	
242-70	50226-50229	60%	_	
242-71	50230-50232	of	_	
242-72	50233-50249	inter-individual	_	
242-73	50250-50261	variability	_	
242-74	50262-50267	being	_	
242-75	50268-50280	attributable	_	
242-76	50281-50283	to	_	
242-77	50284-50291	genetic	_	
242-78	50292-50299	factors	_	
242-79	50299-50300	;	_	
242-80	50301-50302	4	_	
242-81	50302-50303	)	_	
242-82	50304-50307	the	_	
242-83	50308-50320	contribution	_	
242-84	50321-50323	of	_	
242-85	50324-50330	shared	_	
242-86	50331-50344	environmental	_	
242-87	50345-50352	factors	_	
242-88	50353-50355	is	_	
242-89	50356-50371	non-significant	_	
242-90	50371-50372	;	_	
242-91	50373-50374	5	_	
242-92	50374-50375	)	_	
242-93	50376-50383	overall	_	
242-94	50384-50396	heritability	_	
242-95	50397-50404	remains	_	
242-96	50405-50415	relatively	_	
242-97	50416-50422	stable	_	
242-98	50423-50427	with	_	
242-99	50428-50431	age	_	
242-100	50431-50432	;	_	
242-101	50433-50434	6	_	
242-102	50434-50435	)	_	
242-103	50436-50443	genetic	_	
242-104	50444-50454	influences	_	
242-105	50455-50463	included	_	
242-106	50464-50468	both	_	
242-107	50469-50475	common	_	
242-108	50476-50483	genetic	_	
242-109	50484-50491	factors	_	
242-110	50492-50498	shared	_	
242-111	50499-50505	across	_	
242-112	50506-50510	ages	_	
242-113	50511-50513	as	_	
242-114	50514-50518	well	_	
242-115	50519-50521	as	_	
242-116	50522-50527	novel	_	
242-117	50528-50535	genetic	_	
242-118	50536-50546	influences	_	
242-119	50547-50555	emerging	_	
242-120	50556-50562	during	_	
242-121	50563-50574	development	_	
242-122	50575-50576	(	_	
242-123	50576-50578	at	_	
242-124	50579-50582	age	_	
242-125	50583-50585	14	_	
242-126	50586-50589	and	_	
242-127	50590-50593	age	_	
242-128	50594-50596	16	_	
242-129	50596-50597	)	_	
242-130	50597-50598	;	_	
242-131	50599-50600	7	_	
242-132	50600-50601	)	_	
242-133	50602-50605	the	_	
242-134	50606-50610	rate	_	
242-135	50611-50613	of	_	
242-136	50614-50627	developmental	_	
242-137	50628-50635	changes	_	
242-138	50636-50638	in	_	
242-139	50639-50642	the	_	
242-140	50643-50649	neural	_	
242-141	50650-50660	correlates	_	
242-142	50661-50663	of	_	
242-143	50664-50672	response	_	
242-144	50673-50683	inhibition	_	
242-145	50684-50686	is	_	
242-146	50687-50700	significantly	_	
242-147	50701-50711	influenced	_	
242-148	50712-50714	by	_	
242-149	50715-50722	genetic	_	
242-150	50723-50730	factors	_	
242-151	50730-50731	,	_	
242-152	50732-50740	although	_	
242-153	50741-50753	heritability	_	
242-154	50754-50756	is	_	
242-155	50757-50763	modest	_	
242-156	50763-50764	.	_	

#Text=These findings provide a foundation for studies aimed at the identification of specific genes influencing the neurophysiological mechanisms of response inhibition, investigation of behavioral correlates of genetically transmitted differences in inhibitory control and, ultimately, elucidation of gene-brain-behavior relationships in normal personality variation and psychopathology.
243-1	50765-50770	These	_	
243-2	50771-50779	findings	_	
243-3	50780-50787	provide	_	
243-4	50788-50789	a	_	
243-5	50790-50800	foundation	_	
243-6	50801-50804	for	_	
243-7	50805-50812	studies	_	
243-8	50813-50818	aimed	_	
243-9	50819-50821	at	_	
243-10	50822-50825	the	_	
243-11	50826-50840	identification	_	
243-12	50841-50843	of	_	
243-13	50844-50852	specific	_	
243-14	50853-50858	genes	_	
243-15	50859-50870	influencing	_	
243-16	50871-50874	the	_	
243-17	50875-50893	neurophysiological	_	
243-18	50894-50904	mechanisms	_	
243-19	50905-50907	of	_	
243-20	50908-50916	response	_	
243-21	50917-50927	inhibition	_	
243-22	50927-50928	,	_	
243-23	50929-50942	investigation	_	
243-24	50943-50945	of	_	
243-25	50946-50956	behavioral	_	
243-26	50957-50967	correlates	_	
243-27	50968-50970	of	_	
243-28	50971-50982	genetically	_	
243-29	50983-50994	transmitted	_	
243-30	50995-51006	differences	_	
243-31	51007-51009	in	_	
243-32	51010-51020	inhibitory	_	
243-33	51021-51028	control	_	
243-34	51029-51032	and	_	
243-35	51032-51033	,	_	
243-36	51034-51044	ultimately	_	
243-37	51044-51045	,	_	
243-38	51046-51057	elucidation	_	
243-39	51058-51060	of	_	
243-40	51061-51080	gene-brain-behavior	_	
243-41	51081-51094	relationships	_	
243-42	51095-51097	in	_	
243-43	51098-51104	normal	_	
243-44	51105-51116	personality	_	
243-45	51117-51126	variation	_	
243-46	51127-51130	and	_	
243-47	51131-51146	psychopathology	_	
243-48	51146-51147	.	_	

#Text=Supplementary Material
#Text=This is a PDF file of an unedited manuscript that has been accepted for publication.
244-1	51148-51161	Supplementary	_	
244-2	51162-51170	Material	_	
244-3	51171-51175	This	_	
244-4	51176-51178	is	_	
244-5	51179-51180	a	_	
244-6	51181-51184	PDF	_	
244-7	51185-51189	file	_	
244-8	51190-51192	of	_	
244-9	51193-51195	an	_	
244-10	51196-51204	unedited	_	
244-11	51205-51215	manuscript	_	
244-12	51216-51220	that	_	
244-13	51221-51224	has	_	
244-14	51225-51229	been	_	
244-15	51230-51238	accepted	_	
244-16	51239-51242	for	_	
244-17	51243-51254	publication	_	
244-18	51254-51255	.	_	

#Text=As a service to our customers we are providing this early version of the manuscript.
245-1	51256-51258	As	_	
245-2	51259-51260	a	_	
245-3	51261-51268	service	_	
245-4	51269-51271	to	_	
245-5	51272-51275	our	_	
245-6	51276-51285	customers	_	
245-7	51286-51288	we	_	
245-8	51289-51292	are	_	
245-9	51293-51302	providing	_	
245-10	51303-51307	this	_	
245-11	51308-51313	early	_	
245-12	51314-51321	version	_	
245-13	51322-51324	of	_	
245-14	51325-51328	the	_	
245-15	51329-51339	manuscript	_	
245-16	51339-51340	.	_	

#Text=The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form.
246-1	51341-51344	The	_	
246-2	51345-51355	manuscript	_	
246-3	51356-51360	will	_	
246-4	51361-51368	undergo	_	
246-5	51369-51380	copyediting	_	
246-6	51380-51381	,	_	
246-7	51382-51393	typesetting	_	
246-8	51393-51394	,	_	
246-9	51395-51398	and	_	
246-10	51399-51405	review	_	
246-11	51406-51408	of	_	
246-12	51409-51412	the	_	
246-13	51413-51422	resulting	_	
246-14	51423-51428	proof	_	
246-15	51429-51435	before	_	
246-16	51436-51438	it	_	
246-17	51439-51441	is	_	
246-18	51442-51451	published	_	
246-19	51452-51454	in	_	
246-20	51455-51458	its	_	
246-21	51459-51464	final	_	
246-22	51465-51472	citable	_	
246-23	51473-51477	form	_	
246-24	51477-51478	.	_	

#Text=Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
247-1	51479-51485	Please	_	
247-2	51486-51490	note	_	
247-3	51491-51495	that	_	
247-4	51496-51502	during	_	
247-5	51503-51506	the	_	
247-6	51507-51517	production	_	
247-7	51518-51525	process	_	
247-8	51526-51532	errors	_	
247-9	51533-51536	may	_	
247-10	51537-51539	be	_	
247-11	51540-51550	discovered	_	
247-12	51551-51556	which	_	
247-13	51557-51562	could	_	
247-14	51563-51569	affect	_	
247-15	51570-51573	the	_	
247-16	51574-51581	content	_	
247-17	51581-51582	,	_	
247-18	51583-51586	and	_	
247-19	51587-51590	all	_	
247-20	51591-51596	legal	_	
247-21	51597-51608	disclaimers	_	
247-22	51609-51613	that	_	
247-23	51614-51619	apply	_	
247-24	51620-51622	to	_	
247-25	51623-51626	the	_	
247-26	51627-51634	journal	_	
247-27	51635-51642	pertain	_	
247-28	51642-51643	.	_	

#Text=Supplementary Figures: Captions are provided with figures (see Supplementary Material).
248-1	51644-51657	Supplementary	_	
248-2	51658-51665	Figures	_	
248-3	51665-51666	:	_	
248-4	51667-51675	Captions	_	
248-5	51676-51679	are	_	
248-6	51680-51688	provided	_	
248-7	51689-51693	with	_	
248-8	51694-51701	figures	_	
248-9	51702-51703	(	_	
248-10	51703-51706	see	_	
248-11	51707-51720	Supplementary	_	
248-12	51721-51729	Material	_	
248-13	51729-51730	)	_	
248-14	51730-51731	.	_	

#Text=Genetic psychophysiology: advances, problems, and future directions
#Text=Genetics, prefrontal cortex, and cognitive control: A twin study of event-related potentials in a response inhibition task
#Text=Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD
#Text=Performance and ERP components in the equiprobable go/no-go task: Inhibition in children
#Text=Electrophysiological correlates of attention, inhibition, sensitivity and bias in a continuous performance task
#Text=Classical twin studies and beyond
#Text=Multicenter P300 brain mapping of impaired attention to cues in hyperkinetic children
#Text=Inhibition, response mode, and stimulus probability: a comparative event-related potential study
#Text=Beyond simple models of self-control to circuit-based accounts of adolescent behavior
#Text=Insights into the neural basis of response inhibition from cognitive and clinical neuroscience
#Text=Cognitive and neurophysiological markers of ADHD persistence and remission
#Text=Impulsivity, compulsivity, and top-down cognitive control
#Text=Changing plans: a high density electrical mapping study of cortical control
#Text=The N2 in go/no-go tasks reflects conflict monitoring not response inhibition
#Text=Effects of attention and stimulus probability on ERPs in a Go/Nogo task
#Text=ERP components in Go Nogo tasks and their relation to inhibition
#Text=Electrophysiological measurements of anterior cingulate function
#Text=Test-retest reliability of electrophysiological parameters related to cognitive motor control
#Text=A robust assessment of the NoGo-anteriorisation of P300 microstates in a cued Continuous Performance Test
#Text=Altered response control and anterior cingulate function in attention-deficit/hyperactivity disorder boys
#Text=Serotonin transporter promoter polymorphism influences topography of inhibitory motor control
#Text=The NoGo-anteriorization as a neurophysiological standard-index for cognitive response control
#Text=Dissociable executive functions in the dynamic control of behavior: inhibition, error detection, and correction
#Text=A model of the go/no-go task
#Text=Disinhibitory psychopathology: a new perspective and a model for research
#Text=The endophenotype concept in psychiatry: etymology and strategic intentions
#Text=Impaired response inhibition in juvenile delinquents with antisocial personality characteristics: A preliminary ERP study in a Go/Nogo task
#Text=Impaired engagement of the ventral attentional pathway in ADHD
#Text=Multimodal imaging of functional networks and event-related potentials in performance monitoring
#Text=Electroencephalography of response inhibition tasks: functional networks and cognitive contributions
#Text=Variations in midcingulate morphology are related to ERP indices of cognitive control
#Text=Behavioral disinhibition and the development of early-onset addiction: common and specific influences
#Text=Relation of a negative ERP component to response inhibition in a Go/No-go task
#Text=Development of Inhibitory Processing During the Go/NoGo Task
#Text=The development of preparation, conflict monitoring and inhibition from early childhood to young adulthood: a Go/Nogo ERP study
#Text=Developmental differences in behavioral and event-related brain responses associated with response preparation and inhibition in a go/nogo task
#Text=Alcoholism is a disinhibitory disorder: neurophysiological evidence from a Go/No-Go task
#Text=Spatial-anatomical mapping of NoGo-P3 in the offspring of alcoholics: evidence of cognitive and neural disinhibition as a risk for alcoholism
#Text=The association of childhood obesity to neuroelectric indices of inhibition
#Text=Flexible cognitive control: effects of individual differences and brief practice on a complex cognitive task
#Text=The time course of brain activations during response inhibition: evidence from event-related potentials in a go/no go task
#Text=An event-related potential investigation of response inhibition in schizophrenia and psychopathy
#Text=Comparative analysis of event-related potentials during Go/NoGo and CPT: decomposition of electrophysiological markers of response inhibition and sustained attention
#Text=Etiologic connections among substance dependence, antisocial behavior, and personality: modeling the externalizing spectrum
#Text=Linking antisocial behavior, substance use, and personality: an integrative quantitative model of the adult externalizing spectrum
#Text=Cognitive control moderates early childhood temperament in predicting social behavior in 7-year-old children: an ERP study
#Text=Neurophysiological correlates of emotion regulation in children and adolescents
#Text=What has fMRI told us about the development of cognitive control through adolescence?
249-1	51732-51739	Genetic	_	
249-2	51740-51756	psychophysiology	_	
249-3	51756-51757	:	_	
249-4	51758-51766	advances	_	
249-5	51766-51767	,	_	
249-6	51768-51776	problems	_	
249-7	51776-51777	,	_	
249-8	51778-51781	and	_	
249-9	51782-51788	future	_	
249-10	51789-51799	directions	_	
249-11	51800-51808	Genetics	_	
249-12	51808-51809	,	_	
249-13	51810-51820	prefrontal	_	
249-14	51821-51827	cortex	_	
249-15	51827-51828	,	_	
249-16	51829-51832	and	_	
249-17	51833-51842	cognitive	_	
249-18	51843-51850	control	_	
249-19	51850-51851	:	_	
249-20	51852-51853	A	_	
249-21	51854-51858	twin	_	
249-22	51859-51864	study	_	
249-23	51865-51867	of	_	
249-24	51868-51881	event-related	_	
249-25	51882-51892	potentials	_	
249-26	51893-51895	in	_	
249-27	51896-51897	a	_	
249-28	51898-51906	response	_	
249-29	51907-51917	inhibition	_	
249-30	51918-51922	task	_	
249-31	51923-51933	Behavioral	_	
249-32	51934-51944	inhibition	_	
249-33	51944-51945	,	_	
249-34	51946-51955	sustained	_	
249-35	51956-51965	attention	_	
249-36	51965-51966	,	_	
249-37	51967-51970	and	_	
249-38	51971-51980	executive	_	
249-39	51981-51990	functions	_	
249-40	51990-51991	:	_	
249-41	51992-52004	constructing	_	
249-42	52005-52006	a	_	
249-43	52007-52015	unifying	_	
249-44	52016-52022	theory	_	
249-45	52023-52025	of	_	
249-46	52026-52030	ADHD	_	
249-47	52031-52042	Performance	_	
249-48	52043-52046	and	_	
249-49	52047-52050	ERP	_	
249-50	52051-52061	components	_	
249-51	52062-52064	in	_	
249-52	52065-52068	the	_	
249-53	52069-52081	equiprobable	_	
249-54	52082-52084	go	_	
249-55	52084-52085	/	_	
249-56	52085-52090	no-go	_	
249-57	52091-52095	task	_	
249-58	52095-52096	:	_	
249-59	52097-52107	Inhibition	_	
249-60	52108-52110	in	_	
249-61	52111-52119	children	_	
249-62	52120-52140	Electrophysiological	_	
249-63	52141-52151	correlates	_	
249-64	52152-52154	of	_	
249-65	52155-52164	attention	_	
249-66	52164-52165	,	_	
249-67	52166-52176	inhibition	_	
249-68	52176-52177	,	_	
249-69	52178-52189	sensitivity	_	
249-70	52190-52193	and	_	
249-71	52194-52198	bias	_	
249-72	52199-52201	in	_	
249-73	52202-52203	a	_	
249-74	52204-52214	continuous	_	
249-75	52215-52226	performance	_	
249-76	52227-52231	task	_	
249-77	52232-52241	Classical	_	
249-78	52242-52246	twin	_	
249-79	52247-52254	studies	_	
249-80	52255-52258	and	_	
249-81	52259-52265	beyond	_	
249-82	52266-52277	Multicenter	_	
249-83	52278-52282	P300	_	
249-84	52283-52288	brain	_	
249-85	52289-52296	mapping	_	
249-86	52297-52299	of	_	
249-87	52300-52308	impaired	_	
249-88	52309-52318	attention	_	
249-89	52319-52321	to	_	
249-90	52322-52326	cues	_	
249-91	52327-52329	in	_	
249-92	52330-52342	hyperkinetic	_	
249-93	52343-52351	children	_	
249-94	52352-52362	Inhibition	_	
249-95	52362-52363	,	_	
249-96	52364-52372	response	_	
249-97	52373-52377	mode	_	
249-98	52377-52378	,	_	
249-99	52379-52382	and	_	
249-100	52383-52391	stimulus	_	
249-101	52392-52403	probability	_	
249-102	52403-52404	:	_	
249-103	52405-52406	a	_	
249-104	52407-52418	comparative	_	
249-105	52419-52432	event-related	_	
249-106	52433-52442	potential	_	
249-107	52443-52448	study	_	
249-108	52449-52455	Beyond	_	
249-109	52456-52462	simple	_	
249-110	52463-52469	models	_	
249-111	52470-52472	of	_	
249-112	52473-52485	self-control	_	
249-113	52486-52488	to	_	
249-114	52489-52502	circuit-based	_	
249-115	52503-52511	accounts	_	
249-116	52512-52514	of	_	
249-117	52515-52525	adolescent	_	
249-118	52526-52534	behavior	_	
249-119	52535-52543	Insights	_	
249-120	52544-52548	into	_	
249-121	52549-52552	the	_	
249-122	52553-52559	neural	_	
249-123	52560-52565	basis	_	
249-124	52566-52568	of	_	
249-125	52569-52577	response	_	
249-126	52578-52588	inhibition	_	
249-127	52589-52593	from	_	
249-128	52594-52603	cognitive	_	
249-129	52604-52607	and	_	
249-130	52608-52616	clinical	_	
249-131	52617-52629	neuroscience	_	
249-132	52630-52639	Cognitive	_	
249-133	52640-52643	and	_	
249-134	52644-52662	neurophysiological	_	
249-135	52663-52670	markers	_	
249-136	52671-52673	of	_	
249-137	52674-52678	ADHD	_	
249-138	52679-52690	persistence	_	
249-139	52691-52694	and	_	
249-140	52695-52704	remission	_	
249-141	52705-52716	Impulsivity	_	
249-142	52716-52717	,	_	
249-143	52718-52730	compulsivity	_	
249-144	52730-52731	,	_	
249-145	52732-52735	and	_	
249-146	52736-52744	top-down	_	
249-147	52745-52754	cognitive	_	
249-148	52755-52762	control	_	
249-149	52763-52771	Changing	_	
249-150	52772-52777	plans	_	
249-151	52777-52778	:	_	
249-152	52779-52780	a	_	
249-153	52781-52785	high	_	
249-154	52786-52793	density	_	
249-155	52794-52804	electrical	_	
249-156	52805-52812	mapping	_	
249-157	52813-52818	study	_	
249-158	52819-52821	of	_	
249-159	52822-52830	cortical	_	
249-160	52831-52838	control	_	
249-161	52839-52842	The	_	
249-162	52843-52845	N2	_	
249-163	52846-52848	in	_	
249-164	52849-52851	go	_	
249-165	52851-52852	/	_	
249-166	52852-52857	no-go	_	
249-167	52858-52863	tasks	_	
249-168	52864-52872	reflects	_	
249-169	52873-52881	conflict	_	
249-170	52882-52892	monitoring	_	
249-171	52893-52896	not	_	
249-172	52897-52905	response	_	
249-173	52906-52916	inhibition	_	
249-174	52917-52924	Effects	_	
249-175	52925-52927	of	_	
249-176	52928-52937	attention	_	
249-177	52938-52941	and	_	
249-178	52942-52950	stimulus	_	
249-179	52951-52962	probability	_	
249-180	52963-52965	on	_	
249-181	52966-52970	ERPs	_	
249-182	52971-52973	in	_	
249-183	52974-52975	a	_	
249-184	52976-52978	Go	_	
249-185	52978-52979	/	_	
249-186	52979-52983	Nogo	_	
249-187	52984-52988	task	_	
249-188	52989-52992	ERP	_	
249-189	52993-53003	components	_	
249-190	53004-53006	in	_	
249-191	53007-53009	Go	_	
249-192	53010-53014	Nogo	_	
249-193	53015-53020	tasks	_	
249-194	53021-53024	and	_	
249-195	53025-53030	their	_	
249-196	53031-53039	relation	_	
249-197	53040-53042	to	_	
249-198	53043-53053	inhibition	_	
249-199	53054-53074	Electrophysiological	_	
249-200	53075-53087	measurements	_	
249-201	53088-53090	of	_	
249-202	53091-53099	anterior	_	
249-203	53100-53109	cingulate	_	
249-204	53110-53118	function	_	
249-205	53119-53130	Test-retest	_	
249-206	53131-53142	reliability	_	
249-207	53143-53145	of	_	
249-208	53146-53166	electrophysiological	_	
249-209	53167-53177	parameters	_	
249-210	53178-53185	related	_	
249-211	53186-53188	to	_	
249-212	53189-53198	cognitive	_	
249-213	53199-53204	motor	_	
249-214	53205-53212	control	_	
249-215	53213-53214	A	_	
249-216	53215-53221	robust	_	
249-217	53222-53232	assessment	_	
249-218	53233-53235	of	_	
249-219	53236-53239	the	_	
249-220	53240-53260	NoGo-anteriorisation	_	
249-221	53261-53263	of	_	
249-222	53264-53268	P300	_	
249-223	53269-53280	microstates	_	
249-224	53281-53283	in	_	
249-225	53284-53285	a	_	
249-226	53286-53290	cued	_	
249-227	53291-53301	Continuous	_	
249-228	53302-53313	Performance	_	
249-229	53314-53318	Test	_	
249-230	53319-53326	Altered	_	
249-231	53327-53335	response	_	
249-232	53336-53343	control	_	
249-233	53344-53347	and	_	
249-234	53348-53356	anterior	_	
249-235	53357-53366	cingulate	_	
249-236	53367-53375	function	_	
249-237	53376-53378	in	_	
249-238	53379-53396	attention-deficit	_	
249-239	53396-53397	/	_	
249-240	53397-53410	hyperactivity	_	
249-241	53411-53419	disorder	_	
249-242	53420-53424	boys	_	
249-243	53425-53434	Serotonin	_	
249-244	53435-53446	transporter	_	
249-245	53447-53455	promoter	_	
249-246	53456-53468	polymorphism	_	
249-247	53469-53479	influences	_	
249-248	53480-53490	topography	_	
249-249	53491-53493	of	_	
249-250	53494-53504	inhibitory	_	
249-251	53505-53510	motor	_	
249-252	53511-53518	control	_	
249-253	53519-53522	The	_	
249-254	53523-53543	NoGo-anteriorization	_	
249-255	53544-53546	as	_	
249-256	53547-53548	a	_	
249-257	53549-53567	neurophysiological	_	
249-258	53568-53582	standard-index	_	
249-259	53583-53586	for	_	
249-260	53587-53596	cognitive	_	
249-261	53597-53605	response	_	
249-262	53606-53613	control	_	
249-263	53614-53625	Dissociable	_	
249-264	53626-53635	executive	_	
249-265	53636-53645	functions	_	
249-266	53646-53648	in	_	
249-267	53649-53652	the	_	
249-268	53653-53660	dynamic	_	
249-269	53661-53668	control	_	
249-270	53669-53671	of	_	
249-271	53672-53680	behavior	_	
249-272	53680-53681	:	_	
249-273	53682-53692	inhibition	_	
249-274	53692-53693	,	_	
249-275	53694-53699	error	_	
249-276	53700-53709	detection	_	
249-277	53709-53710	,	_	
249-278	53711-53714	and	_	
249-279	53715-53725	correction	_	
249-280	53726-53727	A	_	
249-281	53728-53733	model	_	
249-282	53734-53736	of	_	
249-283	53737-53740	the	_	
249-284	53741-53743	go	_	
249-285	53743-53744	/	_	
249-286	53744-53749	no-go	_	
249-287	53750-53754	task	_	
249-288	53755-53768	Disinhibitory	_	
249-289	53769-53784	psychopathology	_	
249-290	53784-53785	:	_	
249-291	53786-53787	a	_	
249-292	53788-53791	new	_	
249-293	53792-53803	perspective	_	
249-294	53804-53807	and	_	
249-295	53808-53809	a	_	
249-296	53810-53815	model	_	
249-297	53816-53819	for	_	
249-298	53820-53828	research	_	
249-299	53829-53832	The	_	
249-300	53833-53846	endophenotype	_	
249-301	53847-53854	concept	_	
249-302	53855-53857	in	_	
249-303	53858-53868	psychiatry	_	
249-304	53868-53869	:	_	
249-305	53870-53879	etymology	_	
249-306	53880-53883	and	_	
249-307	53884-53893	strategic	_	
249-308	53894-53904	intentions	_	
249-309	53905-53913	Impaired	_	
249-310	53914-53922	response	_	
249-311	53923-53933	inhibition	_	
249-312	53934-53936	in	_	
249-313	53937-53945	juvenile	_	
249-314	53946-53957	delinquents	_	
249-315	53958-53962	with	_	
249-316	53963-53973	antisocial	_	
249-317	53974-53985	personality	_	
249-318	53986-54001	characteristics	_	
249-319	54001-54002	:	_	
249-320	54003-54004	A	_	
249-321	54005-54016	preliminary	_	
249-322	54017-54020	ERP	_	
249-323	54021-54026	study	_	
249-324	54027-54029	in	_	
249-325	54030-54031	a	_	
249-326	54032-54034	Go	_	
249-327	54034-54035	/	_	
249-328	54035-54039	Nogo	_	
249-329	54040-54044	task	_	
249-330	54045-54053	Impaired	_	
249-331	54054-54064	engagement	_	
249-332	54065-54067	of	_	
249-333	54068-54071	the	_	
249-334	54072-54079	ventral	_	
249-335	54080-54091	attentional	_	
249-336	54092-54099	pathway	_	
249-337	54100-54102	in	_	
249-338	54103-54107	ADHD	_	
249-339	54108-54118	Multimodal	_	
249-340	54119-54126	imaging	_	
249-341	54127-54129	of	_	
249-342	54130-54140	functional	_	
249-343	54141-54149	networks	_	
249-344	54150-54153	and	_	
249-345	54154-54167	event-related	_	
249-346	54168-54178	potentials	_	
249-347	54179-54181	in	_	
249-348	54182-54193	performance	_	
249-349	54194-54204	monitoring	_	
249-350	54205-54227	Electroencephalography	_	
249-351	54228-54230	of	_	
249-352	54231-54239	response	_	
249-353	54240-54250	inhibition	_	
249-354	54251-54256	tasks	_	
249-355	54256-54257	:	_	
249-356	54258-54268	functional	_	
249-357	54269-54277	networks	_	
249-358	54278-54281	and	_	
249-359	54282-54291	cognitive	_	
249-360	54292-54305	contributions	_	
249-361	54306-54316	Variations	_	
249-362	54317-54319	in	_	
249-363	54320-54332	midcingulate	_	
249-364	54333-54343	morphology	_	
249-365	54344-54347	are	_	
249-366	54348-54355	related	_	
249-367	54356-54358	to	_	
249-368	54359-54362	ERP	_	
249-369	54363-54370	indices	_	
249-370	54371-54373	of	_	
249-371	54374-54383	cognitive	_	
249-372	54384-54391	control	_	
249-373	54392-54402	Behavioral	_	
249-374	54403-54416	disinhibition	_	
249-375	54417-54420	and	_	
249-376	54421-54424	the	_	
249-377	54425-54436	development	_	
249-378	54437-54439	of	_	
249-379	54440-54451	early-onset	_	
249-380	54452-54461	addiction	_	
249-381	54461-54462	:	_	
249-382	54463-54469	common	_	
249-383	54470-54473	and	_	
249-384	54474-54482	specific	_	
249-385	54483-54493	influences	_	
249-386	54494-54502	Relation	_	
249-387	54503-54505	of	_	
249-388	54506-54507	a	_	
249-389	54508-54516	negative	_	
249-390	54517-54520	ERP	_	
249-391	54521-54530	component	_	
249-392	54531-54533	to	_	
249-393	54534-54542	response	_	
249-394	54543-54553	inhibition	_	
249-395	54554-54556	in	_	
249-396	54557-54558	a	_	
249-397	54559-54561	Go	_	
249-398	54561-54562	/	_	
249-399	54562-54567	No-go	_	
249-400	54568-54572	task	_	
249-401	54573-54584	Development	_	
249-402	54585-54587	of	_	
249-403	54588-54598	Inhibitory	_	
249-404	54599-54609	Processing	_	
249-405	54610-54616	During	_	
249-406	54617-54620	the	_	
249-407	54621-54623	Go	_	
249-408	54623-54624	/	_	
249-409	54624-54628	NoGo	_	
249-410	54629-54633	Task	_	
249-411	54634-54637	The	_	
249-412	54638-54649	development	_	
249-413	54650-54652	of	_	
249-414	54653-54664	preparation	_	
249-415	54664-54665	,	_	
249-416	54666-54674	conflict	_	
249-417	54675-54685	monitoring	_	
249-418	54686-54689	and	_	
249-419	54690-54700	inhibition	_	
249-420	54701-54705	from	_	
249-421	54706-54711	early	_	
249-422	54712-54721	childhood	_	
249-423	54722-54724	to	_	
249-424	54725-54730	young	_	
249-425	54731-54740	adulthood	_	
249-426	54740-54741	:	_	
249-427	54742-54743	a	_	
249-428	54744-54746	Go	_	
249-429	54746-54747	/	_	
249-430	54747-54751	Nogo	_	
249-431	54752-54755	ERP	_	
249-432	54756-54761	study	_	
249-433	54762-54775	Developmental	_	
249-434	54776-54787	differences	_	
249-435	54788-54790	in	_	
249-436	54791-54801	behavioral	_	
249-437	54802-54805	and	_	
249-438	54806-54819	event-related	_	
249-439	54820-54825	brain	_	
249-440	54826-54835	responses	_	
249-441	54836-54846	associated	_	
249-442	54847-54851	with	_	
249-443	54852-54860	response	_	
249-444	54861-54872	preparation	_	
249-445	54873-54876	and	_	
249-446	54877-54887	inhibition	_	
249-447	54888-54890	in	_	
249-448	54891-54892	a	_	
249-449	54893-54895	go	_	
249-450	54895-54896	/	_	
249-451	54896-54900	nogo	_	
249-452	54901-54905	task	_	
249-453	54906-54916	Alcoholism	_	
249-454	54917-54919	is	_	
249-455	54920-54921	a	_	
249-456	54922-54935	disinhibitory	_	
249-457	54936-54944	disorder	_	
249-458	54944-54945	:	_	
249-459	54946-54964	neurophysiological	_	
249-460	54965-54973	evidence	_	
249-461	54974-54978	from	_	
249-462	54979-54980	a	_	
249-463	54981-54983	Go	_	
249-464	54983-54984	/	_	
249-465	54984-54989	No-Go	_	
249-466	54990-54994	task	_	
249-467	54995-55013	Spatial-anatomical	_	
249-468	55014-55021	mapping	_	
249-469	55022-55024	of	_	
249-470	55025-55032	NoGo-P3	_	
249-471	55033-55035	in	_	
249-472	55036-55039	the	_	
249-473	55040-55049	offspring	_	
249-474	55050-55052	of	_	
249-475	55053-55063	alcoholics	_	
249-476	55063-55064	:	_	
249-477	55065-55073	evidence	_	
249-478	55074-55076	of	_	
249-479	55077-55086	cognitive	_	
249-480	55087-55090	and	_	
249-481	55091-55097	neural	_	
249-482	55098-55111	disinhibition	_	
249-483	55112-55114	as	_	
249-484	55115-55116	a	_	
249-485	55117-55121	risk	_	
249-486	55122-55125	for	_	
249-487	55126-55136	alcoholism	_	
249-488	55137-55140	The	_	
249-489	55141-55152	association	_	
249-490	55153-55155	of	_	
249-491	55156-55165	childhood	_	
249-492	55166-55173	obesity	_	
249-493	55174-55176	to	_	
249-494	55177-55190	neuroelectric	_	
249-495	55191-55198	indices	_	
249-496	55199-55201	of	_	
249-497	55202-55212	inhibition	_	
249-498	55213-55221	Flexible	_	
249-499	55222-55231	cognitive	_	
249-500	55232-55239	control	_	
249-501	55239-55240	:	_	
249-502	55241-55248	effects	_	
249-503	55249-55251	of	_	
249-504	55252-55262	individual	_	
249-505	55263-55274	differences	_	
249-506	55275-55278	and	_	
249-507	55279-55284	brief	_	
249-508	55285-55293	practice	_	
249-509	55294-55296	on	_	
249-510	55297-55298	a	_	
249-511	55299-55306	complex	_	
249-512	55307-55316	cognitive	_	
249-513	55317-55321	task	_	
249-514	55322-55325	The	_	
249-515	55326-55330	time	_	
249-516	55331-55337	course	_	
249-517	55338-55340	of	_	
249-518	55341-55346	brain	_	
249-519	55347-55358	activations	_	
249-520	55359-55365	during	_	
249-521	55366-55374	response	_	
249-522	55375-55385	inhibition	_	
249-523	55385-55386	:	_	
249-524	55387-55395	evidence	_	
249-525	55396-55400	from	_	
249-526	55401-55414	event-related	_	
249-527	55415-55425	potentials	_	
249-528	55426-55428	in	_	
249-529	55429-55430	a	_	
249-530	55431-55433	go	_	
249-531	55433-55434	/	_	
249-532	55434-55436	no	_	
249-533	55437-55439	go	_	
249-534	55440-55444	task	_	
249-535	55445-55447	An	_	
249-536	55448-55461	event-related	_	
249-537	55462-55471	potential	_	
249-538	55472-55485	investigation	_	
249-539	55486-55488	of	_	
249-540	55489-55497	response	_	
249-541	55498-55508	inhibition	_	
249-542	55509-55511	in	_	
249-543	55512-55525	schizophrenia	_	
249-544	55526-55529	and	_	
249-545	55530-55541	psychopathy	_	
249-546	55542-55553	Comparative	_	
249-547	55554-55562	analysis	_	
249-548	55563-55565	of	_	
249-549	55566-55579	event-related	_	
249-550	55580-55590	potentials	_	
249-551	55591-55597	during	_	
249-552	55598-55600	Go	_	
249-553	55600-55601	/	_	
249-554	55601-55605	NoGo	_	
249-555	55606-55609	and	_	
249-556	55610-55613	CPT	_	
249-557	55613-55614	:	_	
249-558	55615-55628	decomposition	_	
249-559	55629-55631	of	_	
249-560	55632-55652	electrophysiological	_	
249-561	55653-55660	markers	_	
249-562	55661-55663	of	_	
249-563	55664-55672	response	_	
249-564	55673-55683	inhibition	_	
249-565	55684-55687	and	_	
249-566	55688-55697	sustained	_	
249-567	55698-55707	attention	_	
249-568	55708-55717	Etiologic	_	
249-569	55718-55729	connections	_	
249-570	55730-55735	among	_	
249-571	55736-55745	substance	_	
249-572	55746-55756	dependence	_	
249-573	55756-55757	,	_	
249-574	55758-55768	antisocial	_	
249-575	55769-55777	behavior	_	
249-576	55777-55778	,	_	
249-577	55779-55782	and	_	
249-578	55783-55794	personality	_	
249-579	55794-55795	:	_	
249-580	55796-55804	modeling	_	
249-581	55805-55808	the	_	
249-582	55809-55822	externalizing	_	
249-583	55823-55831	spectrum	_	
249-584	55832-55839	Linking	_	
249-585	55840-55850	antisocial	_	
249-586	55851-55859	behavior	_	
249-587	55859-55860	,	_	
249-588	55861-55870	substance	_	
249-589	55871-55874	use	_	
249-590	55874-55875	,	_	
249-591	55876-55879	and	_	
249-592	55880-55891	personality	_	
249-593	55891-55892	:	_	
249-594	55893-55895	an	_	
249-595	55896-55907	integrative	_	
249-596	55908-55920	quantitative	_	
249-597	55921-55926	model	_	
249-598	55927-55929	of	_	
249-599	55930-55933	the	_	
249-600	55934-55939	adult	_	
249-601	55940-55953	externalizing	_	
249-602	55954-55962	spectrum	_	
249-603	55963-55972	Cognitive	_	
249-604	55973-55980	control	_	
249-605	55981-55990	moderates	_	
249-606	55991-55996	early	_	
249-607	55997-56006	childhood	_	
249-608	56007-56018	temperament	_	
249-609	56019-56021	in	_	
249-610	56022-56032	predicting	_	
249-611	56033-56039	social	_	
249-612	56040-56048	behavior	_	
249-613	56049-56051	in	_	
249-614	56052-56053	7	_	
249-615	56053-56054	-	_	
249-616	56054-56062	year-old	_	
249-617	56063-56071	children	_	
249-618	56071-56072	:	_	
249-619	56073-56075	an	_	
249-620	56076-56079	ERP	_	
249-621	56080-56085	study	_	
249-622	56086-56104	Neurophysiological	_	
249-623	56105-56115	correlates	_	
249-624	56116-56118	of	_	
249-625	56119-56126	emotion	_	
249-626	56127-56137	regulation	_	
249-627	56138-56140	in	_	
249-628	56141-56149	children	_	
249-629	56150-56153	and	_	
249-630	56154-56165	adolescents	_	
249-631	56166-56170	What	_	
249-632	56171-56174	has	_	
249-633	56175-56179	fMRI	_	
249-634	56180-56184	told	_	
249-635	56185-56187	us	_	
249-636	56188-56193	about	_	
249-637	56194-56197	the	_	
249-638	56198-56209	development	_	
249-639	56210-56212	of	_	
249-640	56213-56222	cognitive	_	
249-641	56223-56230	control	_	
249-642	56231-56238	through	_	
249-643	56239-56250	adolescence	_	
249-644	56250-56251	?	_	

#Text=Anatomy of an error: ERP and fMRI
#Text=Electrophysiological evidence for abnormal preparatory states and inhibitory processing in adult ADHD
#Text=Neural synchrony during response production and inhibition
#Text=
#Text=
#Text=Stimulus modality, perceptual overlap, and the go/no-go N2
#Text=Electrophysiological correlates of anterior cingulate function in a go/no-go task: effects of response conflict and trial type frequency
#Text=Neural activation during inhibition predicts initiation of substance use in adolescence
#Text=Associations between event-related potentials and measures of attention and inhibition in the Continuous Performance Task in children with ADHD and normal controls
#Text=ERPs to response production and inhibition
#Text=Theory and practice in quantitative genetics
#Text=Conflict and inhibition in the cued-Go/NoGo task
#Text=Inhibitory control in otherwise healthy overweight 10-year-old children
#Text=Analytic approaches to twin data using structural equation models
#Text=Mapping P300 waves onto inhibition: Go/No-Go discrimination
#Text=“Cool” inferior frontostriatal dysfunction in attention-deficit/hyperactivity disorder versus “hot” ventromedial orbitofrontal-limbic dysfunction in conduct disorder: a review
#Text=Functional brain imaging across development
#Text=Functional frontalisation with age: mapping neurodevelopmental trajectories with fMRI
#Text=Linear age-correlated functional development of right inferior fronto-striato-cerebellar networks during response inhibition and anterior cingulate during error-related processes
#Text=Progressive increase of frontostriatal brain activation from childhood to adulthood during event-related tasks of cognitive control
#Text=A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP
#Text=
#Text=Movement-related potentials in the Go/NoGo task: the P3 reflects both cognitive and motor inhibition
#Text=Sequence effects support the conflict theory of N2 and P3 in the Go/NoGo task
#Text=Cognitive control mechanisms revealed by ERP and fMRI: evidence from repeated task-switching
#Text=Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder
#Text=Attention and inhibition in children with ASD, ADHD and co-morbid ASD + ADHD: an event-related potential study
#Text=A psychophysiological analysis of inhibitory motor control in the stop-signal paradigm
#Text=The continuing value of twin studies in the omics era
#Text=The anterior cingulate as a conflict monitor: fMRI and ERP studies
#Text=The timing of action-monitoring processes in the anterior cingulate cortex
#Text=Response preparation and response inhibition after lesions of the medial frontal lobe
#Text=Neurobiological approaches in human behavior genetics
#Text=Electroencephalogram (Eeg) as a Research Tool in Human-Behavior Genetics - Psychological Examinations in Healthy Males with Various Inherited Eeg Variants .1 Rationale of the Study.
250-1	56252-56259	Anatomy	_	
250-2	56260-56262	of	_	
250-3	56263-56265	an	_	
250-4	56266-56271	error	_	
250-5	56271-56272	:	_	
250-6	56273-56276	ERP	_	
250-7	56277-56280	and	_	
250-8	56281-56285	fMRI	_	
250-9	56286-56306	Electrophysiological	_	
250-10	56307-56315	evidence	_	
250-11	56316-56319	for	_	
250-12	56320-56328	abnormal	_	
250-13	56329-56340	preparatory	_	
250-14	56341-56347	states	_	
250-15	56348-56351	and	_	
250-16	56352-56362	inhibitory	_	
250-17	56363-56373	processing	_	
250-18	56374-56376	in	_	
250-19	56377-56382	adult	_	
250-20	56383-56387	ADHD	_	
250-21	56388-56394	Neural	_	
250-22	56395-56404	synchrony	_	
250-23	56405-56411	during	_	
250-24	56412-56420	response	_	
250-25	56421-56431	production	_	
250-26	56432-56435	and	_	
250-27	56436-56446	inhibition	_	
250-28	56449-56457	Stimulus	_	
250-29	56458-56466	modality	_	
250-30	56466-56467	,	_	
250-31	56468-56478	perceptual	_	
250-32	56479-56486	overlap	_	
250-33	56486-56487	,	_	
250-34	56488-56491	and	_	
250-35	56492-56495	the	_	
250-36	56496-56498	go	_	
250-37	56498-56499	/	_	
250-38	56499-56504	no-go	_	
250-39	56505-56507	N2	_	
250-40	56508-56528	Electrophysiological	_	
250-41	56529-56539	correlates	_	
250-42	56540-56542	of	_	
250-43	56543-56551	anterior	_	
250-44	56552-56561	cingulate	_	
250-45	56562-56570	function	_	
250-46	56571-56573	in	_	
250-47	56574-56575	a	_	
250-48	56576-56578	go	_	
250-49	56578-56579	/	_	
250-50	56579-56584	no-go	_	
250-51	56585-56589	task	_	
250-52	56589-56590	:	_	
250-53	56591-56598	effects	_	
250-54	56599-56601	of	_	
250-55	56602-56610	response	_	
250-56	56611-56619	conflict	_	
250-57	56620-56623	and	_	
250-58	56624-56629	trial	_	
250-59	56630-56634	type	_	
250-60	56635-56644	frequency	_	
250-61	56645-56651	Neural	_	
250-62	56652-56662	activation	_	
250-63	56663-56669	during	_	
250-64	56670-56680	inhibition	_	
250-65	56681-56689	predicts	_	
250-66	56690-56700	initiation	_	
250-67	56701-56703	of	_	
250-68	56704-56713	substance	_	
250-69	56714-56717	use	_	
250-70	56718-56720	in	_	
250-71	56721-56732	adolescence	_	
250-72	56733-56745	Associations	_	
250-73	56746-56753	between	_	
250-74	56754-56767	event-related	_	
250-75	56768-56778	potentials	_	
250-76	56779-56782	and	_	
250-77	56783-56791	measures	_	
250-78	56792-56794	of	_	
250-79	56795-56804	attention	_	
250-80	56805-56808	and	_	
250-81	56809-56819	inhibition	_	
250-82	56820-56822	in	_	
250-83	56823-56826	the	_	
250-84	56827-56837	Continuous	_	
250-85	56838-56849	Performance	_	
250-86	56850-56854	Task	_	
250-87	56855-56857	in	_	
250-88	56858-56866	children	_	
250-89	56867-56871	with	_	
250-90	56872-56876	ADHD	_	
250-91	56877-56880	and	_	
250-92	56881-56887	normal	_	
250-93	56888-56896	controls	_	
250-94	56897-56901	ERPs	_	
250-95	56902-56904	to	_	
250-96	56905-56913	response	_	
250-97	56914-56924	production	_	
250-98	56925-56928	and	_	
250-99	56929-56939	inhibition	_	
250-100	56940-56946	Theory	_	
250-101	56947-56950	and	_	
250-102	56951-56959	practice	_	
250-103	56960-56962	in	_	
250-104	56963-56975	quantitative	_	
250-105	56976-56984	genetics	_	
250-106	56985-56993	Conflict	_	
250-107	56994-56997	and	_	
250-108	56998-57008	inhibition	_	
250-109	57009-57011	in	_	
250-110	57012-57015	the	_	
250-111	57016-57023	cued-Go	_	
250-112	57023-57024	/	_	
250-113	57024-57028	NoGo	_	
250-114	57029-57033	task	_	
250-115	57034-57044	Inhibitory	_	
250-116	57045-57052	control	_	
250-117	57053-57055	in	_	
250-118	57056-57065	otherwise	_	
250-119	57066-57073	healthy	_	
250-120	57074-57084	overweight	_	
250-121	57085-57087	10	_	
250-122	57087-57088	-	_	
250-123	57088-57096	year-old	_	
250-124	57097-57105	children	_	
250-125	57106-57114	Analytic	_	
250-126	57115-57125	approaches	_	
250-127	57126-57128	to	_	
250-128	57129-57133	twin	_	
250-129	57134-57138	data	_	
250-130	57139-57144	using	_	
250-131	57145-57155	structural	_	
250-132	57156-57164	equation	_	
250-133	57165-57171	models	_	
250-134	57172-57179	Mapping	_	
250-135	57180-57184	P300	_	
250-136	57185-57190	waves	_	
250-137	57191-57195	onto	_	
250-138	57196-57206	inhibition	_	
250-139	57206-57207	:	_	
250-140	57208-57210	Go	_	
250-141	57210-57211	/	_	
250-142	57211-57216	No-Go	_	
250-143	57217-57231	discrimination	_	
250-144	57232-57233	“	_	
250-145	57233-57237	Cool	_	
250-146	57237-57238	”	_	
250-147	57239-57247	inferior	_	
250-148	57248-57262	frontostriatal	_	
250-149	57263-57274	dysfunction	_	
250-150	57275-57277	in	_	
250-151	57278-57295	attention-deficit	_	
250-152	57295-57296	/	_	
250-153	57296-57309	hyperactivity	_	
250-154	57310-57318	disorder	_	
250-155	57319-57325	versus	_	
250-156	57326-57327	“	_	
250-157	57327-57330	hot	_	
250-158	57330-57331	”	_	
250-159	57332-57344	ventromedial	_	
250-160	57345-57365	orbitofrontal-limbic	_	
250-161	57366-57377	dysfunction	_	
250-162	57378-57380	in	_	
250-163	57381-57388	conduct	_	
250-164	57389-57397	disorder	_	
250-165	57397-57398	:	_	
250-166	57399-57400	a	_	
250-167	57401-57407	review	_	
250-168	57408-57418	Functional	_	
250-169	57419-57424	brain	_	
250-170	57425-57432	imaging	_	
250-171	57433-57439	across	_	
250-172	57440-57451	development	_	
250-173	57452-57462	Functional	_	
250-174	57463-57477	frontalisation	_	
250-175	57478-57482	with	_	
250-176	57483-57486	age	_	
250-177	57486-57487	:	_	
250-178	57488-57495	mapping	_	
250-179	57496-57514	neurodevelopmental	_	
250-180	57515-57527	trajectories	_	
250-181	57528-57532	with	_	
250-182	57533-57537	fMRI	_	
250-183	57538-57544	Linear	_	
250-184	57545-57559	age-correlated	_	
250-185	57560-57570	functional	_	
250-186	57571-57582	development	_	
250-187	57583-57585	of	_	
250-188	57586-57591	right	_	
250-189	57592-57600	inferior	_	
250-190	57601-57626	fronto-striato-cerebellar	_	
250-191	57627-57635	networks	_	
250-192	57636-57642	during	_	
250-193	57643-57651	response	_	
250-194	57652-57662	inhibition	_	
250-195	57663-57666	and	_	
250-196	57667-57675	anterior	_	
250-197	57676-57685	cingulate	_	
250-198	57686-57692	during	_	
250-199	57693-57706	error-related	_	
250-200	57707-57716	processes	_	
250-201	57717-57728	Progressive	_	
250-202	57729-57737	increase	_	
250-203	57738-57740	of	_	
250-204	57741-57755	frontostriatal	_	
250-205	57756-57761	brain	_	
250-206	57762-57772	activation	_	
250-207	57773-57777	from	_	
250-208	57778-57787	childhood	_	
250-209	57788-57790	to	_	
250-210	57791-57800	adulthood	_	
250-211	57801-57807	during	_	
250-212	57808-57821	event-related	_	
250-213	57822-57827	tasks	_	
250-214	57828-57830	of	_	
250-215	57831-57840	cognitive	_	
250-216	57841-57848	control	_	
250-217	57849-57850	A	_	
250-218	57851-57859	solution	_	
250-219	57860-57863	for	_	
250-220	57864-57872	reliable	_	
250-221	57873-57876	and	_	
250-222	57877-57882	valid	_	
250-223	57883-57892	reduction	_	
250-224	57893-57895	of	_	
250-225	57896-57902	ocular	_	
250-226	57903-57912	artifacts	_	
250-227	57912-57913	,	_	
250-228	57914-57921	applied	_	
250-229	57922-57924	to	_	
250-230	57925-57928	the	_	
250-231	57929-57933	P300	_	
250-232	57934-57937	ERP	_	
250-233	57939-57955	Movement-related	_	
250-234	57956-57966	potentials	_	
250-235	57967-57969	in	_	
250-236	57970-57973	the	_	
250-237	57974-57976	Go	_	
250-238	57976-57977	/	_	
250-239	57977-57981	NoGo	_	
250-240	57982-57986	task	_	
250-241	57986-57987	:	_	
250-242	57988-57991	the	_	
250-243	57992-57994	P3	_	
250-244	57995-58003	reflects	_	
250-245	58004-58008	both	_	
250-246	58009-58018	cognitive	_	
250-247	58019-58022	and	_	
250-248	58023-58028	motor	_	
250-249	58029-58039	inhibition	_	
250-250	58040-58048	Sequence	_	
250-251	58049-58056	effects	_	
250-252	58057-58064	support	_	
250-253	58065-58068	the	_	
250-254	58069-58077	conflict	_	
250-255	58078-58084	theory	_	
250-256	58085-58087	of	_	
250-257	58088-58090	N2	_	
250-258	58091-58094	and	_	
250-259	58095-58097	P3	_	
250-260	58098-58100	in	_	
250-261	58101-58104	the	_	
250-262	58105-58107	Go	_	
250-263	58107-58108	/	_	
250-264	58108-58112	NoGo	_	
250-265	58113-58117	task	_	
250-266	58118-58127	Cognitive	_	
250-267	58128-58135	control	_	
250-268	58136-58146	mechanisms	_	
250-269	58147-58155	revealed	_	
250-270	58156-58158	by	_	
250-271	58159-58162	ERP	_	
250-272	58163-58166	and	_	
250-273	58167-58171	fMRI	_	
250-274	58171-58172	:	_	
250-275	58173-58181	evidence	_	
250-276	58182-58186	from	_	
250-277	58187-58195	repeated	_	
250-278	58196-58210	task-switching	_	
250-279	58211-58226	Neurobehavioral	_	
250-280	58227-58240	disinhibition	_	
250-281	58241-58243	in	_	
250-282	58244-58253	childhood	_	
250-283	58254-58262	predicts	_	
250-284	58263-58268	early	_	
250-285	58269-58272	age	_	
250-286	58273-58275	at	_	
250-287	58276-58281	onset	_	
250-288	58282-58284	of	_	
250-289	58285-58294	substance	_	
250-290	58295-58298	use	_	
250-291	58299-58307	disorder	_	
250-292	58308-58317	Attention	_	
250-293	58318-58321	and	_	
250-294	58322-58332	inhibition	_	
250-295	58333-58335	in	_	
250-296	58336-58344	children	_	
250-297	58345-58349	with	_	
250-298	58350-58353	ASD	_	
250-299	58353-58354	,	_	
250-300	58355-58359	ADHD	_	
250-301	58360-58363	and	_	
250-302	58364-58373	co-morbid	_	
250-303	58374-58377	ASD	_	
250-304	58378-58379	+	_	
250-305	58380-58384	ADHD	_	
250-306	58384-58385	:	_	
250-307	58386-58388	an	_	
250-308	58389-58402	event-related	_	
250-309	58403-58412	potential	_	
250-310	58413-58418	study	_	
250-311	58419-58420	A	_	
250-312	58421-58440	psychophysiological	_	
250-313	58441-58449	analysis	_	
250-314	58450-58452	of	_	
250-315	58453-58463	inhibitory	_	
250-316	58464-58469	motor	_	
250-317	58470-58477	control	_	
250-318	58478-58480	in	_	
250-319	58481-58484	the	_	
250-320	58485-58496	stop-signal	_	
250-321	58497-58505	paradigm	_	
250-322	58506-58509	The	_	
250-323	58510-58520	continuing	_	
250-324	58521-58526	value	_	
250-325	58527-58529	of	_	
250-326	58530-58534	twin	_	
250-327	58535-58542	studies	_	
250-328	58543-58545	in	_	
250-329	58546-58549	the	_	
250-330	58550-58555	omics	_	
250-331	58556-58559	era	_	
250-332	58560-58563	The	_	
250-333	58564-58572	anterior	_	
250-334	58573-58582	cingulate	_	
250-335	58583-58585	as	_	
250-336	58586-58587	a	_	
250-337	58588-58596	conflict	_	
250-338	58597-58604	monitor	_	
250-339	58604-58605	:	_	
250-340	58606-58610	fMRI	_	
250-341	58611-58614	and	_	
250-342	58615-58618	ERP	_	
250-343	58619-58626	studies	_	
250-344	58627-58630	The	_	
250-345	58631-58637	timing	_	
250-346	58638-58640	of	_	
250-347	58641-58658	action-monitoring	_	
250-348	58659-58668	processes	_	
250-349	58669-58671	in	_	
250-350	58672-58675	the	_	
250-351	58676-58684	anterior	_	
250-352	58685-58694	cingulate	_	
250-353	58695-58701	cortex	_	
250-354	58702-58710	Response	_	
250-355	58711-58722	preparation	_	
250-356	58723-58726	and	_	
250-357	58727-58735	response	_	
250-358	58736-58746	inhibition	_	
250-359	58747-58752	after	_	
250-360	58753-58760	lesions	_	
250-361	58761-58763	of	_	
250-362	58764-58767	the	_	
250-363	58768-58774	medial	_	
250-364	58775-58782	frontal	_	
250-365	58783-58787	lobe	_	
250-366	58788-58803	Neurobiological	_	
250-367	58804-58814	approaches	_	
250-368	58815-58817	in	_	
250-369	58818-58823	human	_	
250-370	58824-58832	behavior	_	
250-371	58833-58841	genetics	_	
250-372	58842-58862	Electroencephalogram	_	
250-373	58863-58864	(	_	
250-374	58864-58867	Eeg	_	
250-375	58867-58868	)	_	
250-376	58869-58871	as	_	
250-377	58872-58873	a	_	
250-378	58874-58882	Research	_	
250-379	58883-58887	Tool	_	
250-380	58888-58890	in	_	
250-381	58891-58905	Human-Behavior	_	
250-382	58906-58914	Genetics	_	
250-383	58915-58916	-	_	
250-384	58917-58930	Psychological	_	
250-385	58931-58943	Examinations	_	
250-386	58944-58946	in	_	
250-387	58947-58954	Healthy	_	
250-388	58955-58960	Males	_	
250-389	58961-58965	with	_	
250-390	58966-58973	Various	_	
250-391	58974-58983	Inherited	_	
250-392	58984-58987	Eeg	_	
250-393	58988-58996	Variants	_	
250-394	58997-58999	.1	_	
250-395	59000-59009	Rationale	_	
250-396	59010-59012	of	_	
250-397	59013-59016	the	_	
250-398	59017-59022	Study	_	
250-399	59022-59023	.	_	

#Text=Material.
251-1	59024-59032	Material	_	
251-2	59032-59033	.	_	

#Text=Methods.
252-1	59034-59041	Methods	_	
252-2	59041-59042	.	_	

#Text=Heritability of Test Parameters
#Text=Adolescent impulsivity phenotypes characterized by distinct brain networks
#Text=Neural activity associated with executive functions in adolescents with attention-deficit/hyperactivity disorder (ADHD)
#Text=Neural changes associated with treatment outcome in children with externalizing problems
#Text=Neurophysiological differences in inhibitory control between adults with ADHD and their peers
#Text=The myelogenetic cycles of regional maturation of the brain
#Text=Behavioral disinhibition: liability for externalizing spectrum disorders and its genetic and environmental relation to response inhibition across adolescence
#Text=Genetic and environmental influences on behavioral disinhibition
#Text=The Go/No-Go Continuous Performance Task (CPT).
253-1	59043-59055	Heritability	_	
253-2	59056-59058	of	_	
253-3	59059-59063	Test	_	
253-4	59064-59074	Parameters	_	
253-5	59075-59085	Adolescent	_	
253-6	59086-59097	impulsivity	_	
253-7	59098-59108	phenotypes	_	
253-8	59109-59122	characterized	_	
253-9	59123-59125	by	_	
253-10	59126-59134	distinct	_	
253-11	59135-59140	brain	_	
253-12	59141-59149	networks	_	
253-13	59150-59156	Neural	_	
253-14	59157-59165	activity	_	
253-15	59166-59176	associated	_	
253-16	59177-59181	with	_	
253-17	59182-59191	executive	_	
253-18	59192-59201	functions	_	
253-19	59202-59204	in	_	
253-20	59205-59216	adolescents	_	
253-21	59217-59221	with	_	
253-22	59222-59239	attention-deficit	_	
253-23	59239-59240	/	_	
253-24	59240-59253	hyperactivity	_	
253-25	59254-59262	disorder	_	
253-26	59263-59264	(	_	
253-27	59264-59268	ADHD	_	
253-28	59268-59269	)	_	
253-29	59270-59276	Neural	_	
253-30	59277-59284	changes	_	
253-31	59285-59295	associated	_	
253-32	59296-59300	with	_	
253-33	59301-59310	treatment	_	
253-34	59311-59318	outcome	_	
253-35	59319-59321	in	_	
253-36	59322-59330	children	_	
253-37	59331-59335	with	_	
253-38	59336-59349	externalizing	_	
253-39	59350-59358	problems	_	
253-40	59359-59377	Neurophysiological	_	
253-41	59378-59389	differences	_	
253-42	59390-59392	in	_	
253-43	59393-59403	inhibitory	_	
253-44	59404-59411	control	_	
253-45	59412-59419	between	_	
253-46	59420-59426	adults	_	
253-47	59427-59431	with	_	
253-48	59432-59436	ADHD	_	
253-49	59437-59440	and	_	
253-50	59441-59446	their	_	
253-51	59447-59452	peers	_	
253-52	59453-59456	The	_	
253-53	59457-59469	myelogenetic	_	
253-54	59470-59476	cycles	_	
253-55	59477-59479	of	_	
253-56	59480-59488	regional	_	
253-57	59489-59499	maturation	_	
253-58	59500-59502	of	_	
253-59	59503-59506	the	_	
253-60	59507-59512	brain	_	
253-61	59513-59523	Behavioral	_	
253-62	59524-59537	disinhibition	_	
253-63	59537-59538	:	_	
253-64	59539-59548	liability	_	
253-65	59549-59552	for	_	
253-66	59553-59566	externalizing	_	
253-67	59567-59575	spectrum	_	
253-68	59576-59585	disorders	_	
253-69	59586-59589	and	_	
253-70	59590-59593	its	_	
253-71	59594-59601	genetic	_	
253-72	59602-59605	and	_	
253-73	59606-59619	environmental	_	
253-74	59620-59628	relation	_	
253-75	59629-59631	to	_	
253-76	59632-59640	response	_	
253-77	59641-59651	inhibition	_	
253-78	59652-59658	across	_	
253-79	59659-59670	adolescence	_	
253-80	59671-59678	Genetic	_	
253-81	59679-59682	and	_	
253-82	59683-59696	environmental	_	
253-83	59697-59707	influences	_	
253-84	59708-59710	on	_	
253-85	59711-59721	behavioral	_	
253-86	59722-59735	disinhibition	_	
253-87	59736-59739	The	_	
253-88	59740-59742	Go	_	
253-89	59742-59743	/	_	
253-90	59743-59748	No-Go	_	
253-91	59749-59759	Continuous	_	
253-92	59760-59771	Performance	_	
253-93	59772-59776	Task	_	
253-94	59777-59778	(	_	
253-95	59778-59781	CPT	_	
253-96	59781-59782	)	_	
253-97	59782-59783	.	_	

#Text=An X following O is a target stimulus requiring a speeded response, while any other letter following O is a No-Go stimulus.
254-1	59784-59786	An	_	
254-2	59787-59788	X	_	
254-3	59789-59798	following	_	
254-4	59799-59800	O	_	
254-5	59801-59803	is	_	
254-6	59804-59805	a	_	
254-7	59806-59812	target	_	
254-8	59813-59821	stimulus	_	
254-9	59822-59831	requiring	_	
254-10	59832-59833	a	_	
254-11	59834-59841	speeded	_	
254-12	59842-59850	response	_	
254-13	59850-59851	,	_	
254-14	59852-59857	while	_	
254-15	59858-59861	any	_	
254-16	59862-59867	other	_	
254-17	59868-59874	letter	_	
254-18	59875-59884	following	_	
254-19	59885-59886	O	_	
254-20	59887-59889	is	_	
254-21	59890-59891	a	_	
254-22	59892-59897	No-Go	_	
254-23	59898-59906	stimulus	_	
254-24	59906-59907	.	_	

#Text=Since O is relatively rare (20%), it serves as a warning stimulus triggering motor preparation and thus creating a response prepotency.
255-1	59908-59913	Since	_	
255-2	59914-59915	O	_	
255-3	59916-59918	is	_	
255-4	59919-59929	relatively	_	
255-5	59930-59934	rare	_	
255-6	59935-59936	(	_	
255-7	59936-59939	20%	_	
255-8	59939-59940	)	_	
255-9	59940-59941	,	_	
255-10	59942-59944	it	_	
255-11	59945-59951	serves	_	
255-12	59952-59954	as	_	
255-13	59955-59956	a	_	
255-14	59957-59964	warning	_	
255-15	59965-59973	stimulus	_	
255-16	59974-59984	triggering	_	
255-17	59985-59990	motor	_	
255-18	59991-60002	preparation	_	
255-19	60003-60006	and	_	
255-20	60007-60011	thus	_	
255-21	60012-60020	creating	_	
255-22	60021-60022	a	_	
255-23	60023-60031	response	_	
255-24	60032-60042	prepotency	_	
255-25	60042-60043	.	_	

#Text=Event-related brain potentials (ERPs) elicited at midline frontal (Fz), central (Cz), and parietal (Pz) scalp locations at ages 12, 14, and 16.
256-1	60044-60057	Event-related	_	
256-2	60058-60063	brain	_	
256-3	60064-60074	potentials	_	
256-4	60075-60076	(	_	
256-5	60076-60080	ERPs	_	
256-6	60080-60081	)	_	
256-7	60082-60090	elicited	_	
256-8	60091-60093	at	_	
256-9	60094-60101	midline	_	
256-10	60102-60109	frontal	_	
256-11	60110-60111	(	_	
256-12	60111-60113	Fz	_	
256-13	60113-60114	)	_	
256-14	60114-60115	,	_	
256-15	60116-60123	central	_	
256-16	60124-60125	(	_	
256-17	60125-60127	Cz	_	
256-18	60127-60128	)	_	
256-19	60128-60129	,	_	
256-20	60130-60133	and	_	
256-21	60134-60142	parietal	_	
256-22	60143-60144	(	_	
256-23	60144-60146	Pz	_	
256-24	60146-60147	)	_	
256-25	60148-60153	scalp	_	
256-26	60154-60163	locations	_	
256-27	60164-60166	at	_	
256-28	60167-60171	ages	_	
256-29	60172-60174	12	_	
256-30	60174-60175	,	_	
256-31	60176-60178	14	_	
256-32	60178-60179	,	_	
256-33	60180-60183	and	_	
256-34	60184-60186	16	_	
256-35	60186-60187	.	_	

#Text=No-Go stimuli produced a prominent frontal N2 potential and “anteriorized” P3 potential (P3n), whereas Go stimuli elicited a P3 wave peaking in the mid-parietal area (P3g), similar to a classical oddball P3.
257-1	60188-60193	No-Go	_	
257-2	60194-60201	stimuli	_	
257-3	60202-60210	produced	_	
257-4	60211-60212	a	_	
257-5	60213-60222	prominent	_	
257-6	60223-60230	frontal	_	
257-7	60231-60233	N2	_	
257-8	60234-60243	potential	_	
257-9	60244-60247	and	_	
257-10	60248-60249	“	_	
257-11	60249-60261	anteriorized	_	
257-12	60261-60262	”	_	
257-13	60263-60265	P3	_	
257-14	60266-60275	potential	_	
257-15	60276-60277	(	_	
257-16	60277-60280	P3n	_	
257-17	60280-60281	)	_	
257-18	60281-60282	,	_	
257-19	60283-60290	whereas	_	
257-20	60291-60293	Go	_	
257-21	60294-60301	stimuli	_	
257-22	60302-60310	elicited	_	
257-23	60311-60312	a	_	
257-24	60313-60315	P3	_	
257-25	60316-60320	wave	_	
257-26	60321-60328	peaking	_	
257-27	60329-60331	in	_	
257-28	60332-60335	the	_	
257-29	60336-60348	mid-parietal	_	
257-30	60349-60353	area	_	
257-31	60354-60355	(	_	
257-32	60355-60358	P3g	_	
257-33	60358-60359	)	_	
257-34	60359-60360	,	_	
257-35	60361-60368	similar	_	
257-36	60369-60371	to	_	
257-37	60372-60373	a	_	
257-38	60374-60383	classical	_	
257-39	60384-60391	oddball	_	
257-40	60392-60394	P3	_	
257-41	60394-60395	.	_	

#Text=Scalp potential maps of ERPs in No-Go and Go conditions at ages 12, 14, and 16.
258-1	60396-60401	Scalp	_	
258-2	60402-60411	potential	_	
258-3	60412-60416	maps	_	
258-4	60417-60419	of	_	
258-5	60420-60424	ERPs	_	
258-6	60425-60427	in	_	
258-7	60428-60433	No-Go	_	
258-8	60434-60437	and	_	
258-9	60438-60440	Go	_	
258-10	60441-60451	conditions	_	
258-11	60452-60454	at	_	
258-12	60455-60459	ages	_	
258-13	60460-60462	12	_	
258-14	60462-60463	,	_	
258-15	60464-60466	14	_	
258-16	60466-60467	,	_	
258-17	60468-60471	and	_	
258-18	60472-60474	16	_	
258-19	60474-60475	.	_	

#Text=Age-related changes in the amplitudes of ERP components (all trends are significant, p<.001).
259-1	60476-60487	Age-related	_	
259-2	60488-60495	changes	_	
259-3	60496-60498	in	_	
259-4	60499-60502	the	_	
259-5	60503-60513	amplitudes	_	
259-6	60514-60516	of	_	
259-7	60517-60520	ERP	_	
259-8	60521-60531	components	_	
259-9	60532-60533	(	_	
259-10	60533-60536	all	_	
259-11	60537-60543	trends	_	
259-12	60544-60547	are	_	
259-13	60548-60559	significant	_	
259-14	60559-60560	,	_	
259-15	60561-60562	p	_	
259-16	60562-60563	<	_	
259-17	60563-60567	.001	_	
259-18	60567-60568	)	_	
259-19	60568-60569	.	_	

#Text=Path diagrams for structural equation models, No-Go P3 amplitude.
260-1	60570-60574	Path	_	
260-2	60575-60583	diagrams	_	
260-3	60584-60587	for	_	
260-4	60588-60598	structural	_	
260-5	60599-60607	equation	_	
260-6	60608-60614	models	_	
260-7	60614-60615	,	_	
260-8	60616-60621	No-Go	_	
260-9	60622-60624	P3	_	
260-10	60625-60634	amplitude	_	
260-11	60634-60635	.	_	

#Text=A.
261-1	60636-60637	A	_	
261-2	60637-60638	.	_	

#Text=Cholesky (triangular decomposition) model.
262-1	60639-60647	Cholesky	_	
262-2	60648-60649	(	_	
262-3	60649-60659	triangular	_	
262-4	60660-60673	decomposition	_	
262-5	60673-60674	)	_	
262-6	60675-60680	model	_	
262-7	60680-60681	.	_	

#Text=Rectangles are observed (measured) ERP phenotypes, circles are latent factors (A, additive genetic; E, non-shared environmental).
263-1	60682-60692	Rectangles	_	
263-2	60693-60696	are	_	
263-3	60697-60705	observed	_	
263-4	60706-60707	(	_	
263-5	60707-60715	measured	_	
263-6	60715-60716	)	_	
263-7	60717-60720	ERP	_	
263-8	60721-60731	phenotypes	_	
263-9	60731-60732	,	_	
263-10	60733-60740	circles	_	
263-11	60741-60744	are	_	
263-12	60745-60751	latent	_	
263-13	60752-60759	factors	_	
263-14	60760-60761	(	_	
263-15	60761-60762	A	_	
263-16	60762-60763	,	_	
263-17	60764-60772	additive	_	
263-18	60773-60780	genetic	_	
263-19	60780-60781	;	_	
263-20	60782-60783	E	_	
263-21	60783-60784	,	_	
263-22	60785-60795	non-shared	_	
263-23	60796-60809	environmental	_	
263-24	60809-60810	)	_	
263-25	60810-60811	.	_	

#Text=Arrows show causal paths from latent factors to phenotypes.
264-1	60812-60818	Arrows	_	
264-2	60819-60823	show	_	
264-3	60824-60830	causal	_	
264-4	60831-60836	paths	_	
264-5	60837-60841	from	_	
264-6	60842-60848	latent	_	
264-7	60849-60856	factors	_	
264-8	60857-60859	to	_	
264-9	60860-60870	phenotypes	_	
264-10	60870-60871	.	_	

#Text=Note that the paths from genetic factors at age 12 lead to the phenotype at all three ages, allowing for the possibility of genetic overlap across ages (i.e. continuity of genetic influences).
265-1	60872-60876	Note	_	
265-2	60877-60881	that	_	
265-3	60882-60885	the	_	
265-4	60886-60891	paths	_	
265-5	60892-60896	from	_	
265-6	60897-60904	genetic	_	
265-7	60905-60912	factors	_	
265-8	60913-60915	at	_	
265-9	60916-60919	age	_	
265-10	60920-60922	12	_	
265-11	60923-60927	lead	_	
265-12	60928-60930	to	_	
265-13	60931-60934	the	_	
265-14	60935-60944	phenotype	_	
265-15	60945-60947	at	_	
265-16	60948-60951	all	_	
265-17	60952-60957	three	_	
265-18	60958-60962	ages	_	
265-19	60962-60963	,	_	
265-20	60964-60972	allowing	_	
265-21	60973-60976	for	_	
265-22	60977-60980	the	_	
265-23	60981-60992	possibility	_	
265-24	60993-60995	of	_	
265-25	60996-61003	genetic	_	
265-26	61004-61011	overlap	_	
265-27	61012-61018	across	_	
265-28	61019-61023	ages	_	
265-29	61024-61025	(	_	
265-30	61025-61028	i.e	_	
265-31	61028-61029	.	_	
265-32	61030-61040	continuity	_	
265-33	61041-61043	of	_	
265-34	61044-61051	genetic	_	
265-35	61052-61062	influences	_	
265-36	61062-61063	)	_	
265-37	61063-61064	.	_	

#Text=Additional paths at ages 14 and 16 allow for the possibility of age-specific genetic influences (i.e. new genetic influences emerging in the course of development).
266-1	61065-61075	Additional	_	
266-2	61076-61081	paths	_	
266-3	61082-61084	at	_	
266-4	61085-61089	ages	_	
266-5	61090-61092	14	_	
266-6	61093-61096	and	_	
266-7	61097-61099	16	_	
266-8	61100-61105	allow	_	
266-9	61106-61109	for	_	
266-10	61110-61113	the	_	
266-11	61114-61125	possibility	_	
266-12	61126-61128	of	_	
266-13	61129-61141	age-specific	_	
266-14	61142-61149	genetic	_	
266-15	61150-61160	influences	_	
266-16	61161-61162	(	_	
266-17	61162-61165	i.e	_	
266-18	61165-61166	.	_	
266-19	61167-61170	new	_	
266-20	61171-61178	genetic	_	
266-21	61179-61189	influences	_	
266-22	61190-61198	emerging	_	
266-23	61199-61201	in	_	
266-24	61202-61205	the	_	
266-25	61206-61212	course	_	
266-26	61213-61215	of	_	
266-27	61216-61227	development	_	
266-28	61227-61228	)	_	
266-29	61228-61229	.	_	

#Text=Paths from the environmental factors have similar interpretation.
267-1	61230-61235	Paths	_	
267-2	61236-61240	from	_	
267-3	61241-61244	the	_	
267-4	61245-61258	environmental	_	
267-5	61259-61266	factors	_	
267-6	61267-61271	have	_	
267-7	61272-61279	similar	_	
267-8	61280-61294	interpretation	_	
267-9	61294-61295	.	_	

#Text=B.
268-1	61296-61297	B	_	
268-2	61297-61298	.	_	

#Text=Standardized solution showing proportions of variance attributable to genetic and environmental factors at each age, and the genetic and environmental correlations.
269-1	61299-61311	Standardized	_	
269-2	61312-61320	solution	_	
269-3	61321-61328	showing	_	
269-4	61329-61340	proportions	_	
269-5	61341-61343	of	_	
269-6	61344-61352	variance	_	
269-7	61353-61365	attributable	_	
269-8	61366-61368	to	_	
269-9	61369-61376	genetic	_	
269-10	61377-61380	and	_	
269-11	61381-61394	environmental	_	
269-12	61395-61402	factors	_	
269-13	61403-61405	at	_	
269-14	61406-61410	each	_	
269-15	61411-61414	age	_	
269-16	61414-61415	,	_	
269-17	61416-61419	and	_	
269-18	61420-61423	the	_	
269-19	61424-61431	genetic	_	
269-20	61432-61435	and	_	
269-21	61436-61449	environmental	_	
269-22	61450-61462	correlations	_	
269-23	61462-61463	.	_	

#Text=Same models for other ERP phenotypes (N2 and Go P3) are presented in Supplementary Material.
270-1	61464-61468	Same	_	
270-2	61469-61475	models	_	
270-3	61476-61479	for	_	
270-4	61480-61485	other	_	
270-5	61486-61489	ERP	_	
270-6	61490-61500	phenotypes	_	
270-7	61501-61502	(	_	
270-8	61502-61504	N2	_	
270-9	61505-61508	and	_	
270-10	61509-61511	Go	_	
270-11	61512-61514	P3	_	
270-12	61514-61515	)	_	
270-13	61516-61519	are	_	
270-14	61520-61529	presented	_	
270-15	61530-61532	in	_	
270-16	61533-61546	Supplementary	_	
270-17	61547-61555	Material	_	
270-18	61555-61556	.	_	

#Text=Heritability of ERP components at different ages.
271-1	61557-61569	Heritability	_	
271-2	61570-61572	of	_	
271-3	61573-61576	ERP	_	
271-4	61577-61587	components	_	
271-5	61588-61590	at	_	
271-6	61591-61600	different	_	
271-7	61601-61605	ages	_	
271-8	61605-61606	.	_	

#Text=The proportions of variance attributable to genetic factors (heritability) is shown in red, the residual environmental variance including measurement error is shown in blue.
272-1	61607-61610	The	_	
272-2	61611-61622	proportions	_	
272-3	61623-61625	of	_	
272-4	61626-61634	variance	_	
272-5	61635-61647	attributable	_	
272-6	61648-61650	to	_	
272-7	61651-61658	genetic	_	
272-8	61659-61666	factors	_	
272-9	61667-61668	(	_	
272-10	61668-61680	heritability	_	
272-11	61680-61681	)	_	
272-12	61682-61684	is	_	
272-13	61685-61690	shown	_	
272-14	61691-61693	in	_	
272-15	61694-61697	red	_	
272-16	61697-61698	,	_	
272-17	61699-61702	the	_	
272-18	61703-61711	residual	_	
272-19	61712-61725	environmental	_	
272-20	61726-61734	variance	_	
272-21	61735-61744	including	_	
272-22	61745-61756	measurement	_	
272-23	61757-61762	error	_	
272-24	61763-61765	is	_	
272-25	61766-61771	shown	_	
272-26	61772-61774	in	_	
272-27	61775-61779	blue	_	
272-28	61779-61780	.	_	

#Text=Sample characteristics across longitudinal waves.
273-1	61781-61787	Sample	_	
273-2	61788-61803	characteristics	_	
273-3	61804-61810	across	_	
273-4	61811-61823	longitudinal	_	
273-5	61824-61829	waves	_	
273-6	61829-61830	.	_	

#Text=Assessment wave\tTotal n\t% female\tAge (M±SD)\tComplete MZ pairs\tComplete DZ pairs\t \t1\t743\t47.8\t12.58±.31\t157\t179\t \t2\t614\t48.5\t14.61±.28\t142\t153\t \t3\t404\t47.1\t16.61±.29\t91\t108\t \t
#Text=Longitudinal test-retest correlations for ERP amplitudes.
274-1	61831-61841	Assessment	_	
274-2	61842-61846	wave	_	
274-3	61847-61852	Total	_	
274-4	61853-61854	n	_	
274-5	61855-61856	%	_	
274-6	61857-61863	female	_	
274-7	61864-61867	Age	_	
274-8	61868-61869	(	_	
274-9	61869-61870	M	_	
274-10	61870-61871	±	_	
274-11	61871-61873	SD	_	
274-12	61873-61874	)	_	
274-13	61875-61883	Complete	_	
274-14	61884-61886	MZ	_	
274-15	61887-61892	pairs	_	
274-16	61893-61901	Complete	_	
274-17	61902-61904	DZ	_	
274-18	61905-61910	pairs	_	
274-19	61913-61914	1	_	
274-20	61915-61918	743	_	
274-21	61919-61923	47.8	_	
274-22	61924-61929	12.58	_	
274-23	61929-61930	±	_	
274-24	61930-61933	.31	_	
274-25	61934-61937	157	_	
274-26	61938-61941	179	_	
274-27	61944-61945	2	_	
274-28	61946-61949	614	_	
274-29	61950-61954	48.5	_	
274-30	61955-61960	14.61	_	
274-31	61960-61961	±	_	
274-32	61961-61964	.28	_	
274-33	61965-61968	142	_	
274-34	61969-61972	153	_	
274-35	61975-61976	3	_	
274-36	61977-61980	404	_	
274-37	61981-61985	47.1	_	
274-38	61986-61991	16.61	_	
274-39	61991-61992	±	_	
274-40	61992-61995	.29	_	
274-41	61996-61998	91	_	
274-42	61999-62002	108	_	
274-43	62006-62018	Longitudinal	_	
274-44	62019-62030	test-retest	_	
274-45	62031-62043	correlations	_	
274-46	62044-62047	for	_	
274-47	62048-62051	ERP	_	
274-48	62052-62062	amplitudes	_	
274-49	62062-62063	.	_	

#Text=Retest interval\tn\tNo-Go N2\tNo-Go P3\tGo P3\t \t12 – 14\t606\t.58\t.58\t.64\t \t14 – 16\t281\t.61\t.64\t.74\t \t12 – 16\t292\t.51\t.54\t.61\t \t
#Text=Note: all correlations are significant at p<.001 level.
275-1	62064-62070	Retest	_	
275-2	62071-62079	interval	_	
275-3	62080-62081	n	_	
275-4	62082-62087	No-Go	_	
275-5	62088-62090	N2	_	
275-6	62091-62096	No-Go	_	
275-7	62097-62099	P3	_	
275-8	62100-62102	Go	_	
275-9	62103-62105	P3	_	
275-10	62108-62110	12	_	
275-11	62111-62112	–	_	
275-12	62113-62115	14	_	
275-13	62116-62119	606	_	
275-14	62120-62123	.58	_	
275-15	62124-62127	.58	_	
275-16	62128-62131	.64	_	
275-17	62134-62136	14	_	
275-18	62137-62138	–	_	
275-19	62139-62141	16	_	
275-20	62142-62145	281	_	
275-21	62146-62149	.61	_	
275-22	62150-62153	.64	_	
275-23	62154-62157	.74	_	
275-24	62160-62162	12	_	
275-25	62163-62164	–	_	
275-26	62165-62167	16	_	
275-27	62168-62171	292	_	
275-28	62172-62175	.51	_	
275-29	62176-62179	.54	_	
275-30	62180-62183	.61	_	
275-31	62187-62191	Note	_	
275-32	62191-62192	:	_	
275-33	62193-62196	all	_	
275-34	62197-62209	correlations	_	
275-35	62210-62213	are	_	
275-36	62214-62225	significant	_	
275-37	62226-62228	at	_	
275-38	62229-62230	p	_	
275-39	62230-62231	<	_	
275-40	62231-62235	.001	_	
275-41	62236-62241	level	_	
275-42	62241-62242	.	_	

#Text=Twin correlations and heritability estimates (with 95% confidence intervals) for longitudinal measures of No-Go and Go ERP components.
276-1	62243-62247	Twin	_	
276-2	62248-62260	correlations	_	
276-3	62261-62264	and	_	
276-4	62265-62277	heritability	_	
276-5	62278-62287	estimates	_	
276-6	62288-62289	(	_	
276-7	62289-62293	with	_	
276-8	62294-62297	95%	_	
276-9	62298-62308	confidence	_	
276-10	62309-62318	intervals	_	
276-11	62318-62319	)	_	
276-12	62320-62323	for	_	
276-13	62324-62336	longitudinal	_	
276-14	62337-62345	measures	_	
276-15	62346-62348	of	_	
276-16	62349-62354	No-Go	_	
276-17	62355-62358	and	_	
276-18	62359-62361	Go	_	
276-19	62362-62365	ERP	_	
276-20	62366-62376	components	_	
276-21	62376-62377	.	_	

#Text=ERP phenotype\tAge\trMZ\trDZ\tAdditive Genetic (Heritability)\tNon-shared Environmental\t \tN2, FCZ\t12\t0.60* (0.49 – 0.69)\t0.33* (0.19 – 0.45)\t0.62* (0.53 – 0.69)\t0.38* (0.31 – 0.47)\t \t\t14\t0.56* (0.43 – 0.66)\t0.26* (0.10 – 0.40)\t0.56* (0.45 – 0.65)\t0.44* (0.35 – 0.55)\t \t\t16\t0.52* (0.30 – 0.69)\t0.08 (−0.14 – 0.29)\t0.49* (0.33 – 0.63)\t0.51* (0.37 – 0.67)\t \tP3N, FCZ\t12\t0.60* (0.48 – 0.69)\t0.28* (0.13 – 0.41)\t0.60* (0.50 – 0.68)\t0.40* (0.32 – 0.50)\t \t\t14\t0.55* (0.42 – 0.65)\t0.32* (0.17 – 0.46)\t0.58* (0.47 – 0.67)\t0.42* (0.34 – 0.53)\t \t\t16\t0.64* (0.46 – 0.77)\t0.06 (−0.16 – 0.27)\t0.61* (0.45 – 0.73)\t0.39* (0.27 – 0.55)\t \tP3G, PZ\t12\t0.60* (0.49 – 0.69)\t0.28* (0.13 – 0.41)\t0.62* (0.53 – 0.69)\t0.38* (0.31 – 0.47)\t \t\t14\t0.66* (0.55 – 0.74)\t0.21* (0.06 – 0.37)\t0.63* (0.53 – 0.71)\t0.37* (0.29 – 0.47)\t \t\t16\t0.66* (0.47 – 0.78)\t0.22 (−0.00 – 0.42)\t0.63* (0.48 – 0.74)\t0.37* (0.26 – 0.52)\t \t
#Text=N2, FCZ: amplitude of the No-Go N2 component at the fronto-central midline electrode (FCz); P3N, FCZ: amplitude of the No-Go P3 component at FCz; P3G, PZ: amplitude of the Go P3 component at the parietal midline electrode (Pz). rMZ and rDZ are intrapair correlations for MZ and DZ twin pairs, respectively (95% confidence intervals are shown in brackets);
#Text=p<.05;
#Text=a2 is the proportion of total phenotypic variance explained by genetic factors (heritability) and e2 is the proportion of variance due to non-shared environmental factors.
277-1	62378-62381	ERP	_	
277-2	62382-62391	phenotype	_	
277-3	62392-62395	Age	_	
277-4	62396-62399	rMZ	_	
277-5	62400-62403	rDZ	_	
277-6	62404-62412	Additive	_	
277-7	62413-62420	Genetic	_	
277-8	62421-62422	(	_	
277-9	62422-62434	Heritability	_	
277-10	62434-62435	)	_	
277-11	62436-62446	Non-shared	_	
277-12	62447-62460	Environmental	_	
277-13	62463-62465	N2	_	
277-14	62465-62466	,	_	
277-15	62467-62470	FCZ	_	
277-16	62471-62473	12	_	
277-17	62474-62478	0.60	_	
277-18	62478-62479	*	_	
277-19	62480-62481	(	_	
277-20	62481-62485	0.49	_	
277-21	62486-62487	–	_	
277-22	62488-62492	0.69	_	
277-23	62492-62493	)	_	
277-24	62494-62498	0.33	_	
277-25	62498-62499	*	_	
277-26	62500-62501	(	_	
277-27	62501-62505	0.19	_	
277-28	62506-62507	–	_	
277-29	62508-62512	0.45	_	
277-30	62512-62513	)	_	
277-31	62514-62518	0.62	_	
277-32	62518-62519	*	_	
277-33	62520-62521	(	_	
277-34	62521-62525	0.53	_	
277-35	62526-62527	–	_	
277-36	62528-62532	0.69	_	
277-37	62532-62533	)	_	
277-38	62534-62538	0.38	_	
277-39	62538-62539	*	_	
277-40	62540-62541	(	_	
277-41	62541-62545	0.31	_	
277-42	62546-62547	–	_	
277-43	62548-62552	0.47	_	
277-44	62552-62553	)	_	
277-45	62557-62559	14	_	
277-46	62560-62564	0.56	_	
277-47	62564-62565	*	_	
277-48	62566-62567	(	_	
277-49	62567-62571	0.43	_	
277-50	62572-62573	–	_	
277-51	62574-62578	0.66	_	
277-52	62578-62579	)	_	
277-53	62580-62584	0.26	_	
277-54	62584-62585	*	_	
277-55	62586-62587	(	_	
277-56	62587-62591	0.10	_	
277-57	62592-62593	–	_	
277-58	62594-62598	0.40	_	
277-59	62598-62599	)	_	
277-60	62600-62604	0.56	_	
277-61	62604-62605	*	_	
277-62	62606-62607	(	_	
277-63	62607-62611	0.45	_	
277-64	62612-62613	–	_	
277-65	62614-62618	0.65	_	
277-66	62618-62619	)	_	
277-67	62620-62624	0.44	_	
277-68	62624-62625	*	_	
277-69	62626-62627	(	_	
277-70	62627-62631	0.35	_	
277-71	62632-62633	–	_	
277-72	62634-62638	0.55	_	
277-73	62638-62639	)	_	
277-74	62643-62645	16	_	
277-75	62646-62650	0.52	_	
277-76	62650-62651	*	_	
277-77	62652-62653	(	_	
277-78	62653-62657	0.30	_	
277-79	62658-62659	–	_	
277-80	62660-62664	0.69	_	
277-81	62664-62665	)	_	
277-82	62666-62670	0.08	_	
277-83	62671-62672	(	_	
277-84	62672-62673	−	_	
277-85	62673-62677	0.14	_	
277-86	62678-62679	–	_	
277-87	62680-62684	0.29	_	
277-88	62684-62685	)	_	
277-89	62686-62690	0.49	_	
277-90	62690-62691	*	_	
277-91	62692-62693	(	_	
277-92	62693-62697	0.33	_	
277-93	62698-62699	–	_	
277-94	62700-62704	0.63	_	
277-95	62704-62705	)	_	
277-96	62706-62710	0.51	_	
277-97	62710-62711	*	_	
277-98	62712-62713	(	_	
277-99	62713-62717	0.37	_	
277-100	62718-62719	–	_	
277-101	62720-62724	0.67	_	
277-102	62724-62725	)	_	
277-103	62728-62731	P3N	_	
277-104	62731-62732	,	_	
277-105	62733-62736	FCZ	_	
277-106	62737-62739	12	_	
277-107	62740-62744	0.60	_	
277-108	62744-62745	*	_	
277-109	62746-62747	(	_	
277-110	62747-62751	0.48	_	
277-111	62752-62753	–	_	
277-112	62754-62758	0.69	_	
277-113	62758-62759	)	_	
277-114	62760-62764	0.28	_	
277-115	62764-62765	*	_	
277-116	62766-62767	(	_	
277-117	62767-62771	0.13	_	
277-118	62772-62773	–	_	
277-119	62774-62778	0.41	_	
277-120	62778-62779	)	_	
277-121	62780-62784	0.60	_	
277-122	62784-62785	*	_	
277-123	62786-62787	(	_	
277-124	62787-62791	0.50	_	
277-125	62792-62793	–	_	
277-126	62794-62798	0.68	_	
277-127	62798-62799	)	_	
277-128	62800-62804	0.40	_	
277-129	62804-62805	*	_	
277-130	62806-62807	(	_	
277-131	62807-62811	0.32	_	
277-132	62812-62813	–	_	
277-133	62814-62818	0.50	_	
277-134	62818-62819	)	_	
277-135	62823-62825	14	_	
277-136	62826-62830	0.55	_	
277-137	62830-62831	*	_	
277-138	62832-62833	(	_	
277-139	62833-62837	0.42	_	
277-140	62838-62839	–	_	
277-141	62840-62844	0.65	_	
277-142	62844-62845	)	_	
277-143	62846-62850	0.32	_	
277-144	62850-62851	*	_	
277-145	62852-62853	(	_	
277-146	62853-62857	0.17	_	
277-147	62858-62859	–	_	
277-148	62860-62864	0.46	_	
277-149	62864-62865	)	_	
277-150	62866-62870	0.58	_	
277-151	62870-62871	*	_	
277-152	62872-62873	(	_	
277-153	62873-62877	0.47	_	
277-154	62878-62879	–	_	
277-155	62880-62884	0.67	_	
277-156	62884-62885	)	_	
277-157	62886-62890	0.42	_	
277-158	62890-62891	*	_	
277-159	62892-62893	(	_	
277-160	62893-62897	0.34	_	
277-161	62898-62899	–	_	
277-162	62900-62904	0.53	_	
277-163	62904-62905	)	_	
277-164	62909-62911	16	_	
277-165	62912-62916	0.64	_	
277-166	62916-62917	*	_	
277-167	62918-62919	(	_	
277-168	62919-62923	0.46	_	
277-169	62924-62925	–	_	
277-170	62926-62930	0.77	_	
277-171	62930-62931	)	_	
277-172	62932-62936	0.06	_	
277-173	62937-62938	(	_	
277-174	62938-62939	−	_	
277-175	62939-62943	0.16	_	
277-176	62944-62945	–	_	
277-177	62946-62950	0.27	_	
277-178	62950-62951	)	_	
277-179	62952-62956	0.61	_	
277-180	62956-62957	*	_	
277-181	62958-62959	(	_	
277-182	62959-62963	0.45	_	
277-183	62964-62965	–	_	
277-184	62966-62970	0.73	_	
277-185	62970-62971	)	_	
277-186	62972-62976	0.39	_	
277-187	62976-62977	*	_	
277-188	62978-62979	(	_	
277-189	62979-62983	0.27	_	
277-190	62984-62985	–	_	
277-191	62986-62990	0.55	_	
277-192	62990-62991	)	_	
277-193	62994-62997	P3G	_	
277-194	62997-62998	,	_	
277-195	62999-63001	PZ	_	
277-196	63002-63004	12	_	
277-197	63005-63009	0.60	_	
277-198	63009-63010	*	_	
277-199	63011-63012	(	_	
277-200	63012-63016	0.49	_	
277-201	63017-63018	–	_	
277-202	63019-63023	0.69	_	
277-203	63023-63024	)	_	
277-204	63025-63029	0.28	_	
277-205	63029-63030	*	_	
277-206	63031-63032	(	_	
277-207	63032-63036	0.13	_	
277-208	63037-63038	–	_	
277-209	63039-63043	0.41	_	
277-210	63043-63044	)	_	
277-211	63045-63049	0.62	_	
277-212	63049-63050	*	_	
277-213	63051-63052	(	_	
277-214	63052-63056	0.53	_	
277-215	63057-63058	–	_	
277-216	63059-63063	0.69	_	
277-217	63063-63064	)	_	
277-218	63065-63069	0.38	_	
277-219	63069-63070	*	_	
277-220	63071-63072	(	_	
277-221	63072-63076	0.31	_	
277-222	63077-63078	–	_	
277-223	63079-63083	0.47	_	
277-224	63083-63084	)	_	
277-225	63088-63090	14	_	
277-226	63091-63095	0.66	_	
277-227	63095-63096	*	_	
277-228	63097-63098	(	_	
277-229	63098-63102	0.55	_	
277-230	63103-63104	–	_	
277-231	63105-63109	0.74	_	
277-232	63109-63110	)	_	
277-233	63111-63115	0.21	_	
277-234	63115-63116	*	_	
277-235	63117-63118	(	_	
277-236	63118-63122	0.06	_	
277-237	63123-63124	–	_	
277-238	63125-63129	0.37	_	
277-239	63129-63130	)	_	
277-240	63131-63135	0.63	_	
277-241	63135-63136	*	_	
277-242	63137-63138	(	_	
277-243	63138-63142	0.53	_	
277-244	63143-63144	–	_	
277-245	63145-63149	0.71	_	
277-246	63149-63150	)	_	
277-247	63151-63155	0.37	_	
277-248	63155-63156	*	_	
277-249	63157-63158	(	_	
277-250	63158-63162	0.29	_	
277-251	63163-63164	–	_	
277-252	63165-63169	0.47	_	
277-253	63169-63170	)	_	
277-254	63174-63176	16	_	
277-255	63177-63181	0.66	_	
277-256	63181-63182	*	_	
277-257	63183-63184	(	_	
277-258	63184-63188	0.47	_	
277-259	63189-63190	–	_	
277-260	63191-63195	0.78	_	
277-261	63195-63196	)	_	
277-262	63197-63201	0.22	_	
277-263	63202-63203	(	_	
277-264	63203-63204	−	_	
277-265	63204-63208	0.00	_	
277-266	63209-63210	–	_	
277-267	63211-63215	0.42	_	
277-268	63215-63216	)	_	
277-269	63217-63221	0.63	_	
277-270	63221-63222	*	_	
277-271	63223-63224	(	_	
277-272	63224-63228	0.48	_	
277-273	63229-63230	–	_	
277-274	63231-63235	0.74	_	
277-275	63235-63236	)	_	
277-276	63237-63241	0.37	_	
277-277	63241-63242	*	_	
277-278	63243-63244	(	_	
277-279	63244-63248	0.26	_	
277-280	63249-63250	–	_	
277-281	63251-63255	0.52	_	
277-282	63255-63256	)	_	
277-283	63260-63262	N2	_	
277-284	63262-63263	,	_	
277-285	63264-63267	FCZ	_	
277-286	63267-63268	:	_	
277-287	63269-63278	amplitude	_	
277-288	63279-63281	of	_	
277-289	63282-63285	the	_	
277-290	63286-63291	No-Go	_	
277-291	63292-63294	N2	_	
277-292	63295-63304	component	_	
277-293	63305-63307	at	_	
277-294	63308-63311	the	_	
277-295	63312-63326	fronto-central	_	
277-296	63327-63334	midline	_	
277-297	63335-63344	electrode	_	
277-298	63345-63346	(	_	
277-299	63346-63349	FCz	_	
277-300	63349-63350	)	_	
277-301	63350-63351	;	_	
277-302	63352-63355	P3N	_	
277-303	63355-63356	,	_	
277-304	63357-63360	FCZ	_	
277-305	63360-63361	:	_	
277-306	63362-63371	amplitude	_	
277-307	63372-63374	of	_	
277-308	63375-63378	the	_	
277-309	63379-63384	No-Go	_	
277-310	63385-63387	P3	_	
277-311	63388-63397	component	_	
277-312	63398-63400	at	_	
277-313	63401-63404	FCz	_	
277-314	63404-63405	;	_	
277-315	63406-63409	P3G	_	
277-316	63409-63410	,	_	
277-317	63411-63413	PZ	_	
277-318	63413-63414	:	_	
277-319	63415-63424	amplitude	_	
277-320	63425-63427	of	_	
277-321	63428-63431	the	_	
277-322	63432-63434	Go	_	
277-323	63435-63437	P3	_	
277-324	63438-63447	component	_	
277-325	63448-63450	at	_	
277-326	63451-63454	the	_	
277-327	63455-63463	parietal	_	
277-328	63464-63471	midline	_	
277-329	63472-63481	electrode	_	
277-330	63482-63483	(	_	
277-331	63483-63485	Pz	_	
277-332	63485-63486	)	_	
277-333	63486-63487	.	_	
277-334	63488-63491	rMZ	_	
277-335	63492-63495	and	_	
277-336	63496-63499	rDZ	_	
277-337	63500-63503	are	_	
277-338	63504-63513	intrapair	_	
277-339	63514-63526	correlations	_	
277-340	63527-63530	for	_	
277-341	63531-63533	MZ	_	
277-342	63534-63537	and	_	
277-343	63538-63540	DZ	_	
277-344	63541-63545	twin	_	
277-345	63546-63551	pairs	_	
277-346	63551-63552	,	_	
277-347	63553-63565	respectively	_	
277-348	63566-63567	(	_	
277-349	63567-63570	95%	_	
277-350	63571-63581	confidence	_	
277-351	63582-63591	intervals	_	
277-352	63592-63595	are	_	
277-353	63596-63601	shown	_	
277-354	63602-63604	in	_	
277-355	63605-63613	brackets	_	
277-356	63613-63614	)	_	
277-357	63614-63615	;	_	
277-358	63616-63617	p	_	
277-359	63617-63618	<	_	
277-360	63618-63621	.05	_	
277-361	63621-63622	;	_	
277-362	63623-63625	a2	_	
277-363	63626-63628	is	_	
277-364	63629-63632	the	_	
277-365	63633-63643	proportion	_	
277-366	63644-63646	of	_	
277-367	63647-63652	total	_	
277-368	63653-63663	phenotypic	_	
277-369	63664-63672	variance	_	
277-370	63673-63682	explained	_	
277-371	63683-63685	by	_	
277-372	63686-63693	genetic	_	
277-373	63694-63701	factors	_	
277-374	63702-63703	(	_	
277-375	63703-63715	heritability	_	
277-376	63715-63716	)	_	
277-377	63717-63720	and	_	
277-378	63721-63723	e2	_	
277-379	63724-63726	is	_	
277-380	63727-63730	the	_	
277-381	63731-63741	proportion	_	
277-382	63742-63744	of	_	
277-383	63745-63753	variance	_	
277-384	63754-63757	due	_	
277-385	63758-63760	to	_	
277-386	63761-63771	non-shared	_	
277-387	63772-63785	environmental	_	
277-388	63786-63793	factors	_	
277-389	63793-63794	.	_	

#Text=Variance component estimates are based on the best-fitting model (see text and Supplementary Table 1).
278-1	63795-63803	Variance	_	
278-2	63804-63813	component	_	
278-3	63814-63823	estimates	_	
278-4	63824-63827	are	_	
278-5	63828-63833	based	_	
278-6	63834-63836	on	_	
278-7	63837-63840	the	_	
278-8	63841-63853	best-fitting	_	
278-9	63854-63859	model	_	
278-10	63860-63861	(	_	
278-11	63861-63864	see	_	
278-12	63865-63869	text	_	
278-13	63870-63873	and	_	
278-14	63874-63887	Supplementary	_	
278-15	63888-63893	Table	_	
278-16	63894-63895	1	_	
278-17	63895-63896	)	_	
278-18	63896-63897	.	_	

#Text=Longitudinal genetic and environmental correlations across ages for peak amplitudes of ERP components (based on the trivariate AE models).
279-1	63898-63910	Longitudinal	_	
279-2	63911-63918	genetic	_	
279-3	63919-63922	and	_	
279-4	63923-63936	environmental	_	
279-5	63937-63949	correlations	_	
279-6	63950-63956	across	_	
279-7	63957-63961	ages	_	
279-8	63962-63965	for	_	
279-9	63966-63970	peak	_	
279-10	63971-63981	amplitudes	_	
279-11	63982-63984	of	_	
279-12	63985-63988	ERP	_	
279-13	63989-63999	components	_	
279-14	64000-64001	(	_	
279-15	64001-64006	based	_	
279-16	64007-64009	on	_	
279-17	64010-64013	the	_	
279-18	64014-64024	trivariate	_	
279-19	64025-64027	AE	_	
279-20	64028-64034	models	_	
279-21	64034-64035	)	_	
279-22	64035-64036	.	_	

#Text=Measure\tAges\trG\trE\tGenetic overlap\t \tNo-Go N2, FCZ\t12 – 14\t0.84* (0.74 – 0.94)\t0.18* (0.04 – 0.32)\t0.71* (0.55 – 0.88)\t \t14 – 16\t0.88* (0.73 – 1.00)\t0.34* (0.15 – 0.51)\t0.77* (0.53 – 1.00)\t \t12 – 16\t0.79* (0.62 – 0.97)\t0.16 (−0.04 – 0.34)\t0.63* (0.39 – 0.93)\t \tNo-Go P3, FCZ\t12 – 14\t0.82* (0.71 – 0.91)\t0.29* (0.14 – 0.42)\t0.67* (0.51 – 0.83)\t \t14 – 16\t0.83* (0.70 – 0.95)\t0.44* (0.26 – 0.59)\t0.69* (0.49 – 0.89)\t \t12 – 16\t0.85* (0.68 – 1.00)\t0.14 (−0.09 – 0.36)\t0.72* (0.46 – 1.00)\t \tGo P3, PZ\t12 – 14\t0.93* (0.84 – 0.99)\t0.15 (−0.00 – 0.30)\t0.87* (0.70 – 0.99)\t \t14 – 16\t0.91* (0.81 – 0.99)\t0.46* (0.28 – 0.61)\t0.83* (0.66 – 0.99)\t \t12 – 16\t0.99* (0.84 – 1.00)\t0.03 (−0.15 – 0.24)\t0.98* (0.72 – 1.00)\t \t
#Text=Notes: rG and rE are genetic and environmental correlations, respectively, between different longitudinal assessments of the same ERP variable;
#Text=indicates significant at p<0.05; Genetic overlap is the proportion of genetic variance shared across ages.
280-1	64037-64044	Measure	_	
280-2	64045-64049	Ages	_	
280-3	64050-64052	rG	_	
280-4	64053-64055	rE	_	
280-5	64056-64063	Genetic	_	
280-6	64064-64071	overlap	_	
280-7	64074-64079	No-Go	_	
280-8	64080-64082	N2	_	
280-9	64082-64083	,	_	
280-10	64084-64087	FCZ	_	
280-11	64088-64090	12	_	
280-12	64091-64092	–	_	
280-13	64093-64095	14	_	
280-14	64096-64100	0.84	_	
280-15	64100-64101	*	_	
280-16	64102-64103	(	_	
280-17	64103-64107	0.74	_	
280-18	64108-64109	–	_	
280-19	64110-64114	0.94	_	
280-20	64114-64115	)	_	
280-21	64116-64120	0.18	_	
280-22	64120-64121	*	_	
280-23	64122-64123	(	_	
280-24	64123-64127	0.04	_	
280-25	64128-64129	–	_	
280-26	64130-64134	0.32	_	
280-27	64134-64135	)	_	
280-28	64136-64140	0.71	_	
280-29	64140-64141	*	_	
280-30	64142-64143	(	_	
280-31	64143-64147	0.55	_	
280-32	64148-64149	–	_	
280-33	64150-64154	0.88	_	
280-34	64154-64155	)	_	
280-35	64158-64160	14	_	
280-36	64161-64162	–	_	
280-37	64163-64165	16	_	
280-38	64166-64170	0.88	_	
280-39	64170-64171	*	_	
280-40	64172-64173	(	_	
280-41	64173-64177	0.73	_	
280-42	64178-64179	–	_	
280-43	64180-64184	1.00	_	
280-44	64184-64185	)	_	
280-45	64186-64190	0.34	_	
280-46	64190-64191	*	_	
280-47	64192-64193	(	_	
280-48	64193-64197	0.15	_	
280-49	64198-64199	–	_	
280-50	64200-64204	0.51	_	
280-51	64204-64205	)	_	
280-52	64206-64210	0.77	_	
280-53	64210-64211	*	_	
280-54	64212-64213	(	_	
280-55	64213-64217	0.53	_	
280-56	64218-64219	–	_	
280-57	64220-64224	1.00	_	
280-58	64224-64225	)	_	
280-59	64228-64230	12	_	
280-60	64231-64232	–	_	
280-61	64233-64235	16	_	
280-62	64236-64240	0.79	_	
280-63	64240-64241	*	_	
280-64	64242-64243	(	_	
280-65	64243-64247	0.62	_	
280-66	64248-64249	–	_	
280-67	64250-64254	0.97	_	
280-68	64254-64255	)	_	
280-69	64256-64260	0.16	_	
280-70	64261-64262	(	_	
280-71	64262-64263	−	_	
280-72	64263-64267	0.04	_	
280-73	64268-64269	–	_	
280-74	64270-64274	0.34	_	
280-75	64274-64275	)	_	
280-76	64276-64280	0.63	_	
280-77	64280-64281	*	_	
280-78	64282-64283	(	_	
280-79	64283-64287	0.39	_	
280-80	64288-64289	–	_	
280-81	64290-64294	0.93	_	
280-82	64294-64295	)	_	
280-83	64298-64303	No-Go	_	
280-84	64304-64306	P3	_	
280-85	64306-64307	,	_	
280-86	64308-64311	FCZ	_	
280-87	64312-64314	12	_	
280-88	64315-64316	–	_	
280-89	64317-64319	14	_	
280-90	64320-64324	0.82	_	
280-91	64324-64325	*	_	
280-92	64326-64327	(	_	
280-93	64327-64331	0.71	_	
280-94	64332-64333	–	_	
280-95	64334-64338	0.91	_	
280-96	64338-64339	)	_	
280-97	64340-64344	0.29	_	
280-98	64344-64345	*	_	
280-99	64346-64347	(	_	
280-100	64347-64351	0.14	_	
280-101	64352-64353	–	_	
280-102	64354-64358	0.42	_	
280-103	64358-64359	)	_	
280-104	64360-64364	0.67	_	
280-105	64364-64365	*	_	
280-106	64366-64367	(	_	
280-107	64367-64371	0.51	_	
280-108	64372-64373	–	_	
280-109	64374-64378	0.83	_	
280-110	64378-64379	)	_	
280-111	64382-64384	14	_	
280-112	64385-64386	–	_	
280-113	64387-64389	16	_	
280-114	64390-64394	0.83	_	
280-115	64394-64395	*	_	
280-116	64396-64397	(	_	
280-117	64397-64401	0.70	_	
280-118	64402-64403	–	_	
280-119	64404-64408	0.95	_	
280-120	64408-64409	)	_	
280-121	64410-64414	0.44	_	
280-122	64414-64415	*	_	
280-123	64416-64417	(	_	
280-124	64417-64421	0.26	_	
280-125	64422-64423	–	_	
280-126	64424-64428	0.59	_	
280-127	64428-64429	)	_	
280-128	64430-64434	0.69	_	
280-129	64434-64435	*	_	
280-130	64436-64437	(	_	
280-131	64437-64441	0.49	_	
280-132	64442-64443	–	_	
280-133	64444-64448	0.89	_	
280-134	64448-64449	)	_	
280-135	64452-64454	12	_	
280-136	64455-64456	–	_	
280-137	64457-64459	16	_	
280-138	64460-64464	0.85	_	
280-139	64464-64465	*	_	
280-140	64466-64467	(	_	
280-141	64467-64471	0.68	_	
280-142	64472-64473	–	_	
280-143	64474-64478	1.00	_	
280-144	64478-64479	)	_	
280-145	64480-64484	0.14	_	
280-146	64485-64486	(	_	
280-147	64486-64487	−	_	
280-148	64487-64491	0.09	_	
280-149	64492-64493	–	_	
280-150	64494-64498	0.36	_	
280-151	64498-64499	)	_	
280-152	64500-64504	0.72	_	
280-153	64504-64505	*	_	
280-154	64506-64507	(	_	
280-155	64507-64511	0.46	_	
280-156	64512-64513	–	_	
280-157	64514-64518	1.00	_	
280-158	64518-64519	)	_	
280-159	64522-64524	Go	_	
280-160	64525-64527	P3	_	
280-161	64527-64528	,	_	
280-162	64529-64531	PZ	_	
280-163	64532-64534	12	_	
280-164	64535-64536	–	_	
280-165	64537-64539	14	_	
280-166	64540-64544	0.93	_	
280-167	64544-64545	*	_	
280-168	64546-64547	(	_	
280-169	64547-64551	0.84	_	
280-170	64552-64553	–	_	
280-171	64554-64558	0.99	_	
280-172	64558-64559	)	_	
280-173	64560-64564	0.15	_	
280-174	64565-64566	(	_	
280-175	64566-64567	−	_	
280-176	64567-64571	0.00	_	
280-177	64572-64573	–	_	
280-178	64574-64578	0.30	_	
280-179	64578-64579	)	_	
280-180	64580-64584	0.87	_	
280-181	64584-64585	*	_	
280-182	64586-64587	(	_	
280-183	64587-64591	0.70	_	
280-184	64592-64593	–	_	
280-185	64594-64598	0.99	_	
280-186	64598-64599	)	_	
280-187	64602-64604	14	_	
280-188	64605-64606	–	_	
280-189	64607-64609	16	_	
280-190	64610-64614	0.91	_	
280-191	64614-64615	*	_	
280-192	64616-64617	(	_	
280-193	64617-64621	0.81	_	
280-194	64622-64623	–	_	
280-195	64624-64628	0.99	_	
280-196	64628-64629	)	_	
280-197	64630-64634	0.46	_	
280-198	64634-64635	*	_	
280-199	64636-64637	(	_	
280-200	64637-64641	0.28	_	
280-201	64642-64643	–	_	
280-202	64644-64648	0.61	_	
280-203	64648-64649	)	_	
280-204	64650-64654	0.83	_	
280-205	64654-64655	*	_	
280-206	64656-64657	(	_	
280-207	64657-64661	0.66	_	
280-208	64662-64663	–	_	
280-209	64664-64668	0.99	_	
280-210	64668-64669	)	_	
280-211	64672-64674	12	_	
280-212	64675-64676	–	_	
280-213	64677-64679	16	_	
280-214	64680-64684	0.99	_	
280-215	64684-64685	*	_	
280-216	64686-64687	(	_	
280-217	64687-64691	0.84	_	
280-218	64692-64693	–	_	
280-219	64694-64698	1.00	_	
280-220	64698-64699	)	_	
280-221	64700-64704	0.03	_	
280-222	64705-64706	(	_	
280-223	64706-64707	−	_	
280-224	64707-64711	0.15	_	
280-225	64712-64713	–	_	
280-226	64714-64718	0.24	_	
280-227	64718-64719	)	_	
280-228	64720-64724	0.98	_	
280-229	64724-64725	*	_	
280-230	64726-64727	(	_	
280-231	64727-64731	0.72	_	
280-232	64732-64733	–	_	
280-233	64734-64738	1.00	_	
280-234	64738-64739	)	_	
280-235	64743-64748	Notes	_	
280-236	64748-64749	:	_	
280-237	64750-64752	rG	_	
280-238	64753-64756	and	_	
280-239	64757-64759	rE	_	
280-240	64760-64763	are	_	
280-241	64764-64771	genetic	_	
280-242	64772-64775	and	_	
280-243	64776-64789	environmental	_	
280-244	64790-64802	correlations	_	
280-245	64802-64803	,	_	
280-246	64804-64816	respectively	_	
280-247	64816-64817	,	_	
280-248	64818-64825	between	_	
280-249	64826-64835	different	_	
280-250	64836-64848	longitudinal	_	
280-251	64849-64860	assessments	_	
280-252	64861-64863	of	_	
280-253	64864-64867	the	_	
280-254	64868-64872	same	_	
280-255	64873-64876	ERP	_	
280-256	64877-64885	variable	_	
280-257	64885-64886	;	_	
280-258	64887-64896	indicates	_	
280-259	64897-64908	significant	_	
280-260	64909-64911	at	_	
280-261	64912-64913	p	_	
280-262	64913-64914	<	_	
280-263	64914-64918	0.05	_	
280-264	64918-64919	;	_	
280-265	64920-64927	Genetic	_	
280-266	64928-64935	overlap	_	
280-267	64936-64938	is	_	
280-268	64939-64942	the	_	
280-269	64943-64953	proportion	_	
280-270	64954-64956	of	_	
280-271	64957-64964	genetic	_	
280-272	64965-64973	variance	_	
280-273	64974-64980	shared	_	
280-274	64981-64987	across	_	
280-275	64988-64992	ages	_	
280-276	64992-64993	.	_	

#Text=Genetic and environmental contributions to the rate of developmental changes in the amplitudes of No-Go and Go ERP components (difference scores, age 16 – age 12).
281-1	64994-65001	Genetic	_	
281-2	65002-65005	and	_	
281-3	65006-65019	environmental	_	
281-4	65020-65033	contributions	_	
281-5	65034-65036	to	_	
281-6	65037-65040	the	_	
281-7	65041-65045	rate	_	
281-8	65046-65048	of	_	
281-9	65049-65062	developmental	_	
281-10	65063-65070	changes	_	
281-11	65071-65073	in	_	
281-12	65074-65077	the	_	
281-13	65078-65088	amplitudes	_	
281-14	65089-65091	of	_	
281-15	65092-65097	No-Go	_	
281-16	65098-65101	and	_	
281-17	65102-65104	Go	_	
281-18	65105-65108	ERP	_	
281-19	65109-65119	components	_	
281-20	65120-65121	(	_	
281-21	65121-65131	difference	_	
281-22	65132-65138	scores	_	
281-23	65138-65139	,	_	
281-24	65140-65143	age	_	
281-25	65144-65146	16	_	
281-26	65147-65148	–	_	
281-27	65149-65152	age	_	
281-28	65153-65155	12	_	
281-29	65155-65156	)	_	
281-30	65156-65157	.	_	

#Text=ERP phenotype\trMZ\trDZ\tAdditive Genetic (Heritability)\tNon-shared Environmental\t \tN2, FCZ\t0.30* (0.09 – 0.49)\t0.10 (−0.11 – 0.30)\t0.29* (0.10 – 0.46)\t0.71* (0.54 – 0.90)\t \tP3N, FCZ\t0.22* (0.001 – 0.42)\t0.09 (−0.12 – 0.29)\t0.21* (0.01 – 0.39)\t0.79* (0.61 – 0.99)\t \tP3G, PZ\t0.40* (0.19 – 0.56)\t−0.05 (−0.26 – 0.16)\t0.28* (0.09 – 0.45)\t0.72* (0.55 – 0.91)\t \t
#Text=rMZ and rDZ are intrapair correlations for MZ and DZ twin pairs, respectively (95% confidence intervals are shown in brackets);
#Text=p<.05;
#Text=a2 is the proportion of total phenotypic variance explained by genetic factors (heritability) and e2 is the proportion of variance due to non-shared environmental factors.
282-1	65158-65161	ERP	_	
282-2	65162-65171	phenotype	_	
282-3	65172-65175	rMZ	_	
282-4	65176-65179	rDZ	_	
282-5	65180-65188	Additive	_	
282-6	65189-65196	Genetic	_	
282-7	65197-65198	(	_	
282-8	65198-65210	Heritability	_	
282-9	65210-65211	)	_	
282-10	65212-65222	Non-shared	_	
282-11	65223-65236	Environmental	_	
282-12	65239-65241	N2	_	
282-13	65241-65242	,	_	
282-14	65243-65246	FCZ	_	
282-15	65247-65251	0.30	_	
282-16	65251-65252	*	_	
282-17	65253-65254	(	_	
282-18	65254-65258	0.09	_	
282-19	65259-65260	–	_	
282-20	65261-65265	0.49	_	
282-21	65265-65266	)	_	
282-22	65267-65271	0.10	_	
282-23	65272-65273	(	_	
282-24	65273-65274	−	_	
282-25	65274-65278	0.11	_	
282-26	65279-65280	–	_	
282-27	65281-65285	0.30	_	
282-28	65285-65286	)	_	
282-29	65287-65291	0.29	_	
282-30	65291-65292	*	_	
282-31	65293-65294	(	_	
282-32	65294-65298	0.10	_	
282-33	65299-65300	–	_	
282-34	65301-65305	0.46	_	
282-35	65305-65306	)	_	
282-36	65307-65311	0.71	_	
282-37	65311-65312	*	_	
282-38	65313-65314	(	_	
282-39	65314-65318	0.54	_	
282-40	65319-65320	–	_	
282-41	65321-65325	0.90	_	
282-42	65325-65326	)	_	
282-43	65329-65332	P3N	_	
282-44	65332-65333	,	_	
282-45	65334-65337	FCZ	_	
282-46	65338-65342	0.22	_	
282-47	65342-65343	*	_	
282-48	65344-65345	(	_	
282-49	65345-65350	0.001	_	
282-50	65351-65352	–	_	
282-51	65353-65357	0.42	_	
282-52	65357-65358	)	_	
282-53	65359-65363	0.09	_	
282-54	65364-65365	(	_	
282-55	65365-65366	−	_	
282-56	65366-65370	0.12	_	
282-57	65371-65372	–	_	
282-58	65373-65377	0.29	_	
282-59	65377-65378	)	_	
282-60	65379-65383	0.21	_	
282-61	65383-65384	*	_	
282-62	65385-65386	(	_	
282-63	65386-65390	0.01	_	
282-64	65391-65392	–	_	
282-65	65393-65397	0.39	_	
282-66	65397-65398	)	_	
282-67	65399-65403	0.79	_	
282-68	65403-65404	*	_	
282-69	65405-65406	(	_	
282-70	65406-65410	0.61	_	
282-71	65411-65412	–	_	
282-72	65413-65417	0.99	_	
282-73	65417-65418	)	_	
282-74	65421-65424	P3G	_	
282-75	65424-65425	,	_	
282-76	65426-65428	PZ	_	
282-77	65429-65433	0.40	_	
282-78	65433-65434	*	_	
282-79	65435-65436	(	_	
282-80	65436-65440	0.19	_	
282-81	65441-65442	–	_	
282-82	65443-65447	0.56	_	
282-83	65447-65448	)	_	
282-84	65449-65450	−	_	
282-85	65450-65454	0.05	_	
282-86	65455-65456	(	_	
282-87	65456-65457	−	_	
282-88	65457-65461	0.26	_	
282-89	65462-65463	–	_	
282-90	65464-65468	0.16	_	
282-91	65468-65469	)	_	
282-92	65470-65474	0.28	_	
282-93	65474-65475	*	_	
282-94	65476-65477	(	_	
282-95	65477-65481	0.09	_	
282-96	65482-65483	–	_	
282-97	65484-65488	0.45	_	
282-98	65488-65489	)	_	
282-99	65490-65494	0.72	_	
282-100	65494-65495	*	_	
282-101	65496-65497	(	_	
282-102	65497-65501	0.55	_	
282-103	65502-65503	–	_	
282-104	65504-65508	0.91	_	
282-105	65508-65509	)	_	
282-106	65513-65516	rMZ	_	
282-107	65517-65520	and	_	
282-108	65521-65524	rDZ	_	
282-109	65525-65528	are	_	
282-110	65529-65538	intrapair	_	
282-111	65539-65551	correlations	_	
282-112	65552-65555	for	_	
282-113	65556-65558	MZ	_	
282-114	65559-65562	and	_	
282-115	65563-65565	DZ	_	
282-116	65566-65570	twin	_	
282-117	65571-65576	pairs	_	
282-118	65576-65577	,	_	
282-119	65578-65590	respectively	_	
282-120	65591-65592	(	_	
282-121	65592-65595	95%	_	
282-122	65596-65606	confidence	_	
282-123	65607-65616	intervals	_	
282-124	65617-65620	are	_	
282-125	65621-65626	shown	_	
282-126	65627-65629	in	_	
282-127	65630-65638	brackets	_	
282-128	65638-65639	)	_	
282-129	65639-65640	;	_	
282-130	65641-65642	p	_	
282-131	65642-65643	<	_	
282-132	65643-65646	.05	_	
282-133	65646-65647	;	_	
282-134	65648-65650	a2	_	
282-135	65651-65653	is	_	
282-136	65654-65657	the	_	
282-137	65658-65668	proportion	_	
282-138	65669-65671	of	_	
282-139	65672-65677	total	_	
282-140	65678-65688	phenotypic	_	
282-141	65689-65697	variance	_	
282-142	65698-65707	explained	_	
282-143	65708-65710	by	_	
282-144	65711-65718	genetic	_	
282-145	65719-65726	factors	_	
282-146	65727-65728	(	_	
282-147	65728-65740	heritability	_	
282-148	65740-65741	)	_	
282-149	65742-65745	and	_	
282-150	65746-65748	e2	_	
282-151	65749-65751	is	_	
282-152	65752-65755	the	_	
282-153	65756-65766	proportion	_	
282-154	65767-65769	of	_	
282-155	65770-65778	variance	_	
282-156	65779-65782	due	_	
282-157	65783-65785	to	_	
282-158	65786-65796	non-shared	_	
282-159	65797-65810	environmental	_	
282-160	65811-65818	factors	_	
282-161	65818-65819	.	_	

#Text=Variance component estimates are based on the best-fitting model.
283-1	65820-65828	Variance	_	
283-2	65829-65838	component	_	
283-3	65839-65848	estimates	_	
283-4	65849-65852	are	_	
283-5	65853-65858	based	_	
283-6	65859-65861	on	_	
283-7	65862-65865	the	_	
283-8	65866-65878	best-fitting	_	
283-9	65879-65884	model	_	
283-10	65884-65885	.	_	

#Text=Highlights
#Text=Neural correlates of response inhibition undergo significant developmental changes during adolescence, but Individual differences remain relatively stable
#Text=Inhibition-related brain activity is heritable, with evidence for both continued and age-limited genetic influences
#Text=Individual differences in developmental trajectories are strongly influenced by genetic factors
284-1	65886-65896	Highlights	_	
284-2	65897-65903	Neural	_	
284-3	65904-65914	correlates	_	
284-4	65915-65917	of	_	
284-5	65918-65926	response	_	
284-6	65927-65937	inhibition	_	
284-7	65938-65945	undergo	_	
284-8	65946-65957	significant	_	
284-9	65958-65971	developmental	_	
284-10	65972-65979	changes	_	
284-11	65980-65986	during	_	
284-12	65987-65998	adolescence	_	
284-13	65998-65999	,	_	
284-14	66000-66003	but	_	
284-15	66004-66014	Individual	_	
284-16	66015-66026	differences	_	
284-17	66027-66033	remain	_	
284-18	66034-66044	relatively	_	
284-19	66045-66051	stable	_	
284-20	66052-66070	Inhibition-related	_	
284-21	66071-66076	brain	_	
284-22	66077-66085	activity	_	
284-23	66086-66088	is	_	
284-24	66089-66098	heritable	_	
284-25	66098-66099	,	_	
284-26	66100-66104	with	_	
284-27	66105-66113	evidence	_	
284-28	66114-66117	for	_	
284-29	66118-66122	both	_	
284-30	66123-66132	continued	_	
284-31	66133-66136	and	_	
284-32	66137-66148	age-limited	_	
284-33	66149-66156	genetic	_	
284-34	66157-66167	influences	_	
284-35	66168-66178	Individual	_	
284-36	66179-66190	differences	_	
284-37	66191-66193	in	_	
284-38	66194-66207	developmental	_	
284-39	66208-66220	trajectories	_	
284-40	66221-66224	are	_	
284-41	66225-66233	strongly	_	
284-42	66234-66244	influenced	_	
284-43	66245-66247	by	_	
284-44	66248-66255	genetic	_	
284-45	66256-66263	factors	_	
